<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />

<meta name="viewport" content="width=device-width, initial-scale=1" />



<title>Chevron Catalog</title>

<script>// Pandoc 2.9 adds attributes on both header and div. We remove the former (to
// be compatible with the behavior of Pandoc < 2.8).
document.addEventListener('DOMContentLoaded', function(e) {
  var hs = document.querySelectorAll("div.section[class*='level'] > :first-child");
  var i, h, a;
  for (i = 0; i < hs.length; i++) {
    h = hs[i];
    if (!/^h[1-6]$/i.test(h.tagName)) continue;  // it should be a header h1-h6
    a = h.attributes;
    while (a.length > 0) h.removeAttribute(a[0].name);
  }
});
</script>

<style type="text/css">
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
</style>



<style type="text/css">
code {
white-space: pre;
}
.sourceCode {
overflow: visible;
}
</style>
<style type="text/css" data-origin="pandoc">
pre > code.sourceCode { white-space: pre; position: relative; }
pre > code.sourceCode > span { display: inline-block; line-height: 1.25; }
pre > code.sourceCode > span:empty { height: 1.2em; }
.sourceCode { overflow: visible; }
code.sourceCode > span { color: inherit; text-decoration: inherit; }
div.sourceCode { margin: 1em 0; }
pre.sourceCode { margin: 0; }
@media screen {
div.sourceCode { overflow: auto; }
}
@media print {
pre > code.sourceCode { white-space: pre-wrap; }
pre > code.sourceCode > span { text-indent: -5em; padding-left: 5em; }
}
pre.numberSource code
{ counter-reset: source-line 0; }
pre.numberSource code > span
{ position: relative; left: -4em; counter-increment: source-line; }
pre.numberSource code > span > a:first-child::before
{ content: counter(source-line);
position: relative; left: -1em; text-align: right; vertical-align: baseline;
border: none; display: inline-block;
-webkit-touch-callout: none; -webkit-user-select: none;
-khtml-user-select: none; -moz-user-select: none;
-ms-user-select: none; user-select: none;
padding: 0 4px; width: 4em;
color: #aaaaaa;
}
pre.numberSource { margin-left: 3em; border-left: 1px solid #aaaaaa; padding-left: 4px; }
div.sourceCode
{ }
@media screen {
pre > code.sourceCode > span > a:first-child::before { text-decoration: underline; }
}
code span.al { color: #ff0000; font-weight: bold; } 
code span.an { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.at { color: #7d9029; } 
code span.bn { color: #40a070; } 
code span.bu { color: #008000; } 
code span.cf { color: #007020; font-weight: bold; } 
code span.ch { color: #4070a0; } 
code span.cn { color: #880000; } 
code span.co { color: #60a0b0; font-style: italic; } 
code span.cv { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.do { color: #ba2121; font-style: italic; } 
code span.dt { color: #902000; } 
code span.dv { color: #40a070; } 
code span.er { color: #ff0000; font-weight: bold; } 
code span.ex { } 
code span.fl { color: #40a070; } 
code span.fu { color: #06287e; } 
code span.im { color: #008000; font-weight: bold; } 
code span.in { color: #60a0b0; font-weight: bold; font-style: italic; } 
code span.kw { color: #007020; font-weight: bold; } 
code span.op { color: #666666; } 
code span.ot { color: #007020; } 
code span.pp { color: #bc7a00; } 
code span.sc { color: #4070a0; } 
code span.ss { color: #bb6688; } 
code span.st { color: #4070a0; } 
code span.va { color: #19177c; } 
code span.vs { color: #4070a0; } 
code span.wa { color: #60a0b0; font-weight: bold; font-style: italic; } 
</style>
<script>
// apply pandoc div.sourceCode style to pre.sourceCode instead
(function() {
  var sheets = document.styleSheets;
  for (var i = 0; i < sheets.length; i++) {
    if (sheets[i].ownerNode.dataset["origin"] !== "pandoc") continue;
    try { var rules = sheets[i].cssRules; } catch (e) { continue; }
    var j = 0;
    while (j < rules.length) {
      var rule = rules[j];
      // check if there is a div.sourceCode rule
      if (rule.type !== rule.STYLE_RULE || rule.selectorText !== "div.sourceCode") {
        j++;
        continue;
      }
      var style = rule.style.cssText;
      // check if color or background-color is set
      if (rule.style.color === '' && rule.style.backgroundColor === '') {
        j++;
        continue;
      }
      // replace div.sourceCode by a pre.sourceCode rule
      sheets[i].deleteRule(j);
      sheets[i].insertRule('pre.sourceCode{' + style + '}', j);
    }
  }
})();
</script>




<style type="text/css">body {
background-color: #fff;
margin: 1em auto;
max-width: 700px;
overflow: visible;
padding-left: 2em;
padding-right: 2em;
font-family: "Open Sans", "Helvetica Neue", Helvetica, Arial, sans-serif;
font-size: 14px;
line-height: 1.35;
}
#TOC {
clear: both;
margin: 0 0 10px 10px;
padding: 4px;
width: 400px;
border: 1px solid #CCCCCC;
border-radius: 5px;
background-color: #f6f6f6;
font-size: 13px;
line-height: 1.3;
}
#TOC .toctitle {
font-weight: bold;
font-size: 15px;
margin-left: 5px;
}
#TOC ul {
padding-left: 40px;
margin-left: -1.5em;
margin-top: 5px;
margin-bottom: 5px;
}
#TOC ul ul {
margin-left: -2em;
}
#TOC li {
line-height: 16px;
}
table {
margin: 1em auto;
border-width: 1px;
border-color: #DDDDDD;
border-style: outset;
border-collapse: collapse;
}
table th {
border-width: 2px;
padding: 5px;
border-style: inset;
}
table td {
border-width: 1px;
border-style: inset;
line-height: 18px;
padding: 5px 5px;
}
table, table th, table td {
border-left-style: none;
border-right-style: none;
}
table thead, table tr.even {
background-color: #f7f7f7;
}
p {
margin: 0.5em 0;
}
blockquote {
background-color: #f6f6f6;
padding: 0.25em 0.75em;
}
hr {
border-style: solid;
border: none;
border-top: 1px solid #777;
margin: 28px 0;
}
dl {
margin-left: 0;
}
dl dd {
margin-bottom: 13px;
margin-left: 13px;
}
dl dt {
font-weight: bold;
}
ul {
margin-top: 0;
}
ul li {
list-style: circle outside;
}
ul ul {
margin-bottom: 0;
}
pre, code {
background-color: #f7f7f7;
border-radius: 3px;
color: #333;
white-space: pre-wrap; 
}
pre {
border-radius: 3px;
margin: 5px 0px 10px 0px;
padding: 10px;
}
pre:not([class]) {
background-color: #f7f7f7;
}
code {
font-family: Consolas, Monaco, 'Courier New', monospace;
font-size: 85%;
}
p > code, li > code {
padding: 2px 0px;
}
div.figure {
text-align: center;
}
img {
background-color: #FFFFFF;
padding: 2px;
border: 1px solid #DDDDDD;
border-radius: 3px;
border: 1px solid #CCCCCC;
margin: 0 5px;
}
h1 {
margin-top: 0;
font-size: 35px;
line-height: 40px;
}
h2 {
border-bottom: 4px solid #f7f7f7;
padding-top: 10px;
padding-bottom: 2px;
font-size: 145%;
}
h3 {
border-bottom: 2px solid #f7f7f7;
padding-top: 10px;
font-size: 120%;
}
h4 {
border-bottom: 1px solid #f7f7f7;
margin-left: 8px;
font-size: 105%;
}
h5, h6 {
border-bottom: 1px solid #ccc;
font-size: 105%;
}
a {
color: #0033dd;
text-decoration: none;
}
a:hover {
color: #6666ff; }
a:visited {
color: #800080; }
a:visited:hover {
color: #BB00BB; }
a[href^="http:"] {
text-decoration: underline; }
a[href^="https:"] {
text-decoration: underline; }

code > span.kw { color: #555; font-weight: bold; } 
code > span.dt { color: #902000; } 
code > span.dv { color: #40a070; } 
code > span.bn { color: #d14; } 
code > span.fl { color: #d14; } 
code > span.ch { color: #d14; } 
code > span.st { color: #d14; } 
code > span.co { color: #888888; font-style: italic; } 
code > span.ot { color: #007020; } 
code > span.al { color: #ff0000; font-weight: bold; } 
code > span.fu { color: #900; font-weight: bold; } 
code > span.er { color: #a61717; background-color: #e3d2d2; } 
</style>




</head>

<body>




<h1 class="title toc-ignore">Chevron Catalog</h1>



<div id="general" class="section level2">
<h2><strong>GENERAL</strong></h2>
<div id="general-concepts" class="section level3">
<h3><strong>General Concepts</strong></h3>
<p><code>chevron</code> is a collection of functions to creates tables,
listings, and graphs following Roche standards for clinical trials
reporting. After loading the R packages and the trial data, the output
is to be created by the main function <code>run(...)</code> . Two
arguments <code>object=</code> and <code>adam_db=</code> are always
expected in the function. <code>object=</code> specifies which Roche
Standard Template ID to use. <code>adam_db=</code> specifies the input
dataset. Other mandatory and optional arguments within the
<code>run</code> function vary depending on which template ID is called.
To access which arguments are required and what functions are used in
each template, simply try <code>?template</code>
(e.g.Â <code>?aet01</code>) to see more detailed descriptions and
instructions.</p>
<div id="input-dataset-and-dataset-names" class="section level4">
<h4><strong>1. Input dataset and dataset names</strong></h4>
<p>The input dataset expected by the argument <code>adam_db=</code> in
the <code>run(...)</code> function is a collection of <code>ADaM</code>
datasets as a list object. Each <code>ADaM</code> dataset is expected to
be an object of data frame. If the <code>ADaM</code> datasets are read
in individually, user will need to combine them into a list object and
provide the name of the list to <code>adam_db=</code>. Also, each
element in the list are expected to have corresponding <code>ADaM</code>
dataset names. Conventional <code>ADaM</code> dataset names, including
<code>adsl</code>,<code>adex</code>, <code>adae</code>,
<code>adlb</code>,<code>advs</code>,<code>adeg</code>,<code>adcm</code>,<code>admh</code>,<code>adrs</code>,
and <code>adtte</code>, can be picked up by <code>chevron</code> with
one exception.</p>
<div class="sourceCode" id="cb1"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb1-1"><a href="#cb1-1" tabindex="-1"></a>std_data <span class="ot">&lt;-</span> <span class="fu">list</span>(<span class="at">adsl =</span> adsl, <span class="at">adae =</span> adae)</span>
<span id="cb1-2"><a href="#cb1-2" tabindex="-1"></a><span class="fu">run</span>(<span class="at">object =</span> aet01_nollt, <span class="at">adam_db =</span> std_data)</span></code></pre></div>
</div>
<div id="expected-variables-in-input-analysis-dataset" class="section level4">
<h4><strong>2. Expected variables in input analysis
dataset</strong></h4>
<p>By default, <code>chevron</code> does not pull any subject-level
information from either <code>adsl</code> or <code>adsub</code> and
merge into the analysis dataset in the underlying preprocessing steps.
The analysis dataset fed into <code>adam_db=</code> is expected to have
all variables required for analysis available.</p>
</div>
<div id="character-vs-factor" class="section level4">
<h4><strong>3. Character vs Factor</strong></h4>
<p>In the output generation, we often need to specify a particular
sorting order of a variable at the time of display. In
<code>chevron</code>, a character variable needs to be factorized with
pre-specified levels to display in order. When encountering cases, for
instance, <code>&quot;ARM A&quot;</code> has an Asian group only while
<code>&quot;ARM B&quot;</code> has both Asian and White groups, it is not able to
produce outputs like the demographic table unless <code>&quot;RACE&quot;</code> is
factorized to provide access to the same level attribute of the variable
<code>&quot;RACE&quot;</code> after the arm split. It is noted that the feature
comes from <code>rtables</code> instead of <code>chevron</code>.</p>
<div class="sourceCode" id="cb2"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb2-1"><a href="#cb2-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> syn_data</span>
<span id="cb2-2"><a href="#cb2-2" tabindex="-1"></a>proc_data<span class="sc">$</span>adsl <span class="ot">&lt;-</span> proc_data<span class="sc">$</span>adsl <span class="sc">%&gt;%</span></span>
<span id="cb2-3"><a href="#cb2-3" tabindex="-1"></a>  <span class="fu">mutate</span>(<span class="at">RACE =</span> <span class="fu">case_when</span>(</span>
<span id="cb2-4"><a href="#cb2-4" tabindex="-1"></a>    ARMCD <span class="sc">==</span> <span class="st">&quot;ARM A&quot;</span> <span class="sc">~</span> <span class="st">&quot;ASIAN&quot;</span>,</span>
<span id="cb2-5"><a href="#cb2-5" tabindex="-1"></a>    ARMCD <span class="sc">==</span> <span class="st">&quot;ARM B&quot;</span> <span class="sc">&amp;</span> <span class="sc">!</span>.data<span class="sc">$</span>RACE <span class="sc">%in%</span> <span class="fu">c</span>(<span class="st">&quot;WHITE&quot;</span>, <span class="st">&quot;ASIAN&quot;</span>) <span class="sc">~</span> <span class="st">&quot;ASIAN&quot;</span>,</span>
<span id="cb2-6"><a href="#cb2-6" tabindex="-1"></a>    <span class="cn">TRUE</span> <span class="sc">~</span> RACE</span>
<span id="cb2-7"><a href="#cb2-7" tabindex="-1"></a>  ))</span></code></pre></div>
<p>Having <code>&quot;RACE&quot;</code> as a character variable rather than a
factor leads to error message showing up as âError: Error applying
analysis function (var - RACE): Number of rows generated by analysis
function do not match across all columns,â and it is recommended to
convert analysis variable <code>&quot;RACE&quot;</code> to a factor.</p>
<div class="sourceCode" id="cb3"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb3-1"><a href="#cb3-1" tabindex="-1"></a><span class="fu">run</span>(dmt01, proc_data)</span></code></pre></div>
<p>To resolve this issue, simply try factorizing the variable
<code>&quot;RACE&quot;</code>:</p>
<div class="sourceCode" id="cb4"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb4-1"><a href="#cb4-1" tabindex="-1"></a>proc_data<span class="sc">$</span>adsl<span class="sc">$</span>RACE <span class="ot">&lt;-</span> <span class="fu">as.factor</span>(proc_data<span class="sc">$</span>adsl<span class="sc">$</span>RACE)</span>
<span id="cb4-2"><a href="#cb4-2" tabindex="-1"></a><span class="fu">run</span>(dmt01, proc_data)</span>
<span id="cb4-3"><a href="#cb4-3" tabindex="-1"></a><span class="co">#&gt;                                        A: Drug X    B: Placebo   C: Combination   All Patients</span></span>
<span id="cb4-4"><a href="#cb4-4" tabindex="-1"></a><span class="co">#&gt;                                          (N=15)       (N=15)         (N=15)          (N=45)   </span></span>
<span id="cb4-5"><a href="#cb4-5" tabindex="-1"></a><span class="co">#&gt;   ââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb4-6"><a href="#cb4-6" tabindex="-1"></a><span class="co">#&gt;   Age (yr)                                                                                    </span></span>
<span id="cb4-7"><a href="#cb4-7" tabindex="-1"></a><span class="co">#&gt;     n                                      15           15             15              45     </span></span>
<span id="cb4-8"><a href="#cb4-8" tabindex="-1"></a><span class="co">#&gt;     Mean (SD)                          31.3 (5.3)   35.1 (9.0)     36.6 (6.4)      34.3 (7.3) </span></span>
<span id="cb4-9"><a href="#cb4-9" tabindex="-1"></a><span class="co">#&gt;     Median                                31.0         35.0           35.0            34.0    </span></span>
<span id="cb4-10"><a href="#cb4-10" tabindex="-1"></a><span class="co">#&gt;     Min - Max                           24 - 40      24 - 57        24 - 49         24 - 57   </span></span>
<span id="cb4-11"><a href="#cb4-11" tabindex="-1"></a><span class="co">#&gt;   Age Group                                                                                   </span></span>
<span id="cb4-12"><a href="#cb4-12" tabindex="-1"></a><span class="co">#&gt;     n                                      15           15             15              45     </span></span>
<span id="cb4-13"><a href="#cb4-13" tabindex="-1"></a><span class="co">#&gt;     &lt;65                                15 (100%)    15 (100%)      15 (100%)       45 (100%)  </span></span>
<span id="cb4-14"><a href="#cb4-14" tabindex="-1"></a><span class="co">#&gt;   Sex                                                                                         </span></span>
<span id="cb4-15"><a href="#cb4-15" tabindex="-1"></a><span class="co">#&gt;     n                                      15           15             15              45     </span></span>
<span id="cb4-16"><a href="#cb4-16" tabindex="-1"></a><span class="co">#&gt;     Male                               3 (20.0%)    7 (46.7%)      5 (33.3%)       15 (33.3%) </span></span>
<span id="cb4-17"><a href="#cb4-17" tabindex="-1"></a><span class="co">#&gt;     Female                             12 (80.0%)   8 (53.3%)      10 (66.7%)      30 (66.7%) </span></span>
<span id="cb4-18"><a href="#cb4-18" tabindex="-1"></a><span class="co">#&gt;   Ethnicity                                                                                   </span></span>
<span id="cb4-19"><a href="#cb4-19" tabindex="-1"></a><span class="co">#&gt;     n                                      15           15             15              45     </span></span>
<span id="cb4-20"><a href="#cb4-20" tabindex="-1"></a><span class="co">#&gt;     NOT REPORTED                           0            0          2 (13.3%)        2 (4.4%)  </span></span>
<span id="cb4-21"><a href="#cb4-21" tabindex="-1"></a><span class="co">#&gt;     HISPANIC OR LATINO                 2 (13.3%)        0              0            2 (4.4%)  </span></span>
<span id="cb4-22"><a href="#cb4-22" tabindex="-1"></a><span class="co">#&gt;     NOT HISPANIC OR LATINO             13 (86.7%)   15 (100%)      13 (86.7%)      41 (91.1%) </span></span>
<span id="cb4-23"><a href="#cb4-23" tabindex="-1"></a><span class="co">#&gt;   RACE                                                                                        </span></span>
<span id="cb4-24"><a href="#cb4-24" tabindex="-1"></a><span class="co">#&gt;     n                                      15           15             15              45     </span></span>
<span id="cb4-25"><a href="#cb4-25" tabindex="-1"></a><span class="co">#&gt;     AMERICAN INDIAN OR ALASKA NATIVE       0            0           1 (6.7%)        1 (2.2%)  </span></span>
<span id="cb4-26"><a href="#cb4-26" tabindex="-1"></a><span class="co">#&gt;     ASIAN                              15 (100%)    13 (86.7%)     8 (53.3%)       36 (80.0%) </span></span>
<span id="cb4-27"><a href="#cb4-27" tabindex="-1"></a><span class="co">#&gt;     BLACK OR AFRICAN AMERICAN              0            0          4 (26.7%)        4 (8.9%)  </span></span>
<span id="cb4-28"><a href="#cb4-28" tabindex="-1"></a><span class="co">#&gt;     WHITE                                  0        2 (13.3%)      2 (13.3%)        4 (8.9%)</span></span></code></pre></div>
</div>
<div id="testing-the-codes-for-plot-generation" class="section level4">
<h4><strong>4. Testing the codes for plot generation</strong></h4>
<p>The <code>run</code> function when calling a Graphics Template ID
returns a <code>gTree</code> object which will be used in the downstream
workflow for output generation. There are two alternative approaches to
rendering the plot: (1) having <code>draw = TRUE</code> in the
<code>run</code> function to enable the generated plot to be
automatically created and viewed via the <code>Plots</code> tab, and (2)
calling the function <code>grid.draw</code> from the package
<code>grid</code> which can be utilized to render the plot for viewing
and testing purpose. See example below:</p>
<div class="sourceCode" id="cb5"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb5-1"><a href="#cb5-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;OS&quot;</span>, <span class="st">&quot;adtte&quot;</span>)</span>
<span id="cb5-2"><a href="#cb5-2" tabindex="-1"></a></span>
<span id="cb5-3"><a href="#cb5-3" tabindex="-1"></a><span class="co"># method 1</span></span>
<span id="cb5-4"><a href="#cb5-4" tabindex="-1"></a><span class="fu">run</span>(kmg01, proc_data, <span class="at">dataset =</span> <span class="st">&quot;adtte&quot;</span>, <span class="at">draw =</span> <span class="cn">TRUE</span>)</span>
<span id="cb5-5"><a href="#cb5-5" tabindex="-1"></a></span>
<span id="cb5-6"><a href="#cb5-6" tabindex="-1"></a><span class="co"># method 2</span></span>
<span id="cb5-7"><a href="#cb5-7" tabindex="-1"></a>res <span class="ot">&lt;-</span> <span class="fu">run</span>(kmg01, proc_data, <span class="at">dataset =</span> <span class="st">&quot;adtte&quot;</span>)</span>
<span id="cb5-8"><a href="#cb5-8" tabindex="-1"></a>grid<span class="sc">::</span><span class="fu">grid.newpage</span>()</span>
<span id="cb5-9"><a href="#cb5-9" tabindex="-1"></a>grid<span class="sc">::</span><span class="fu">grid.draw</span>(res)</span></code></pre></div>
</div>
</div>
<div id="general-control-arguments" class="section level3">
<h3><strong>General Control Arguments</strong></h3>
<div id="lbl_overall-column-of-total" class="section level4">
<h4><strong>1. <code>lbl_overall</code>: Column of Total</strong></h4>
<p>The generic argument <code>lbl_overall</code> controls whether the
column of total will be produced or not. <code>lbl_overall = NULL</code>
suppresses the total, <code>lbl_overall = &quot;All Patients&quot;</code> produces
the total.</p>
</div>
<div id="column-counts-nxxx" class="section level4">
<h4><strong>2. Column counts: N=xxx</strong></h4>
<p>Column counts are displayed by default. There is no generic argument
controlling whether the count of unique number of subjects (N=xxx) will
be displayed in the column header or not. Users are allowed to customize
the display of N=xxx by forcing
<code>display_columncounts = FALSE</code> to wipe column counts away
during the postprocessing (with precautions and it is not
recommended).</p>
<div class="sourceCode" id="cb6"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb6-1"><a href="#cb6-1" tabindex="-1"></a>tbl <span class="ot">&lt;-</span> <span class="fu">run</span>(dmt01, syn_data) <span class="co"># table with column counts</span></span>
<span id="cb6-2"><a href="#cb6-2" tabindex="-1"></a>tbl<span class="sc">@</span>col_info<span class="sc">@</span>display_columncounts <span class="ot">&lt;-</span> <span class="cn">FALSE</span></span>
<span id="cb6-3"><a href="#cb6-3" tabindex="-1"></a>tbl <span class="co"># no column counts now</span></span>
<span id="cb6-4"><a href="#cb6-4" tabindex="-1"></a><span class="co">#&gt;                                        A: Drug X    B: Placebo   C: Combination   All Patients</span></span>
<span id="cb6-5"><a href="#cb6-5" tabindex="-1"></a><span class="co">#&gt;   ââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb6-6"><a href="#cb6-6" tabindex="-1"></a><span class="co">#&gt;   Age (yr)                                                                                    </span></span>
<span id="cb6-7"><a href="#cb6-7" tabindex="-1"></a><span class="co">#&gt;     n                                      15           15             15              45     </span></span>
<span id="cb6-8"><a href="#cb6-8" tabindex="-1"></a><span class="co">#&gt;     Mean (SD)                          31.3 (5.3)   35.1 (9.0)     36.6 (6.4)      34.3 (7.3) </span></span>
<span id="cb6-9"><a href="#cb6-9" tabindex="-1"></a><span class="co">#&gt;     Median                                31.0         35.0           35.0            34.0    </span></span>
<span id="cb6-10"><a href="#cb6-10" tabindex="-1"></a><span class="co">#&gt;     Min - Max                           24 - 40      24 - 57        24 - 49         24 - 57   </span></span>
<span id="cb6-11"><a href="#cb6-11" tabindex="-1"></a><span class="co">#&gt;   Age Group                                                                                   </span></span>
<span id="cb6-12"><a href="#cb6-12" tabindex="-1"></a><span class="co">#&gt;     n                                      15           15             15              45     </span></span>
<span id="cb6-13"><a href="#cb6-13" tabindex="-1"></a><span class="co">#&gt;     &lt;65                                15 (100%)    15 (100%)      15 (100%)       45 (100%)  </span></span>
<span id="cb6-14"><a href="#cb6-14" tabindex="-1"></a><span class="co">#&gt;   Sex                                                                                         </span></span>
<span id="cb6-15"><a href="#cb6-15" tabindex="-1"></a><span class="co">#&gt;     n                                      15           15             15              45     </span></span>
<span id="cb6-16"><a href="#cb6-16" tabindex="-1"></a><span class="co">#&gt;     Male                               3 (20.0%)    7 (46.7%)      5 (33.3%)       15 (33.3%) </span></span>
<span id="cb6-17"><a href="#cb6-17" tabindex="-1"></a><span class="co">#&gt;     Female                             12 (80.0%)   8 (53.3%)      10 (66.7%)      30 (66.7%) </span></span>
<span id="cb6-18"><a href="#cb6-18" tabindex="-1"></a><span class="co">#&gt;   Ethnicity                                                                                   </span></span>
<span id="cb6-19"><a href="#cb6-19" tabindex="-1"></a><span class="co">#&gt;     n                                      15           15             15              45     </span></span>
<span id="cb6-20"><a href="#cb6-20" tabindex="-1"></a><span class="co">#&gt;     NOT REPORTED                           0            0          2 (13.3%)        2 (4.4%)  </span></span>
<span id="cb6-21"><a href="#cb6-21" tabindex="-1"></a><span class="co">#&gt;     HISPANIC OR LATINO                 2 (13.3%)        0              0            2 (4.4%)  </span></span>
<span id="cb6-22"><a href="#cb6-22" tabindex="-1"></a><span class="co">#&gt;     NOT HISPANIC OR LATINO             13 (86.7%)   15 (100%)      13 (86.7%)      41 (91.1%) </span></span>
<span id="cb6-23"><a href="#cb6-23" tabindex="-1"></a><span class="co">#&gt;   RACE                                                                                        </span></span>
<span id="cb6-24"><a href="#cb6-24" tabindex="-1"></a><span class="co">#&gt;     n                                      15           15             15              45     </span></span>
<span id="cb6-25"><a href="#cb6-25" tabindex="-1"></a><span class="co">#&gt;     AMERICAN INDIAN OR ALASKA NATIVE       0        2 (13.3%)       1 (6.7%)        3 (6.7%)  </span></span>
<span id="cb6-26"><a href="#cb6-26" tabindex="-1"></a><span class="co">#&gt;     ASIAN                              8 (53.3%)    10 (66.7%)     8 (53.3%)       26 (57.8%) </span></span>
<span id="cb6-27"><a href="#cb6-27" tabindex="-1"></a><span class="co">#&gt;     BLACK OR AFRICAN AMERICAN          4 (26.7%)     1 (6.7%)      4 (26.7%)       9 (20.0%)  </span></span>
<span id="cb6-28"><a href="#cb6-28" tabindex="-1"></a><span class="co">#&gt;     WHITE                              3 (20.0%)    2 (13.3%)      2 (13.3%)       7 (15.6%)</span></span></code></pre></div>
</div>
</div>
</div>
<div id="tables" class="section level2">
<h2><strong>TABLES</strong></h2>
<div id="safety-summary-aet01" class="section level3">
<h3><strong>Safety Summary (<code>AET01</code>)</strong></h3>
<div id="safety-summary" class="section level4">
<h4><strong>1. Safety Summary</strong></h4>
<p>The <strong><code>aet01</code></strong> template produces the
standard safety summary.</p>
<div class="sourceCode" id="cb7"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb7-1"><a href="#cb7-1" tabindex="-1"></a><span class="fu">run</span>(aet01, syn_data, <span class="at">arm_var =</span> <span class="st">&quot;ARM&quot;</span>)</span>
<span id="cb7-2"><a href="#cb7-2" tabindex="-1"></a><span class="co">#&gt;                                                                A: Drug X    B: Placebo   C: Combination</span></span>
<span id="cb7-3"><a href="#cb7-3" tabindex="-1"></a><span class="co">#&gt;                                                                  (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb7-4"><a href="#cb7-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb7-5"><a href="#cb7-5" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with at least one AE                13 (86.7%)   14 (93.3%)     15 (100%)   </span></span>
<span id="cb7-6"><a href="#cb7-6" tabindex="-1"></a><span class="co">#&gt;   Total number of AEs                                              58           59             99      </span></span>
<span id="cb7-7"><a href="#cb7-7" tabindex="-1"></a><span class="co">#&gt;   Total number of deaths                                       2 (13.3%)    4 (26.7%)      3 (20.0%)   </span></span>
<span id="cb7-8"><a href="#cb7-8" tabindex="-1"></a><span class="co">#&gt;   Total number of patients withdrawn from study due to an AE       0            0           1 (6.7%)   </span></span>
<span id="cb7-9"><a href="#cb7-9" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with at least one                                                           </span></span>
<span id="cb7-10"><a href="#cb7-10" tabindex="-1"></a><span class="co">#&gt;     AE with fatal outcome                                      8 (53.3%)    8 (53.3%)      10 (66.7%)  </span></span>
<span id="cb7-11"><a href="#cb7-11" tabindex="-1"></a><span class="co">#&gt;     Serious AE                                                 12 (80.0%)   12 (80.0%)     11 (73.3%)  </span></span>
<span id="cb7-12"><a href="#cb7-12" tabindex="-1"></a><span class="co">#&gt;     Serious AE leading to withdrawal from treatment                0            0          2 (13.3%)   </span></span>
<span id="cb7-13"><a href="#cb7-13" tabindex="-1"></a><span class="co">#&gt;     Serious AE leading to dose modification/interruption       4 (26.7%)    3 (20.0%)      4 (26.7%)   </span></span>
<span id="cb7-14"><a href="#cb7-14" tabindex="-1"></a><span class="co">#&gt;     Related Serious AE                                         8 (53.3%)    8 (53.3%)      10 (66.7%)  </span></span>
<span id="cb7-15"><a href="#cb7-15" tabindex="-1"></a><span class="co">#&gt;     AE leading to withdrawal from treatment                    2 (13.3%)    3 (20.0%)      3 (20.0%)   </span></span>
<span id="cb7-16"><a href="#cb7-16" tabindex="-1"></a><span class="co">#&gt;     AE leading to dose modification/interruption               6 (40.0%)    9 (60.0%)      11 (73.3%)  </span></span>
<span id="cb7-17"><a href="#cb7-17" tabindex="-1"></a><span class="co">#&gt;     Related AE                                                 11 (73.3%)   10 (66.7%)     13 (86.7%)  </span></span>
<span id="cb7-18"><a href="#cb7-18" tabindex="-1"></a><span class="co">#&gt;     Related AE leading to withdrawal from treatment                0        3 (20.0%)          0       </span></span>
<span id="cb7-19"><a href="#cb7-19" tabindex="-1"></a><span class="co">#&gt;     Related AE leading to dose modification/interruption        1 (6.7%)    4 (26.7%)      9 (60.0%)   </span></span>
<span id="cb7-20"><a href="#cb7-20" tabindex="-1"></a><span class="co">#&gt;     Severe AE (at greatest intensity)                          11 (73.3%)   10 (66.7%)     12 (80.0%)</span></span></code></pre></div>
</div>
<div id="safety-summary-with-modified-rows" class="section level4">
<h4><strong>2. Safety Summary with Modified Rows</strong></h4>
<p>Analyses under âTotal number of patients with at least oneâ can be
removed, added, or modified by editing the parameter
<code>anl_vars</code>. An analysis here is an abbreviated name of the
analysis of interest, and supported by a variable in <code>ADAE</code>
derived under the condition of interest. The defined analyses currently
include <code>&quot;FATAL&quot;</code>, <code>&quot;SER&quot;</code>, <code>&quot;SERWD&quot;</code>,
<code>&quot;SERDSM&quot;</code>, <code>&quot;RELSER&quot;</code>, <code>&quot;WD&quot;</code>,
<code>&quot;DSM&quot;</code>, <code>&quot;REL&quot;</code>, <code>&quot;RELWD&quot;</code>,
<code>&quot;RELDSM&quot;</code>, and <code>&quot;SEV&quot;</code>. When modification is
made, analyses must all be listed in the argument <code>anl_vars</code>.
The example below shows adding the customized analysis
<code>&quot;RELCTC35&quot;</code>.</p>
<div class="sourceCode" id="cb8"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb8-1"><a href="#cb8-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> syn_data</span>
<span id="cb8-2"><a href="#cb8-2" tabindex="-1"></a>proc_data<span class="sc">$</span>adae <span class="ot">&lt;-</span> proc_data<span class="sc">$</span>adae <span class="sc">%&gt;%</span></span>
<span id="cb8-3"><a href="#cb8-3" tabindex="-1"></a>  <span class="fu">filter</span>(.data<span class="sc">$</span>ANL01FL <span class="sc">==</span> <span class="st">&quot;Y&quot;</span>) <span class="sc">%&gt;%</span></span>
<span id="cb8-4"><a href="#cb8-4" tabindex="-1"></a>  <span class="fu">mutate</span>(</span>
<span id="cb8-5"><a href="#cb8-5" tabindex="-1"></a>    <span class="at">FATAL =</span> <span class="fu">with_label</span>(.data<span class="sc">$</span>AESDTH <span class="sc">==</span> <span class="st">&quot;Y&quot;</span>, <span class="st">&quot;AE with fatal outcome&quot;</span>),</span>
<span id="cb8-6"><a href="#cb8-6" tabindex="-1"></a>    <span class="at">SER =</span> <span class="fu">with_label</span>(.data<span class="sc">$</span>AESER <span class="sc">==</span> <span class="st">&quot;Y&quot;</span>, <span class="st">&quot;Serious AE&quot;</span>),</span>
<span id="cb8-7"><a href="#cb8-7" tabindex="-1"></a>    <span class="at">SEV =</span> <span class="fu">with_label</span>(.data<span class="sc">$</span>ASEV <span class="sc">==</span> <span class="st">&quot;SEVERE&quot;</span>, <span class="st">&quot;Severe AE (at greatest intensity)&quot;</span>),</span>
<span id="cb8-8"><a href="#cb8-8" tabindex="-1"></a>    <span class="at">REL =</span> <span class="fu">with_label</span>(.data<span class="sc">$</span>AREL <span class="sc">==</span> <span class="st">&quot;Y&quot;</span>, <span class="st">&quot;Related AE&quot;</span>),</span>
<span id="cb8-9"><a href="#cb8-9" tabindex="-1"></a>    <span class="at">WD =</span> <span class="fu">with_label</span>(.data<span class="sc">$</span>AEACN <span class="sc">==</span> <span class="st">&quot;DRUG WITHDRAWN&quot;</span>, <span class="st">&quot;AE leading to withdrawal from treatment&quot;</span>),</span>
<span id="cb8-10"><a href="#cb8-10" tabindex="-1"></a>    <span class="at">DSM =</span> <span class="fu">with_label</span>(</span>
<span id="cb8-11"><a href="#cb8-11" tabindex="-1"></a>      .data<span class="sc">$</span>AEACN <span class="sc">%in%</span> <span class="fu">c</span>(<span class="st">&quot;DRUG INTERRUPTED&quot;</span>, <span class="st">&quot;DOSE INCREASED&quot;</span>, <span class="st">&quot;DOSE REDUCED&quot;</span>),</span>
<span id="cb8-12"><a href="#cb8-12" tabindex="-1"></a>      <span class="st">&quot;AE leading to dose modification/interruption&quot;</span></span>
<span id="cb8-13"><a href="#cb8-13" tabindex="-1"></a>    ),</span>
<span id="cb8-14"><a href="#cb8-14" tabindex="-1"></a>    <span class="at">SERWD =</span> <span class="fu">with_label</span>(.data<span class="sc">$</span>SER <span class="sc">&amp;</span> .data<span class="sc">$</span>WD, <span class="st">&quot;Serious AE leading to withdrawal from treatment&quot;</span>),</span>
<span id="cb8-15"><a href="#cb8-15" tabindex="-1"></a>    <span class="at">SERDSM =</span> <span class="fu">with_label</span>(.data<span class="sc">$</span>SER <span class="sc">&amp;</span> .data<span class="sc">$</span>DSM, <span class="st">&quot;Serious AE leading to dose modification/interruption&quot;</span>),</span>
<span id="cb8-16"><a href="#cb8-16" tabindex="-1"></a>    <span class="at">RELSER =</span> <span class="fu">with_label</span>(.data<span class="sc">$</span>SER <span class="sc">&amp;</span> .data<span class="sc">$</span>REL, <span class="st">&quot;Related Serious AE&quot;</span>),</span>
<span id="cb8-17"><a href="#cb8-17" tabindex="-1"></a>    <span class="at">RELWD =</span> <span class="fu">with_label</span>(.data<span class="sc">$</span>REL <span class="sc">&amp;</span> .data<span class="sc">$</span>WD, <span class="st">&quot;Related AE leading to withdrawal from treatment&quot;</span>),</span>
<span id="cb8-18"><a href="#cb8-18" tabindex="-1"></a>    <span class="at">RELDSM =</span> <span class="fu">with_label</span>(.data<span class="sc">$</span>REL <span class="sc">&amp;</span> .data<span class="sc">$</span>DSM, <span class="st">&quot;Related AE leading to dose modification/interruption&quot;</span>),</span>
<span id="cb8-19"><a href="#cb8-19" tabindex="-1"></a>    <span class="at">CTC35 =</span> <span class="fu">with_label</span>(.data<span class="sc">$</span>ATOXGR <span class="sc">%in%</span> <span class="fu">c</span>(<span class="st">&quot;3&quot;</span>, <span class="st">&quot;4&quot;</span>, <span class="st">&quot;5&quot;</span>), <span class="st">&quot;Grade 3-5 AE&quot;</span>),</span>
<span id="cb8-20"><a href="#cb8-20" tabindex="-1"></a>    <span class="at">CTC45 =</span> <span class="fu">with_label</span>(.data<span class="sc">$</span>ATOXGR <span class="sc">%in%</span> <span class="fu">c</span>(<span class="st">&quot;4&quot;</span>, <span class="st">&quot;5&quot;</span>), <span class="st">&quot;Grade 4/5 AE&quot;</span>),</span>
<span id="cb8-21"><a href="#cb8-21" tabindex="-1"></a>    <span class="at">RELCTC35 =</span> <span class="fu">with_label</span>(.data<span class="sc">$</span>ATOXGR <span class="sc">%in%</span> <span class="fu">c</span>(<span class="st">&quot;3&quot;</span>, <span class="st">&quot;4&quot;</span>, <span class="st">&quot;5&quot;</span>) <span class="sc">&amp;</span> .data<span class="sc">$</span>AEREL <span class="sc">==</span> <span class="st">&quot;Y&quot;</span>, <span class="st">&quot;Related Grade 3-5&quot;</span>)</span>
<span id="cb8-22"><a href="#cb8-22" tabindex="-1"></a>  )</span>
<span id="cb8-23"><a href="#cb8-23" tabindex="-1"></a></span>
<span id="cb8-24"><a href="#cb8-24" tabindex="-1"></a>proc_data<span class="sc">$</span>adsl <span class="ot">&lt;-</span> proc_data<span class="sc">$</span>adsl <span class="sc">%&gt;%</span></span>
<span id="cb8-25"><a href="#cb8-25" tabindex="-1"></a>  <span class="fu">mutate</span>(<span class="at">DCSREAS =</span> <span class="fu">reformat</span>(.data<span class="sc">$</span>DCSREAS, missing_rule))</span>
<span id="cb8-26"><a href="#cb8-26" tabindex="-1"></a></span>
<span id="cb8-27"><a href="#cb8-27" tabindex="-1"></a><span class="fu">run</span>(aet01, proc_data, <span class="at">anl_vars =</span> <span class="fu">list</span>(<span class="at">safety_var =</span> <span class="fu">c</span>(<span class="st">&quot;FATAL&quot;</span>, <span class="st">&quot;SER&quot;</span>, <span class="st">&quot;RELSER&quot;</span>, <span class="st">&quot;RELCTC35&quot;</span>)), <span class="at">auto_pre =</span> <span class="cn">FALSE</span>)</span>
<span id="cb8-28"><a href="#cb8-28" tabindex="-1"></a><span class="co">#&gt;                                                                A: Drug X    B: Placebo   C: Combination</span></span>
<span id="cb8-29"><a href="#cb8-29" tabindex="-1"></a><span class="co">#&gt;                                                                  (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb8-30"><a href="#cb8-30" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb8-31"><a href="#cb8-31" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with at least one AE                13 (86.7%)   14 (93.3%)     15 (100%)   </span></span>
<span id="cb8-32"><a href="#cb8-32" tabindex="-1"></a><span class="co">#&gt;   Total number of AEs                                              58           59             99      </span></span>
<span id="cb8-33"><a href="#cb8-33" tabindex="-1"></a><span class="co">#&gt;   Total number of deaths                                       2 (13.3%)    4 (26.7%)      3 (20.0%)   </span></span>
<span id="cb8-34"><a href="#cb8-34" tabindex="-1"></a><span class="co">#&gt;   Total number of patients withdrawn from study due to an AE       0            0           1 (6.7%)   </span></span>
<span id="cb8-35"><a href="#cb8-35" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with at least one                                                           </span></span>
<span id="cb8-36"><a href="#cb8-36" tabindex="-1"></a><span class="co">#&gt;     AE with fatal outcome                                      8 (53.3%)    8 (53.3%)      10 (66.7%)  </span></span>
<span id="cb8-37"><a href="#cb8-37" tabindex="-1"></a><span class="co">#&gt;     Serious AE                                                 12 (80.0%)   12 (80.0%)     11 (73.3%)  </span></span>
<span id="cb8-38"><a href="#cb8-38" tabindex="-1"></a><span class="co">#&gt;     Related Serious AE                                         8 (53.3%)    8 (53.3%)      10 (66.7%)  </span></span>
<span id="cb8-39"><a href="#cb8-39" tabindex="-1"></a><span class="co">#&gt;     Related Grade 3-5                                          11 (73.3%)   10 (66.7%)     12 (80.0%)</span></span></code></pre></div>
</div>
</div>
<div id="safety-summary-adverse-events-of-special-interest-aet01_aesi" class="section level3">
<h3><strong>Safety Summary (Adverse Events of Special Interest)
(<code>AET01_AESI</code>)</strong></h3>
<div id="safety-summary-adverse-events-of-special-interest" class="section level4">
<h4><strong>1. Safety Summary (Adverse Events of Special
Interest)</strong></h4>
<p>The <strong><code>aet01_aesi</code></strong> template produces the
standard safety summary for adverse events of special interest.</p>
<div class="sourceCode" id="cb9"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb9-1"><a href="#cb9-1" tabindex="-1"></a><span class="fu">run</span>(aet01_aesi, syn_data)</span>
<span id="cb9-2"><a href="#cb9-2" tabindex="-1"></a><span class="co">#&gt;                                                                                   A: Drug X    B: Placebo   C: Combination</span></span>
<span id="cb9-3"><a href="#cb9-3" tabindex="-1"></a><span class="co">#&gt;                                                                                     (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb9-4"><a href="#cb9-4" tabindex="-1"></a><span class="co">#&gt;   ââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb9-5"><a href="#cb9-5" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with at least one AE                                   13 (86.7%)   14 (93.3%)     15 (100%)   </span></span>
<span id="cb9-6"><a href="#cb9-6" tabindex="-1"></a><span class="co">#&gt;   Total number of AEs                                                                 58           59             99      </span></span>
<span id="cb9-7"><a href="#cb9-7" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with at least one AE by worst grade                                                            </span></span>
<span id="cb9-8"><a href="#cb9-8" tabindex="-1"></a><span class="co">#&gt;     Grade 1                                                                           0         1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb9-9"><a href="#cb9-9" tabindex="-1"></a><span class="co">#&gt;     Grade 2                                                                        1 (6.7%)     1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb9-10"><a href="#cb9-10" tabindex="-1"></a><span class="co">#&gt;     Grade 3                                                                        1 (6.7%)    2 (13.3%)       1 (6.7%)   </span></span>
<span id="cb9-11"><a href="#cb9-11" tabindex="-1"></a><span class="co">#&gt;     Grade 4                                                                       3 (20.0%)    2 (13.3%)      2 (13.3%)   </span></span>
<span id="cb9-12"><a href="#cb9-12" tabindex="-1"></a><span class="co">#&gt;     Grade 5 (fatal outcome)                                                       8 (53.3%)    8 (53.3%)      10 (66.7%)  </span></span>
<span id="cb9-13"><a href="#cb9-13" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with study drug withdrawn due to AE                    2 (13.3%)    3 (20.0%)      3 (20.0%)   </span></span>
<span id="cb9-14"><a href="#cb9-14" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with dose modified/interrupted due to AE               6 (40.0%)    9 (60.0%)      11 (73.3%)  </span></span>
<span id="cb9-15"><a href="#cb9-15" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with treatment received for AE                         10 (66.7%)   10 (66.7%)     14 (93.3%)  </span></span>
<span id="cb9-16"><a href="#cb9-16" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with all non-fatal AEs resolved                        9 (60.0%)    10 (66.7%)     12 (80.0%)  </span></span>
<span id="cb9-17"><a href="#cb9-17" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with at least one unresolved or ongoing non-fatal AE   10 (66.7%)   9 (60.0%)      14 (93.3%)  </span></span>
<span id="cb9-18"><a href="#cb9-18" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with at least one serious AE                           12 (80.0%)   12 (80.0%)     11 (73.3%)  </span></span>
<span id="cb9-19"><a href="#cb9-19" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with at least one related AE                           11 (73.3%)   10 (66.7%)     13 (86.7%)</span></span></code></pre></div>
</div>
<div id="safety-summary-adverse-events-of-special-interest-optional-lines" class="section level4">
<h4><strong>2. Safety Summary (Adverse Events of Special Interest)
(optional lines)</strong></h4>
<p>Additional analyses can be added with the argument
<code>aesi_vars</code>, please type <code>?aet01_aesi</code> in console
to find out the list of all pre-defined optional analyses in the
HELP.</p>
<div class="sourceCode" id="cb10"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb10-1"><a href="#cb10-1" tabindex="-1"></a><span class="fu">run</span>(aet01_aesi, syn_data, <span class="at">aesi_vars =</span> <span class="fu">c</span>(<span class="st">&quot;RESLWD&quot;</span>, <span class="st">&quot;RELSER&quot;</span>))</span>
<span id="cb10-2"><a href="#cb10-2" tabindex="-1"></a><span class="co">#&gt;                                                                                   A: Drug X    B: Placebo   C: Combination</span></span>
<span id="cb10-3"><a href="#cb10-3" tabindex="-1"></a><span class="co">#&gt;                                                                                     (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb10-4"><a href="#cb10-4" tabindex="-1"></a><span class="co">#&gt;   ââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb10-5"><a href="#cb10-5" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with at least one AE                                   13 (86.7%)   14 (93.3%)     15 (100%)   </span></span>
<span id="cb10-6"><a href="#cb10-6" tabindex="-1"></a><span class="co">#&gt;   Total number of AEs                                                                 58           59             99      </span></span>
<span id="cb10-7"><a href="#cb10-7" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with at least one AE by worst grade                                                            </span></span>
<span id="cb10-8"><a href="#cb10-8" tabindex="-1"></a><span class="co">#&gt;     Grade 1                                                                           0         1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb10-9"><a href="#cb10-9" tabindex="-1"></a><span class="co">#&gt;     Grade 2                                                                        1 (6.7%)     1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb10-10"><a href="#cb10-10" tabindex="-1"></a><span class="co">#&gt;     Grade 3                                                                        1 (6.7%)    2 (13.3%)       1 (6.7%)   </span></span>
<span id="cb10-11"><a href="#cb10-11" tabindex="-1"></a><span class="co">#&gt;     Grade 4                                                                       3 (20.0%)    2 (13.3%)      2 (13.3%)   </span></span>
<span id="cb10-12"><a href="#cb10-12" tabindex="-1"></a><span class="co">#&gt;     Grade 5 (fatal outcome)                                                       8 (53.3%)    8 (53.3%)      10 (66.7%)  </span></span>
<span id="cb10-13"><a href="#cb10-13" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with study drug withdrawn due to AE                    2 (13.3%)    3 (20.0%)      3 (20.0%)   </span></span>
<span id="cb10-14"><a href="#cb10-14" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with dose modified/interrupted due to AE               6 (40.0%)    9 (60.0%)      11 (73.3%)  </span></span>
<span id="cb10-15"><a href="#cb10-15" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with treatment received for AE                         10 (66.7%)   10 (66.7%)     14 (93.3%)  </span></span>
<span id="cb10-16"><a href="#cb10-16" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with all non-fatal AEs resolved                        9 (60.0%)    10 (66.7%)     12 (80.0%)  </span></span>
<span id="cb10-17"><a href="#cb10-17" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with at least one unresolved or ongoing non-fatal AE   10 (66.7%)   9 (60.0%)      14 (93.3%)  </span></span>
<span id="cb10-18"><a href="#cb10-18" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with at least one serious AE                           12 (80.0%)   12 (80.0%)     11 (73.3%)  </span></span>
<span id="cb10-19"><a href="#cb10-19" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with at least one related AE                           11 (73.3%)   10 (66.7%)     13 (86.7%)  </span></span>
<span id="cb10-20"><a href="#cb10-20" tabindex="-1"></a><span class="co">#&gt;     No. of patients with serious, related AE                                      8 (53.3%)    8 (53.3%)      10 (66.7%)</span></span></code></pre></div>
</div>
<div id="safety-summary-adverse-events-of-special-interest-for-studies-with-multiple-drugs" class="section level4">
<h4><strong>3. Safety Summary (Adverse Events of Special Interest) (for
studies with multiple drugs)</strong></h4>
<p>For studies with more than one study drug, users need to define the
analyses in <code>adae</code> and add to the argument
<code>aesi_vars</code> following the example above. No pre-defined
analysis is available at this moment.</p>
</div>
</div>
<div id="adverse-events-aet02" class="section level3">
<h3><strong>Adverse Events (<code>AET02</code>)</strong></h3>
<div id="adverse-events" class="section level4">
<h4><strong>1. Adverse Events</strong></h4>
<ol style="list-style-type: decimal">
<li>The template <code>aet02</code> produces the standard adverse event
summary by MedDRA system organ class and preferred term.</li>
<li>The template does not include the column of total as default. The
âAll Patientsâ column can be added with the argument
<code>lbl_overall = &quot;All Patients&quot;</code>.</li>
<li>Missing values in <code>&quot;AEBODSYS&quot;</code>, and
<code>&quot;AEDECOD&quot;</code> are labeled as
<code>No Coding Available</code>.</li>
</ol>
<div class="sourceCode" id="cb11"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb11-1"><a href="#cb11-1" tabindex="-1"></a><span class="fu">run</span>(aet02, syn_data)</span>
<span id="cb11-2"><a href="#cb11-2" tabindex="-1"></a><span class="co">#&gt;   MedDRA System Organ Class                                    A: Drug X    B: Placebo   C: Combination</span></span>
<span id="cb11-3"><a href="#cb11-3" tabindex="-1"></a><span class="co">#&gt;     MedDRA Preferred Term                                        (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb11-4"><a href="#cb11-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb11-5"><a href="#cb11-5" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with at least one adverse event     13 (86.7%)   14 (93.3%)     15 (100%)   </span></span>
<span id="cb11-6"><a href="#cb11-6" tabindex="-1"></a><span class="co">#&gt;   Overall total number of events                                   58           59             99      </span></span>
<span id="cb11-7"><a href="#cb11-7" tabindex="-1"></a><span class="co">#&gt;   cl B.2                                                                                               </span></span>
<span id="cb11-8"><a href="#cb11-8" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one adverse event   11 (73.3%)   8 (53.3%)      10 (66.7%)  </span></span>
<span id="cb11-9"><a href="#cb11-9" tabindex="-1"></a><span class="co">#&gt;     Total number of events                                         18           15             20      </span></span>
<span id="cb11-10"><a href="#cb11-10" tabindex="-1"></a><span class="co">#&gt;     dcd B.2.2.3.1                                              8 (53.3%)    6 (40.0%)      7 (46.7%)   </span></span>
<span id="cb11-11"><a href="#cb11-11" tabindex="-1"></a><span class="co">#&gt;     dcd B.2.1.2.1                                              5 (33.3%)    6 (40.0%)      5 (33.3%)   </span></span>
<span id="cb11-12"><a href="#cb11-12" tabindex="-1"></a><span class="co">#&gt;   cl D.1                                                                                               </span></span>
<span id="cb11-13"><a href="#cb11-13" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one adverse event   9 (60.0%)    5 (33.3%)      11 (73.3%)  </span></span>
<span id="cb11-14"><a href="#cb11-14" tabindex="-1"></a><span class="co">#&gt;     Total number of events                                         13           9              19      </span></span>
<span id="cb11-15"><a href="#cb11-15" tabindex="-1"></a><span class="co">#&gt;     dcd D.1.1.1.1                                              4 (26.7%)    4 (26.7%)      7 (46.7%)   </span></span>
<span id="cb11-16"><a href="#cb11-16" tabindex="-1"></a><span class="co">#&gt;     dcd D.1.1.4.2                                              6 (40.0%)    2 (13.3%)      7 (46.7%)   </span></span>
<span id="cb11-17"><a href="#cb11-17" tabindex="-1"></a><span class="co">#&gt;   cl A.1                                                                                               </span></span>
<span id="cb11-18"><a href="#cb11-18" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one adverse event   7 (46.7%)    6 (40.0%)      10 (66.7%)  </span></span>
<span id="cb11-19"><a href="#cb11-19" tabindex="-1"></a><span class="co">#&gt;     Total number of events                                         8            11             16      </span></span>
<span id="cb11-20"><a href="#cb11-20" tabindex="-1"></a><span class="co">#&gt;     dcd A.1.1.1.2                                              5 (33.3%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb11-21"><a href="#cb11-21" tabindex="-1"></a><span class="co">#&gt;     dcd A.1.1.1.1                                              3 (20.0%)     1 (6.7%)      6 (40.0%)   </span></span>
<span id="cb11-22"><a href="#cb11-22" tabindex="-1"></a><span class="co">#&gt;   cl B.1                                                                                               </span></span>
<span id="cb11-23"><a href="#cb11-23" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one adverse event   5 (33.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb11-24"><a href="#cb11-24" tabindex="-1"></a><span class="co">#&gt;     Total number of events                                         6            6              12      </span></span>
<span id="cb11-25"><a href="#cb11-25" tabindex="-1"></a><span class="co">#&gt;     dcd B.1.1.1.1                                              5 (33.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb11-26"><a href="#cb11-26" tabindex="-1"></a><span class="co">#&gt;   cl C.2                                                                                               </span></span>
<span id="cb11-27"><a href="#cb11-27" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one adverse event   6 (40.0%)    4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb11-28"><a href="#cb11-28" tabindex="-1"></a><span class="co">#&gt;     Total number of events                                         6            4              12      </span></span>
<span id="cb11-29"><a href="#cb11-29" tabindex="-1"></a><span class="co">#&gt;     dcd C.2.1.2.1                                              6 (40.0%)    4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb11-30"><a href="#cb11-30" tabindex="-1"></a><span class="co">#&gt;   cl D.2                                                                                               </span></span>
<span id="cb11-31"><a href="#cb11-31" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one adverse event   2 (13.3%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb11-32"><a href="#cb11-32" tabindex="-1"></a><span class="co">#&gt;     Total number of events                                         3            5              10      </span></span>
<span id="cb11-33"><a href="#cb11-33" tabindex="-1"></a><span class="co">#&gt;     dcd D.2.1.5.3                                              2 (13.3%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb11-34"><a href="#cb11-34" tabindex="-1"></a><span class="co">#&gt;   cl C.1                                                                                               </span></span>
<span id="cb11-35"><a href="#cb11-35" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one adverse event   4 (26.7%)    4 (26.7%)      5 (33.3%)   </span></span>
<span id="cb11-36"><a href="#cb11-36" tabindex="-1"></a><span class="co">#&gt;     Total number of events                                         4            9              10      </span></span>
<span id="cb11-37"><a href="#cb11-37" tabindex="-1"></a><span class="co">#&gt;     dcd C.1.1.1.3                                              4 (26.7%)    4 (26.7%)      5 (33.3%)</span></span></code></pre></div>
</div>
<div id="adverse-events-with-high-level-term" class="section level4">
<h4><strong>2. Adverse Events (with High-level Term)</strong></h4>
<p>The syntax below displays adverse events by MedDRA system organ
class, high-level term and preferred term.</p>
<div class="sourceCode" id="cb12"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb12-1"><a href="#cb12-1" tabindex="-1"></a><span class="fu">run</span>(aet02, syn_data, <span class="at">row_split_var =</span> <span class="fu">c</span>(<span class="st">&quot;AEBODSYS&quot;</span>, <span class="st">&quot;AEHLT&quot;</span>))</span>
<span id="cb12-2"><a href="#cb12-2" tabindex="-1"></a><span class="co">#&gt;   MedDRA System Organ Class                                                                              </span></span>
<span id="cb12-3"><a href="#cb12-3" tabindex="-1"></a><span class="co">#&gt;     High Level Term                                              A: Drug X    B: Placebo   C: Combination</span></span>
<span id="cb12-4"><a href="#cb12-4" tabindex="-1"></a><span class="co">#&gt;       MedDRA Preferred Term                                        (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb12-5"><a href="#cb12-5" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb12-6"><a href="#cb12-6" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with at least one adverse event       13 (86.7%)   14 (93.3%)     15 (100%)   </span></span>
<span id="cb12-7"><a href="#cb12-7" tabindex="-1"></a><span class="co">#&gt;   Overall total number of events                                     58           59             99      </span></span>
<span id="cb12-8"><a href="#cb12-8" tabindex="-1"></a><span class="co">#&gt;   cl B.2                                                                                                 </span></span>
<span id="cb12-9"><a href="#cb12-9" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one adverse event     11 (73.3%)   8 (53.3%)      10 (66.7%)  </span></span>
<span id="cb12-10"><a href="#cb12-10" tabindex="-1"></a><span class="co">#&gt;     Total number of events                                           18           15             20      </span></span>
<span id="cb12-11"><a href="#cb12-11" tabindex="-1"></a><span class="co">#&gt;     hlt B.2.2.3                                                                                          </span></span>
<span id="cb12-12"><a href="#cb12-12" tabindex="-1"></a><span class="co">#&gt;       Total number of patients with at least one adverse event   8 (53.3%)    6 (40.0%)      7 (46.7%)   </span></span>
<span id="cb12-13"><a href="#cb12-13" tabindex="-1"></a><span class="co">#&gt;       Total number of events                                         9            7              13      </span></span>
<span id="cb12-14"><a href="#cb12-14" tabindex="-1"></a><span class="co">#&gt;       dcd B.2.2.3.1                                              8 (53.3%)    6 (40.0%)      7 (46.7%)   </span></span>
<span id="cb12-15"><a href="#cb12-15" tabindex="-1"></a><span class="co">#&gt;     hlt B.2.1.2                                                                                          </span></span>
<span id="cb12-16"><a href="#cb12-16" tabindex="-1"></a><span class="co">#&gt;       Total number of patients with at least one adverse event   5 (33.3%)    6 (40.0%)      5 (33.3%)   </span></span>
<span id="cb12-17"><a href="#cb12-17" tabindex="-1"></a><span class="co">#&gt;       Total number of events                                         9            8              7       </span></span>
<span id="cb12-18"><a href="#cb12-18" tabindex="-1"></a><span class="co">#&gt;       dcd B.2.1.2.1                                              5 (33.3%)    6 (40.0%)      5 (33.3%)   </span></span>
<span id="cb12-19"><a href="#cb12-19" tabindex="-1"></a><span class="co">#&gt;   cl D.1                                                                                                 </span></span>
<span id="cb12-20"><a href="#cb12-20" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one adverse event     9 (60.0%)    5 (33.3%)      11 (73.3%)  </span></span>
<span id="cb12-21"><a href="#cb12-21" tabindex="-1"></a><span class="co">#&gt;     Total number of events                                           13           9              19      </span></span>
<span id="cb12-22"><a href="#cb12-22" tabindex="-1"></a><span class="co">#&gt;     hlt D.1.1.1                                                                                          </span></span>
<span id="cb12-23"><a href="#cb12-23" tabindex="-1"></a><span class="co">#&gt;       Total number of patients with at least one adverse event   4 (26.7%)    4 (26.7%)      7 (46.7%)   </span></span>
<span id="cb12-24"><a href="#cb12-24" tabindex="-1"></a><span class="co">#&gt;       Total number of events                                         5            7              11      </span></span>
<span id="cb12-25"><a href="#cb12-25" tabindex="-1"></a><span class="co">#&gt;       dcd D.1.1.1.1                                              4 (26.7%)    4 (26.7%)      7 (46.7%)   </span></span>
<span id="cb12-26"><a href="#cb12-26" tabindex="-1"></a><span class="co">#&gt;     hlt D.1.1.4                                                                                          </span></span>
<span id="cb12-27"><a href="#cb12-27" tabindex="-1"></a><span class="co">#&gt;       Total number of patients with at least one adverse event   6 (40.0%)    2 (13.3%)      7 (46.7%)   </span></span>
<span id="cb12-28"><a href="#cb12-28" tabindex="-1"></a><span class="co">#&gt;       Total number of events                                         8            2              8       </span></span>
<span id="cb12-29"><a href="#cb12-29" tabindex="-1"></a><span class="co">#&gt;       dcd D.1.1.4.2                                              6 (40.0%)    2 (13.3%)      7 (46.7%)   </span></span>
<span id="cb12-30"><a href="#cb12-30" tabindex="-1"></a><span class="co">#&gt;   cl A.1                                                                                                 </span></span>
<span id="cb12-31"><a href="#cb12-31" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one adverse event     7 (46.7%)    6 (40.0%)      10 (66.7%)  </span></span>
<span id="cb12-32"><a href="#cb12-32" tabindex="-1"></a><span class="co">#&gt;     Total number of events                                           8            11             16      </span></span>
<span id="cb12-33"><a href="#cb12-33" tabindex="-1"></a><span class="co">#&gt;     hlt A.1.1.1                                                                                          </span></span>
<span id="cb12-34"><a href="#cb12-34" tabindex="-1"></a><span class="co">#&gt;       Total number of patients with at least one adverse event   7 (46.7%)    6 (40.0%)      10 (66.7%)  </span></span>
<span id="cb12-35"><a href="#cb12-35" tabindex="-1"></a><span class="co">#&gt;       Total number of events                                         8            11             16      </span></span>
<span id="cb12-36"><a href="#cb12-36" tabindex="-1"></a><span class="co">#&gt;       dcd A.1.1.1.2                                              5 (33.3%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb12-37"><a href="#cb12-37" tabindex="-1"></a><span class="co">#&gt;       dcd A.1.1.1.1                                              3 (20.0%)     1 (6.7%)      6 (40.0%)   </span></span>
<span id="cb12-38"><a href="#cb12-38" tabindex="-1"></a><span class="co">#&gt;   cl B.1                                                                                                 </span></span>
<span id="cb12-39"><a href="#cb12-39" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one adverse event     5 (33.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb12-40"><a href="#cb12-40" tabindex="-1"></a><span class="co">#&gt;     Total number of events                                           6            6              12      </span></span>
<span id="cb12-41"><a href="#cb12-41" tabindex="-1"></a><span class="co">#&gt;     hlt B.1.1.1                                                                                          </span></span>
<span id="cb12-42"><a href="#cb12-42" tabindex="-1"></a><span class="co">#&gt;       Total number of patients with at least one adverse event   5 (33.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb12-43"><a href="#cb12-43" tabindex="-1"></a><span class="co">#&gt;       Total number of events                                         6            6              12      </span></span>
<span id="cb12-44"><a href="#cb12-44" tabindex="-1"></a><span class="co">#&gt;       dcd B.1.1.1.1                                              5 (33.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb12-45"><a href="#cb12-45" tabindex="-1"></a><span class="co">#&gt;   cl C.2                                                                                                 </span></span>
<span id="cb12-46"><a href="#cb12-46" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one adverse event     6 (40.0%)    4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb12-47"><a href="#cb12-47" tabindex="-1"></a><span class="co">#&gt;     Total number of events                                           6            4              12      </span></span>
<span id="cb12-48"><a href="#cb12-48" tabindex="-1"></a><span class="co">#&gt;     hlt C.2.1.2                                                                                          </span></span>
<span id="cb12-49"><a href="#cb12-49" tabindex="-1"></a><span class="co">#&gt;       Total number of patients with at least one adverse event   6 (40.0%)    4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb12-50"><a href="#cb12-50" tabindex="-1"></a><span class="co">#&gt;       Total number of events                                         6            4              12      </span></span>
<span id="cb12-51"><a href="#cb12-51" tabindex="-1"></a><span class="co">#&gt;       dcd C.2.1.2.1                                              6 (40.0%)    4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb12-52"><a href="#cb12-52" tabindex="-1"></a><span class="co">#&gt;   cl D.2                                                                                                 </span></span>
<span id="cb12-53"><a href="#cb12-53" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one adverse event     2 (13.3%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb12-54"><a href="#cb12-54" tabindex="-1"></a><span class="co">#&gt;     Total number of events                                           3            5              10      </span></span>
<span id="cb12-55"><a href="#cb12-55" tabindex="-1"></a><span class="co">#&gt;     hlt D.2.1.5                                                                                          </span></span>
<span id="cb12-56"><a href="#cb12-56" tabindex="-1"></a><span class="co">#&gt;       Total number of patients with at least one adverse event   2 (13.3%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb12-57"><a href="#cb12-57" tabindex="-1"></a><span class="co">#&gt;       Total number of events                                         3            5              10      </span></span>
<span id="cb12-58"><a href="#cb12-58" tabindex="-1"></a><span class="co">#&gt;       dcd D.2.1.5.3                                              2 (13.3%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb12-59"><a href="#cb12-59" tabindex="-1"></a><span class="co">#&gt;   cl C.1                                                                                                 </span></span>
<span id="cb12-60"><a href="#cb12-60" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one adverse event     4 (26.7%)    4 (26.7%)      5 (33.3%)   </span></span>
<span id="cb12-61"><a href="#cb12-61" tabindex="-1"></a><span class="co">#&gt;     Total number of events                                           4            9              10      </span></span>
<span id="cb12-62"><a href="#cb12-62" tabindex="-1"></a><span class="co">#&gt;     hlt C.1.1.1                                                                                          </span></span>
<span id="cb12-63"><a href="#cb12-63" tabindex="-1"></a><span class="co">#&gt;       Total number of patients with at least one adverse event   4 (26.7%)    4 (26.7%)      5 (33.3%)   </span></span>
<span id="cb12-64"><a href="#cb12-64" tabindex="-1"></a><span class="co">#&gt;       Total number of events                                         4            9              10      </span></span>
<span id="cb12-65"><a href="#cb12-65" tabindex="-1"></a><span class="co">#&gt;       dcd C.1.1.1.3                                              4 (26.7%)    4 (26.7%)      5 (33.3%)</span></span></code></pre></div>
</div>
<div id="adverse-events-preferred-terms-only" class="section level4">
<h4><strong>3. Adverse Events (Preferred Terms only)</strong></h4>
<p>The syntax below displays adverse events by preferred term only.</p>
<div class="sourceCode" id="cb13"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb13-1"><a href="#cb13-1" tabindex="-1"></a><span class="fu">run</span>(aet02, syn_data, <span class="at">row_split_var =</span> <span class="cn">NULL</span>)</span>
<span id="cb13-2"><a href="#cb13-2" tabindex="-1"></a><span class="co">#&gt;                                                              A: Drug X    B: Placebo   C: Combination</span></span>
<span id="cb13-3"><a href="#cb13-3" tabindex="-1"></a><span class="co">#&gt;   MedDRA Preferred Term                                        (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb13-4"><a href="#cb13-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb13-5"><a href="#cb13-5" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with at least one adverse event   13 (86.7%)   14 (93.3%)     15 (100%)   </span></span>
<span id="cb13-6"><a href="#cb13-6" tabindex="-1"></a><span class="co">#&gt;   Overall total number of events                                 58           59             99      </span></span>
<span id="cb13-7"><a href="#cb13-7" tabindex="-1"></a><span class="co">#&gt;   dcd B.2.2.3.1                                              8 (53.3%)    6 (40.0%)      7 (46.7%)   </span></span>
<span id="cb13-8"><a href="#cb13-8" tabindex="-1"></a><span class="co">#&gt;   dcd B.1.1.1.1                                              5 (33.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb13-9"><a href="#cb13-9" tabindex="-1"></a><span class="co">#&gt;   dcd C.2.1.2.1                                              6 (40.0%)    4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb13-10"><a href="#cb13-10" tabindex="-1"></a><span class="co">#&gt;   dcd A.1.1.1.2                                              5 (33.3%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb13-11"><a href="#cb13-11" tabindex="-1"></a><span class="co">#&gt;   dcd B.2.1.2.1                                              5 (33.3%)    6 (40.0%)      5 (33.3%)   </span></span>
<span id="cb13-12"><a href="#cb13-12" tabindex="-1"></a><span class="co">#&gt;   dcd D.1.1.1.1                                              4 (26.7%)    4 (26.7%)      7 (46.7%)   </span></span>
<span id="cb13-13"><a href="#cb13-13" tabindex="-1"></a><span class="co">#&gt;   dcd D.1.1.4.2                                              6 (40.0%)    2 (13.3%)      7 (46.7%)   </span></span>
<span id="cb13-14"><a href="#cb13-14" tabindex="-1"></a><span class="co">#&gt;   dcd D.2.1.5.3                                              2 (13.3%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb13-15"><a href="#cb13-15" tabindex="-1"></a><span class="co">#&gt;   dcd C.1.1.1.3                                              4 (26.7%)    4 (26.7%)      5 (33.3%)   </span></span>
<span id="cb13-16"><a href="#cb13-16" tabindex="-1"></a><span class="co">#&gt;   dcd A.1.1.1.1                                              3 (20.0%)     1 (6.7%)      6 (40.0%)</span></span></code></pre></div>
</div>
</div>
<div id="adverse-events-by-greatest-intensityaet03" class="section level3">
<h3><strong>Adverse Events by Greatest
Intensity(<code>AET03</code>)</strong></h3>
<div id="adverse-events-by-greatest-intensity" class="section level4">
<h4><strong>1. Adverse Events by Greatest Intensity</strong></h4>
<p>This <strong><code>aet03</code></strong> template produces the
standard adverse event by greatest intensity summary</p>
<div class="sourceCode" id="cb14"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb14-1"><a href="#cb14-1" tabindex="-1"></a><span class="fu">run</span>(aet03, syn_data)</span>
<span id="cb14-2"><a href="#cb14-2" tabindex="-1"></a><span class="co">#&gt;   MedDRA System Organ Class   A: Drug X    B: Placebo   C: Combination</span></span>
<span id="cb14-3"><a href="#cb14-3" tabindex="-1"></a><span class="co">#&gt;     MedDRA Preferred Term       (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb14-4"><a href="#cb14-4" tabindex="-1"></a><span class="co">#&gt;   ââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb14-5"><a href="#cb14-5" tabindex="-1"></a><span class="co">#&gt;   - Any Intensity -           13 (86.7%)   14 (93.3%)     15 (100%)   </span></span>
<span id="cb14-6"><a href="#cb14-6" tabindex="-1"></a><span class="co">#&gt;   MILD                            0         1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb14-7"><a href="#cb14-7" tabindex="-1"></a><span class="co">#&gt;   MODERATE                    2 (13.3%)    3 (20.0%)      2 (13.3%)   </span></span>
<span id="cb14-8"><a href="#cb14-8" tabindex="-1"></a><span class="co">#&gt;   SEVERE                      11 (73.3%)   10 (66.7%)     12 (80.0%)  </span></span>
<span id="cb14-9"><a href="#cb14-9" tabindex="-1"></a><span class="co">#&gt;   cl B.2                                                              </span></span>
<span id="cb14-10"><a href="#cb14-10" tabindex="-1"></a><span class="co">#&gt;     - Any Intensity -         11 (73.3%)   8 (53.3%)      10 (66.7%)  </span></span>
<span id="cb14-11"><a href="#cb14-11" tabindex="-1"></a><span class="co">#&gt;     MILD                      6 (40.0%)    2 (13.3%)      5 (33.3%)   </span></span>
<span id="cb14-12"><a href="#cb14-12" tabindex="-1"></a><span class="co">#&gt;     MODERATE                  5 (33.3%)    6 (40.0%)      5 (33.3%)   </span></span>
<span id="cb14-13"><a href="#cb14-13" tabindex="-1"></a><span class="co">#&gt;     dcd B.2.2.3.1                                                     </span></span>
<span id="cb14-14"><a href="#cb14-14" tabindex="-1"></a><span class="co">#&gt;       - Any Intensity -       8 (53.3%)    6 (40.0%)      7 (46.7%)   </span></span>
<span id="cb14-15"><a href="#cb14-15" tabindex="-1"></a><span class="co">#&gt;       MILD                    8 (53.3%)    6 (40.0%)      7 (46.7%)   </span></span>
<span id="cb14-16"><a href="#cb14-16" tabindex="-1"></a><span class="co">#&gt;     dcd B.2.1.2.1                                                     </span></span>
<span id="cb14-17"><a href="#cb14-17" tabindex="-1"></a><span class="co">#&gt;       - Any Intensity -       5 (33.3%)    6 (40.0%)      5 (33.3%)   </span></span>
<span id="cb14-18"><a href="#cb14-18" tabindex="-1"></a><span class="co">#&gt;       MODERATE                5 (33.3%)    6 (40.0%)      5 (33.3%)   </span></span>
<span id="cb14-19"><a href="#cb14-19" tabindex="-1"></a><span class="co">#&gt;   cl D.1                                                              </span></span>
<span id="cb14-20"><a href="#cb14-20" tabindex="-1"></a><span class="co">#&gt;     - Any Intensity -         9 (60.0%)    5 (33.3%)      11 (73.3%)  </span></span>
<span id="cb14-21"><a href="#cb14-21" tabindex="-1"></a><span class="co">#&gt;     MODERATE                  5 (33.3%)     1 (6.7%)      4 (26.7%)   </span></span>
<span id="cb14-22"><a href="#cb14-22" tabindex="-1"></a><span class="co">#&gt;     SEVERE                    4 (26.7%)    4 (26.7%)      7 (46.7%)   </span></span>
<span id="cb14-23"><a href="#cb14-23" tabindex="-1"></a><span class="co">#&gt;     dcd D.1.1.1.1                                                     </span></span>
<span id="cb14-24"><a href="#cb14-24" tabindex="-1"></a><span class="co">#&gt;       - Any Intensity -       4 (26.7%)    4 (26.7%)      7 (46.7%)   </span></span>
<span id="cb14-25"><a href="#cb14-25" tabindex="-1"></a><span class="co">#&gt;       SEVERE                  4 (26.7%)    4 (26.7%)      7 (46.7%)   </span></span>
<span id="cb14-26"><a href="#cb14-26" tabindex="-1"></a><span class="co">#&gt;     dcd D.1.1.4.2                                                     </span></span>
<span id="cb14-27"><a href="#cb14-27" tabindex="-1"></a><span class="co">#&gt;       - Any Intensity -       6 (40.0%)    2 (13.3%)      7 (46.7%)   </span></span>
<span id="cb14-28"><a href="#cb14-28" tabindex="-1"></a><span class="co">#&gt;       MODERATE                6 (40.0%)    2 (13.3%)      7 (46.7%)   </span></span>
<span id="cb14-29"><a href="#cb14-29" tabindex="-1"></a><span class="co">#&gt;   cl A.1                                                              </span></span>
<span id="cb14-30"><a href="#cb14-30" tabindex="-1"></a><span class="co">#&gt;     - Any Intensity -         7 (46.7%)    6 (40.0%)      10 (66.7%)  </span></span>
<span id="cb14-31"><a href="#cb14-31" tabindex="-1"></a><span class="co">#&gt;     MILD                      2 (13.3%)        0          4 (26.7%)   </span></span>
<span id="cb14-32"><a href="#cb14-32" tabindex="-1"></a><span class="co">#&gt;     MODERATE                  5 (33.3%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb14-33"><a href="#cb14-33" tabindex="-1"></a><span class="co">#&gt;     dcd A.1.1.1.2                                                     </span></span>
<span id="cb14-34"><a href="#cb14-34" tabindex="-1"></a><span class="co">#&gt;       - Any Intensity -       5 (33.3%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb14-35"><a href="#cb14-35" tabindex="-1"></a><span class="co">#&gt;       MODERATE                5 (33.3%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb14-36"><a href="#cb14-36" tabindex="-1"></a><span class="co">#&gt;     dcd A.1.1.1.1                                                     </span></span>
<span id="cb14-37"><a href="#cb14-37" tabindex="-1"></a><span class="co">#&gt;       - Any Intensity -       3 (20.0%)     1 (6.7%)      6 (40.0%)   </span></span>
<span id="cb14-38"><a href="#cb14-38" tabindex="-1"></a><span class="co">#&gt;       MILD                    3 (20.0%)     1 (6.7%)      6 (40.0%)   </span></span>
<span id="cb14-39"><a href="#cb14-39" tabindex="-1"></a><span class="co">#&gt;   cl B.1                                                              </span></span>
<span id="cb14-40"><a href="#cb14-40" tabindex="-1"></a><span class="co">#&gt;     - Any Intensity -         5 (33.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb14-41"><a href="#cb14-41" tabindex="-1"></a><span class="co">#&gt;     SEVERE                    5 (33.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb14-42"><a href="#cb14-42" tabindex="-1"></a><span class="co">#&gt;     dcd B.1.1.1.1                                                     </span></span>
<span id="cb14-43"><a href="#cb14-43" tabindex="-1"></a><span class="co">#&gt;       - Any Intensity -       5 (33.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb14-44"><a href="#cb14-44" tabindex="-1"></a><span class="co">#&gt;       SEVERE                  5 (33.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb14-45"><a href="#cb14-45" tabindex="-1"></a><span class="co">#&gt;   cl C.2                                                              </span></span>
<span id="cb14-46"><a href="#cb14-46" tabindex="-1"></a><span class="co">#&gt;     - Any Intensity -         6 (40.0%)    4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb14-47"><a href="#cb14-47" tabindex="-1"></a><span class="co">#&gt;     MODERATE                  6 (40.0%)    4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb14-48"><a href="#cb14-48" tabindex="-1"></a><span class="co">#&gt;     dcd C.2.1.2.1                                                     </span></span>
<span id="cb14-49"><a href="#cb14-49" tabindex="-1"></a><span class="co">#&gt;       - Any Intensity -       6 (40.0%)    4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb14-50"><a href="#cb14-50" tabindex="-1"></a><span class="co">#&gt;       MODERATE                6 (40.0%)    4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb14-51"><a href="#cb14-51" tabindex="-1"></a><span class="co">#&gt;   cl D.2                                                              </span></span>
<span id="cb14-52"><a href="#cb14-52" tabindex="-1"></a><span class="co">#&gt;     - Any Intensity -         2 (13.3%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb14-53"><a href="#cb14-53" tabindex="-1"></a><span class="co">#&gt;     MILD                      2 (13.3%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb14-54"><a href="#cb14-54" tabindex="-1"></a><span class="co">#&gt;     dcd D.2.1.5.3                                                     </span></span>
<span id="cb14-55"><a href="#cb14-55" tabindex="-1"></a><span class="co">#&gt;       - Any Intensity -       2 (13.3%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb14-56"><a href="#cb14-56" tabindex="-1"></a><span class="co">#&gt;       MILD                    2 (13.3%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb14-57"><a href="#cb14-57" tabindex="-1"></a><span class="co">#&gt;   cl C.1                                                              </span></span>
<span id="cb14-58"><a href="#cb14-58" tabindex="-1"></a><span class="co">#&gt;     - Any Intensity -         4 (26.7%)    4 (26.7%)      5 (33.3%)   </span></span>
<span id="cb14-59"><a href="#cb14-59" tabindex="-1"></a><span class="co">#&gt;     SEVERE                    4 (26.7%)    4 (26.7%)      5 (33.3%)   </span></span>
<span id="cb14-60"><a href="#cb14-60" tabindex="-1"></a><span class="co">#&gt;     dcd C.1.1.1.3                                                     </span></span>
<span id="cb14-61"><a href="#cb14-61" tabindex="-1"></a><span class="co">#&gt;       - Any Intensity -       4 (26.7%)    4 (26.7%)      5 (33.3%)   </span></span>
<span id="cb14-62"><a href="#cb14-62" tabindex="-1"></a><span class="co">#&gt;       SEVERE                  4 (26.7%)    4 (26.7%)      5 (33.3%)</span></span></code></pre></div>
</div>
</div>
<div id="adverse-events-by-highest-nci-ctcae-grade-aet04" class="section level3">
<h3><strong>Adverse Events by Highest <code>NCI CTCAE</code> Grade
(<code>AET04</code>)</strong></h3>
<div id="adverse-events-by-highest-nci-ctcae-grade" class="section level4">
<h4><strong>1. Adverse Events by Highest <code>NCI CTCAE</code>
Grade</strong></h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>aet04</code></strong> template produces the
standard adverse event by highest <code>NCI CTCAE</code> grade
summary.</li>
<li>By default, this template includes the grouped grades of âGrade 1-2â
and âGrade 3-4â.</li>
<li>By default this template removes the rows with 0 count.</li>
<li>If a treatment group does not have any adverse event, the treatment
group is automatically displayed providing that it is defined in
<code>ADSL</code>.</li>
</ol>
<div class="sourceCode" id="cb15"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb15-1"><a href="#cb15-1" tabindex="-1"></a><span class="fu">run</span>(aet04, syn_data)</span>
<span id="cb15-2"><a href="#cb15-2" tabindex="-1"></a><span class="co">#&gt;   MedDRA System Organ Class                                                           </span></span>
<span id="cb15-3"><a href="#cb15-3" tabindex="-1"></a><span class="co">#&gt;     MedDRA Preferred Term                     A: Drug X    B: Placebo   C: Combination</span></span>
<span id="cb15-4"><a href="#cb15-4" tabindex="-1"></a><span class="co">#&gt;                               Grade             (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb15-5"><a href="#cb15-5" tabindex="-1"></a><span class="co">#&gt;   ââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb15-6"><a href="#cb15-6" tabindex="-1"></a><span class="co">#&gt;   - Any adverse events -                                                              </span></span>
<span id="cb15-7"><a href="#cb15-7" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   13 (86.7%)   14 (93.3%)     15 (100%)   </span></span>
<span id="cb15-8"><a href="#cb15-8" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2        1 (6.7%)    2 (13.3%)      2 (13.3%)   </span></span>
<span id="cb15-9"><a href="#cb15-9" tabindex="-1"></a><span class="co">#&gt;                               1                   0         1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb15-10"><a href="#cb15-10" tabindex="-1"></a><span class="co">#&gt;                               2                1 (6.7%)     1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb15-11"><a href="#cb15-11" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-4       4 (26.7%)    4 (26.7%)      3 (20.0%)   </span></span>
<span id="cb15-12"><a href="#cb15-12" tabindex="-1"></a><span class="co">#&gt;                               3                1 (6.7%)    2 (13.3%)       1 (6.7%)   </span></span>
<span id="cb15-13"><a href="#cb15-13" tabindex="-1"></a><span class="co">#&gt;                               4               3 (20.0%)    2 (13.3%)      2 (13.3%)   </span></span>
<span id="cb15-14"><a href="#cb15-14" tabindex="-1"></a><span class="co">#&gt;                               Grade 5         8 (53.3%)    8 (53.3%)      10 (66.7%)  </span></span>
<span id="cb15-15"><a href="#cb15-15" tabindex="-1"></a><span class="co">#&gt;   cl B.2                                                                              </span></span>
<span id="cb15-16"><a href="#cb15-16" tabindex="-1"></a><span class="co">#&gt;     - Overall -                                                                       </span></span>
<span id="cb15-17"><a href="#cb15-17" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   11 (73.3%)   8 (53.3%)      10 (66.7%)  </span></span>
<span id="cb15-18"><a href="#cb15-18" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2       6 (40.0%)    2 (13.3%)      5 (33.3%)   </span></span>
<span id="cb15-19"><a href="#cb15-19" tabindex="-1"></a><span class="co">#&gt;                               1               6 (40.0%)    2 (13.3%)      5 (33.3%)   </span></span>
<span id="cb15-20"><a href="#cb15-20" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-4       5 (33.3%)    6 (40.0%)      5 (33.3%)   </span></span>
<span id="cb15-21"><a href="#cb15-21" tabindex="-1"></a><span class="co">#&gt;                               3               5 (33.3%)    6 (40.0%)      5 (33.3%)   </span></span>
<span id="cb15-22"><a href="#cb15-22" tabindex="-1"></a><span class="co">#&gt;     dcd B.2.2.3.1                                                                     </span></span>
<span id="cb15-23"><a href="#cb15-23" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   8 (53.3%)    6 (40.0%)      7 (46.7%)   </span></span>
<span id="cb15-24"><a href="#cb15-24" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2       8 (53.3%)    6 (40.0%)      7 (46.7%)   </span></span>
<span id="cb15-25"><a href="#cb15-25" tabindex="-1"></a><span class="co">#&gt;                               1               8 (53.3%)    6 (40.0%)      7 (46.7%)   </span></span>
<span id="cb15-26"><a href="#cb15-26" tabindex="-1"></a><span class="co">#&gt;     dcd B.2.1.2.1                                                                     </span></span>
<span id="cb15-27"><a href="#cb15-27" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   5 (33.3%)    6 (40.0%)      5 (33.3%)   </span></span>
<span id="cb15-28"><a href="#cb15-28" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-4       5 (33.3%)    6 (40.0%)      5 (33.3%)   </span></span>
<span id="cb15-29"><a href="#cb15-29" tabindex="-1"></a><span class="co">#&gt;                               3               5 (33.3%)    6 (40.0%)      5 (33.3%)   </span></span>
<span id="cb15-30"><a href="#cb15-30" tabindex="-1"></a><span class="co">#&gt;   cl D.1                                                                              </span></span>
<span id="cb15-31"><a href="#cb15-31" tabindex="-1"></a><span class="co">#&gt;     - Overall -                                                                       </span></span>
<span id="cb15-32"><a href="#cb15-32" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   9 (60.0%)    5 (33.3%)      11 (73.3%)  </span></span>
<span id="cb15-33"><a href="#cb15-33" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-4       5 (33.3%)     1 (6.7%)      4 (26.7%)   </span></span>
<span id="cb15-34"><a href="#cb15-34" tabindex="-1"></a><span class="co">#&gt;                               3               5 (33.3%)     1 (6.7%)      4 (26.7%)   </span></span>
<span id="cb15-35"><a href="#cb15-35" tabindex="-1"></a><span class="co">#&gt;                               Grade 5         4 (26.7%)    4 (26.7%)      7 (46.7%)   </span></span>
<span id="cb15-36"><a href="#cb15-36" tabindex="-1"></a><span class="co">#&gt;     dcd D.1.1.1.1                                                                     </span></span>
<span id="cb15-37"><a href="#cb15-37" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   4 (26.7%)    4 (26.7%)      7 (46.7%)   </span></span>
<span id="cb15-38"><a href="#cb15-38" tabindex="-1"></a><span class="co">#&gt;                               Grade 5         4 (26.7%)    4 (26.7%)      7 (46.7%)   </span></span>
<span id="cb15-39"><a href="#cb15-39" tabindex="-1"></a><span class="co">#&gt;     dcd D.1.1.4.2                                                                     </span></span>
<span id="cb15-40"><a href="#cb15-40" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   6 (40.0%)    2 (13.3%)      7 (46.7%)   </span></span>
<span id="cb15-41"><a href="#cb15-41" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-4       6 (40.0%)    2 (13.3%)      7 (46.7%)   </span></span>
<span id="cb15-42"><a href="#cb15-42" tabindex="-1"></a><span class="co">#&gt;                               3               6 (40.0%)    2 (13.3%)      7 (46.7%)   </span></span>
<span id="cb15-43"><a href="#cb15-43" tabindex="-1"></a><span class="co">#&gt;   cl A.1                                                                              </span></span>
<span id="cb15-44"><a href="#cb15-44" tabindex="-1"></a><span class="co">#&gt;     - Overall -                                                                       </span></span>
<span id="cb15-45"><a href="#cb15-45" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   7 (46.7%)    6 (40.0%)      10 (66.7%)  </span></span>
<span id="cb15-46"><a href="#cb15-46" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2       7 (46.7%)    6 (40.0%)      10 (66.7%)  </span></span>
<span id="cb15-47"><a href="#cb15-47" tabindex="-1"></a><span class="co">#&gt;                               1               2 (13.3%)        0          4 (26.7%)   </span></span>
<span id="cb15-48"><a href="#cb15-48" tabindex="-1"></a><span class="co">#&gt;                               2               5 (33.3%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb15-49"><a href="#cb15-49" tabindex="-1"></a><span class="co">#&gt;     dcd A.1.1.1.2                                                                     </span></span>
<span id="cb15-50"><a href="#cb15-50" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   5 (33.3%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb15-51"><a href="#cb15-51" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2       5 (33.3%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb15-52"><a href="#cb15-52" tabindex="-1"></a><span class="co">#&gt;                               2               5 (33.3%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb15-53"><a href="#cb15-53" tabindex="-1"></a><span class="co">#&gt;     dcd A.1.1.1.1                                                                     </span></span>
<span id="cb15-54"><a href="#cb15-54" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   3 (20.0%)     1 (6.7%)      6 (40.0%)   </span></span>
<span id="cb15-55"><a href="#cb15-55" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2       3 (20.0%)     1 (6.7%)      6 (40.0%)   </span></span>
<span id="cb15-56"><a href="#cb15-56" tabindex="-1"></a><span class="co">#&gt;                               1               3 (20.0%)     1 (6.7%)      6 (40.0%)   </span></span>
<span id="cb15-57"><a href="#cb15-57" tabindex="-1"></a><span class="co">#&gt;   cl B.1                                                                              </span></span>
<span id="cb15-58"><a href="#cb15-58" tabindex="-1"></a><span class="co">#&gt;     - Overall -                                                                       </span></span>
<span id="cb15-59"><a href="#cb15-59" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   5 (33.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb15-60"><a href="#cb15-60" tabindex="-1"></a><span class="co">#&gt;                               Grade 5         5 (33.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb15-61"><a href="#cb15-61" tabindex="-1"></a><span class="co">#&gt;     dcd B.1.1.1.1                                                                     </span></span>
<span id="cb15-62"><a href="#cb15-62" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   5 (33.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb15-63"><a href="#cb15-63" tabindex="-1"></a><span class="co">#&gt;                               Grade 5         5 (33.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb15-64"><a href="#cb15-64" tabindex="-1"></a><span class="co">#&gt;   cl C.2                                                                              </span></span>
<span id="cb15-65"><a href="#cb15-65" tabindex="-1"></a><span class="co">#&gt;     - Overall -                                                                       </span></span>
<span id="cb15-66"><a href="#cb15-66" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   6 (40.0%)    4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb15-67"><a href="#cb15-67" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2       6 (40.0%)    4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb15-68"><a href="#cb15-68" tabindex="-1"></a><span class="co">#&gt;                               2               6 (40.0%)    4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb15-69"><a href="#cb15-69" tabindex="-1"></a><span class="co">#&gt;     dcd C.2.1.2.1                                                                     </span></span>
<span id="cb15-70"><a href="#cb15-70" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   6 (40.0%)    4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb15-71"><a href="#cb15-71" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2       6 (40.0%)    4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb15-72"><a href="#cb15-72" tabindex="-1"></a><span class="co">#&gt;                               2               6 (40.0%)    4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb15-73"><a href="#cb15-73" tabindex="-1"></a><span class="co">#&gt;   cl D.2                                                                              </span></span>
<span id="cb15-74"><a href="#cb15-74" tabindex="-1"></a><span class="co">#&gt;     - Overall -                                                                       </span></span>
<span id="cb15-75"><a href="#cb15-75" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   2 (13.3%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb15-76"><a href="#cb15-76" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2       2 (13.3%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb15-77"><a href="#cb15-77" tabindex="-1"></a><span class="co">#&gt;                               1               2 (13.3%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb15-78"><a href="#cb15-78" tabindex="-1"></a><span class="co">#&gt;     dcd D.2.1.5.3                                                                     </span></span>
<span id="cb15-79"><a href="#cb15-79" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   2 (13.3%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb15-80"><a href="#cb15-80" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2       2 (13.3%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb15-81"><a href="#cb15-81" tabindex="-1"></a><span class="co">#&gt;                               1               2 (13.3%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb15-82"><a href="#cb15-82" tabindex="-1"></a><span class="co">#&gt;   cl C.1                                                                              </span></span>
<span id="cb15-83"><a href="#cb15-83" tabindex="-1"></a><span class="co">#&gt;     - Overall -                                                                       </span></span>
<span id="cb15-84"><a href="#cb15-84" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   4 (26.7%)    4 (26.7%)      5 (33.3%)   </span></span>
<span id="cb15-85"><a href="#cb15-85" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-4       4 (26.7%)    4 (26.7%)      5 (33.3%)   </span></span>
<span id="cb15-86"><a href="#cb15-86" tabindex="-1"></a><span class="co">#&gt;                               4               4 (26.7%)    4 (26.7%)      5 (33.3%)   </span></span>
<span id="cb15-87"><a href="#cb15-87" tabindex="-1"></a><span class="co">#&gt;     dcd C.1.1.1.3                                                                     </span></span>
<span id="cb15-88"><a href="#cb15-88" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   4 (26.7%)    4 (26.7%)      5 (33.3%)   </span></span>
<span id="cb15-89"><a href="#cb15-89" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-4       4 (26.7%)    4 (26.7%)      5 (33.3%)   </span></span>
<span id="cb15-90"><a href="#cb15-90" tabindex="-1"></a><span class="co">#&gt;                               4               4 (26.7%)    4 (26.7%)      5 (33.3%)</span></span></code></pre></div>
</div>
<div id="adverse-events-by-highest-nci-ctcae-grade-fill-in-of-grades" class="section level4">
<h4><strong>2. Adverse Events by Highest <code>NCI CTCAE</code> Grade
(Fill in of Grades)</strong></h4>
<p>If, for some preferred terms, not all grades occur but all grades
should be displayed, this can be achieved by specifying the argument
<code>prune_0 = FALSE</code>.</p>
<div class="sourceCode" id="cb16"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb16-1"><a href="#cb16-1" tabindex="-1"></a><span class="fu">run</span>(aet04, syn_data, <span class="at">prune_0 =</span> <span class="cn">FALSE</span>)</span>
<span id="cb16-2"><a href="#cb16-2" tabindex="-1"></a><span class="co">#&gt;   MedDRA System Organ Class                                                           </span></span>
<span id="cb16-3"><a href="#cb16-3" tabindex="-1"></a><span class="co">#&gt;     MedDRA Preferred Term                     A: Drug X    B: Placebo   C: Combination</span></span>
<span id="cb16-4"><a href="#cb16-4" tabindex="-1"></a><span class="co">#&gt;                               Grade             (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb16-5"><a href="#cb16-5" tabindex="-1"></a><span class="co">#&gt;   ââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb16-6"><a href="#cb16-6" tabindex="-1"></a><span class="co">#&gt;   - Any adverse events -                                                              </span></span>
<span id="cb16-7"><a href="#cb16-7" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   13 (86.7%)   14 (93.3%)     15 (100%)   </span></span>
<span id="cb16-8"><a href="#cb16-8" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2        1 (6.7%)    2 (13.3%)      2 (13.3%)   </span></span>
<span id="cb16-9"><a href="#cb16-9" tabindex="-1"></a><span class="co">#&gt;                               1                   0         1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb16-10"><a href="#cb16-10" tabindex="-1"></a><span class="co">#&gt;                               2                1 (6.7%)     1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb16-11"><a href="#cb16-11" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-4       4 (26.7%)    4 (26.7%)      3 (20.0%)   </span></span>
<span id="cb16-12"><a href="#cb16-12" tabindex="-1"></a><span class="co">#&gt;                               3                1 (6.7%)    2 (13.3%)       1 (6.7%)   </span></span>
<span id="cb16-13"><a href="#cb16-13" tabindex="-1"></a><span class="co">#&gt;                               4               3 (20.0%)    2 (13.3%)      2 (13.3%)   </span></span>
<span id="cb16-14"><a href="#cb16-14" tabindex="-1"></a><span class="co">#&gt;                               Grade 5         8 (53.3%)    8 (53.3%)      10 (66.7%)  </span></span>
<span id="cb16-15"><a href="#cb16-15" tabindex="-1"></a><span class="co">#&gt;   cl B.2                                                                              </span></span>
<span id="cb16-16"><a href="#cb16-16" tabindex="-1"></a><span class="co">#&gt;     - Overall -                                                                       </span></span>
<span id="cb16-17"><a href="#cb16-17" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   11 (73.3%)   8 (53.3%)      10 (66.7%)  </span></span>
<span id="cb16-18"><a href="#cb16-18" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2       6 (40.0%)    2 (13.3%)      5 (33.3%)   </span></span>
<span id="cb16-19"><a href="#cb16-19" tabindex="-1"></a><span class="co">#&gt;                               1               6 (40.0%)    2 (13.3%)      5 (33.3%)   </span></span>
<span id="cb16-20"><a href="#cb16-20" tabindex="-1"></a><span class="co">#&gt;                               2                   0            0              0       </span></span>
<span id="cb16-21"><a href="#cb16-21" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-4       5 (33.3%)    6 (40.0%)      5 (33.3%)   </span></span>
<span id="cb16-22"><a href="#cb16-22" tabindex="-1"></a><span class="co">#&gt;                               3               5 (33.3%)    6 (40.0%)      5 (33.3%)   </span></span>
<span id="cb16-23"><a href="#cb16-23" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb16-24"><a href="#cb16-24" tabindex="-1"></a><span class="co">#&gt;                               Grade 5             0            0              0       </span></span>
<span id="cb16-25"><a href="#cb16-25" tabindex="-1"></a><span class="co">#&gt;     dcd B.2.2.3.1                                                                     </span></span>
<span id="cb16-26"><a href="#cb16-26" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   8 (53.3%)    6 (40.0%)      7 (46.7%)   </span></span>
<span id="cb16-27"><a href="#cb16-27" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2       8 (53.3%)    6 (40.0%)      7 (46.7%)   </span></span>
<span id="cb16-28"><a href="#cb16-28" tabindex="-1"></a><span class="co">#&gt;                               1               8 (53.3%)    6 (40.0%)      7 (46.7%)   </span></span>
<span id="cb16-29"><a href="#cb16-29" tabindex="-1"></a><span class="co">#&gt;                               2                   0            0              0       </span></span>
<span id="cb16-30"><a href="#cb16-30" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-4           0            0              0       </span></span>
<span id="cb16-31"><a href="#cb16-31" tabindex="-1"></a><span class="co">#&gt;                               3                   0            0              0       </span></span>
<span id="cb16-32"><a href="#cb16-32" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb16-33"><a href="#cb16-33" tabindex="-1"></a><span class="co">#&gt;                               Grade 5             0            0              0       </span></span>
<span id="cb16-34"><a href="#cb16-34" tabindex="-1"></a><span class="co">#&gt;     dcd B.2.1.2.1                                                                     </span></span>
<span id="cb16-35"><a href="#cb16-35" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   5 (33.3%)    6 (40.0%)      5 (33.3%)   </span></span>
<span id="cb16-36"><a href="#cb16-36" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2           0            0              0       </span></span>
<span id="cb16-37"><a href="#cb16-37" tabindex="-1"></a><span class="co">#&gt;                               1                   0            0              0       </span></span>
<span id="cb16-38"><a href="#cb16-38" tabindex="-1"></a><span class="co">#&gt;                               2                   0            0              0       </span></span>
<span id="cb16-39"><a href="#cb16-39" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-4       5 (33.3%)    6 (40.0%)      5 (33.3%)   </span></span>
<span id="cb16-40"><a href="#cb16-40" tabindex="-1"></a><span class="co">#&gt;                               3               5 (33.3%)    6 (40.0%)      5 (33.3%)   </span></span>
<span id="cb16-41"><a href="#cb16-41" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb16-42"><a href="#cb16-42" tabindex="-1"></a><span class="co">#&gt;                               Grade 5             0            0              0       </span></span>
<span id="cb16-43"><a href="#cb16-43" tabindex="-1"></a><span class="co">#&gt;   cl D.1                                                                              </span></span>
<span id="cb16-44"><a href="#cb16-44" tabindex="-1"></a><span class="co">#&gt;     - Overall -                                                                       </span></span>
<span id="cb16-45"><a href="#cb16-45" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   9 (60.0%)    5 (33.3%)      11 (73.3%)  </span></span>
<span id="cb16-46"><a href="#cb16-46" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2           0            0              0       </span></span>
<span id="cb16-47"><a href="#cb16-47" tabindex="-1"></a><span class="co">#&gt;                               1                   0            0              0       </span></span>
<span id="cb16-48"><a href="#cb16-48" tabindex="-1"></a><span class="co">#&gt;                               2                   0            0              0       </span></span>
<span id="cb16-49"><a href="#cb16-49" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-4       5 (33.3%)     1 (6.7%)      4 (26.7%)   </span></span>
<span id="cb16-50"><a href="#cb16-50" tabindex="-1"></a><span class="co">#&gt;                               3               5 (33.3%)     1 (6.7%)      4 (26.7%)   </span></span>
<span id="cb16-51"><a href="#cb16-51" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb16-52"><a href="#cb16-52" tabindex="-1"></a><span class="co">#&gt;                               Grade 5         4 (26.7%)    4 (26.7%)      7 (46.7%)   </span></span>
<span id="cb16-53"><a href="#cb16-53" tabindex="-1"></a><span class="co">#&gt;     dcd D.1.1.1.1                                                                     </span></span>
<span id="cb16-54"><a href="#cb16-54" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   4 (26.7%)    4 (26.7%)      7 (46.7%)   </span></span>
<span id="cb16-55"><a href="#cb16-55" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2           0            0              0       </span></span>
<span id="cb16-56"><a href="#cb16-56" tabindex="-1"></a><span class="co">#&gt;                               1                   0            0              0       </span></span>
<span id="cb16-57"><a href="#cb16-57" tabindex="-1"></a><span class="co">#&gt;                               2                   0            0              0       </span></span>
<span id="cb16-58"><a href="#cb16-58" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-4           0            0              0       </span></span>
<span id="cb16-59"><a href="#cb16-59" tabindex="-1"></a><span class="co">#&gt;                               3                   0            0              0       </span></span>
<span id="cb16-60"><a href="#cb16-60" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb16-61"><a href="#cb16-61" tabindex="-1"></a><span class="co">#&gt;                               Grade 5         4 (26.7%)    4 (26.7%)      7 (46.7%)   </span></span>
<span id="cb16-62"><a href="#cb16-62" tabindex="-1"></a><span class="co">#&gt;     dcd D.1.1.4.2                                                                     </span></span>
<span id="cb16-63"><a href="#cb16-63" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   6 (40.0%)    2 (13.3%)      7 (46.7%)   </span></span>
<span id="cb16-64"><a href="#cb16-64" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2           0            0              0       </span></span>
<span id="cb16-65"><a href="#cb16-65" tabindex="-1"></a><span class="co">#&gt;                               1                   0            0              0       </span></span>
<span id="cb16-66"><a href="#cb16-66" tabindex="-1"></a><span class="co">#&gt;                               2                   0            0              0       </span></span>
<span id="cb16-67"><a href="#cb16-67" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-4       6 (40.0%)    2 (13.3%)      7 (46.7%)   </span></span>
<span id="cb16-68"><a href="#cb16-68" tabindex="-1"></a><span class="co">#&gt;                               3               6 (40.0%)    2 (13.3%)      7 (46.7%)   </span></span>
<span id="cb16-69"><a href="#cb16-69" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb16-70"><a href="#cb16-70" tabindex="-1"></a><span class="co">#&gt;                               Grade 5             0            0              0       </span></span>
<span id="cb16-71"><a href="#cb16-71" tabindex="-1"></a><span class="co">#&gt;   cl A.1                                                                              </span></span>
<span id="cb16-72"><a href="#cb16-72" tabindex="-1"></a><span class="co">#&gt;     - Overall -                                                                       </span></span>
<span id="cb16-73"><a href="#cb16-73" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   7 (46.7%)    6 (40.0%)      10 (66.7%)  </span></span>
<span id="cb16-74"><a href="#cb16-74" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2       7 (46.7%)    6 (40.0%)      10 (66.7%)  </span></span>
<span id="cb16-75"><a href="#cb16-75" tabindex="-1"></a><span class="co">#&gt;                               1               2 (13.3%)        0          4 (26.7%)   </span></span>
<span id="cb16-76"><a href="#cb16-76" tabindex="-1"></a><span class="co">#&gt;                               2               5 (33.3%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb16-77"><a href="#cb16-77" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-4           0            0              0       </span></span>
<span id="cb16-78"><a href="#cb16-78" tabindex="-1"></a><span class="co">#&gt;                               3                   0            0              0       </span></span>
<span id="cb16-79"><a href="#cb16-79" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb16-80"><a href="#cb16-80" tabindex="-1"></a><span class="co">#&gt;                               Grade 5             0            0              0       </span></span>
<span id="cb16-81"><a href="#cb16-81" tabindex="-1"></a><span class="co">#&gt;     dcd A.1.1.1.2                                                                     </span></span>
<span id="cb16-82"><a href="#cb16-82" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   5 (33.3%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb16-83"><a href="#cb16-83" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2       5 (33.3%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb16-84"><a href="#cb16-84" tabindex="-1"></a><span class="co">#&gt;                               1                   0            0              0       </span></span>
<span id="cb16-85"><a href="#cb16-85" tabindex="-1"></a><span class="co">#&gt;                               2               5 (33.3%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb16-86"><a href="#cb16-86" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-4           0            0              0       </span></span>
<span id="cb16-87"><a href="#cb16-87" tabindex="-1"></a><span class="co">#&gt;                               3                   0            0              0       </span></span>
<span id="cb16-88"><a href="#cb16-88" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb16-89"><a href="#cb16-89" tabindex="-1"></a><span class="co">#&gt;                               Grade 5             0            0              0       </span></span>
<span id="cb16-90"><a href="#cb16-90" tabindex="-1"></a><span class="co">#&gt;     dcd A.1.1.1.1                                                                     </span></span>
<span id="cb16-91"><a href="#cb16-91" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   3 (20.0%)     1 (6.7%)      6 (40.0%)   </span></span>
<span id="cb16-92"><a href="#cb16-92" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2       3 (20.0%)     1 (6.7%)      6 (40.0%)   </span></span>
<span id="cb16-93"><a href="#cb16-93" tabindex="-1"></a><span class="co">#&gt;                               1               3 (20.0%)     1 (6.7%)      6 (40.0%)   </span></span>
<span id="cb16-94"><a href="#cb16-94" tabindex="-1"></a><span class="co">#&gt;                               2                   0            0              0       </span></span>
<span id="cb16-95"><a href="#cb16-95" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-4           0            0              0       </span></span>
<span id="cb16-96"><a href="#cb16-96" tabindex="-1"></a><span class="co">#&gt;                               3                   0            0              0       </span></span>
<span id="cb16-97"><a href="#cb16-97" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb16-98"><a href="#cb16-98" tabindex="-1"></a><span class="co">#&gt;                               Grade 5             0            0              0       </span></span>
<span id="cb16-99"><a href="#cb16-99" tabindex="-1"></a><span class="co">#&gt;   cl B.1                                                                              </span></span>
<span id="cb16-100"><a href="#cb16-100" tabindex="-1"></a><span class="co">#&gt;     - Overall -                                                                       </span></span>
<span id="cb16-101"><a href="#cb16-101" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   5 (33.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb16-102"><a href="#cb16-102" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2           0            0              0       </span></span>
<span id="cb16-103"><a href="#cb16-103" tabindex="-1"></a><span class="co">#&gt;                               1                   0            0              0       </span></span>
<span id="cb16-104"><a href="#cb16-104" tabindex="-1"></a><span class="co">#&gt;                               2                   0            0              0       </span></span>
<span id="cb16-105"><a href="#cb16-105" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-4           0            0              0       </span></span>
<span id="cb16-106"><a href="#cb16-106" tabindex="-1"></a><span class="co">#&gt;                               3                   0            0              0       </span></span>
<span id="cb16-107"><a href="#cb16-107" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb16-108"><a href="#cb16-108" tabindex="-1"></a><span class="co">#&gt;                               Grade 5         5 (33.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb16-109"><a href="#cb16-109" tabindex="-1"></a><span class="co">#&gt;     dcd B.1.1.1.1                                                                     </span></span>
<span id="cb16-110"><a href="#cb16-110" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   5 (33.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb16-111"><a href="#cb16-111" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2           0            0              0       </span></span>
<span id="cb16-112"><a href="#cb16-112" tabindex="-1"></a><span class="co">#&gt;                               1                   0            0              0       </span></span>
<span id="cb16-113"><a href="#cb16-113" tabindex="-1"></a><span class="co">#&gt;                               2                   0            0              0       </span></span>
<span id="cb16-114"><a href="#cb16-114" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-4           0            0              0       </span></span>
<span id="cb16-115"><a href="#cb16-115" tabindex="-1"></a><span class="co">#&gt;                               3                   0            0              0       </span></span>
<span id="cb16-116"><a href="#cb16-116" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb16-117"><a href="#cb16-117" tabindex="-1"></a><span class="co">#&gt;                               Grade 5         5 (33.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb16-118"><a href="#cb16-118" tabindex="-1"></a><span class="co">#&gt;   cl C.2                                                                              </span></span>
<span id="cb16-119"><a href="#cb16-119" tabindex="-1"></a><span class="co">#&gt;     - Overall -                                                                       </span></span>
<span id="cb16-120"><a href="#cb16-120" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   6 (40.0%)    4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb16-121"><a href="#cb16-121" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2       6 (40.0%)    4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb16-122"><a href="#cb16-122" tabindex="-1"></a><span class="co">#&gt;                               1                   0            0              0       </span></span>
<span id="cb16-123"><a href="#cb16-123" tabindex="-1"></a><span class="co">#&gt;                               2               6 (40.0%)    4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb16-124"><a href="#cb16-124" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-4           0            0              0       </span></span>
<span id="cb16-125"><a href="#cb16-125" tabindex="-1"></a><span class="co">#&gt;                               3                   0            0              0       </span></span>
<span id="cb16-126"><a href="#cb16-126" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb16-127"><a href="#cb16-127" tabindex="-1"></a><span class="co">#&gt;                               Grade 5             0            0              0       </span></span>
<span id="cb16-128"><a href="#cb16-128" tabindex="-1"></a><span class="co">#&gt;     dcd C.2.1.2.1                                                                     </span></span>
<span id="cb16-129"><a href="#cb16-129" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   6 (40.0%)    4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb16-130"><a href="#cb16-130" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2       6 (40.0%)    4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb16-131"><a href="#cb16-131" tabindex="-1"></a><span class="co">#&gt;                               1                   0            0              0       </span></span>
<span id="cb16-132"><a href="#cb16-132" tabindex="-1"></a><span class="co">#&gt;                               2               6 (40.0%)    4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb16-133"><a href="#cb16-133" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-4           0            0              0       </span></span>
<span id="cb16-134"><a href="#cb16-134" tabindex="-1"></a><span class="co">#&gt;                               3                   0            0              0       </span></span>
<span id="cb16-135"><a href="#cb16-135" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb16-136"><a href="#cb16-136" tabindex="-1"></a><span class="co">#&gt;                               Grade 5             0            0              0       </span></span>
<span id="cb16-137"><a href="#cb16-137" tabindex="-1"></a><span class="co">#&gt;   cl D.2                                                                              </span></span>
<span id="cb16-138"><a href="#cb16-138" tabindex="-1"></a><span class="co">#&gt;     - Overall -                                                                       </span></span>
<span id="cb16-139"><a href="#cb16-139" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   2 (13.3%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb16-140"><a href="#cb16-140" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2       2 (13.3%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb16-141"><a href="#cb16-141" tabindex="-1"></a><span class="co">#&gt;                               1               2 (13.3%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb16-142"><a href="#cb16-142" tabindex="-1"></a><span class="co">#&gt;                               2                   0            0              0       </span></span>
<span id="cb16-143"><a href="#cb16-143" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-4           0            0              0       </span></span>
<span id="cb16-144"><a href="#cb16-144" tabindex="-1"></a><span class="co">#&gt;                               3                   0            0              0       </span></span>
<span id="cb16-145"><a href="#cb16-145" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb16-146"><a href="#cb16-146" tabindex="-1"></a><span class="co">#&gt;                               Grade 5             0            0              0       </span></span>
<span id="cb16-147"><a href="#cb16-147" tabindex="-1"></a><span class="co">#&gt;     dcd D.2.1.5.3                                                                     </span></span>
<span id="cb16-148"><a href="#cb16-148" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   2 (13.3%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb16-149"><a href="#cb16-149" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2       2 (13.3%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb16-150"><a href="#cb16-150" tabindex="-1"></a><span class="co">#&gt;                               1               2 (13.3%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb16-151"><a href="#cb16-151" tabindex="-1"></a><span class="co">#&gt;                               2                   0            0              0       </span></span>
<span id="cb16-152"><a href="#cb16-152" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-4           0            0              0       </span></span>
<span id="cb16-153"><a href="#cb16-153" tabindex="-1"></a><span class="co">#&gt;                               3                   0            0              0       </span></span>
<span id="cb16-154"><a href="#cb16-154" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb16-155"><a href="#cb16-155" tabindex="-1"></a><span class="co">#&gt;                               Grade 5             0            0              0       </span></span>
<span id="cb16-156"><a href="#cb16-156" tabindex="-1"></a><span class="co">#&gt;   cl C.1                                                                              </span></span>
<span id="cb16-157"><a href="#cb16-157" tabindex="-1"></a><span class="co">#&gt;     - Overall -                                                                       </span></span>
<span id="cb16-158"><a href="#cb16-158" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   4 (26.7%)    4 (26.7%)      5 (33.3%)   </span></span>
<span id="cb16-159"><a href="#cb16-159" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2           0            0              0       </span></span>
<span id="cb16-160"><a href="#cb16-160" tabindex="-1"></a><span class="co">#&gt;                               1                   0            0              0       </span></span>
<span id="cb16-161"><a href="#cb16-161" tabindex="-1"></a><span class="co">#&gt;                               2                   0            0              0       </span></span>
<span id="cb16-162"><a href="#cb16-162" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-4       4 (26.7%)    4 (26.7%)      5 (33.3%)   </span></span>
<span id="cb16-163"><a href="#cb16-163" tabindex="-1"></a><span class="co">#&gt;                               3                   0            0              0       </span></span>
<span id="cb16-164"><a href="#cb16-164" tabindex="-1"></a><span class="co">#&gt;                               4               4 (26.7%)    4 (26.7%)      5 (33.3%)   </span></span>
<span id="cb16-165"><a href="#cb16-165" tabindex="-1"></a><span class="co">#&gt;                               Grade 5             0            0              0       </span></span>
<span id="cb16-166"><a href="#cb16-166" tabindex="-1"></a><span class="co">#&gt;     dcd C.1.1.1.3                                                                     </span></span>
<span id="cb16-167"><a href="#cb16-167" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   4 (26.7%)    4 (26.7%)      5 (33.3%)   </span></span>
<span id="cb16-168"><a href="#cb16-168" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2           0            0              0       </span></span>
<span id="cb16-169"><a href="#cb16-169" tabindex="-1"></a><span class="co">#&gt;                               1                   0            0              0       </span></span>
<span id="cb16-170"><a href="#cb16-170" tabindex="-1"></a><span class="co">#&gt;                               2                   0            0              0       </span></span>
<span id="cb16-171"><a href="#cb16-171" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-4       4 (26.7%)    4 (26.7%)      5 (33.3%)   </span></span>
<span id="cb16-172"><a href="#cb16-172" tabindex="-1"></a><span class="co">#&gt;                               3                   0            0              0       </span></span>
<span id="cb16-173"><a href="#cb16-173" tabindex="-1"></a><span class="co">#&gt;                               4               4 (26.7%)    4 (26.7%)      5 (33.3%)   </span></span>
<span id="cb16-174"><a href="#cb16-174" tabindex="-1"></a><span class="co">#&gt;                               Grade 5             0            0              0</span></span></code></pre></div>
</div>
<div id="adverse-events-by-highest-nci-ctcae-grade-with-modified-grouping-of-grade" class="section level4">
<h4><strong>3. Adverse Events by Highest <code>NCI CTCAE</code> Grade
with modified grouping of grade</strong></h4>
<p>Collapsing grade 3-4 with grade 5, can be achieved by modifying the
definition of grade groups in the argument
<code>grade_groups</code>.</p>
<div class="sourceCode" id="cb17"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb17-1"><a href="#cb17-1" tabindex="-1"></a>grade_groups <span class="ot">&lt;-</span> <span class="fu">list</span>(</span>
<span id="cb17-2"><a href="#cb17-2" tabindex="-1"></a>  <span class="st">&quot;Grade 1-2&quot;</span> <span class="ot">=</span> <span class="fu">c</span>(<span class="st">&quot;1&quot;</span>, <span class="st">&quot;2&quot;</span>),</span>
<span id="cb17-3"><a href="#cb17-3" tabindex="-1"></a>  <span class="st">&quot;Grade 3-5&quot;</span> <span class="ot">=</span> <span class="fu">c</span>(<span class="st">&quot;3&quot;</span>, <span class="st">&quot;4&quot;</span>, <span class="st">&quot;5&quot;</span>)</span>
<span id="cb17-4"><a href="#cb17-4" tabindex="-1"></a>)</span>
<span id="cb17-5"><a href="#cb17-5" tabindex="-1"></a></span>
<span id="cb17-6"><a href="#cb17-6" tabindex="-1"></a><span class="fu">run</span>(aet04, syn_data, <span class="at">grade_groups =</span> grade_groups, <span class="at">prune_0 =</span> <span class="cn">FALSE</span>)</span>
<span id="cb17-7"><a href="#cb17-7" tabindex="-1"></a><span class="co">#&gt;   MedDRA System Organ Class                                                           </span></span>
<span id="cb17-8"><a href="#cb17-8" tabindex="-1"></a><span class="co">#&gt;     MedDRA Preferred Term                     A: Drug X    B: Placebo   C: Combination</span></span>
<span id="cb17-9"><a href="#cb17-9" tabindex="-1"></a><span class="co">#&gt;                               Grade             (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb17-10"><a href="#cb17-10" tabindex="-1"></a><span class="co">#&gt;   ââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb17-11"><a href="#cb17-11" tabindex="-1"></a><span class="co">#&gt;   - Any adverse events -                                                              </span></span>
<span id="cb17-12"><a href="#cb17-12" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   13 (86.7%)   14 (93.3%)     15 (100%)   </span></span>
<span id="cb17-13"><a href="#cb17-13" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2        1 (6.7%)    2 (13.3%)      2 (13.3%)   </span></span>
<span id="cb17-14"><a href="#cb17-14" tabindex="-1"></a><span class="co">#&gt;                               1                   0         1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb17-15"><a href="#cb17-15" tabindex="-1"></a><span class="co">#&gt;                               2                1 (6.7%)     1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb17-16"><a href="#cb17-16" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-5       12 (80.0%)   12 (80.0%)     13 (86.7%)  </span></span>
<span id="cb17-17"><a href="#cb17-17" tabindex="-1"></a><span class="co">#&gt;                               3                1 (6.7%)    2 (13.3%)       1 (6.7%)   </span></span>
<span id="cb17-18"><a href="#cb17-18" tabindex="-1"></a><span class="co">#&gt;                               4               3 (20.0%)    2 (13.3%)      2 (13.3%)   </span></span>
<span id="cb17-19"><a href="#cb17-19" tabindex="-1"></a><span class="co">#&gt;                               5               8 (53.3%)    8 (53.3%)      10 (66.7%)  </span></span>
<span id="cb17-20"><a href="#cb17-20" tabindex="-1"></a><span class="co">#&gt;   cl B.2                                                                              </span></span>
<span id="cb17-21"><a href="#cb17-21" tabindex="-1"></a><span class="co">#&gt;     - Overall -                                                                       </span></span>
<span id="cb17-22"><a href="#cb17-22" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   11 (73.3%)   8 (53.3%)      10 (66.7%)  </span></span>
<span id="cb17-23"><a href="#cb17-23" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2       6 (40.0%)    2 (13.3%)      5 (33.3%)   </span></span>
<span id="cb17-24"><a href="#cb17-24" tabindex="-1"></a><span class="co">#&gt;                               1               6 (40.0%)    2 (13.3%)      5 (33.3%)   </span></span>
<span id="cb17-25"><a href="#cb17-25" tabindex="-1"></a><span class="co">#&gt;                               2                   0            0              0       </span></span>
<span id="cb17-26"><a href="#cb17-26" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-5       5 (33.3%)    6 (40.0%)      5 (33.3%)   </span></span>
<span id="cb17-27"><a href="#cb17-27" tabindex="-1"></a><span class="co">#&gt;                               3               5 (33.3%)    6 (40.0%)      5 (33.3%)   </span></span>
<span id="cb17-28"><a href="#cb17-28" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb17-29"><a href="#cb17-29" tabindex="-1"></a><span class="co">#&gt;                               5                   0            0              0       </span></span>
<span id="cb17-30"><a href="#cb17-30" tabindex="-1"></a><span class="co">#&gt;     dcd B.2.2.3.1                                                                     </span></span>
<span id="cb17-31"><a href="#cb17-31" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   8 (53.3%)    6 (40.0%)      7 (46.7%)   </span></span>
<span id="cb17-32"><a href="#cb17-32" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2       8 (53.3%)    6 (40.0%)      7 (46.7%)   </span></span>
<span id="cb17-33"><a href="#cb17-33" tabindex="-1"></a><span class="co">#&gt;                               1               8 (53.3%)    6 (40.0%)      7 (46.7%)   </span></span>
<span id="cb17-34"><a href="#cb17-34" tabindex="-1"></a><span class="co">#&gt;                               2                   0            0              0       </span></span>
<span id="cb17-35"><a href="#cb17-35" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-5           0            0              0       </span></span>
<span id="cb17-36"><a href="#cb17-36" tabindex="-1"></a><span class="co">#&gt;                               3                   0            0              0       </span></span>
<span id="cb17-37"><a href="#cb17-37" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb17-38"><a href="#cb17-38" tabindex="-1"></a><span class="co">#&gt;                               5                   0            0              0       </span></span>
<span id="cb17-39"><a href="#cb17-39" tabindex="-1"></a><span class="co">#&gt;     dcd B.2.1.2.1                                                                     </span></span>
<span id="cb17-40"><a href="#cb17-40" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   5 (33.3%)    6 (40.0%)      5 (33.3%)   </span></span>
<span id="cb17-41"><a href="#cb17-41" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2           0            0              0       </span></span>
<span id="cb17-42"><a href="#cb17-42" tabindex="-1"></a><span class="co">#&gt;                               1                   0            0              0       </span></span>
<span id="cb17-43"><a href="#cb17-43" tabindex="-1"></a><span class="co">#&gt;                               2                   0            0              0       </span></span>
<span id="cb17-44"><a href="#cb17-44" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-5       5 (33.3%)    6 (40.0%)      5 (33.3%)   </span></span>
<span id="cb17-45"><a href="#cb17-45" tabindex="-1"></a><span class="co">#&gt;                               3               5 (33.3%)    6 (40.0%)      5 (33.3%)   </span></span>
<span id="cb17-46"><a href="#cb17-46" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb17-47"><a href="#cb17-47" tabindex="-1"></a><span class="co">#&gt;                               5                   0            0              0       </span></span>
<span id="cb17-48"><a href="#cb17-48" tabindex="-1"></a><span class="co">#&gt;   cl D.1                                                                              </span></span>
<span id="cb17-49"><a href="#cb17-49" tabindex="-1"></a><span class="co">#&gt;     - Overall -                                                                       </span></span>
<span id="cb17-50"><a href="#cb17-50" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   9 (60.0%)    5 (33.3%)      11 (73.3%)  </span></span>
<span id="cb17-51"><a href="#cb17-51" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2           0            0              0       </span></span>
<span id="cb17-52"><a href="#cb17-52" tabindex="-1"></a><span class="co">#&gt;                               1                   0            0              0       </span></span>
<span id="cb17-53"><a href="#cb17-53" tabindex="-1"></a><span class="co">#&gt;                               2                   0            0              0       </span></span>
<span id="cb17-54"><a href="#cb17-54" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-5       9 (60.0%)    5 (33.3%)      11 (73.3%)  </span></span>
<span id="cb17-55"><a href="#cb17-55" tabindex="-1"></a><span class="co">#&gt;                               3               5 (33.3%)     1 (6.7%)      4 (26.7%)   </span></span>
<span id="cb17-56"><a href="#cb17-56" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb17-57"><a href="#cb17-57" tabindex="-1"></a><span class="co">#&gt;                               5               4 (26.7%)    4 (26.7%)      7 (46.7%)   </span></span>
<span id="cb17-58"><a href="#cb17-58" tabindex="-1"></a><span class="co">#&gt;     dcd D.1.1.1.1                                                                     </span></span>
<span id="cb17-59"><a href="#cb17-59" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   4 (26.7%)    4 (26.7%)      7 (46.7%)   </span></span>
<span id="cb17-60"><a href="#cb17-60" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2           0            0              0       </span></span>
<span id="cb17-61"><a href="#cb17-61" tabindex="-1"></a><span class="co">#&gt;                               1                   0            0              0       </span></span>
<span id="cb17-62"><a href="#cb17-62" tabindex="-1"></a><span class="co">#&gt;                               2                   0            0              0       </span></span>
<span id="cb17-63"><a href="#cb17-63" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-5       4 (26.7%)    4 (26.7%)      7 (46.7%)   </span></span>
<span id="cb17-64"><a href="#cb17-64" tabindex="-1"></a><span class="co">#&gt;                               3                   0            0              0       </span></span>
<span id="cb17-65"><a href="#cb17-65" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb17-66"><a href="#cb17-66" tabindex="-1"></a><span class="co">#&gt;                               5               4 (26.7%)    4 (26.7%)      7 (46.7%)   </span></span>
<span id="cb17-67"><a href="#cb17-67" tabindex="-1"></a><span class="co">#&gt;     dcd D.1.1.4.2                                                                     </span></span>
<span id="cb17-68"><a href="#cb17-68" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   6 (40.0%)    2 (13.3%)      7 (46.7%)   </span></span>
<span id="cb17-69"><a href="#cb17-69" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2           0            0              0       </span></span>
<span id="cb17-70"><a href="#cb17-70" tabindex="-1"></a><span class="co">#&gt;                               1                   0            0              0       </span></span>
<span id="cb17-71"><a href="#cb17-71" tabindex="-1"></a><span class="co">#&gt;                               2                   0            0              0       </span></span>
<span id="cb17-72"><a href="#cb17-72" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-5       6 (40.0%)    2 (13.3%)      7 (46.7%)   </span></span>
<span id="cb17-73"><a href="#cb17-73" tabindex="-1"></a><span class="co">#&gt;                               3               6 (40.0%)    2 (13.3%)      7 (46.7%)   </span></span>
<span id="cb17-74"><a href="#cb17-74" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb17-75"><a href="#cb17-75" tabindex="-1"></a><span class="co">#&gt;                               5                   0            0              0       </span></span>
<span id="cb17-76"><a href="#cb17-76" tabindex="-1"></a><span class="co">#&gt;   cl A.1                                                                              </span></span>
<span id="cb17-77"><a href="#cb17-77" tabindex="-1"></a><span class="co">#&gt;     - Overall -                                                                       </span></span>
<span id="cb17-78"><a href="#cb17-78" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   7 (46.7%)    6 (40.0%)      10 (66.7%)  </span></span>
<span id="cb17-79"><a href="#cb17-79" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2       7 (46.7%)    6 (40.0%)      10 (66.7%)  </span></span>
<span id="cb17-80"><a href="#cb17-80" tabindex="-1"></a><span class="co">#&gt;                               1               2 (13.3%)        0          4 (26.7%)   </span></span>
<span id="cb17-81"><a href="#cb17-81" tabindex="-1"></a><span class="co">#&gt;                               2               5 (33.3%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb17-82"><a href="#cb17-82" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-5           0            0              0       </span></span>
<span id="cb17-83"><a href="#cb17-83" tabindex="-1"></a><span class="co">#&gt;                               3                   0            0              0       </span></span>
<span id="cb17-84"><a href="#cb17-84" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb17-85"><a href="#cb17-85" tabindex="-1"></a><span class="co">#&gt;                               5                   0            0              0       </span></span>
<span id="cb17-86"><a href="#cb17-86" tabindex="-1"></a><span class="co">#&gt;     dcd A.1.1.1.2                                                                     </span></span>
<span id="cb17-87"><a href="#cb17-87" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   5 (33.3%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb17-88"><a href="#cb17-88" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2       5 (33.3%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb17-89"><a href="#cb17-89" tabindex="-1"></a><span class="co">#&gt;                               1                   0            0              0       </span></span>
<span id="cb17-90"><a href="#cb17-90" tabindex="-1"></a><span class="co">#&gt;                               2               5 (33.3%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb17-91"><a href="#cb17-91" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-5           0            0              0       </span></span>
<span id="cb17-92"><a href="#cb17-92" tabindex="-1"></a><span class="co">#&gt;                               3                   0            0              0       </span></span>
<span id="cb17-93"><a href="#cb17-93" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb17-94"><a href="#cb17-94" tabindex="-1"></a><span class="co">#&gt;                               5                   0            0              0       </span></span>
<span id="cb17-95"><a href="#cb17-95" tabindex="-1"></a><span class="co">#&gt;     dcd A.1.1.1.1                                                                     </span></span>
<span id="cb17-96"><a href="#cb17-96" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   3 (20.0%)     1 (6.7%)      6 (40.0%)   </span></span>
<span id="cb17-97"><a href="#cb17-97" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2       3 (20.0%)     1 (6.7%)      6 (40.0%)   </span></span>
<span id="cb17-98"><a href="#cb17-98" tabindex="-1"></a><span class="co">#&gt;                               1               3 (20.0%)     1 (6.7%)      6 (40.0%)   </span></span>
<span id="cb17-99"><a href="#cb17-99" tabindex="-1"></a><span class="co">#&gt;                               2                   0            0              0       </span></span>
<span id="cb17-100"><a href="#cb17-100" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-5           0            0              0       </span></span>
<span id="cb17-101"><a href="#cb17-101" tabindex="-1"></a><span class="co">#&gt;                               3                   0            0              0       </span></span>
<span id="cb17-102"><a href="#cb17-102" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb17-103"><a href="#cb17-103" tabindex="-1"></a><span class="co">#&gt;                               5                   0            0              0       </span></span>
<span id="cb17-104"><a href="#cb17-104" tabindex="-1"></a><span class="co">#&gt;   cl B.1                                                                              </span></span>
<span id="cb17-105"><a href="#cb17-105" tabindex="-1"></a><span class="co">#&gt;     - Overall -                                                                       </span></span>
<span id="cb17-106"><a href="#cb17-106" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   5 (33.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb17-107"><a href="#cb17-107" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2           0            0              0       </span></span>
<span id="cb17-108"><a href="#cb17-108" tabindex="-1"></a><span class="co">#&gt;                               1                   0            0              0       </span></span>
<span id="cb17-109"><a href="#cb17-109" tabindex="-1"></a><span class="co">#&gt;                               2                   0            0              0       </span></span>
<span id="cb17-110"><a href="#cb17-110" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-5       5 (33.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb17-111"><a href="#cb17-111" tabindex="-1"></a><span class="co">#&gt;                               3                   0            0              0       </span></span>
<span id="cb17-112"><a href="#cb17-112" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb17-113"><a href="#cb17-113" tabindex="-1"></a><span class="co">#&gt;                               5               5 (33.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb17-114"><a href="#cb17-114" tabindex="-1"></a><span class="co">#&gt;     dcd B.1.1.1.1                                                                     </span></span>
<span id="cb17-115"><a href="#cb17-115" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   5 (33.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb17-116"><a href="#cb17-116" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2           0            0              0       </span></span>
<span id="cb17-117"><a href="#cb17-117" tabindex="-1"></a><span class="co">#&gt;                               1                   0            0              0       </span></span>
<span id="cb17-118"><a href="#cb17-118" tabindex="-1"></a><span class="co">#&gt;                               2                   0            0              0       </span></span>
<span id="cb17-119"><a href="#cb17-119" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-5       5 (33.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb17-120"><a href="#cb17-120" tabindex="-1"></a><span class="co">#&gt;                               3                   0            0              0       </span></span>
<span id="cb17-121"><a href="#cb17-121" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb17-122"><a href="#cb17-122" tabindex="-1"></a><span class="co">#&gt;                               5               5 (33.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb17-123"><a href="#cb17-123" tabindex="-1"></a><span class="co">#&gt;   cl C.2                                                                              </span></span>
<span id="cb17-124"><a href="#cb17-124" tabindex="-1"></a><span class="co">#&gt;     - Overall -                                                                       </span></span>
<span id="cb17-125"><a href="#cb17-125" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   6 (40.0%)    4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb17-126"><a href="#cb17-126" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2       6 (40.0%)    4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb17-127"><a href="#cb17-127" tabindex="-1"></a><span class="co">#&gt;                               1                   0            0              0       </span></span>
<span id="cb17-128"><a href="#cb17-128" tabindex="-1"></a><span class="co">#&gt;                               2               6 (40.0%)    4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb17-129"><a href="#cb17-129" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-5           0            0              0       </span></span>
<span id="cb17-130"><a href="#cb17-130" tabindex="-1"></a><span class="co">#&gt;                               3                   0            0              0       </span></span>
<span id="cb17-131"><a href="#cb17-131" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb17-132"><a href="#cb17-132" tabindex="-1"></a><span class="co">#&gt;                               5                   0            0              0       </span></span>
<span id="cb17-133"><a href="#cb17-133" tabindex="-1"></a><span class="co">#&gt;     dcd C.2.1.2.1                                                                     </span></span>
<span id="cb17-134"><a href="#cb17-134" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   6 (40.0%)    4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb17-135"><a href="#cb17-135" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2       6 (40.0%)    4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb17-136"><a href="#cb17-136" tabindex="-1"></a><span class="co">#&gt;                               1                   0            0              0       </span></span>
<span id="cb17-137"><a href="#cb17-137" tabindex="-1"></a><span class="co">#&gt;                               2               6 (40.0%)    4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb17-138"><a href="#cb17-138" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-5           0            0              0       </span></span>
<span id="cb17-139"><a href="#cb17-139" tabindex="-1"></a><span class="co">#&gt;                               3                   0            0              0       </span></span>
<span id="cb17-140"><a href="#cb17-140" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb17-141"><a href="#cb17-141" tabindex="-1"></a><span class="co">#&gt;                               5                   0            0              0       </span></span>
<span id="cb17-142"><a href="#cb17-142" tabindex="-1"></a><span class="co">#&gt;   cl D.2                                                                              </span></span>
<span id="cb17-143"><a href="#cb17-143" tabindex="-1"></a><span class="co">#&gt;     - Overall -                                                                       </span></span>
<span id="cb17-144"><a href="#cb17-144" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   2 (13.3%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb17-145"><a href="#cb17-145" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2       2 (13.3%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb17-146"><a href="#cb17-146" tabindex="-1"></a><span class="co">#&gt;                               1               2 (13.3%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb17-147"><a href="#cb17-147" tabindex="-1"></a><span class="co">#&gt;                               2                   0            0              0       </span></span>
<span id="cb17-148"><a href="#cb17-148" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-5           0            0              0       </span></span>
<span id="cb17-149"><a href="#cb17-149" tabindex="-1"></a><span class="co">#&gt;                               3                   0            0              0       </span></span>
<span id="cb17-150"><a href="#cb17-150" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb17-151"><a href="#cb17-151" tabindex="-1"></a><span class="co">#&gt;                               5                   0            0              0       </span></span>
<span id="cb17-152"><a href="#cb17-152" tabindex="-1"></a><span class="co">#&gt;     dcd D.2.1.5.3                                                                     </span></span>
<span id="cb17-153"><a href="#cb17-153" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   2 (13.3%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb17-154"><a href="#cb17-154" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2       2 (13.3%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb17-155"><a href="#cb17-155" tabindex="-1"></a><span class="co">#&gt;                               1               2 (13.3%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb17-156"><a href="#cb17-156" tabindex="-1"></a><span class="co">#&gt;                               2                   0            0              0       </span></span>
<span id="cb17-157"><a href="#cb17-157" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-5           0            0              0       </span></span>
<span id="cb17-158"><a href="#cb17-158" tabindex="-1"></a><span class="co">#&gt;                               3                   0            0              0       </span></span>
<span id="cb17-159"><a href="#cb17-159" tabindex="-1"></a><span class="co">#&gt;                               4                   0            0              0       </span></span>
<span id="cb17-160"><a href="#cb17-160" tabindex="-1"></a><span class="co">#&gt;                               5                   0            0              0       </span></span>
<span id="cb17-161"><a href="#cb17-161" tabindex="-1"></a><span class="co">#&gt;   cl C.1                                                                              </span></span>
<span id="cb17-162"><a href="#cb17-162" tabindex="-1"></a><span class="co">#&gt;     - Overall -                                                                       </span></span>
<span id="cb17-163"><a href="#cb17-163" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   4 (26.7%)    4 (26.7%)      5 (33.3%)   </span></span>
<span id="cb17-164"><a href="#cb17-164" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2           0            0              0       </span></span>
<span id="cb17-165"><a href="#cb17-165" tabindex="-1"></a><span class="co">#&gt;                               1                   0            0              0       </span></span>
<span id="cb17-166"><a href="#cb17-166" tabindex="-1"></a><span class="co">#&gt;                               2                   0            0              0       </span></span>
<span id="cb17-167"><a href="#cb17-167" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-5       4 (26.7%)    4 (26.7%)      5 (33.3%)   </span></span>
<span id="cb17-168"><a href="#cb17-168" tabindex="-1"></a><span class="co">#&gt;                               3                   0            0              0       </span></span>
<span id="cb17-169"><a href="#cb17-169" tabindex="-1"></a><span class="co">#&gt;                               4               4 (26.7%)    4 (26.7%)      5 (33.3%)   </span></span>
<span id="cb17-170"><a href="#cb17-170" tabindex="-1"></a><span class="co">#&gt;                               5                   0            0              0       </span></span>
<span id="cb17-171"><a href="#cb17-171" tabindex="-1"></a><span class="co">#&gt;     dcd C.1.1.1.3                                                                     </span></span>
<span id="cb17-172"><a href="#cb17-172" tabindex="-1"></a><span class="co">#&gt;                               - Any Grade -   4 (26.7%)    4 (26.7%)      5 (33.3%)   </span></span>
<span id="cb17-173"><a href="#cb17-173" tabindex="-1"></a><span class="co">#&gt;                               Grade 1-2           0            0              0       </span></span>
<span id="cb17-174"><a href="#cb17-174" tabindex="-1"></a><span class="co">#&gt;                               1                   0            0              0       </span></span>
<span id="cb17-175"><a href="#cb17-175" tabindex="-1"></a><span class="co">#&gt;                               2                   0            0              0       </span></span>
<span id="cb17-176"><a href="#cb17-176" tabindex="-1"></a><span class="co">#&gt;                               Grade 3-5       4 (26.7%)    4 (26.7%)      5 (33.3%)   </span></span>
<span id="cb17-177"><a href="#cb17-177" tabindex="-1"></a><span class="co">#&gt;                               3                   0            0              0       </span></span>
<span id="cb17-178"><a href="#cb17-178" tabindex="-1"></a><span class="co">#&gt;                               4               4 (26.7%)    4 (26.7%)      5 (33.3%)   </span></span>
<span id="cb17-179"><a href="#cb17-179" tabindex="-1"></a><span class="co">#&gt;                               5                   0            0              0</span></span></code></pre></div>
</div>
</div>
<div id="adverse-event-rate-adjusted-for-patient-years-at-risk---first-occurrence-aet05" class="section level3">
<h3><strong>Adverse Event Rate Adjusted for Patient-Years at Risk -
First Occurrence (<code>AET05</code>)</strong></h3>
<div id="adverse-event-rate-adjusted-for-patient-years-at-risk---first-occurrence" class="section level4">
<h4><strong>1. Adverse Event Rate Adjusted for Patient-Years at Risk -
First Occurrence</strong></h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>aet05</code></strong> template produces the
standard adverse event rate adjusted for patient-years at risk summary
considering first occurrence only.</li>
<li>By default, all <code>adsaftte</code> parameter codes containing the
string <code>&quot;TTE&quot;</code> are included in the output. Users are expected
to filter the parameter(s) of interest from input safety time-to-event
dataset in pre-processing if needed.</li>
<li>In the input safety time-to-event dataset, in the censoring variable
<code>CNSR</code>, <code>0</code> indicates the occurrence of an event
of interest and <code>1</code> denotes censoring.</li>
</ol>
<div class="sourceCode" id="cb18"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb18-1"><a href="#cb18-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;AETTE1&quot;</span>, <span class="st">&quot;adsaftte&quot;</span>)</span>
<span id="cb18-2"><a href="#cb18-2" tabindex="-1"></a></span>
<span id="cb18-3"><a href="#cb18-3" tabindex="-1"></a><span class="fu">run</span>(aet05, proc_data)</span>
<span id="cb18-4"><a href="#cb18-4" tabindex="-1"></a><span class="co">#&gt;                                                     A: Drug X       B: Placebo      C: Combination</span></span>
<span id="cb18-5"><a href="#cb18-5" tabindex="-1"></a><span class="co">#&gt;                                                      (N=15)           (N=15)            (N=15)    </span></span>
<span id="cb18-6"><a href="#cb18-6" tabindex="-1"></a><span class="co">#&gt;   ââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb18-7"><a href="#cb18-7" tabindex="-1"></a><span class="co">#&gt;   Time to first occurrence of any adverse event                                                   </span></span>
<span id="cb18-8"><a href="#cb18-8" tabindex="-1"></a><span class="co">#&gt;     Total patient-years at risk                       31.0              9.0              22.0     </span></span>
<span id="cb18-9"><a href="#cb18-9" tabindex="-1"></a><span class="co">#&gt;     Number of adverse events observed                   5               13                8       </span></span>
<span id="cb18-10"><a href="#cb18-10" tabindex="-1"></a><span class="co">#&gt;     AE rate per 100 patient-years                     16.13           143.84            36.30     </span></span>
<span id="cb18-11"><a href="#cb18-11" tabindex="-1"></a><span class="co">#&gt;     95% CI                                        (1.99, 30.27)   (65.65, 222.03)   (11.15, 61.46)</span></span></code></pre></div>
</div>
<div id="adverse-event-rate-adjusted-for-patient-years-at-risk---first-occurrence-setting-type-of-confidence-interval" class="section level4">
<h4><strong>2. Adverse Event Rate Adjusted for Patient-Years at Risk -
First Occurrence (setting type of confidence interval)</strong></h4>
<ol style="list-style-type: decimal">
<li>The type of the confidence interval for rate can be specified by the
argument <code>conf_type</code>. Options include <code>normal</code>
(default), <code>normal_log</code> and <code>exact</code>.</li>
<li>The confidence interval can be adjusted by the argument
<code>conf_level</code>.</li>
</ol>
<div class="sourceCode" id="cb19"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb19-1"><a href="#cb19-1" tabindex="-1"></a><span class="fu">run</span>(aet05, syn_data, <span class="at">conf_level =</span> <span class="fl">0.90</span>, <span class="at">conf_type =</span> <span class="st">&quot;exact&quot;</span>)</span>
<span id="cb19-2"><a href="#cb19-2" tabindex="-1"></a><span class="co">#&gt;                                                              A: Drug X         B: Placebo      C: Combination </span></span>
<span id="cb19-3"><a href="#cb19-3" tabindex="-1"></a><span class="co">#&gt;                                                               (N=15)             (N=15)            (N=15)     </span></span>
<span id="cb19-4"><a href="#cb19-4" tabindex="-1"></a><span class="co">#&gt;   ââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb19-5"><a href="#cb19-5" tabindex="-1"></a><span class="co">#&gt;   Time to first occurrence of a grade 3-5 adverse event                                                       </span></span>
<span id="cb19-6"><a href="#cb19-6" tabindex="-1"></a><span class="co">#&gt;     Total patient-years at risk                                10.3               6.3                8.3      </span></span>
<span id="cb19-7"><a href="#cb19-7" tabindex="-1"></a><span class="co">#&gt;     Number of adverse events observed                           12                 14                13       </span></span>
<span id="cb19-8"><a href="#cb19-8" tabindex="-1"></a><span class="co">#&gt;     AE rate per 100 patient-years                             116.36             223.84            156.98     </span></span>
<span id="cb19-9"><a href="#cb19-9" tabindex="-1"></a><span class="co">#&gt;     90% CI                                                (67.14, 188.53)   (135.32, 349.93)   (92.86, 249.59)</span></span>
<span id="cb19-10"><a href="#cb19-10" tabindex="-1"></a><span class="co">#&gt;   Time to first occurrence of any adverse event                                                               </span></span>
<span id="cb19-11"><a href="#cb19-11" tabindex="-1"></a><span class="co">#&gt;     Total patient-years at risk                                31.0               9.0               22.0      </span></span>
<span id="cb19-12"><a href="#cb19-12" tabindex="-1"></a><span class="co">#&gt;     Number of adverse events observed                            5                 13                 8       </span></span>
<span id="cb19-13"><a href="#cb19-13" tabindex="-1"></a><span class="co">#&gt;     AE rate per 100 patient-years                              16.13             143.84             36.30     </span></span>
<span id="cb19-14"><a href="#cb19-14" tabindex="-1"></a><span class="co">#&gt;     90% CI                                                 (6.36, 33.91)    (85.08, 228.69)    (18.07, 65.51) </span></span>
<span id="cb19-15"><a href="#cb19-15" tabindex="-1"></a><span class="co">#&gt;   Time to first occurrence of any serious adverse event                                                       </span></span>
<span id="cb19-16"><a href="#cb19-16" tabindex="-1"></a><span class="co">#&gt;     Total patient-years at risk                                32.9               7.6                9.4      </span></span>
<span id="cb19-17"><a href="#cb19-17" tabindex="-1"></a><span class="co">#&gt;     Number of adverse events observed                            4                 14                13       </span></span>
<span id="cb19-18"><a href="#cb19-18" tabindex="-1"></a><span class="co">#&gt;     AE rate per 100 patient-years                              12.15             183.83            137.79     </span></span>
<span id="cb19-19"><a href="#cb19-19" tabindex="-1"></a><span class="co">#&gt;     90% CI                                                 (4.15, 27.80)    (111.14, 287.38)   (81.50, 219.06)</span></span></code></pre></div>
</div>
</div>
<div id="adverse-event-rate-adjusted-for-patient-years-at-risk---all-occurrences-aet05_all" class="section level3">
<h3><strong>Adverse Event Rate Adjusted for Patient-Years at Risk - All
Occurrences (<code>AET05_ALL</code>)</strong></h3>
<div id="adverse-event-rate-adjusted-for-patient-years-at-risk---all-occurrences" class="section level4">
<h4><strong>1. Adverse Event Rate Adjusted for Patient-Years at Risk -
All Occurrences</strong></h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>aet05_all</code></strong> template produces the
standard adverse event rate adjusted for patient-years at risk summary
considering all occurrences.</li>
<li>By default, all <code>adsaftte</code> parameter codes containing the
string <code>&quot;TOT&quot;</code> and the parameter code <code>&quot;AEREPTTE&quot;</code>
are required. <code>&quot;TOT&quot;</code> parameters store the number of
occurrences of adverse event of interests. Parameter code
<code>&quot;AEREPTTE&quot;</code> stores the time to end of adverse event
reporting period in years that contribute to the summary of âtotal
patient-years at riskâ in the output. Users are expected to filter
parameters of interest from input analysis dataset in pre-processing, if
needed.</li>
<li>In the input safety time-to-event dataset, in the censoring variable
<code>CNSR</code>, <code>0</code> indicates the occurrence of an event
of interest and <code>1</code> denotes censoring.</li>
</ol>
<div class="sourceCode" id="cb20"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb20-1"><a href="#cb20-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;AETOT1&quot;</span> <span class="sc">|</span> PARAMCD <span class="sc">==</span> <span class="st">&quot;AEREPTTE&quot;</span>, <span class="st">&quot;adsaftte&quot;</span>)</span>
<span id="cb20-2"><a href="#cb20-2" tabindex="-1"></a></span>
<span id="cb20-3"><a href="#cb20-3" tabindex="-1"></a><span class="fu">run</span>(aet05_all, proc_data)</span>
<span id="cb20-4"><a href="#cb20-4" tabindex="-1"></a><span class="co">#&gt;                                                  A: Drug X        B: Placebo      C: Combination </span></span>
<span id="cb20-5"><a href="#cb20-5" tabindex="-1"></a><span class="co">#&gt;                                                    (N=15)           (N=15)            (N=15)     </span></span>
<span id="cb20-6"><a href="#cb20-6" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb20-7"><a href="#cb20-7" tabindex="-1"></a><span class="co">#&gt;   Number of occurrences of any adverse event                                                     </span></span>
<span id="cb20-8"><a href="#cb20-8" tabindex="-1"></a><span class="co">#&gt;     Total patient-years at risk                     44.4             44.2              44.4      </span></span>
<span id="cb20-9"><a href="#cb20-9" tabindex="-1"></a><span class="co">#&gt;     Number of adverse events observed                29               49                56       </span></span>
<span id="cb20-10"><a href="#cb20-10" tabindex="-1"></a><span class="co">#&gt;     AE rate per 100 patient-years                  65.32            110.78            126.16     </span></span>
<span id="cb20-11"><a href="#cb20-11" tabindex="-1"></a><span class="co">#&gt;     95% CI                                     (41.55, 89.09)   (79.76, 141.79)   (93.12, 159.20)</span></span></code></pre></div>
</div>
<div id="adverse-event-rate-adjusted-for-patient-years-at-risk---all-occurrences-setting-type-of-confidence-interval" class="section level4">
<h4><strong>2. Adverse Event Rate Adjusted for Patient-Years at Risk -
All Occurrences (setting type of confidence interval)</strong></h4>
<ol style="list-style-type: decimal">
<li>The type of the confidence interval for rate can be specified by the
argument <code>conf_type</code>. Options include <code>normal</code>
(default), <code>normal_log</code>, <code>exact</code>, and
<code>byar</code>.</li>
<li>The confidence interval can be adjusted by the argument
<code>conf_level</code>.</li>
</ol>
<div class="sourceCode" id="cb21"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb21-1"><a href="#cb21-1" tabindex="-1"></a><span class="fu">run</span>(aet05_all, syn_data, <span class="at">conf_level =</span> <span class="fl">0.90</span>, <span class="at">conf_type =</span> <span class="st">&quot;exact&quot;</span>)</span>
<span id="cb21-2"><a href="#cb21-2" tabindex="-1"></a><span class="co">#&gt;                                                           A: Drug X         B: Placebo       C: Combination </span></span>
<span id="cb21-3"><a href="#cb21-3" tabindex="-1"></a><span class="co">#&gt;                                                             (N=15)            (N=15)             (N=15)     </span></span>
<span id="cb21-4"><a href="#cb21-4" tabindex="-1"></a><span class="co">#&gt;   ââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb21-5"><a href="#cb21-5" tabindex="-1"></a><span class="co">#&gt;   Number of occurrences of a grade 3-5 adverse event                                                        </span></span>
<span id="cb21-6"><a href="#cb21-6" tabindex="-1"></a><span class="co">#&gt;     Total patient-years at risk                              44.4              44.2               44.4      </span></span>
<span id="cb21-7"><a href="#cb21-7" tabindex="-1"></a><span class="co">#&gt;     Number of adverse events observed                         65                54                 95       </span></span>
<span id="cb21-8"><a href="#cb21-8" tabindex="-1"></a><span class="co">#&gt;     AE rate per 100 patient-years                           146.41            122.08             214.02     </span></span>
<span id="cb21-9"><a href="#cb21-9" tabindex="-1"></a><span class="co">#&gt;     90% CI                                             (117.87, 179.98)   (96.10, 153.14)   (179.23, 253.81)</span></span>
<span id="cb21-10"><a href="#cb21-10" tabindex="-1"></a><span class="co">#&gt;   Number of occurrences of any adverse event                                                                </span></span>
<span id="cb21-11"><a href="#cb21-11" tabindex="-1"></a><span class="co">#&gt;     Total patient-years at risk                              44.4              44.2               44.4      </span></span>
<span id="cb21-12"><a href="#cb21-12" tabindex="-1"></a><span class="co">#&gt;     Number of adverse events observed                         29                49                 56       </span></span>
<span id="cb21-13"><a href="#cb21-13" tabindex="-1"></a><span class="co">#&gt;     AE rate per 100 patient-years                           65.32             110.78             126.16     </span></span>
<span id="cb21-14"><a href="#cb21-14" tabindex="-1"></a><span class="co">#&gt;     90% CI                                              (46.73, 89.06)    (86.09, 140.55)   (99.77, 157.61) </span></span>
<span id="cb21-15"><a href="#cb21-15" tabindex="-1"></a><span class="co">#&gt;   Number of occurrences of any serious adverse event                                                        </span></span>
<span id="cb21-16"><a href="#cb21-16" tabindex="-1"></a><span class="co">#&gt;     Total patient-years at risk                              44.4              44.2               44.4      </span></span>
<span id="cb21-17"><a href="#cb21-17" tabindex="-1"></a><span class="co">#&gt;     Number of adverse events observed                         9                 36                 60       </span></span>
<span id="cb21-18"><a href="#cb21-18" tabindex="-1"></a><span class="co">#&gt;     AE rate per 100 patient-years                           20.27              81.39             135.17     </span></span>
<span id="cb21-19"><a href="#cb21-19" tabindex="-1"></a><span class="co">#&gt;     90% CI                                              (10.58, 35.37)    (60.43, 107.48)   (107.80, 167.59)</span></span></code></pre></div>
</div>
</div>
<div id="most-common-5-adverse-events-aet10" class="section level3">
<h3><strong>Most Common (&gt;=5%) Adverse Events
(<code>AET10</code>)</strong></h3>
<div id="most-common-5-adverse-events" class="section level4">
<h4><strong>1. Most Common (&gt;=5%) Adverse Events</strong></h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>aet10</code></strong> template produces the
standard most common adverse events occurring with relative frequency
&gt;=5% output.</li>
</ol>
<div class="sourceCode" id="cb22"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb22-1"><a href="#cb22-1" tabindex="-1"></a><span class="fu">run</span>(aet10, syn_data)</span>
<span id="cb22-2"><a href="#cb22-2" tabindex="-1"></a><span class="co">#&gt;                           A: Drug X   B: Placebo   C: Combination</span></span>
<span id="cb22-3"><a href="#cb22-3" tabindex="-1"></a><span class="co">#&gt;   MedDRA Preferred Term    (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb22-4"><a href="#cb22-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb22-5"><a href="#cb22-5" tabindex="-1"></a><span class="co">#&gt;   dcd B.2.2.3.1           8 (53.3%)   6 (40.0%)      7 (46.7%)   </span></span>
<span id="cb22-6"><a href="#cb22-6" tabindex="-1"></a><span class="co">#&gt;   dcd B.1.1.1.1           5 (33.3%)   6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb22-7"><a href="#cb22-7" tabindex="-1"></a><span class="co">#&gt;   dcd C.2.1.2.1           6 (40.0%)   4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb22-8"><a href="#cb22-8" tabindex="-1"></a><span class="co">#&gt;   dcd A.1.1.1.2           5 (33.3%)   6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb22-9"><a href="#cb22-9" tabindex="-1"></a><span class="co">#&gt;   dcd B.2.1.2.1           5 (33.3%)   6 (40.0%)      5 (33.3%)   </span></span>
<span id="cb22-10"><a href="#cb22-10" tabindex="-1"></a><span class="co">#&gt;   dcd D.1.1.1.1           4 (26.7%)   4 (26.7%)      7 (46.7%)   </span></span>
<span id="cb22-11"><a href="#cb22-11" tabindex="-1"></a><span class="co">#&gt;   dcd D.1.1.4.2           6 (40.0%)   2 (13.3%)      7 (46.7%)   </span></span>
<span id="cb22-12"><a href="#cb22-12" tabindex="-1"></a><span class="co">#&gt;   dcd D.2.1.5.3           2 (13.3%)   5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb22-13"><a href="#cb22-13" tabindex="-1"></a><span class="co">#&gt;   dcd C.1.1.1.3           4 (26.7%)   4 (26.7%)      5 (33.3%)   </span></span>
<span id="cb22-14"><a href="#cb22-14" tabindex="-1"></a><span class="co">#&gt;   dcd A.1.1.1.1           3 (20.0%)    1 (6.7%)      6 (40.0%)</span></span></code></pre></div>
</div>
<div id="most-common-8-adverse-events-setting-threshold" class="section level4">
<h4><strong>2. Most Common (&gt;=8%) Adverse Events (setting
threshold)</strong></h4>
<p>To modify the threshold for displaying preferred terms, this can be
achieved by providing the threshold to the argument
<code>atleast</code>.</p>
<div class="sourceCode" id="cb23"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb23-1"><a href="#cb23-1" tabindex="-1"></a><span class="fu">run</span>(aet10, syn_data, <span class="at">atleast =</span> <span class="fl">0.08</span>)</span>
<span id="cb23-2"><a href="#cb23-2" tabindex="-1"></a><span class="co">#&gt;                           A: Drug X   B: Placebo   C: Combination</span></span>
<span id="cb23-3"><a href="#cb23-3" tabindex="-1"></a><span class="co">#&gt;   MedDRA Preferred Term    (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb23-4"><a href="#cb23-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb23-5"><a href="#cb23-5" tabindex="-1"></a><span class="co">#&gt;   dcd B.2.2.3.1           8 (53.3%)   6 (40.0%)      7 (46.7%)   </span></span>
<span id="cb23-6"><a href="#cb23-6" tabindex="-1"></a><span class="co">#&gt;   dcd B.1.1.1.1           5 (33.3%)   6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb23-7"><a href="#cb23-7" tabindex="-1"></a><span class="co">#&gt;   dcd C.2.1.2.1           6 (40.0%)   4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb23-8"><a href="#cb23-8" tabindex="-1"></a><span class="co">#&gt;   dcd A.1.1.1.2           5 (33.3%)   6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb23-9"><a href="#cb23-9" tabindex="-1"></a><span class="co">#&gt;   dcd B.2.1.2.1           5 (33.3%)   6 (40.0%)      5 (33.3%)   </span></span>
<span id="cb23-10"><a href="#cb23-10" tabindex="-1"></a><span class="co">#&gt;   dcd D.1.1.1.1           4 (26.7%)   4 (26.7%)      7 (46.7%)   </span></span>
<span id="cb23-11"><a href="#cb23-11" tabindex="-1"></a><span class="co">#&gt;   dcd D.1.1.4.2           6 (40.0%)   2 (13.3%)      7 (46.7%)   </span></span>
<span id="cb23-12"><a href="#cb23-12" tabindex="-1"></a><span class="co">#&gt;   dcd D.2.1.5.3           2 (13.3%)   5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb23-13"><a href="#cb23-13" tabindex="-1"></a><span class="co">#&gt;   dcd C.1.1.1.3           4 (26.7%)   4 (26.7%)      5 (33.3%)   </span></span>
<span id="cb23-14"><a href="#cb23-14" tabindex="-1"></a><span class="co">#&gt;   dcd A.1.1.1.1           3 (20.0%)    1 (6.7%)      6 (40.0%)</span></span></code></pre></div>
</div>
</div>
<div id="concomitant-medications-by-medication-class-and-preferred-name-cmt01a" class="section level3">
<h3><strong>Concomitant Medications by Medication Class and Preferred
Name (<code>CMT01A</code>)</strong></h3>
<div id="concomitant-medications-by-medication-class-and-preferred-name" class="section level4">
<h4><strong>1. Concomitant Medications by Medication Class and Preferred
Name</strong></h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>cmt01a</code></strong> template displays
concomitant medications by <code>ATC Level 2</code> and Preferred Name
by default.</li>
<li>The template does not include the column of total by default.</li>
<li>The template sort medication class and preferred name by
alphabetical order by default.</li>
</ol>
<div class="sourceCode" id="cb24"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb24-1"><a href="#cb24-1" tabindex="-1"></a><span class="fu">run</span>(cmt01a, syn_data)</span>
<span id="cb24-2"><a href="#cb24-2" tabindex="-1"></a><span class="co">#&gt;   ATC Level 2 Text                                         A: Drug X    B: Placebo   C: Combination</span></span>
<span id="cb24-3"><a href="#cb24-3" tabindex="-1"></a><span class="co">#&gt;     Other Treatment                                          (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb24-4"><a href="#cb24-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb24-5"><a href="#cb24-5" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with at least one treatment     13 (86.7%)   14 (93.3%)     15 (100%)   </span></span>
<span id="cb24-6"><a href="#cb24-6" tabindex="-1"></a><span class="co">#&gt;   Total number of treatments                                   58           59             99      </span></span>
<span id="cb24-7"><a href="#cb24-7" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS2 A                                                                                       </span></span>
<span id="cb24-8"><a href="#cb24-8" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   10 (66.7%)   11 (73.3%)     12 (80.0%)  </span></span>
<span id="cb24-9"><a href="#cb24-9" tabindex="-1"></a><span class="co">#&gt;     Total number of treatments                                 15           21             28      </span></span>
<span id="cb24-10"><a href="#cb24-10" tabindex="-1"></a><span class="co">#&gt;     medname A_3/3                                          5 (33.3%)    8 (53.3%)      6 (40.0%)   </span></span>
<span id="cb24-11"><a href="#cb24-11" tabindex="-1"></a><span class="co">#&gt;     medname A_2/3                                          5 (33.3%)    6 (40.0%)      7 (46.7%)   </span></span>
<span id="cb24-12"><a href="#cb24-12" tabindex="-1"></a><span class="co">#&gt;     medname A_1/3                                          4 (26.7%)    3 (20.0%)      8 (53.3%)   </span></span>
<span id="cb24-13"><a href="#cb24-13" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS2 A p2                                                                                    </span></span>
<span id="cb24-14"><a href="#cb24-14" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   5 (33.3%)    8 (53.3%)      6 (40.0%)   </span></span>
<span id="cb24-15"><a href="#cb24-15" tabindex="-1"></a><span class="co">#&gt;     Total number of treatments                                 6            8              8       </span></span>
<span id="cb24-16"><a href="#cb24-16" tabindex="-1"></a><span class="co">#&gt;     medname A_3/3                                          5 (33.3%)    8 (53.3%)      6 (40.0%)   </span></span>
<span id="cb24-17"><a href="#cb24-17" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS2 B                                                                                       </span></span>
<span id="cb24-18"><a href="#cb24-18" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   12 (80.0%)   10 (66.7%)     14 (93.3%)  </span></span>
<span id="cb24-19"><a href="#cb24-19" tabindex="-1"></a><span class="co">#&gt;     Total number of treatments                                 30           30             52      </span></span>
<span id="cb24-20"><a href="#cb24-20" tabindex="-1"></a><span class="co">#&gt;     medname B_3/4                                          8 (53.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb24-21"><a href="#cb24-21" tabindex="-1"></a><span class="co">#&gt;     medname B_2/4                                          6 (40.0%)    5 (33.3%)      10 (66.7%)  </span></span>
<span id="cb24-22"><a href="#cb24-22" tabindex="-1"></a><span class="co">#&gt;     medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb24-23"><a href="#cb24-23" tabindex="-1"></a><span class="co">#&gt;     medname B_4/4                                          4 (26.7%)    5 (33.3%)      8 (53.3%)   </span></span>
<span id="cb24-24"><a href="#cb24-24" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS2 B p2                                                                                    </span></span>
<span id="cb24-25"><a href="#cb24-25" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   10 (66.7%)   8 (53.3%)      12 (80.0%)  </span></span>
<span id="cb24-26"><a href="#cb24-26" tabindex="-1"></a><span class="co">#&gt;     Total number of treatments                                 18           17             25      </span></span>
<span id="cb24-27"><a href="#cb24-27" tabindex="-1"></a><span class="co">#&gt;     medname B_2/4                                          6 (40.0%)    5 (33.3%)      10 (66.7%)  </span></span>
<span id="cb24-28"><a href="#cb24-28" tabindex="-1"></a><span class="co">#&gt;     medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb24-29"><a href="#cb24-29" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS2 B p3                                                                                    </span></span>
<span id="cb24-30"><a href="#cb24-30" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   10 (66.7%)   8 (53.3%)      12 (80.0%)  </span></span>
<span id="cb24-31"><a href="#cb24-31" tabindex="-1"></a><span class="co">#&gt;     Total number of treatments                                 18           17             25      </span></span>
<span id="cb24-32"><a href="#cb24-32" tabindex="-1"></a><span class="co">#&gt;     medname B_2/4                                          6 (40.0%)    5 (33.3%)      10 (66.7%)  </span></span>
<span id="cb24-33"><a href="#cb24-33" tabindex="-1"></a><span class="co">#&gt;     medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb24-34"><a href="#cb24-34" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS2 C                                                                                       </span></span>
<span id="cb24-35"><a href="#cb24-35" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   9 (60.0%)    7 (46.7%)      12 (80.0%)  </span></span>
<span id="cb24-36"><a href="#cb24-36" tabindex="-1"></a><span class="co">#&gt;     Total number of treatments                                 13           8              19      </span></span>
<span id="cb24-37"><a href="#cb24-37" tabindex="-1"></a><span class="co">#&gt;     medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb24-38"><a href="#cb24-38" tabindex="-1"></a><span class="co">#&gt;     medname C_1/2                                          6 (40.0%)    2 (13.3%)      6 (40.0%)   </span></span>
<span id="cb24-39"><a href="#cb24-39" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS2 C p2                                                                                    </span></span>
<span id="cb24-40"><a href="#cb24-40" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   9 (60.0%)    7 (46.7%)      12 (80.0%)  </span></span>
<span id="cb24-41"><a href="#cb24-41" tabindex="-1"></a><span class="co">#&gt;     Total number of treatments                                 13           8              19      </span></span>
<span id="cb24-42"><a href="#cb24-42" tabindex="-1"></a><span class="co">#&gt;     medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb24-43"><a href="#cb24-43" tabindex="-1"></a><span class="co">#&gt;     medname C_1/2                                          6 (40.0%)    2 (13.3%)      6 (40.0%)   </span></span>
<span id="cb24-44"><a href="#cb24-44" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS2 C p3                                                                                    </span></span>
<span id="cb24-45"><a href="#cb24-45" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   4 (26.7%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb24-46"><a href="#cb24-46" tabindex="-1"></a><span class="co">#&gt;     Total number of treatments                                 5            5              12      </span></span>
<span id="cb24-47"><a href="#cb24-47" tabindex="-1"></a><span class="co">#&gt;     medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)</span></span></code></pre></div>
</div>
<div id="concomitant-medications-by-medication-class-and-preferred-name-changing-atc-class-level" class="section level4">
<h4><strong>2. Concomitant Medications by Medication Class and Preferred
Name (changing <code>ATC class level</code>)</strong></h4>
<div class="sourceCode" id="cb25"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb25-1"><a href="#cb25-1" tabindex="-1"></a><span class="fu">run</span>(cmt01a, syn_data, <span class="at">row_split_var =</span> <span class="st">&quot;ATC1&quot;</span>)</span>
<span id="cb25-2"><a href="#cb25-2" tabindex="-1"></a><span class="co">#&gt;   ATC Level 1 Text                                         A: Drug X    B: Placebo   C: Combination</span></span>
<span id="cb25-3"><a href="#cb25-3" tabindex="-1"></a><span class="co">#&gt;     Other Treatment                                          (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb25-4"><a href="#cb25-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb25-5"><a href="#cb25-5" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with at least one treatment     13 (86.7%)   14 (93.3%)     15 (100%)   </span></span>
<span id="cb25-6"><a href="#cb25-6" tabindex="-1"></a><span class="co">#&gt;   Total number of treatments                                   58           59             99      </span></span>
<span id="cb25-7"><a href="#cb25-7" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS1 A                                                                                       </span></span>
<span id="cb25-8"><a href="#cb25-8" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   10 (66.7%)   11 (73.3%)     12 (80.0%)  </span></span>
<span id="cb25-9"><a href="#cb25-9" tabindex="-1"></a><span class="co">#&gt;     Total number of treatments                                 15           21             28      </span></span>
<span id="cb25-10"><a href="#cb25-10" tabindex="-1"></a><span class="co">#&gt;     medname A_3/3                                          5 (33.3%)    8 (53.3%)      6 (40.0%)   </span></span>
<span id="cb25-11"><a href="#cb25-11" tabindex="-1"></a><span class="co">#&gt;     medname A_2/3                                          5 (33.3%)    6 (40.0%)      7 (46.7%)   </span></span>
<span id="cb25-12"><a href="#cb25-12" tabindex="-1"></a><span class="co">#&gt;     medname A_1/3                                          4 (26.7%)    3 (20.0%)      8 (53.3%)   </span></span>
<span id="cb25-13"><a href="#cb25-13" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS1 A p2                                                                                    </span></span>
<span id="cb25-14"><a href="#cb25-14" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   5 (33.3%)    8 (53.3%)      6 (40.0%)   </span></span>
<span id="cb25-15"><a href="#cb25-15" tabindex="-1"></a><span class="co">#&gt;     Total number of treatments                                 6            8              8       </span></span>
<span id="cb25-16"><a href="#cb25-16" tabindex="-1"></a><span class="co">#&gt;     medname A_3/3                                          5 (33.3%)    8 (53.3%)      6 (40.0%)   </span></span>
<span id="cb25-17"><a href="#cb25-17" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS1 B                                                                                       </span></span>
<span id="cb25-18"><a href="#cb25-18" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   12 (80.0%)   10 (66.7%)     14 (93.3%)  </span></span>
<span id="cb25-19"><a href="#cb25-19" tabindex="-1"></a><span class="co">#&gt;     Total number of treatments                                 30           30             52      </span></span>
<span id="cb25-20"><a href="#cb25-20" tabindex="-1"></a><span class="co">#&gt;     medname B_3/4                                          8 (53.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb25-21"><a href="#cb25-21" tabindex="-1"></a><span class="co">#&gt;     medname B_2/4                                          6 (40.0%)    5 (33.3%)      10 (66.7%)  </span></span>
<span id="cb25-22"><a href="#cb25-22" tabindex="-1"></a><span class="co">#&gt;     medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb25-23"><a href="#cb25-23" tabindex="-1"></a><span class="co">#&gt;     medname B_4/4                                          4 (26.7%)    5 (33.3%)      8 (53.3%)   </span></span>
<span id="cb25-24"><a href="#cb25-24" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS1 B p2                                                                                    </span></span>
<span id="cb25-25"><a href="#cb25-25" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   10 (66.7%)   8 (53.3%)      12 (80.0%)  </span></span>
<span id="cb25-26"><a href="#cb25-26" tabindex="-1"></a><span class="co">#&gt;     Total number of treatments                                 18           17             25      </span></span>
<span id="cb25-27"><a href="#cb25-27" tabindex="-1"></a><span class="co">#&gt;     medname B_2/4                                          6 (40.0%)    5 (33.3%)      10 (66.7%)  </span></span>
<span id="cb25-28"><a href="#cb25-28" tabindex="-1"></a><span class="co">#&gt;     medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb25-29"><a href="#cb25-29" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS1 B p3                                                                                    </span></span>
<span id="cb25-30"><a href="#cb25-30" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   10 (66.7%)   8 (53.3%)      12 (80.0%)  </span></span>
<span id="cb25-31"><a href="#cb25-31" tabindex="-1"></a><span class="co">#&gt;     Total number of treatments                                 18           17             25      </span></span>
<span id="cb25-32"><a href="#cb25-32" tabindex="-1"></a><span class="co">#&gt;     medname B_2/4                                          6 (40.0%)    5 (33.3%)      10 (66.7%)  </span></span>
<span id="cb25-33"><a href="#cb25-33" tabindex="-1"></a><span class="co">#&gt;     medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb25-34"><a href="#cb25-34" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS1 C                                                                                       </span></span>
<span id="cb25-35"><a href="#cb25-35" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   9 (60.0%)    7 (46.7%)      12 (80.0%)  </span></span>
<span id="cb25-36"><a href="#cb25-36" tabindex="-1"></a><span class="co">#&gt;     Total number of treatments                                 13           8              19      </span></span>
<span id="cb25-37"><a href="#cb25-37" tabindex="-1"></a><span class="co">#&gt;     medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb25-38"><a href="#cb25-38" tabindex="-1"></a><span class="co">#&gt;     medname C_1/2                                          6 (40.0%)    2 (13.3%)      6 (40.0%)   </span></span>
<span id="cb25-39"><a href="#cb25-39" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS1 C p2                                                                                    </span></span>
<span id="cb25-40"><a href="#cb25-40" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   9 (60.0%)    7 (46.7%)      12 (80.0%)  </span></span>
<span id="cb25-41"><a href="#cb25-41" tabindex="-1"></a><span class="co">#&gt;     Total number of treatments                                 13           8              19      </span></span>
<span id="cb25-42"><a href="#cb25-42" tabindex="-1"></a><span class="co">#&gt;     medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb25-43"><a href="#cb25-43" tabindex="-1"></a><span class="co">#&gt;     medname C_1/2                                          6 (40.0%)    2 (13.3%)      6 (40.0%)   </span></span>
<span id="cb25-44"><a href="#cb25-44" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS1 C p3                                                                                    </span></span>
<span id="cb25-45"><a href="#cb25-45" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   4 (26.7%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb25-46"><a href="#cb25-46" tabindex="-1"></a><span class="co">#&gt;     Total number of treatments                                 5            5              12      </span></span>
<span id="cb25-47"><a href="#cb25-47" tabindex="-1"></a><span class="co">#&gt;     medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)</span></span></code></pre></div>
</div>
<div id="concomitant-medications-by-medication-class-and-preferred-name-classes-sorted-by-frequency" class="section level4">
<h4><strong>3. Concomitant Medications by Medication Class and Preferred
Name (classes sorted by frequency)</strong></h4>
<p>The argument <code>sort_by_freq = TRUE</code> sort medication class
by frequency.</p>
<div class="sourceCode" id="cb26"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb26-1"><a href="#cb26-1" tabindex="-1"></a><span class="fu">run</span>(cmt01a, syn_data, <span class="at">sort_by_freq =</span> <span class="cn">TRUE</span>)</span>
<span id="cb26-2"><a href="#cb26-2" tabindex="-1"></a><span class="co">#&gt;   ATC Level 2 Text                                         A: Drug X    B: Placebo   C: Combination</span></span>
<span id="cb26-3"><a href="#cb26-3" tabindex="-1"></a><span class="co">#&gt;     Other Treatment                                          (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb26-4"><a href="#cb26-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb26-5"><a href="#cb26-5" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with at least one treatment     13 (86.7%)   14 (93.3%)     15 (100%)   </span></span>
<span id="cb26-6"><a href="#cb26-6" tabindex="-1"></a><span class="co">#&gt;   Total number of treatments                                   58           59             99      </span></span>
<span id="cb26-7"><a href="#cb26-7" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS2 B                                                                                       </span></span>
<span id="cb26-8"><a href="#cb26-8" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   12 (80.0%)   10 (66.7%)     14 (93.3%)  </span></span>
<span id="cb26-9"><a href="#cb26-9" tabindex="-1"></a><span class="co">#&gt;     Total number of treatments                                 30           30             52      </span></span>
<span id="cb26-10"><a href="#cb26-10" tabindex="-1"></a><span class="co">#&gt;     medname B_3/4                                          8 (53.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb26-11"><a href="#cb26-11" tabindex="-1"></a><span class="co">#&gt;     medname B_2/4                                          6 (40.0%)    5 (33.3%)      10 (66.7%)  </span></span>
<span id="cb26-12"><a href="#cb26-12" tabindex="-1"></a><span class="co">#&gt;     medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb26-13"><a href="#cb26-13" tabindex="-1"></a><span class="co">#&gt;     medname B_4/4                                          4 (26.7%)    5 (33.3%)      8 (53.3%)   </span></span>
<span id="cb26-14"><a href="#cb26-14" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS2 A                                                                                       </span></span>
<span id="cb26-15"><a href="#cb26-15" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   10 (66.7%)   11 (73.3%)     12 (80.0%)  </span></span>
<span id="cb26-16"><a href="#cb26-16" tabindex="-1"></a><span class="co">#&gt;     Total number of treatments                                 15           21             28      </span></span>
<span id="cb26-17"><a href="#cb26-17" tabindex="-1"></a><span class="co">#&gt;     medname A_3/3                                          5 (33.3%)    8 (53.3%)      6 (40.0%)   </span></span>
<span id="cb26-18"><a href="#cb26-18" tabindex="-1"></a><span class="co">#&gt;     medname A_2/3                                          5 (33.3%)    6 (40.0%)      7 (46.7%)   </span></span>
<span id="cb26-19"><a href="#cb26-19" tabindex="-1"></a><span class="co">#&gt;     medname A_1/3                                          4 (26.7%)    3 (20.0%)      8 (53.3%)   </span></span>
<span id="cb26-20"><a href="#cb26-20" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS2 B p2                                                                                    </span></span>
<span id="cb26-21"><a href="#cb26-21" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   10 (66.7%)   8 (53.3%)      12 (80.0%)  </span></span>
<span id="cb26-22"><a href="#cb26-22" tabindex="-1"></a><span class="co">#&gt;     Total number of treatments                                 18           17             25      </span></span>
<span id="cb26-23"><a href="#cb26-23" tabindex="-1"></a><span class="co">#&gt;     medname B_2/4                                          6 (40.0%)    5 (33.3%)      10 (66.7%)  </span></span>
<span id="cb26-24"><a href="#cb26-24" tabindex="-1"></a><span class="co">#&gt;     medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb26-25"><a href="#cb26-25" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS2 B p3                                                                                    </span></span>
<span id="cb26-26"><a href="#cb26-26" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   10 (66.7%)   8 (53.3%)      12 (80.0%)  </span></span>
<span id="cb26-27"><a href="#cb26-27" tabindex="-1"></a><span class="co">#&gt;     Total number of treatments                                 18           17             25      </span></span>
<span id="cb26-28"><a href="#cb26-28" tabindex="-1"></a><span class="co">#&gt;     medname B_2/4                                          6 (40.0%)    5 (33.3%)      10 (66.7%)  </span></span>
<span id="cb26-29"><a href="#cb26-29" tabindex="-1"></a><span class="co">#&gt;     medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb26-30"><a href="#cb26-30" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS2 C                                                                                       </span></span>
<span id="cb26-31"><a href="#cb26-31" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   9 (60.0%)    7 (46.7%)      12 (80.0%)  </span></span>
<span id="cb26-32"><a href="#cb26-32" tabindex="-1"></a><span class="co">#&gt;     Total number of treatments                                 13           8              19      </span></span>
<span id="cb26-33"><a href="#cb26-33" tabindex="-1"></a><span class="co">#&gt;     medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb26-34"><a href="#cb26-34" tabindex="-1"></a><span class="co">#&gt;     medname C_1/2                                          6 (40.0%)    2 (13.3%)      6 (40.0%)   </span></span>
<span id="cb26-35"><a href="#cb26-35" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS2 C p2                                                                                    </span></span>
<span id="cb26-36"><a href="#cb26-36" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   9 (60.0%)    7 (46.7%)      12 (80.0%)  </span></span>
<span id="cb26-37"><a href="#cb26-37" tabindex="-1"></a><span class="co">#&gt;     Total number of treatments                                 13           8              19      </span></span>
<span id="cb26-38"><a href="#cb26-38" tabindex="-1"></a><span class="co">#&gt;     medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb26-39"><a href="#cb26-39" tabindex="-1"></a><span class="co">#&gt;     medname C_1/2                                          6 (40.0%)    2 (13.3%)      6 (40.0%)   </span></span>
<span id="cb26-40"><a href="#cb26-40" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS2 A p2                                                                                    </span></span>
<span id="cb26-41"><a href="#cb26-41" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   5 (33.3%)    8 (53.3%)      6 (40.0%)   </span></span>
<span id="cb26-42"><a href="#cb26-42" tabindex="-1"></a><span class="co">#&gt;     Total number of treatments                                 6            8              8       </span></span>
<span id="cb26-43"><a href="#cb26-43" tabindex="-1"></a><span class="co">#&gt;     medname A_3/3                                          5 (33.3%)    8 (53.3%)      6 (40.0%)   </span></span>
<span id="cb26-44"><a href="#cb26-44" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS2 C p3                                                                                    </span></span>
<span id="cb26-45"><a href="#cb26-45" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   4 (26.7%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb26-46"><a href="#cb26-46" tabindex="-1"></a><span class="co">#&gt;     Total number of treatments                                 5            5              12      </span></span>
<span id="cb26-47"><a href="#cb26-47" tabindex="-1"></a><span class="co">#&gt;     medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)</span></span></code></pre></div>
</div>
<div id="concomitant-medications-by-medication-class-and-preferred-name-total-number-of-treatments-per-medication-class-suppressed" class="section level4">
<h4><strong>4. Concomitant Medications by Medication Class and Preferred
Name (total number of treatments per medication class
suppressed)</strong></h4>
<p>The <strong><code>cmt01a</code></strong> template includes the
analysis of âtotal number of treatmentsâ by default, modify the argument
<code>summary_labels</code> to change it.</p>
<div class="sourceCode" id="cb27"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb27-1"><a href="#cb27-1" tabindex="-1"></a><span class="fu">run</span>(cmt01a, syn_data, <span class="at">summary_labels =</span> <span class="fu">list</span>(<span class="at">TOTAL =</span> cmt01_label, <span class="at">ATC2 =</span> cmt01_label[<span class="dv">1</span>]))</span>
<span id="cb27-2"><a href="#cb27-2" tabindex="-1"></a><span class="co">#&gt;   ATC Level 2 Text                                         A: Drug X    B: Placebo   C: Combination</span></span>
<span id="cb27-3"><a href="#cb27-3" tabindex="-1"></a><span class="co">#&gt;     Other Treatment                                          (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb27-4"><a href="#cb27-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb27-5"><a href="#cb27-5" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with at least one treatment     13 (86.7%)   14 (93.3%)     15 (100%)   </span></span>
<span id="cb27-6"><a href="#cb27-6" tabindex="-1"></a><span class="co">#&gt;   Total number of treatments                                   58           59             99      </span></span>
<span id="cb27-7"><a href="#cb27-7" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS2 A                                                                                       </span></span>
<span id="cb27-8"><a href="#cb27-8" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   10 (66.7%)   11 (73.3%)     12 (80.0%)  </span></span>
<span id="cb27-9"><a href="#cb27-9" tabindex="-1"></a><span class="co">#&gt;     medname A_3/3                                          5 (33.3%)    8 (53.3%)      6 (40.0%)   </span></span>
<span id="cb27-10"><a href="#cb27-10" tabindex="-1"></a><span class="co">#&gt;     medname A_2/3                                          5 (33.3%)    6 (40.0%)      7 (46.7%)   </span></span>
<span id="cb27-11"><a href="#cb27-11" tabindex="-1"></a><span class="co">#&gt;     medname A_1/3                                          4 (26.7%)    3 (20.0%)      8 (53.3%)   </span></span>
<span id="cb27-12"><a href="#cb27-12" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS2 A p2                                                                                    </span></span>
<span id="cb27-13"><a href="#cb27-13" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   5 (33.3%)    8 (53.3%)      6 (40.0%)   </span></span>
<span id="cb27-14"><a href="#cb27-14" tabindex="-1"></a><span class="co">#&gt;     medname A_3/3                                          5 (33.3%)    8 (53.3%)      6 (40.0%)   </span></span>
<span id="cb27-15"><a href="#cb27-15" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS2 B                                                                                       </span></span>
<span id="cb27-16"><a href="#cb27-16" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   12 (80.0%)   10 (66.7%)     14 (93.3%)  </span></span>
<span id="cb27-17"><a href="#cb27-17" tabindex="-1"></a><span class="co">#&gt;     medname B_3/4                                          8 (53.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb27-18"><a href="#cb27-18" tabindex="-1"></a><span class="co">#&gt;     medname B_2/4                                          6 (40.0%)    5 (33.3%)      10 (66.7%)  </span></span>
<span id="cb27-19"><a href="#cb27-19" tabindex="-1"></a><span class="co">#&gt;     medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb27-20"><a href="#cb27-20" tabindex="-1"></a><span class="co">#&gt;     medname B_4/4                                          4 (26.7%)    5 (33.3%)      8 (53.3%)   </span></span>
<span id="cb27-21"><a href="#cb27-21" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS2 B p2                                                                                    </span></span>
<span id="cb27-22"><a href="#cb27-22" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   10 (66.7%)   8 (53.3%)      12 (80.0%)  </span></span>
<span id="cb27-23"><a href="#cb27-23" tabindex="-1"></a><span class="co">#&gt;     medname B_2/4                                          6 (40.0%)    5 (33.3%)      10 (66.7%)  </span></span>
<span id="cb27-24"><a href="#cb27-24" tabindex="-1"></a><span class="co">#&gt;     medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb27-25"><a href="#cb27-25" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS2 B p3                                                                                    </span></span>
<span id="cb27-26"><a href="#cb27-26" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   10 (66.7%)   8 (53.3%)      12 (80.0%)  </span></span>
<span id="cb27-27"><a href="#cb27-27" tabindex="-1"></a><span class="co">#&gt;     medname B_2/4                                          6 (40.0%)    5 (33.3%)      10 (66.7%)  </span></span>
<span id="cb27-28"><a href="#cb27-28" tabindex="-1"></a><span class="co">#&gt;     medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb27-29"><a href="#cb27-29" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS2 C                                                                                       </span></span>
<span id="cb27-30"><a href="#cb27-30" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   9 (60.0%)    7 (46.7%)      12 (80.0%)  </span></span>
<span id="cb27-31"><a href="#cb27-31" tabindex="-1"></a><span class="co">#&gt;     medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb27-32"><a href="#cb27-32" tabindex="-1"></a><span class="co">#&gt;     medname C_1/2                                          6 (40.0%)    2 (13.3%)      6 (40.0%)   </span></span>
<span id="cb27-33"><a href="#cb27-33" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS2 C p2                                                                                    </span></span>
<span id="cb27-34"><a href="#cb27-34" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   9 (60.0%)    7 (46.7%)      12 (80.0%)  </span></span>
<span id="cb27-35"><a href="#cb27-35" tabindex="-1"></a><span class="co">#&gt;     medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb27-36"><a href="#cb27-36" tabindex="-1"></a><span class="co">#&gt;     medname C_1/2                                          6 (40.0%)    2 (13.3%)      6 (40.0%)   </span></span>
<span id="cb27-37"><a href="#cb27-37" tabindex="-1"></a><span class="co">#&gt;   ATCCLAS2 C p3                                                                                    </span></span>
<span id="cb27-38"><a href="#cb27-38" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one treatment   4 (26.7%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb27-39"><a href="#cb27-39" tabindex="-1"></a><span class="co">#&gt;     medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)</span></span></code></pre></div>
</div>
</div>
<div id="concomitant-medications-by-preferred-name-cmt02_pt" class="section level3">
<h3><strong>Concomitant Medications by Preferred Name
(<code>CMT02_PT</code>)</strong></h3>
<div id="concomitant-medications-by-preferred-name" class="section level4">
<h4><strong>1. Concomitant Medications by Preferred Name</strong></h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>cmt02_pt</code></strong> template displays
concomitant medications by Preferred Name by default.</li>
<li>The template does not include the column of total by default.</li>
<li>The template sorts preferred name by alphabetical order by default.
Set the argument <code>sort_by_freq = TRUE</code> to sort preferred
names by frequency.</li>
</ol>
<div class="sourceCode" id="cb28"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb28-1"><a href="#cb28-1" tabindex="-1"></a><span class="fu">run</span>(cmt02_pt, syn_data)</span>
<span id="cb28-2"><a href="#cb28-2" tabindex="-1"></a><span class="co">#&gt;                                                          A: Drug X    B: Placebo   C: Combination</span></span>
<span id="cb28-3"><a href="#cb28-3" tabindex="-1"></a><span class="co">#&gt;   Other Treatment                                          (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb28-4"><a href="#cb28-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb28-5"><a href="#cb28-5" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with at least one treatment   13 (86.7%)   14 (93.3%)     15 (100%)   </span></span>
<span id="cb28-6"><a href="#cb28-6" tabindex="-1"></a><span class="co">#&gt;   Total number of treatments                                 58           59             99      </span></span>
<span id="cb28-7"><a href="#cb28-7" tabindex="-1"></a><span class="co">#&gt;   medname B_3/4                                          8 (53.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb28-8"><a href="#cb28-8" tabindex="-1"></a><span class="co">#&gt;   medname B_2/4                                          6 (40.0%)    5 (33.3%)      10 (66.7%)  </span></span>
<span id="cb28-9"><a href="#cb28-9" tabindex="-1"></a><span class="co">#&gt;   medname A_3/3                                          5 (33.3%)    8 (53.3%)      6 (40.0%)   </span></span>
<span id="cb28-10"><a href="#cb28-10" tabindex="-1"></a><span class="co">#&gt;   medname B_1/4                                          7 (46.7%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb28-11"><a href="#cb28-11" tabindex="-1"></a><span class="co">#&gt;   medname A_2/3                                          5 (33.3%)    6 (40.0%)      7 (46.7%)   </span></span>
<span id="cb28-12"><a href="#cb28-12" tabindex="-1"></a><span class="co">#&gt;   medname B_4/4                                          4 (26.7%)    5 (33.3%)      8 (53.3%)   </span></span>
<span id="cb28-13"><a href="#cb28-13" tabindex="-1"></a><span class="co">#&gt;   medname C_2/2                                          4 (26.7%)    5 (33.3%)      7 (46.7%)   </span></span>
<span id="cb28-14"><a href="#cb28-14" tabindex="-1"></a><span class="co">#&gt;   medname A_1/3                                          4 (26.7%)    3 (20.0%)      8 (53.3%)   </span></span>
<span id="cb28-15"><a href="#cb28-15" tabindex="-1"></a><span class="co">#&gt;   medname C_1/2                                          6 (40.0%)    2 (13.3%)      6 (40.0%)</span></span></code></pre></div>
</div>
</div>
<div id="cox-regression-coxt01" class="section level3">
<h3><strong>Cox Regression (<code>COXT01</code>)</strong></h3>
<div id="cox-regression" class="section level4">
<h4><strong>1. Cox Regression</strong></h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>coxt01</code></strong> template produces the
standard Cox regression output.</li>
<li>Users are expected to pre-process the input analysis data by
selecting a time-to-event parameter to be analyzed. The example below is
based on the time-to-event parameter âDuration of Confirmed Response by
Investigatorâ.</li>
<li>The time variable in the model is specified through the
<code>time_var</code> argument. By default, <code>time_var</code> is set
to <code>&quot;AVAL&quot;</code>, which comes from <code>ADTTE.AVAL</code>.</li>
<li>The event variable in the model is specified through the
<code>event_var</code> argument. By default, <code>event_var</code> is
set to <code>&quot;EVENT&quot;</code>, which is derived based on the censoring
indicator <code>ADTTE.CNSR</code> in the pre-processing function
<code>coxt01_pre</code>.</li>
<li>If there are more than two treatment groups present in the input
analysis data, users are also expected to select only two treatment
groups. The example below is based on treatment groups
<code>&quot;Arm A&quot;</code> and <code>&quot;Arm B&quot;</code>.</li>
</ol>
<div class="sourceCode" id="cb29"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb29-1"><a href="#cb29-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;OS&quot;</span>, <span class="st">&quot;adtte&quot;</span>)</span>
<span id="cb29-2"><a href="#cb29-2" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(proc_data, ARMCD <span class="sc">!=</span> <span class="st">&quot;ARM C&quot;</span>, <span class="st">&quot;adsl&quot;</span>)</span>
<span id="cb29-3"><a href="#cb29-3" tabindex="-1"></a><span class="fu">run</span>(coxt01, proc_data, <span class="at">time_var =</span> <span class="st">&quot;AVAL&quot;</span>, <span class="at">event_var =</span> <span class="st">&quot;EVENT&quot;</span>)</span>
<span id="cb29-4"><a href="#cb29-4" tabindex="-1"></a><span class="co">#&gt;                                                Treatment Effect Adjusted for Covariate     </span></span>
<span id="cb29-5"><a href="#cb29-5" tabindex="-1"></a><span class="co">#&gt;   Effect/Covariate Included in the Model    n      Hazard Ratio       95% CI       p-value </span></span>
<span id="cb29-6"><a href="#cb29-6" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb29-7"><a href="#cb29-7" tabindex="-1"></a><span class="co">#&gt;   Treatment:                                                                               </span></span>
<span id="cb29-8"><a href="#cb29-8" tabindex="-1"></a><span class="co">#&gt;     B: Placebo vs control (A: Drug X)       30         1.56        (0.61, 3.95)     0.3501 </span></span>
<span id="cb29-9"><a href="#cb29-9" tabindex="-1"></a><span class="co">#&gt;   Covariate:                                                                               </span></span>
<span id="cb29-10"><a href="#cb29-10" tabindex="-1"></a><span class="co">#&gt;     Sex                                     30         1.29        (0.48, 3.49)     0.6164 </span></span>
<span id="cb29-11"><a href="#cb29-11" tabindex="-1"></a><span class="co">#&gt;     RACE                                    30         1.32        (0.49, 3.56)     0.5836 </span></span>
<span id="cb29-12"><a href="#cb29-12" tabindex="-1"></a><span class="co">#&gt;     Age (yr)                                30         1.56        (0.61, 3.95)     0.3501</span></span></code></pre></div>
</div>
<div id="cox-regression-with-interaction-term" class="section level4">
<h4><strong>2. Cox Regression (with interaction term)</strong></h4>
<p>To add the interaction term to the model,
<code>interaction = TRUE</code>, which is passed to
<code>tern::control_coxreg()</code>, needs to be specified.</p>
<div class="sourceCode" id="cb30"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb30-1"><a href="#cb30-1" tabindex="-1"></a><span class="fu">run</span>(coxt01, proc_data, <span class="at">covariates =</span> <span class="st">&quot;AAGE&quot;</span>, <span class="at">interaction =</span> <span class="cn">TRUE</span>)</span>
<span id="cb30-2"><a href="#cb30-2" tabindex="-1"></a><span class="co">#&gt;                                                        Treatment Effect Adjusted for Covariate             </span></span>
<span id="cb30-3"><a href="#cb30-3" tabindex="-1"></a><span class="co">#&gt;   Effect/Covariate Included in the Model   n    Hazard Ratio      95% CI      p-value   Interaction p-value</span></span>
<span id="cb30-4"><a href="#cb30-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb30-5"><a href="#cb30-5" tabindex="-1"></a><span class="co">#&gt;   Treatment:                                                                                               </span></span>
<span id="cb30-6"><a href="#cb30-6" tabindex="-1"></a><span class="co">#&gt;     B: Placebo vs control (A: Drug X)      30       1.56       (0.61, 3.95)   0.3501                       </span></span>
<span id="cb30-7"><a href="#cb30-7" tabindex="-1"></a><span class="co">#&gt;   Covariate:                                                                                               </span></span>
<span id="cb30-8"><a href="#cb30-8" tabindex="-1"></a><span class="co">#&gt;     Age (yr)                               30                                                 0.0973       </span></span>
<span id="cb30-9"><a href="#cb30-9" tabindex="-1"></a><span class="co">#&gt;       32                                            1.50       (0.57, 3.97)</span></span></code></pre></div>
</div>
<div id="cox-regression-specifying-covariates" class="section level4">
<h4><strong>3. Cox Regression (specifying covariates)</strong></h4>
<ol style="list-style-type: decimal">
<li>By default, <code>&quot;SEX&quot;</code>, <code>&quot;RACE&quot;</code> and
<code>&quot;AAGE&quot;</code> are used as the covariates for the model.</li>
<li>Users can specify a different set of covariates through the
<code>covariates</code> argument. In the example below,
<code>&quot;RACE&quot;</code> and <code>&quot;AAGE&quot;</code> are used as covariates.</li>
</ol>
<div class="sourceCode" id="cb31"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb31-1"><a href="#cb31-1" tabindex="-1"></a><span class="fu">run</span>(coxt01, proc_data, <span class="at">covariates =</span> <span class="fu">c</span>(<span class="st">&quot;RACE&quot;</span>, <span class="st">&quot;AAGE&quot;</span>))</span>
<span id="cb31-2"><a href="#cb31-2" tabindex="-1"></a><span class="co">#&gt;                                                Treatment Effect Adjusted for Covariate     </span></span>
<span id="cb31-3"><a href="#cb31-3" tabindex="-1"></a><span class="co">#&gt;   Effect/Covariate Included in the Model    n      Hazard Ratio       95% CI       p-value </span></span>
<span id="cb31-4"><a href="#cb31-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb31-5"><a href="#cb31-5" tabindex="-1"></a><span class="co">#&gt;   Treatment:                                                                               </span></span>
<span id="cb31-6"><a href="#cb31-6" tabindex="-1"></a><span class="co">#&gt;     B: Placebo vs control (A: Drug X)       30         1.56        (0.61, 3.95)     0.3501 </span></span>
<span id="cb31-7"><a href="#cb31-7" tabindex="-1"></a><span class="co">#&gt;   Covariate:                                                                               </span></span>
<span id="cb31-8"><a href="#cb31-8" tabindex="-1"></a><span class="co">#&gt;     RACE                                    30         1.32        (0.49, 3.56)     0.5836 </span></span>
<span id="cb31-9"><a href="#cb31-9" tabindex="-1"></a><span class="co">#&gt;     Age (yr)                                30         1.56        (0.61, 3.95)     0.3501</span></span></code></pre></div>
</div>
<div id="cox-regression-setting-strata-ties-and-alpha-level" class="section level4">
<h4><strong>4. Cox Regression (setting strata, ties, and alpha
level)</strong></h4>
<ol style="list-style-type: decimal">
<li>By default, <code>strata = NULL</code> (no stratification),
<code>ties = &quot;exact&quot;</code> (equivalent to <code>DISCRETE</code> in
SAS), and <code>conf_level = 0.95</code> are applied.</li>
<li>Users can specify one or more stratification variables via the
<code>strata</code> argument.</li>
<li>Other tie handling methods, i.e., <code>&quot;efron&quot;</code> or
<code>&quot;breslow&quot;</code>, can be specified in the <code>tie</code>
argument, which is passed to <code>tern::control_coxreg()</code>.</li>
<li>Users can also customize the alpha level for the confidence
intervals through the <code>conf_level</code> argument, which is passed
to <code>tern::control_coxreg()</code>.</li>
</ol>
<div class="sourceCode" id="cb32"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb32-1"><a href="#cb32-1" tabindex="-1"></a><span class="fu">run</span>(coxt01, proc_data, <span class="at">covariates =</span> <span class="fu">c</span>(<span class="st">&quot;SEX&quot;</span>, <span class="st">&quot;AAGE&quot;</span>), <span class="at">strata =</span> <span class="fu">c</span>(<span class="st">&quot;RACE&quot;</span>), <span class="at">conf_level =</span> <span class="fl">0.90</span>)</span>
<span id="cb32-2"><a href="#cb32-2" tabindex="-1"></a><span class="co">#&gt;                                                Treatment Effect Adjusted for Covariate     </span></span>
<span id="cb32-3"><a href="#cb32-3" tabindex="-1"></a><span class="co">#&gt;   Effect/Covariate Included in the Model    n      Hazard Ratio       90% CI       p-value </span></span>
<span id="cb32-4"><a href="#cb32-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb32-5"><a href="#cb32-5" tabindex="-1"></a><span class="co">#&gt;   Treatment:                                                                               </span></span>
<span id="cb32-6"><a href="#cb32-6" tabindex="-1"></a><span class="co">#&gt;     B: Placebo vs control (A: Drug X)       30         1.28        (0.55, 2.97)     0.6338 </span></span>
<span id="cb32-7"><a href="#cb32-7" tabindex="-1"></a><span class="co">#&gt;   Covariate:                                                                               </span></span>
<span id="cb32-8"><a href="#cb32-8" tabindex="-1"></a><span class="co">#&gt;     Sex                                     30         1.19        (0.50, 2.84)     0.7360 </span></span>
<span id="cb32-9"><a href="#cb32-9" tabindex="-1"></a><span class="co">#&gt;     Age (yr)                                30         1.28        (0.55, 2.97)     0.6337</span></span></code></pre></div>
</div>
</div>
<div id="multi-variable-cox-regression-coxt02" class="section level3">
<h3><strong>Multi-variable Cox Regression
(<code>COXT02</code>)</strong></h3>
<div id="multi-variable-cox-regression" class="section level4">
<h4><strong>1. Multi-variable Cox Regression</strong></h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>coxt02</code></strong> template produces the
standard multi-variable cox regression output.</li>
<li>Users are expected to pre-process the input analysis data by
selecting a time-to-event parameter to be analyzed. The example below is
based on the time-to-event parameter âDuration of Confirmed Response by
Investigatorâ.</li>
<li>The time variable in the model is specified through the
<code>time_var</code> argument. By default, <code>time_var</code> is set
to <code>&quot;AVAL&quot;</code>, which comes from <code>ADTTE.AVAL</code>.</li>
<li>The event variable in the model is specified through the
<code>event_var</code> argument. By default, <code>event_var</code> is
set to <code>&quot;EVENT&quot;</code>, which is derived based on the censoring
indicator <code>ADTTE.CNSR</code> in the pre-processing function
<code>coxt01_pre</code>.</li>
</ol>
<div class="sourceCode" id="cb33"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb33-1"><a href="#cb33-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;OS&quot;</span>, <span class="st">&quot;adtte&quot;</span>)</span>
<span id="cb33-2"><a href="#cb33-2" tabindex="-1"></a><span class="fu">run</span>(coxt02, proc_data, <span class="at">time_var =</span> <span class="st">&quot;AVAL&quot;</span>, <span class="at">event_var =</span> <span class="st">&quot;EVENT&quot;</span>)</span>
<span id="cb33-3"><a href="#cb33-3" tabindex="-1"></a><span class="co">#&gt;   Effect/Covariate Included in the Model                  Hazard Ratio      95% CI      p-value</span></span>
<span id="cb33-4"><a href="#cb33-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb33-5"><a href="#cb33-5" tabindex="-1"></a><span class="co">#&gt;   Treatment:                                                                                   </span></span>
<span id="cb33-6"><a href="#cb33-6" tabindex="-1"></a><span class="co">#&gt;     Description of Planned Arm (reference = A: Drug X)                                  0.2152 </span></span>
<span id="cb33-7"><a href="#cb33-7" tabindex="-1"></a><span class="co">#&gt;       B: Placebo                                              1.21       (0.45, 3.23)   0.7038 </span></span>
<span id="cb33-8"><a href="#cb33-8" tabindex="-1"></a><span class="co">#&gt;       C: Combination                                          2.24       (0.86, 5.88)   0.0998 </span></span>
<span id="cb33-9"><a href="#cb33-9" tabindex="-1"></a><span class="co">#&gt;   Covariate:                                                                                   </span></span>
<span id="cb33-10"><a href="#cb33-10" tabindex="-1"></a><span class="co">#&gt;     Sex (reference = F)                                                                        </span></span>
<span id="cb33-11"><a href="#cb33-11" tabindex="-1"></a><span class="co">#&gt;       M                                                       1.44       (0.63, 3.28)   0.3903 </span></span>
<span id="cb33-12"><a href="#cb33-12" tabindex="-1"></a><span class="co">#&gt;     RACE (reference = AMERICAN INDIAN OR ALASKA NATIVE)                                 0.6113 </span></span>
<span id="cb33-13"><a href="#cb33-13" tabindex="-1"></a><span class="co">#&gt;       ASIAN                                                   0.42       (0.11, 1.57)   0.1972 </span></span>
<span id="cb33-14"><a href="#cb33-14" tabindex="-1"></a><span class="co">#&gt;       BLACK OR AFRICAN AMERICAN                               0.39       (0.08, 2.01)   0.2627 </span></span>
<span id="cb33-15"><a href="#cb33-15" tabindex="-1"></a><span class="co">#&gt;       WHITE                                                   0.38       (0.07, 1.99)   0.2517 </span></span>
<span id="cb33-16"><a href="#cb33-16" tabindex="-1"></a><span class="co">#&gt;     Age (yr)                                                                                   </span></span>
<span id="cb33-17"><a href="#cb33-17" tabindex="-1"></a><span class="co">#&gt;       All                                                     1.02       (0.96, 1.07)   0.6043</span></span></code></pre></div>
</div>
<div id="multi-variable-cox-regression-specifying-covariates" class="section level4">
<h4><strong>2. Multi-variable Cox Regression (specifying
covariates)</strong></h4>
<ol style="list-style-type: decimal">
<li>By default, <code>&quot;SEX&quot;</code>, <code>&quot;RACE&quot;</code> and
<code>&quot;AAGE&quot;</code> are used as the covariates for the model.</li>
<li>Users can specify a different set of covariates through the
<code>covariates</code> argument. In the example below,
<code>&quot;RACE&quot;</code> and <code>&quot;AAGE&quot;</code> are used as covariates.</li>
</ol>
<div class="sourceCode" id="cb34"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb34-1"><a href="#cb34-1" tabindex="-1"></a><span class="fu">run</span>(coxt02, proc_data, <span class="at">covariates =</span> <span class="fu">c</span>(<span class="st">&quot;RACE&quot;</span>, <span class="st">&quot;AAGE&quot;</span>))</span>
<span id="cb34-2"><a href="#cb34-2" tabindex="-1"></a><span class="co">#&gt;   Effect/Covariate Included in the Model                  Hazard Ratio      95% CI      p-value</span></span>
<span id="cb34-3"><a href="#cb34-3" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb34-4"><a href="#cb34-4" tabindex="-1"></a><span class="co">#&gt;   Treatment:                                                                                   </span></span>
<span id="cb34-5"><a href="#cb34-5" tabindex="-1"></a><span class="co">#&gt;     Description of Planned Arm (reference = A: Drug X)                                  0.1508 </span></span>
<span id="cb34-6"><a href="#cb34-6" tabindex="-1"></a><span class="co">#&gt;       B: Placebo                                              1.36       (0.53, 3.49)   0.5207 </span></span>
<span id="cb34-7"><a href="#cb34-7" tabindex="-1"></a><span class="co">#&gt;       C: Combination                                          2.51       (0.97, 6.49)   0.0574 </span></span>
<span id="cb34-8"><a href="#cb34-8" tabindex="-1"></a><span class="co">#&gt;   Covariate:                                                                                   </span></span>
<span id="cb34-9"><a href="#cb34-9" tabindex="-1"></a><span class="co">#&gt;     RACE (reference = AMERICAN INDIAN OR ALASKA NATIVE)                                 0.6453 </span></span>
<span id="cb34-10"><a href="#cb34-10" tabindex="-1"></a><span class="co">#&gt;       ASIAN                                                   0.45       (0.12, 1.65)   0.2294 </span></span>
<span id="cb34-11"><a href="#cb34-11" tabindex="-1"></a><span class="co">#&gt;       BLACK OR AFRICAN AMERICAN                               0.39       (0.08, 1.94)   0.2487 </span></span>
<span id="cb34-12"><a href="#cb34-12" tabindex="-1"></a><span class="co">#&gt;       WHITE                                                   0.42       (0.08, 2.17)   0.2986 </span></span>
<span id="cb34-13"><a href="#cb34-13" tabindex="-1"></a><span class="co">#&gt;     Age (yr)                                                                                   </span></span>
<span id="cb34-14"><a href="#cb34-14" tabindex="-1"></a><span class="co">#&gt;       All                                                     1.02       (0.97, 1.08)   0.4836</span></span></code></pre></div>
</div>
<div id="multi-variable-cox-regression-setting-strata-ties-and-alpha-level" class="section level4">
<h4><strong>3. Multi-variable Cox Regression (setting strata, ties, and
alpha level)</strong></h4>
<ol style="list-style-type: decimal">
<li>By default, <code>strata = NULL</code> (no stratification),
<code>ties = &quot;exact&quot;</code> (equivalent to <code>DISCRETE</code> in
SAS), and <code>conf_level = 0.95</code> are applied.</li>
<li>Users can specify one or more stratification variables via the
<code>strata</code> argument.</li>
<li>Other tie handling methods, i.e., <code>&quot;efron&quot;</code> or
<code>&quot;breslow&quot;</code>, can be specified in the <code>tie</code>
argument, which is passed to <code>tern::control_coxreg()</code>.</li>
<li>Users can also customize the alpha level for the confidence
intervals through the <code>conf_level</code> argument, which is passed
to <code>tern::control_coxreg()</code>.</li>
</ol>
<div class="sourceCode" id="cb35"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb35-1"><a href="#cb35-1" tabindex="-1"></a><span class="fu">run</span>(coxt02, proc_data, <span class="at">covariates =</span> <span class="fu">c</span>(<span class="st">&quot;SEX&quot;</span>, <span class="st">&quot;AAGE&quot;</span>), <span class="at">strata =</span> <span class="fu">c</span>(<span class="st">&quot;RACE&quot;</span>), <span class="at">conf_level =</span> <span class="fl">0.90</span>, <span class="at">ties =</span> <span class="st">&quot;efron&quot;</span>)</span>
<span id="cb35-2"><a href="#cb35-2" tabindex="-1"></a><span class="co">#&gt;   Effect/Covariate Included in the Model                 Hazard Ratio      90% CI      p-value</span></span>
<span id="cb35-3"><a href="#cb35-3" tabindex="-1"></a><span class="co">#&gt;   ââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb35-4"><a href="#cb35-4" tabindex="-1"></a><span class="co">#&gt;   Treatment:                                                                                  </span></span>
<span id="cb35-5"><a href="#cb35-5" tabindex="-1"></a><span class="co">#&gt;     Description of Planned Arm (reference = A: Drug X)                                 0.1066 </span></span>
<span id="cb35-6"><a href="#cb35-6" tabindex="-1"></a><span class="co">#&gt;       B: Placebo                                             1.28       (0.55, 3.00)   0.6265 </span></span>
<span id="cb35-7"><a href="#cb35-7" tabindex="-1"></a><span class="co">#&gt;       C: Combination                                         2.84       (1.21, 6.69)   0.0447 </span></span>
<span id="cb35-8"><a href="#cb35-8" tabindex="-1"></a><span class="co">#&gt;   Covariate:                                                                                  </span></span>
<span id="cb35-9"><a href="#cb35-9" tabindex="-1"></a><span class="co">#&gt;     Sex (reference = F)                                                                       </span></span>
<span id="cb35-10"><a href="#cb35-10" tabindex="-1"></a><span class="co">#&gt;       M                                                      1.25       (0.61, 2.56)   0.6168 </span></span>
<span id="cb35-11"><a href="#cb35-11" tabindex="-1"></a><span class="co">#&gt;     Age (yr)                                                                                  </span></span>
<span id="cb35-12"><a href="#cb35-12" tabindex="-1"></a><span class="co">#&gt;       All                                                    1.01       (0.96, 1.06)   0.7637</span></span></code></pre></div>
</div>
</div>
<div id="demographics-and-baseline-characteristics-dmt01" class="section level3">
<h3><strong>Demographics and Baseline Characteristics
(<code>DMT01</code>)</strong></h3>
<div id="demographics-and-baseline-characteristics-with-all-patients" class="section level4">
<h4><strong>1. Demographics and Baseline Characteristics with All
Patients</strong></h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>dmt01</code></strong> template produces the
standard demographics and baseline characteristics summary.</li>
<li>This template includes the column of total by default.</li>
</ol>
<div class="sourceCode" id="cb36"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb36-1"><a href="#cb36-1" tabindex="-1"></a><span class="fu">run</span>(dmt01, syn_data)</span>
<span id="cb36-2"><a href="#cb36-2" tabindex="-1"></a><span class="co">#&gt;                                        A: Drug X    B: Placebo   C: Combination   All Patients</span></span>
<span id="cb36-3"><a href="#cb36-3" tabindex="-1"></a><span class="co">#&gt;                                          (N=15)       (N=15)         (N=15)          (N=45)   </span></span>
<span id="cb36-4"><a href="#cb36-4" tabindex="-1"></a><span class="co">#&gt;   ââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb36-5"><a href="#cb36-5" tabindex="-1"></a><span class="co">#&gt;   Age (yr)                                                                                    </span></span>
<span id="cb36-6"><a href="#cb36-6" tabindex="-1"></a><span class="co">#&gt;     n                                      15           15             15              45     </span></span>
<span id="cb36-7"><a href="#cb36-7" tabindex="-1"></a><span class="co">#&gt;     Mean (SD)                          31.3 (5.3)   35.1 (9.0)     36.6 (6.4)      34.3 (7.3) </span></span>
<span id="cb36-8"><a href="#cb36-8" tabindex="-1"></a><span class="co">#&gt;     Median                                31.0         35.0           35.0            34.0    </span></span>
<span id="cb36-9"><a href="#cb36-9" tabindex="-1"></a><span class="co">#&gt;     Min - Max                           24 - 40      24 - 57        24 - 49         24 - 57   </span></span>
<span id="cb36-10"><a href="#cb36-10" tabindex="-1"></a><span class="co">#&gt;   Age Group                                                                                   </span></span>
<span id="cb36-11"><a href="#cb36-11" tabindex="-1"></a><span class="co">#&gt;     n                                      15           15             15              45     </span></span>
<span id="cb36-12"><a href="#cb36-12" tabindex="-1"></a><span class="co">#&gt;     &lt;65                                15 (100%)    15 (100%)      15 (100%)       45 (100%)  </span></span>
<span id="cb36-13"><a href="#cb36-13" tabindex="-1"></a><span class="co">#&gt;   Sex                                                                                         </span></span>
<span id="cb36-14"><a href="#cb36-14" tabindex="-1"></a><span class="co">#&gt;     n                                      15           15             15              45     </span></span>
<span id="cb36-15"><a href="#cb36-15" tabindex="-1"></a><span class="co">#&gt;     Male                               3 (20.0%)    7 (46.7%)      5 (33.3%)       15 (33.3%) </span></span>
<span id="cb36-16"><a href="#cb36-16" tabindex="-1"></a><span class="co">#&gt;     Female                             12 (80.0%)   8 (53.3%)      10 (66.7%)      30 (66.7%) </span></span>
<span id="cb36-17"><a href="#cb36-17" tabindex="-1"></a><span class="co">#&gt;   Ethnicity                                                                                   </span></span>
<span id="cb36-18"><a href="#cb36-18" tabindex="-1"></a><span class="co">#&gt;     n                                      15           15             15              45     </span></span>
<span id="cb36-19"><a href="#cb36-19" tabindex="-1"></a><span class="co">#&gt;     NOT REPORTED                           0            0          2 (13.3%)        2 (4.4%)  </span></span>
<span id="cb36-20"><a href="#cb36-20" tabindex="-1"></a><span class="co">#&gt;     HISPANIC OR LATINO                 2 (13.3%)        0              0            2 (4.4%)  </span></span>
<span id="cb36-21"><a href="#cb36-21" tabindex="-1"></a><span class="co">#&gt;     NOT HISPANIC OR LATINO             13 (86.7%)   15 (100%)      13 (86.7%)      41 (91.1%) </span></span>
<span id="cb36-22"><a href="#cb36-22" tabindex="-1"></a><span class="co">#&gt;   RACE                                                                                        </span></span>
<span id="cb36-23"><a href="#cb36-23" tabindex="-1"></a><span class="co">#&gt;     n                                      15           15             15              45     </span></span>
<span id="cb36-24"><a href="#cb36-24" tabindex="-1"></a><span class="co">#&gt;     AMERICAN INDIAN OR ALASKA NATIVE       0        2 (13.3%)       1 (6.7%)        3 (6.7%)  </span></span>
<span id="cb36-25"><a href="#cb36-25" tabindex="-1"></a><span class="co">#&gt;     ASIAN                              8 (53.3%)    10 (66.7%)     8 (53.3%)       26 (57.8%) </span></span>
<span id="cb36-26"><a href="#cb36-26" tabindex="-1"></a><span class="co">#&gt;     BLACK OR AFRICAN AMERICAN          4 (26.7%)     1 (6.7%)      4 (26.7%)       9 (20.0%)  </span></span>
<span id="cb36-27"><a href="#cb36-27" tabindex="-1"></a><span class="co">#&gt;     WHITE                              3 (20.0%)    2 (13.3%)      2 (13.3%)       7 (15.6%)</span></span></code></pre></div>
</div>
<div id="demographics-and-baseline-characteristics-without-all-patients" class="section level4">
<h4><strong>2. Demographics and Baseline Characteristics without All
Patients</strong></h4>
<p>To remove the column of total, set the argument
<code>lbl_overall</code> to <code>NULL</code>.</p>
<div class="sourceCode" id="cb37"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb37-1"><a href="#cb37-1" tabindex="-1"></a><span class="fu">run</span>(dmt01, syn_data, <span class="at">lbl_overall =</span> <span class="cn">NULL</span>)</span>
<span id="cb37-2"><a href="#cb37-2" tabindex="-1"></a><span class="co">#&gt;                                        A: Drug X    B: Placebo   C: Combination</span></span>
<span id="cb37-3"><a href="#cb37-3" tabindex="-1"></a><span class="co">#&gt;                                          (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb37-4"><a href="#cb37-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb37-5"><a href="#cb37-5" tabindex="-1"></a><span class="co">#&gt;   Age (yr)                                                                     </span></span>
<span id="cb37-6"><a href="#cb37-6" tabindex="-1"></a><span class="co">#&gt;     n                                      15           15             15      </span></span>
<span id="cb37-7"><a href="#cb37-7" tabindex="-1"></a><span class="co">#&gt;     Mean (SD)                          31.3 (5.3)   35.1 (9.0)     36.6 (6.4)  </span></span>
<span id="cb37-8"><a href="#cb37-8" tabindex="-1"></a><span class="co">#&gt;     Median                                31.0         35.0           35.0     </span></span>
<span id="cb37-9"><a href="#cb37-9" tabindex="-1"></a><span class="co">#&gt;     Min - Max                           24 - 40      24 - 57        24 - 49    </span></span>
<span id="cb37-10"><a href="#cb37-10" tabindex="-1"></a><span class="co">#&gt;   Age Group                                                                    </span></span>
<span id="cb37-11"><a href="#cb37-11" tabindex="-1"></a><span class="co">#&gt;     n                                      15           15             15      </span></span>
<span id="cb37-12"><a href="#cb37-12" tabindex="-1"></a><span class="co">#&gt;     &lt;65                                15 (100%)    15 (100%)      15 (100%)   </span></span>
<span id="cb37-13"><a href="#cb37-13" tabindex="-1"></a><span class="co">#&gt;   Sex                                                                          </span></span>
<span id="cb37-14"><a href="#cb37-14" tabindex="-1"></a><span class="co">#&gt;     n                                      15           15             15      </span></span>
<span id="cb37-15"><a href="#cb37-15" tabindex="-1"></a><span class="co">#&gt;     Male                               3 (20.0%)    7 (46.7%)      5 (33.3%)   </span></span>
<span id="cb37-16"><a href="#cb37-16" tabindex="-1"></a><span class="co">#&gt;     Female                             12 (80.0%)   8 (53.3%)      10 (66.7%)  </span></span>
<span id="cb37-17"><a href="#cb37-17" tabindex="-1"></a><span class="co">#&gt;   Ethnicity                                                                    </span></span>
<span id="cb37-18"><a href="#cb37-18" tabindex="-1"></a><span class="co">#&gt;     n                                      15           15             15      </span></span>
<span id="cb37-19"><a href="#cb37-19" tabindex="-1"></a><span class="co">#&gt;     NOT REPORTED                           0            0          2 (13.3%)   </span></span>
<span id="cb37-20"><a href="#cb37-20" tabindex="-1"></a><span class="co">#&gt;     HISPANIC OR LATINO                 2 (13.3%)        0              0       </span></span>
<span id="cb37-21"><a href="#cb37-21" tabindex="-1"></a><span class="co">#&gt;     NOT HISPANIC OR LATINO             13 (86.7%)   15 (100%)      13 (86.7%)  </span></span>
<span id="cb37-22"><a href="#cb37-22" tabindex="-1"></a><span class="co">#&gt;   RACE                                                                         </span></span>
<span id="cb37-23"><a href="#cb37-23" tabindex="-1"></a><span class="co">#&gt;     n                                      15           15             15      </span></span>
<span id="cb37-24"><a href="#cb37-24" tabindex="-1"></a><span class="co">#&gt;     AMERICAN INDIAN OR ALASKA NATIVE       0        2 (13.3%)       1 (6.7%)   </span></span>
<span id="cb37-25"><a href="#cb37-25" tabindex="-1"></a><span class="co">#&gt;     ASIAN                              8 (53.3%)    10 (66.7%)     8 (53.3%)   </span></span>
<span id="cb37-26"><a href="#cb37-26" tabindex="-1"></a><span class="co">#&gt;     BLACK OR AFRICAN AMERICAN          4 (26.7%)     1 (6.7%)      4 (26.7%)   </span></span>
<span id="cb37-27"><a href="#cb37-27" tabindex="-1"></a><span class="co">#&gt;     WHITE                              3 (20.0%)    2 (13.3%)      2 (13.3%)</span></span></code></pre></div>
</div>
<div id="demographics-and-baseline-characteristics-with-an-additional-study-specific-continuous-variable" class="section level4">
<h4><strong>3. Demographics and Baseline Characteristics with an
additional study specific continuous variable</strong></h4>
<ol style="list-style-type: decimal">
<li>Study specific continuous variables can be added to the standard
demographics and baseline characteristics summary by editing the
argument <code>summaryvars</code>. To add or remove analyses, you need
to pass all variables you would like to include to the argument.</li>
<li>CHEVRON performs the analysis based on the type of variable as
defined in the input data.</li>
</ol>
<div class="sourceCode" id="cb38"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb38-1"><a href="#cb38-1" tabindex="-1"></a><span class="fu">run</span>(dmt01, syn_data, <span class="at">summaryvars =</span> <span class="fu">c</span>(<span class="st">&quot;AGE&quot;</span>, <span class="st">&quot;AGEGR1&quot;</span>, <span class="st">&quot;SEX&quot;</span>, <span class="st">&quot;ETHNIC&quot;</span>, <span class="st">&quot;RACE&quot;</span>, <span class="st">&quot;BBMISI&quot;</span>), <span class="at">lbl_overall =</span> <span class="cn">NULL</span>)</span>
<span id="cb38-2"><a href="#cb38-2" tabindex="-1"></a><span class="co">#&gt;                                          A: Drug X      B: Placebo     C: Combination</span></span>
<span id="cb38-3"><a href="#cb38-3" tabindex="-1"></a><span class="co">#&gt;                                           (N=15)          (N=15)           (N=15)    </span></span>
<span id="cb38-4"><a href="#cb38-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb38-5"><a href="#cb38-5" tabindex="-1"></a><span class="co">#&gt;   Age                                                                                </span></span>
<span id="cb38-6"><a href="#cb38-6" tabindex="-1"></a><span class="co">#&gt;     n                                       15              15               15      </span></span>
<span id="cb38-7"><a href="#cb38-7" tabindex="-1"></a><span class="co">#&gt;     Mean (SD)                           31.3 (5.3)      35.1 (9.0)       36.6 (6.4)  </span></span>
<span id="cb38-8"><a href="#cb38-8" tabindex="-1"></a><span class="co">#&gt;     Median                                 31.0            35.0             35.0     </span></span>
<span id="cb38-9"><a href="#cb38-9" tabindex="-1"></a><span class="co">#&gt;     Min - Max                             24 - 40         24 - 57         24 - 49    </span></span>
<span id="cb38-10"><a href="#cb38-10" tabindex="-1"></a><span class="co">#&gt;   Age Group                                                                          </span></span>
<span id="cb38-11"><a href="#cb38-11" tabindex="-1"></a><span class="co">#&gt;     n                                       15              15               15      </span></span>
<span id="cb38-12"><a href="#cb38-12" tabindex="-1"></a><span class="co">#&gt;     &lt;65                                  15 (100%)       15 (100%)       15 (100%)   </span></span>
<span id="cb38-13"><a href="#cb38-13" tabindex="-1"></a><span class="co">#&gt;   Sex                                                                                </span></span>
<span id="cb38-14"><a href="#cb38-14" tabindex="-1"></a><span class="co">#&gt;     n                                       15              15               15      </span></span>
<span id="cb38-15"><a href="#cb38-15" tabindex="-1"></a><span class="co">#&gt;     Male                                 3 (20.0%)       7 (46.7%)       5 (33.3%)   </span></span>
<span id="cb38-16"><a href="#cb38-16" tabindex="-1"></a><span class="co">#&gt;     Female                              12 (80.0%)       8 (53.3%)       10 (66.7%)  </span></span>
<span id="cb38-17"><a href="#cb38-17" tabindex="-1"></a><span class="co">#&gt;   Ethnicity                                                                          </span></span>
<span id="cb38-18"><a href="#cb38-18" tabindex="-1"></a><span class="co">#&gt;     n                                       15              15               15      </span></span>
<span id="cb38-19"><a href="#cb38-19" tabindex="-1"></a><span class="co">#&gt;     NOT REPORTED                             0               0           2 (13.3%)   </span></span>
<span id="cb38-20"><a href="#cb38-20" tabindex="-1"></a><span class="co">#&gt;     HISPANIC OR LATINO                   2 (13.3%)           0               0       </span></span>
<span id="cb38-21"><a href="#cb38-21" tabindex="-1"></a><span class="co">#&gt;     NOT HISPANIC OR LATINO              13 (86.7%)       15 (100%)       13 (86.7%)  </span></span>
<span id="cb38-22"><a href="#cb38-22" tabindex="-1"></a><span class="co">#&gt;   RACE                                                                               </span></span>
<span id="cb38-23"><a href="#cb38-23" tabindex="-1"></a><span class="co">#&gt;     n                                       15              15               15      </span></span>
<span id="cb38-24"><a href="#cb38-24" tabindex="-1"></a><span class="co">#&gt;     AMERICAN INDIAN OR ALASKA NATIVE         0           2 (13.3%)        1 (6.7%)   </span></span>
<span id="cb38-25"><a href="#cb38-25" tabindex="-1"></a><span class="co">#&gt;     ASIAN                                8 (53.3%)      10 (66.7%)       8 (53.3%)   </span></span>
<span id="cb38-26"><a href="#cb38-26" tabindex="-1"></a><span class="co">#&gt;     BLACK OR AFRICAN AMERICAN            4 (26.7%)       1 (6.7%)        4 (26.7%)   </span></span>
<span id="cb38-27"><a href="#cb38-27" tabindex="-1"></a><span class="co">#&gt;     WHITE                                3 (20.0%)       2 (13.3%)       2 (13.3%)   </span></span>
<span id="cb38-28"><a href="#cb38-28" tabindex="-1"></a><span class="co">#&gt;   Baseline BMI                                                                       </span></span>
<span id="cb38-29"><a href="#cb38-29" tabindex="-1"></a><span class="co">#&gt;     n                                       15              15               15      </span></span>
<span id="cb38-30"><a href="#cb38-30" tabindex="-1"></a><span class="co">#&gt;     Mean (SD)                          29.75 (15.10)   41.08 (26.65)   33.90 (15.39) </span></span>
<span id="cb38-31"><a href="#cb38-31" tabindex="-1"></a><span class="co">#&gt;     Median                                 37.00           33.70           37.80     </span></span>
<span id="cb38-32"><a href="#cb38-32" tabindex="-1"></a><span class="co">#&gt;     Min - Max                           6.4 - 47.9      5.3 - 117.9     -3.5 - 59.0</span></span></code></pre></div>
</div>
<div id="demographics-and-baseline-characteristics-with-an-additional-study-specific-categorical-variable" class="section level4">
<h4><strong>4. Demographics and Baseline Characteristics with an
additional study specific categorical variable</strong></h4>
<ol style="list-style-type: decimal">
<li>Study specific categorical variables can be added to the standard
demographics and baseline characteristics summary by editing the
argument <code>summaryvars</code>.</li>
<li>To display the values within a categorical variable in pre-specified
order, the categorical variable need to be factorized with pre-specified
order provided as levels.</li>
</ol>
<div class="sourceCode" id="cb39"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb39-1"><a href="#cb39-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> syn_data</span>
<span id="cb39-2"><a href="#cb39-2" tabindex="-1"></a>proc_data<span class="sc">$</span>adsl <span class="ot">&lt;-</span> proc_data<span class="sc">$</span>adsl <span class="sc">%&gt;%</span></span>
<span id="cb39-3"><a href="#cb39-3" tabindex="-1"></a>  <span class="fu">mutate</span>(</span>
<span id="cb39-4"><a href="#cb39-4" tabindex="-1"></a>    <span class="at">SEX =</span> <span class="fu">reformat</span>(.data<span class="sc">$</span>SEX, <span class="fu">rule</span>(<span class="at">Male =</span> <span class="st">&quot;M&quot;</span>, <span class="at">Female =</span> <span class="st">&quot;F&quot;</span>)),</span>
<span id="cb39-5"><a href="#cb39-5" tabindex="-1"></a>    <span class="at">BBMIGR1 =</span> <span class="fu">factor</span>(<span class="fu">case_when</span>(</span>
<span id="cb39-6"><a href="#cb39-6" tabindex="-1"></a>      BBMISI <span class="sc">&lt;</span> <span class="dv">15</span> <span class="sc">~</span> <span class="st">&quot;Very severely underweight&quot;</span>,</span>
<span id="cb39-7"><a href="#cb39-7" tabindex="-1"></a>      BBMISI <span class="sc">&gt;=</span> <span class="dv">15</span> <span class="sc">&amp;</span> BBMISI <span class="sc">&lt;</span> <span class="dv">16</span> <span class="sc">~</span> <span class="st">&quot;Severely underweight&quot;</span>,</span>
<span id="cb39-8"><a href="#cb39-8" tabindex="-1"></a>      BBMISI <span class="sc">&gt;=</span> <span class="dv">16</span> <span class="sc">&amp;</span> BBMISI <span class="sc">&lt;</span> <span class="fl">18.5</span> <span class="sc">~</span> <span class="st">&quot;Underweight&quot;</span>,</span>
<span id="cb39-9"><a href="#cb39-9" tabindex="-1"></a>      BBMISI <span class="sc">&gt;=</span> <span class="fl">18.5</span> <span class="sc">&amp;</span> BBMISI <span class="sc">&lt;</span> <span class="dv">25</span> <span class="sc">~</span> <span class="st">&quot;Normal (healthy weight)&quot;</span>,</span>
<span id="cb39-10"><a href="#cb39-10" tabindex="-1"></a>      BBMISI <span class="sc">&gt;=</span> <span class="dv">25</span> <span class="sc">&amp;</span> BBMISI <span class="sc">&lt;</span> <span class="dv">30</span> <span class="sc">~</span> <span class="st">&quot;Overweight&quot;</span>,</span>
<span id="cb39-11"><a href="#cb39-11" tabindex="-1"></a>      BBMISI <span class="sc">&gt;=</span> <span class="dv">30</span> <span class="sc">&amp;</span> BBMISI <span class="sc">&lt;</span> <span class="dv">35</span> <span class="sc">~</span> <span class="st">&quot;Obese Class I (Moderately obese)&quot;</span>,</span>
<span id="cb39-12"><a href="#cb39-12" tabindex="-1"></a>      BBMISI <span class="sc">&gt;=</span> <span class="dv">35</span> <span class="sc">&amp;</span> BBMISI <span class="sc">&lt;</span> <span class="dv">40</span> <span class="sc">~</span> <span class="st">&quot;Obese Class II (Severely obese)&quot;</span>,</span>
<span id="cb39-13"><a href="#cb39-13" tabindex="-1"></a>      BBMISI <span class="sc">&gt;=</span> <span class="dv">40</span> <span class="sc">~</span> <span class="st">&quot;Obese Class III (Very severely obese)&quot;</span></span>
<span id="cb39-14"><a href="#cb39-14" tabindex="-1"></a>    ), <span class="at">levels =</span> <span class="fu">c</span>(</span>
<span id="cb39-15"><a href="#cb39-15" tabindex="-1"></a>      <span class="st">&quot;Very severely underweight&quot;</span>,</span>
<span id="cb39-16"><a href="#cb39-16" tabindex="-1"></a>      <span class="st">&quot;Severely underweight&quot;</span>,</span>
<span id="cb39-17"><a href="#cb39-17" tabindex="-1"></a>      <span class="st">&quot;Underweight&quot;</span>,</span>
<span id="cb39-18"><a href="#cb39-18" tabindex="-1"></a>      <span class="st">&quot;Normal (healthy weight)&quot;</span>,</span>
<span id="cb39-19"><a href="#cb39-19" tabindex="-1"></a>      <span class="st">&quot;Overweight&quot;</span>,</span>
<span id="cb39-20"><a href="#cb39-20" tabindex="-1"></a>      <span class="st">&quot;Obese Class I (Moderately obese)&quot;</span>,</span>
<span id="cb39-21"><a href="#cb39-21" tabindex="-1"></a>      <span class="st">&quot;Obese Class II (Severely obese)&quot;</span>,</span>
<span id="cb39-22"><a href="#cb39-22" tabindex="-1"></a>      <span class="st">&quot;Obese Class III (Very severely obese)&quot;</span></span>
<span id="cb39-23"><a href="#cb39-23" tabindex="-1"></a>    ))</span>
<span id="cb39-24"><a href="#cb39-24" tabindex="-1"></a>  )</span>
<span id="cb39-25"><a href="#cb39-25" tabindex="-1"></a></span>
<span id="cb39-26"><a href="#cb39-26" tabindex="-1"></a><span class="fu">run</span>(dmt01, proc_data, <span class="at">summaryvars =</span> <span class="fu">c</span>(<span class="st">&quot;AGE&quot;</span>, <span class="st">&quot;AGEGR1&quot;</span>, <span class="st">&quot;SEX&quot;</span>, <span class="st">&quot;ETHNIC&quot;</span>, <span class="st">&quot;RACE&quot;</span>, <span class="st">&quot;BBMIGR1&quot;</span>), <span class="at">auto_pre =</span> <span class="cn">FALSE</span>)</span>
<span id="cb39-27"><a href="#cb39-27" tabindex="-1"></a><span class="co">#&gt;                                             A: Drug X    B: Placebo   C: Combination   All Patients</span></span>
<span id="cb39-28"><a href="#cb39-28" tabindex="-1"></a><span class="co">#&gt;                                               (N=15)       (N=15)         (N=15)          (N=45)   </span></span>
<span id="cb39-29"><a href="#cb39-29" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb39-30"><a href="#cb39-30" tabindex="-1"></a><span class="co">#&gt;   Age                                                                                              </span></span>
<span id="cb39-31"><a href="#cb39-31" tabindex="-1"></a><span class="co">#&gt;     n                                           15           15             15              45     </span></span>
<span id="cb39-32"><a href="#cb39-32" tabindex="-1"></a><span class="co">#&gt;     Mean (SD)                               31.3 (5.3)   35.1 (9.0)     36.6 (6.4)      34.3 (7.3) </span></span>
<span id="cb39-33"><a href="#cb39-33" tabindex="-1"></a><span class="co">#&gt;     Median                                     31.0         35.0           35.0            34.0    </span></span>
<span id="cb39-34"><a href="#cb39-34" tabindex="-1"></a><span class="co">#&gt;     Min - Max                                24 - 40      24 - 57        24 - 49         24 - 57   </span></span>
<span id="cb39-35"><a href="#cb39-35" tabindex="-1"></a><span class="co">#&gt;   Age Group                                                                                        </span></span>
<span id="cb39-36"><a href="#cb39-36" tabindex="-1"></a><span class="co">#&gt;     n                                           15           15             15              45     </span></span>
<span id="cb39-37"><a href="#cb39-37" tabindex="-1"></a><span class="co">#&gt;     &lt;65                                     15 (100%)    15 (100%)      15 (100%)       45 (100%)  </span></span>
<span id="cb39-38"><a href="#cb39-38" tabindex="-1"></a><span class="co">#&gt;   Sex                                                                                              </span></span>
<span id="cb39-39"><a href="#cb39-39" tabindex="-1"></a><span class="co">#&gt;     n                                           15           15             15              45     </span></span>
<span id="cb39-40"><a href="#cb39-40" tabindex="-1"></a><span class="co">#&gt;     Male                                    3 (20.0%)    7 (46.7%)      5 (33.3%)       15 (33.3%) </span></span>
<span id="cb39-41"><a href="#cb39-41" tabindex="-1"></a><span class="co">#&gt;     Female                                  12 (80.0%)   8 (53.3%)      10 (66.7%)      30 (66.7%) </span></span>
<span id="cb39-42"><a href="#cb39-42" tabindex="-1"></a><span class="co">#&gt;   Ethnicity                                                                                        </span></span>
<span id="cb39-43"><a href="#cb39-43" tabindex="-1"></a><span class="co">#&gt;     n                                           15           15             15              45     </span></span>
<span id="cb39-44"><a href="#cb39-44" tabindex="-1"></a><span class="co">#&gt;     NOT REPORTED                                0            0          2 (13.3%)        2 (4.4%)  </span></span>
<span id="cb39-45"><a href="#cb39-45" tabindex="-1"></a><span class="co">#&gt;     HISPANIC OR LATINO                      2 (13.3%)        0              0            2 (4.4%)  </span></span>
<span id="cb39-46"><a href="#cb39-46" tabindex="-1"></a><span class="co">#&gt;     NOT HISPANIC OR LATINO                  13 (86.7%)   15 (100%)      13 (86.7%)      41 (91.1%) </span></span>
<span id="cb39-47"><a href="#cb39-47" tabindex="-1"></a><span class="co">#&gt;   RACE                                                                                             </span></span>
<span id="cb39-48"><a href="#cb39-48" tabindex="-1"></a><span class="co">#&gt;     n                                           15           15             15              45     </span></span>
<span id="cb39-49"><a href="#cb39-49" tabindex="-1"></a><span class="co">#&gt;     AMERICAN INDIAN OR ALASKA NATIVE            0        2 (13.3%)       1 (6.7%)        3 (6.7%)  </span></span>
<span id="cb39-50"><a href="#cb39-50" tabindex="-1"></a><span class="co">#&gt;     ASIAN                                   8 (53.3%)    10 (66.7%)     8 (53.3%)       26 (57.8%) </span></span>
<span id="cb39-51"><a href="#cb39-51" tabindex="-1"></a><span class="co">#&gt;     BLACK OR AFRICAN AMERICAN               4 (26.7%)     1 (6.7%)      4 (26.7%)       9 (20.0%)  </span></span>
<span id="cb39-52"><a href="#cb39-52" tabindex="-1"></a><span class="co">#&gt;     WHITE                                   3 (20.0%)    2 (13.3%)      2 (13.3%)       7 (15.6%)  </span></span>
<span id="cb39-53"><a href="#cb39-53" tabindex="-1"></a><span class="co">#&gt;   BBMIGR1                                                                                          </span></span>
<span id="cb39-54"><a href="#cb39-54" tabindex="-1"></a><span class="co">#&gt;     n                                           15           15             15              45     </span></span>
<span id="cb39-55"><a href="#cb39-55" tabindex="-1"></a><span class="co">#&gt;     Very severely underweight               4 (26.7%)     1 (6.7%)       1 (6.7%)       6 (13.3%)  </span></span>
<span id="cb39-56"><a href="#cb39-56" tabindex="-1"></a><span class="co">#&gt;     Underweight                              1 (6.7%)        0              0            1 (2.2%)  </span></span>
<span id="cb39-57"><a href="#cb39-57" tabindex="-1"></a><span class="co">#&gt;     Normal (healthy weight)                  1 (6.7%)    3 (20.0%)      4 (26.7%)       8 (17.8%)  </span></span>
<span id="cb39-58"><a href="#cb39-58" tabindex="-1"></a><span class="co">#&gt;     Overweight                                  0         1 (6.7%)       1 (6.7%)        2 (4.4%)  </span></span>
<span id="cb39-59"><a href="#cb39-59" tabindex="-1"></a><span class="co">#&gt;     Obese Class I (Moderately obese)            0        3 (20.0%)          0            3 (6.7%)  </span></span>
<span id="cb39-60"><a href="#cb39-60" tabindex="-1"></a><span class="co">#&gt;     Obese Class II (Severely obese)         4 (26.7%)     1 (6.7%)      3 (20.0%)       8 (17.8%)  </span></span>
<span id="cb39-61"><a href="#cb39-61" tabindex="-1"></a><span class="co">#&gt;     Obese Class III (Very severely obese)   5 (33.3%)    6 (40.0%)      6 (40.0%)       17 (37.8%)</span></span></code></pre></div>
</div>
<div id="demographics-and-baseline-characteristics-with-additional-vital-signs-baseline-values-from-advs-or-adsub" class="section level4">
<h4><strong>5. Demographics and Baseline Characteristics with additional
vital signs baseline values from <code>ADVS</code> or
<code>ADSUB</code></strong></h4>
<p>To add baseline vital signs or other baseline characteristics to the
demographics and baseline characteristics summary, manual preprocess of
input <code>adsl</code> dataset is expected and merge the vital signs
baseline values from <code>advs</code> (where
<code>ADVS.ABLFL == &quot;Y&quot;</code>) or <code>adsub</code> with
<code>adsl</code> by unique subject identifier.</p>
<div class="sourceCode" id="cb40"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb40-1"><a href="#cb40-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> syn_data</span>
<span id="cb40-2"><a href="#cb40-2" tabindex="-1"></a>diabpbl <span class="ot">&lt;-</span> proc_data<span class="sc">$</span>advs <span class="sc">%&gt;%</span></span>
<span id="cb40-3"><a href="#cb40-3" tabindex="-1"></a>  <span class="fu">filter</span>(ABLFL <span class="sc">==</span> <span class="st">&quot;Y&quot;</span> <span class="sc">&amp;</span> PARAMCD <span class="sc">==</span> <span class="st">&quot;DIABP&quot;</span>) <span class="sc">%&gt;%</span></span>
<span id="cb40-4"><a href="#cb40-4" tabindex="-1"></a>  <span class="fu">mutate</span>(<span class="at">DIABPBL =</span> AVAL) <span class="sc">%&gt;%</span></span>
<span id="cb40-5"><a href="#cb40-5" tabindex="-1"></a>  <span class="fu">select</span>(<span class="st">&quot;STUDYID&quot;</span>, <span class="st">&quot;USUBJID&quot;</span>, <span class="st">&quot;DIABPBL&quot;</span>)</span>
<span id="cb40-6"><a href="#cb40-6" tabindex="-1"></a></span>
<span id="cb40-7"><a href="#cb40-7" tabindex="-1"></a>proc_data<span class="sc">$</span>adsl <span class="ot">&lt;-</span> proc_data<span class="sc">$</span>adsl <span class="sc">%&gt;%</span></span>
<span id="cb40-8"><a href="#cb40-8" tabindex="-1"></a>  <span class="fu">mutate</span>(<span class="at">SEX =</span> <span class="fu">reformat</span>(.data<span class="sc">$</span>SEX, <span class="fu">rule</span>(<span class="at">Male =</span> <span class="st">&quot;M&quot;</span>, <span class="at">Female =</span> <span class="st">&quot;F&quot;</span>))) <span class="sc">%&gt;%</span></span>
<span id="cb40-9"><a href="#cb40-9" tabindex="-1"></a>  <span class="fu">left_join</span>(diabpbl, <span class="at">by =</span> <span class="fu">c</span>(<span class="st">&quot;STUDYID&quot;</span>, <span class="st">&quot;USUBJID&quot;</span>))</span>
<span id="cb40-10"><a href="#cb40-10" tabindex="-1"></a></span>
<span id="cb40-11"><a href="#cb40-11" tabindex="-1"></a><span class="fu">run</span>(dmt01, proc_data, <span class="at">summaryvars =</span> <span class="fu">c</span>(<span class="st">&quot;AGE&quot;</span>, <span class="st">&quot;AGEGR1&quot;</span>, <span class="st">&quot;SEX&quot;</span>, <span class="st">&quot;ETHNIC&quot;</span>, <span class="st">&quot;RACE&quot;</span>, <span class="st">&quot;DIABPBL&quot;</span>), <span class="at">auto_pre =</span> <span class="cn">FALSE</span>)</span>
<span id="cb40-12"><a href="#cb40-12" tabindex="-1"></a><span class="co">#&gt;                                             A: Drug X              B: Placebo           C: Combination          All Patients    </span></span>
<span id="cb40-13"><a href="#cb40-13" tabindex="-1"></a><span class="co">#&gt;                                               (N=15)                 (N=15)                 (N=15)                 (N=45)       </span></span>
<span id="cb40-14"><a href="#cb40-14" tabindex="-1"></a><span class="co">#&gt;   ââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb40-15"><a href="#cb40-15" tabindex="-1"></a><span class="co">#&gt;   Age                                                                                                                           </span></span>
<span id="cb40-16"><a href="#cb40-16" tabindex="-1"></a><span class="co">#&gt;     n                                           15                     15                     15                     45         </span></span>
<span id="cb40-17"><a href="#cb40-17" tabindex="-1"></a><span class="co">#&gt;     Mean (SD)                               31.3 (5.3)             35.1 (9.0)             36.6 (6.4)             34.3 (7.3)     </span></span>
<span id="cb40-18"><a href="#cb40-18" tabindex="-1"></a><span class="co">#&gt;     Median                                     31.0                   35.0                   35.0                   34.0        </span></span>
<span id="cb40-19"><a href="#cb40-19" tabindex="-1"></a><span class="co">#&gt;     Min - Max                                24 - 40                24 - 57                24 - 49                24 - 57       </span></span>
<span id="cb40-20"><a href="#cb40-20" tabindex="-1"></a><span class="co">#&gt;   Age Group                                                                                                                     </span></span>
<span id="cb40-21"><a href="#cb40-21" tabindex="-1"></a><span class="co">#&gt;     n                                           15                     15                     15                     45         </span></span>
<span id="cb40-22"><a href="#cb40-22" tabindex="-1"></a><span class="co">#&gt;     &lt;65                                     15 (100%)              15 (100%)              15 (100%)              45 (100%)      </span></span>
<span id="cb40-23"><a href="#cb40-23" tabindex="-1"></a><span class="co">#&gt;   Sex                                                                                                                           </span></span>
<span id="cb40-24"><a href="#cb40-24" tabindex="-1"></a><span class="co">#&gt;     n                                           15                     15                     15                     45         </span></span>
<span id="cb40-25"><a href="#cb40-25" tabindex="-1"></a><span class="co">#&gt;     Male                                    3 (20.0%)              7 (46.7%)              5 (33.3%)              15 (33.3%)     </span></span>
<span id="cb40-26"><a href="#cb40-26" tabindex="-1"></a><span class="co">#&gt;     Female                                  12 (80.0%)             8 (53.3%)              10 (66.7%)             30 (66.7%)     </span></span>
<span id="cb40-27"><a href="#cb40-27" tabindex="-1"></a><span class="co">#&gt;   Ethnicity                                                                                                                     </span></span>
<span id="cb40-28"><a href="#cb40-28" tabindex="-1"></a><span class="co">#&gt;     n                                           15                     15                     15                     45         </span></span>
<span id="cb40-29"><a href="#cb40-29" tabindex="-1"></a><span class="co">#&gt;     NOT REPORTED                                0                      0                  2 (13.3%)               2 (4.4%)      </span></span>
<span id="cb40-30"><a href="#cb40-30" tabindex="-1"></a><span class="co">#&gt;     HISPANIC OR LATINO                      2 (13.3%)                  0                      0                   2 (4.4%)      </span></span>
<span id="cb40-31"><a href="#cb40-31" tabindex="-1"></a><span class="co">#&gt;     NOT HISPANIC OR LATINO                  13 (86.7%)             15 (100%)              13 (86.7%)             41 (91.1%)     </span></span>
<span id="cb40-32"><a href="#cb40-32" tabindex="-1"></a><span class="co">#&gt;   RACE                                                                                                                          </span></span>
<span id="cb40-33"><a href="#cb40-33" tabindex="-1"></a><span class="co">#&gt;     n                                           15                     15                     15                     45         </span></span>
<span id="cb40-34"><a href="#cb40-34" tabindex="-1"></a><span class="co">#&gt;     AMERICAN INDIAN OR ALASKA NATIVE            0                  2 (13.3%)               1 (6.7%)               3 (6.7%)      </span></span>
<span id="cb40-35"><a href="#cb40-35" tabindex="-1"></a><span class="co">#&gt;     ASIAN                                   8 (53.3%)              10 (66.7%)             8 (53.3%)              26 (57.8%)     </span></span>
<span id="cb40-36"><a href="#cb40-36" tabindex="-1"></a><span class="co">#&gt;     BLACK OR AFRICAN AMERICAN               4 (26.7%)               1 (6.7%)              4 (26.7%)              9 (20.0%)      </span></span>
<span id="cb40-37"><a href="#cb40-37" tabindex="-1"></a><span class="co">#&gt;     WHITE                                   3 (20.0%)              2 (13.3%)              2 (13.3%)              7 (15.6%)      </span></span>
<span id="cb40-38"><a href="#cb40-38" tabindex="-1"></a><span class="co">#&gt;   Analysis Value                                                                                                                </span></span>
<span id="cb40-39"><a href="#cb40-39" tabindex="-1"></a><span class="co">#&gt;     n                                           15                     15                     15                     45         </span></span>
<span id="cb40-40"><a href="#cb40-40" tabindex="-1"></a><span class="co">#&gt;     Mean (SD)                          48.453004 (8.983282)   53.244378 (6.029780)   51.259527 (7.900675)   50.985636 (7.813978)</span></span>
<span id="cb40-41"><a href="#cb40-41" tabindex="-1"></a><span class="co">#&gt;     Median                                  47.331328              53.580543              51.139608              50.958451      </span></span>
<span id="cb40-42"><a href="#cb40-42" tabindex="-1"></a><span class="co">#&gt;     Min - Max                          34.23396 - 64.63737    43.37711 - 62.64600    36.42089 - 64.62102    34.23396 - 64.63737</span></span></code></pre></div>
</div>
</div>
<div id="patient-disposition-dst01" class="section level3">
<h3><strong>Patient Disposition (<code>DST01</code>)</strong></h3>
<div id="patient-disposition" class="section level4">
<h4><strong>1. Patient Disposition</strong></h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>dst01</code></strong> template produces the
standard patient disposition summary.</li>
<li>The template includes the column of total by default. Use
<code>lbl_overall = NULL</code> to suppress the default.</li>
</ol>
<div class="sourceCode" id="cb41"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb41-1"><a href="#cb41-1" tabindex="-1"></a><span class="fu">run</span>(dst01, syn_data, <span class="at">lbl_overall =</span> <span class="cn">NULL</span>)</span>
<span id="cb41-2"><a href="#cb41-2" tabindex="-1"></a><span class="co">#&gt;                                     A: Drug X    B: Placebo   C: Combination</span></span>
<span id="cb41-3"><a href="#cb41-3" tabindex="-1"></a><span class="co">#&gt;                                       (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb41-4"><a href="#cb41-4" tabindex="-1"></a><span class="co">#&gt;   ââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb41-5"><a href="#cb41-5" tabindex="-1"></a><span class="co">#&gt;   Completed                         10 (66.7%)   10 (66.7%)     10 (66.7%)  </span></span>
<span id="cb41-6"><a href="#cb41-6" tabindex="-1"></a><span class="co">#&gt;   Discontinued                      5 (33.3%)    5 (33.3%)      5 (33.3%)   </span></span>
<span id="cb41-7"><a href="#cb41-7" tabindex="-1"></a><span class="co">#&gt;     ADVERSE EVENT                       0            0           1 (6.7%)   </span></span>
<span id="cb41-8"><a href="#cb41-8" tabindex="-1"></a><span class="co">#&gt;     DEATH                           2 (13.3%)    4 (26.7%)      3 (20.0%)   </span></span>
<span id="cb41-9"><a href="#cb41-9" tabindex="-1"></a><span class="co">#&gt;     LACK OF EFFICACY                2 (13.3%)        0              0       </span></span>
<span id="cb41-10"><a href="#cb41-10" tabindex="-1"></a><span class="co">#&gt;     PHYSICIAN DECISION                  0            0           1 (6.7%)   </span></span>
<span id="cb41-11"><a href="#cb41-11" tabindex="-1"></a><span class="co">#&gt;     PROTOCOL VIOLATION                  0         1 (6.7%)          0       </span></span>
<span id="cb41-12"><a href="#cb41-12" tabindex="-1"></a><span class="co">#&gt;     WITHDRAWAL BY PARENT/GUARDIAN    1 (6.7%)        0              0</span></span></code></pre></div>
</div>
<div id="patient-disposition-with-grouping-of-reasons" class="section level4">
<h4><strong>2. Patient Disposition (with grouping of
reasons)</strong></h4>
<ol style="list-style-type: decimal">
<li>The syntax below produces the standard patient disposition summary
with grouping of the discontinuation reasons.</li>
<li>The variable [<code>ADSL.DCSREASGP</code>] that groups the
discontinuation reasons needs to be derived manually and provided in the
input <code>adsl</code> dataset.</li>
</ol>
<div class="sourceCode" id="cb42"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb42-1"><a href="#cb42-1" tabindex="-1"></a><span class="fu">run</span>(dst01, syn_data, <span class="at">detail_vars =</span> <span class="fu">list</span>(<span class="at">Discontinued =</span> <span class="fu">c</span>(<span class="st">&quot;DCSREASGP&quot;</span>, <span class="st">&quot;DCSREAS&quot;</span>)), <span class="at">lbl_overall =</span> <span class="cn">NULL</span>)</span>
<span id="cb42-2"><a href="#cb42-2" tabindex="-1"></a><span class="co">#&gt;                                       A: Drug X    B: Placebo   C: Combination</span></span>
<span id="cb42-3"><a href="#cb42-3" tabindex="-1"></a><span class="co">#&gt;                                         (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb42-4"><a href="#cb42-4" tabindex="-1"></a><span class="co">#&gt;   ââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb42-5"><a href="#cb42-5" tabindex="-1"></a><span class="co">#&gt;   Completed                           10 (66.7%)   10 (66.7%)     10 (66.7%)  </span></span>
<span id="cb42-6"><a href="#cb42-6" tabindex="-1"></a><span class="co">#&gt;   Discontinued                        5 (33.3%)    5 (33.3%)      5 (33.3%)   </span></span>
<span id="cb42-7"><a href="#cb42-7" tabindex="-1"></a><span class="co">#&gt;     Safety                                                                    </span></span>
<span id="cb42-8"><a href="#cb42-8" tabindex="-1"></a><span class="co">#&gt;       ADVERSE EVENT                       0            0           1 (6.7%)   </span></span>
<span id="cb42-9"><a href="#cb42-9" tabindex="-1"></a><span class="co">#&gt;       DEATH                           2 (13.3%)    4 (26.7%)      3 (20.0%)   </span></span>
<span id="cb42-10"><a href="#cb42-10" tabindex="-1"></a><span class="co">#&gt;     Non-Safety                                                                </span></span>
<span id="cb42-11"><a href="#cb42-11" tabindex="-1"></a><span class="co">#&gt;       LACK OF EFFICACY                2 (13.3%)        0              0       </span></span>
<span id="cb42-12"><a href="#cb42-12" tabindex="-1"></a><span class="co">#&gt;       PHYSICIAN DECISION                  0            0           1 (6.7%)   </span></span>
<span id="cb42-13"><a href="#cb42-13" tabindex="-1"></a><span class="co">#&gt;       PROTOCOL VIOLATION                  0         1 (6.7%)          0       </span></span>
<span id="cb42-14"><a href="#cb42-14" tabindex="-1"></a><span class="co">#&gt;       WITHDRAWAL BY PARENT/GUARDIAN    1 (6.7%)        0              0</span></span></code></pre></div>
</div>
<div id="patient-disposition-adding-end-of-treatment-status" class="section level4">
<h4><strong>3. Patient Disposition (adding end of treatment
status)</strong></h4>
<p>The syntax below adds the end of treatment status to the standard
patient disposition summary by providing the end of treatment status
variable to the argument <code>trt_status_var</code>.</p>
<div class="sourceCode" id="cb43"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb43-1"><a href="#cb43-1" tabindex="-1"></a><span class="fu">run</span>(dst01, syn_data, <span class="at">trt_status_var =</span> <span class="st">&quot;EOTSTT&quot;</span>, <span class="at">lbl_overall =</span> <span class="cn">NULL</span>)</span>
<span id="cb43-2"><a href="#cb43-2" tabindex="-1"></a><span class="co">#&gt;                                     A: Drug X    B: Placebo   C: Combination</span></span>
<span id="cb43-3"><a href="#cb43-3" tabindex="-1"></a><span class="co">#&gt;                                       (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb43-4"><a href="#cb43-4" tabindex="-1"></a><span class="co">#&gt;   ââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb43-5"><a href="#cb43-5" tabindex="-1"></a><span class="co">#&gt;   Completed                         10 (66.7%)   10 (66.7%)     10 (66.7%)  </span></span>
<span id="cb43-6"><a href="#cb43-6" tabindex="-1"></a><span class="co">#&gt;   Discontinued                      5 (33.3%)    5 (33.3%)      5 (33.3%)   </span></span>
<span id="cb43-7"><a href="#cb43-7" tabindex="-1"></a><span class="co">#&gt;     ADVERSE EVENT                       0            0           1 (6.7%)   </span></span>
<span id="cb43-8"><a href="#cb43-8" tabindex="-1"></a><span class="co">#&gt;     DEATH                           2 (13.3%)    4 (26.7%)      3 (20.0%)   </span></span>
<span id="cb43-9"><a href="#cb43-9" tabindex="-1"></a><span class="co">#&gt;     LACK OF EFFICACY                2 (13.3%)        0              0       </span></span>
<span id="cb43-10"><a href="#cb43-10" tabindex="-1"></a><span class="co">#&gt;     PHYSICIAN DECISION                  0            0           1 (6.7%)   </span></span>
<span id="cb43-11"><a href="#cb43-11" tabindex="-1"></a><span class="co">#&gt;     PROTOCOL VIOLATION                  0         1 (6.7%)          0       </span></span>
<span id="cb43-12"><a href="#cb43-12" tabindex="-1"></a><span class="co">#&gt;     WITHDRAWAL BY PARENT/GUARDIAN    1 (6.7%)        0              0       </span></span>
<span id="cb43-13"><a href="#cb43-13" tabindex="-1"></a><span class="co">#&gt;   Completed Treatment               8 (53.3%)    4 (26.7%)      5 (33.3%)   </span></span>
<span id="cb43-14"><a href="#cb43-14" tabindex="-1"></a><span class="co">#&gt;   Ongoing Treatment                 4 (26.7%)    6 (40.0%)      4 (26.7%)   </span></span>
<span id="cb43-15"><a href="#cb43-15" tabindex="-1"></a><span class="co">#&gt;   Discontinued Treatment            3 (20.0%)    5 (33.3%)      6 (40.0%)</span></span></code></pre></div>
</div>
<div id="patient-disposition-adding-details-of-study-ongoing-status" class="section level4">
<h4><strong>4. Patient Disposition (adding details of study ongoing
status)</strong></h4>
<p>The syntax adds the details of study ongoing/alive status to the
standard patient disposition summary by modifying the argument
<code>detail_vars</code>.</p>
<div class="sourceCode" id="cb44"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb44-1"><a href="#cb44-1" tabindex="-1"></a><span class="fu">run</span>(dst01, syn_data, <span class="at">detail_vars =</span> <span class="fu">list</span>(<span class="at">Discontinued =</span> <span class="st">&quot;DCSREAS&quot;</span>, <span class="at">Ongoing =</span> <span class="st">&quot;STDONS&quot;</span>))</span>
<span id="cb44-2"><a href="#cb44-2" tabindex="-1"></a><span class="co">#&gt;                                     A: Drug X    B: Placebo   C: Combination   All Patients</span></span>
<span id="cb44-3"><a href="#cb44-3" tabindex="-1"></a><span class="co">#&gt;                                       (N=15)       (N=15)         (N=15)          (N=45)   </span></span>
<span id="cb44-4"><a href="#cb44-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb44-5"><a href="#cb44-5" tabindex="-1"></a><span class="co">#&gt;   Completed                         10 (66.7%)   10 (66.7%)     10 (66.7%)      30 (66.7%) </span></span>
<span id="cb44-6"><a href="#cb44-6" tabindex="-1"></a><span class="co">#&gt;   Discontinued                      5 (33.3%)    5 (33.3%)      5 (33.3%)       15 (33.3%) </span></span>
<span id="cb44-7"><a href="#cb44-7" tabindex="-1"></a><span class="co">#&gt;     ADVERSE EVENT                       0            0           1 (6.7%)        1 (2.2%)  </span></span>
<span id="cb44-8"><a href="#cb44-8" tabindex="-1"></a><span class="co">#&gt;     DEATH                           2 (13.3%)    4 (26.7%)      3 (20.0%)       9 (20.0%)  </span></span>
<span id="cb44-9"><a href="#cb44-9" tabindex="-1"></a><span class="co">#&gt;     LACK OF EFFICACY                2 (13.3%)        0              0            2 (4.4%)  </span></span>
<span id="cb44-10"><a href="#cb44-10" tabindex="-1"></a><span class="co">#&gt;     PHYSICIAN DECISION                  0            0           1 (6.7%)        1 (2.2%)  </span></span>
<span id="cb44-11"><a href="#cb44-11" tabindex="-1"></a><span class="co">#&gt;     PROTOCOL VIOLATION                  0         1 (6.7%)          0            1 (2.2%)  </span></span>
<span id="cb44-12"><a href="#cb44-12" tabindex="-1"></a><span class="co">#&gt;     WITHDRAWAL BY PARENT/GUARDIAN    1 (6.7%)        0              0            1 (2.2%)</span></span></code></pre></div>
</div>
</div>
<div id="deaths-dtht01" class="section level3">
<h3><strong>Deaths (<code>DTHT01</code>)</strong></h3>
<div id="deaths" class="section level4">
<h4><strong>1. Deaths</strong></h4>
<p>The <strong><code>dtht01</code></strong> template produces the
standard deaths output.</p>
<div class="sourceCode" id="cb45"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb45-1"><a href="#cb45-1" tabindex="-1"></a><span class="fu">run</span>(dst01, syn_data)</span>
<span id="cb45-2"><a href="#cb45-2" tabindex="-1"></a><span class="co">#&gt;                                     A: Drug X    B: Placebo   C: Combination   All Patients</span></span>
<span id="cb45-3"><a href="#cb45-3" tabindex="-1"></a><span class="co">#&gt;                                       (N=15)       (N=15)         (N=15)          (N=45)   </span></span>
<span id="cb45-4"><a href="#cb45-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb45-5"><a href="#cb45-5" tabindex="-1"></a><span class="co">#&gt;   Completed                         10 (66.7%)   10 (66.7%)     10 (66.7%)      30 (66.7%) </span></span>
<span id="cb45-6"><a href="#cb45-6" tabindex="-1"></a><span class="co">#&gt;   Discontinued                      5 (33.3%)    5 (33.3%)      5 (33.3%)       15 (33.3%) </span></span>
<span id="cb45-7"><a href="#cb45-7" tabindex="-1"></a><span class="co">#&gt;     ADVERSE EVENT                       0            0           1 (6.7%)        1 (2.2%)  </span></span>
<span id="cb45-8"><a href="#cb45-8" tabindex="-1"></a><span class="co">#&gt;     DEATH                           2 (13.3%)    4 (26.7%)      3 (20.0%)       9 (20.0%)  </span></span>
<span id="cb45-9"><a href="#cb45-9" tabindex="-1"></a><span class="co">#&gt;     LACK OF EFFICACY                2 (13.3%)        0              0            2 (4.4%)  </span></span>
<span id="cb45-10"><a href="#cb45-10" tabindex="-1"></a><span class="co">#&gt;     PHYSICIAN DECISION                  0            0           1 (6.7%)        1 (2.2%)  </span></span>
<span id="cb45-11"><a href="#cb45-11" tabindex="-1"></a><span class="co">#&gt;     PROTOCOL VIOLATION                  0         1 (6.7%)          0            1 (2.2%)  </span></span>
<span id="cb45-12"><a href="#cb45-12" tabindex="-1"></a><span class="co">#&gt;     WITHDRAWAL BY PARENT/GUARDIAN    1 (6.7%)        0              0            1 (2.2%)</span></span></code></pre></div>
</div>
<div id="deaths-adding-primary-cause-of-death-details-for-other-category" class="section level4">
<h4><strong>2. Deaths (adding âPrimary Cause of Deathâ details for
âOtherâ category)</strong></h4>
<div class="sourceCode" id="cb46"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb46-1"><a href="#cb46-1" tabindex="-1"></a><span class="fu">run</span>(dtht01, syn_data, <span class="at">other_category =</span> <span class="cn">TRUE</span>)</span>
<span id="cb46-2"><a href="#cb46-2" tabindex="-1"></a><span class="co">#&gt;                            A: Drug X   B: Placebo   C: Combination</span></span>
<span id="cb46-3"><a href="#cb46-3" tabindex="-1"></a><span class="co">#&gt;                             (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb46-4"><a href="#cb46-4" tabindex="-1"></a><span class="co">#&gt;   ââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb46-5"><a href="#cb46-5" tabindex="-1"></a><span class="co">#&gt;   Total number of deaths   2 (13.3%)   4 (26.7%)      3 (20.0%)   </span></span>
<span id="cb46-6"><a href="#cb46-6" tabindex="-1"></a><span class="co">#&gt;   Primary Cause of Death                                          </span></span>
<span id="cb46-7"><a href="#cb46-7" tabindex="-1"></a><span class="co">#&gt;     n                          2           4              3       </span></span>
<span id="cb46-8"><a href="#cb46-8" tabindex="-1"></a><span class="co">#&gt;     Adverse Event          1 (50.0%)   2 (50.0%)      1 (33.3%)   </span></span>
<span id="cb46-9"><a href="#cb46-9" tabindex="-1"></a><span class="co">#&gt;     Progressive Disease    1 (50.0%)       0          2 (66.7%)   </span></span>
<span id="cb46-10"><a href="#cb46-10" tabindex="-1"></a><span class="co">#&gt;     Other                      0       2 (50.0%)          0       </span></span>
<span id="cb46-11"><a href="#cb46-11" tabindex="-1"></a><span class="co">#&gt;       LOST TO FOLLOW UP        0        1 (50%)           0       </span></span>
<span id="cb46-12"><a href="#cb46-12" tabindex="-1"></a><span class="co">#&gt;       SUICIDE                  0        1 (50%)           0</span></span></code></pre></div>
<p>NOTE: In order to avoid the warning above and display âOtherâ as the
last category under âPrimary Cause of Deathâ right above the detailed
reasons for âOtherâ, the user is expected to manually provide levels to
<code>ADSL.DTHCAT</code> based on categories available in the
dataset.</p>
</div>
<div id="deaths-adding-summary-by-days-from-last-study-drug-administration" class="section level4">
<h4><strong>3. Deaths (adding summary by days from last study drug
administration)</strong></h4>
<p>Setting <code>time_since_last_dose</code> to <code>TRUE</code>, the
syntax produces the count of deaths by days from last study drug
administration as well as the count of deaths by primary cause and days
from last study drug administration.</p>
<div class="sourceCode" id="cb47"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb47-1"><a href="#cb47-1" tabindex="-1"></a><span class="fu">run</span>(dtht01, syn_data, <span class="at">time_since_last_dose =</span> <span class="cn">TRUE</span>)</span>
<span id="cb47-2"><a href="#cb47-2" tabindex="-1"></a><span class="co">#&gt;                                                               A: Drug X   B: Placebo   C: Combination</span></span>
<span id="cb47-3"><a href="#cb47-3" tabindex="-1"></a><span class="co">#&gt;                                                                (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb47-4"><a href="#cb47-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb47-5"><a href="#cb47-5" tabindex="-1"></a><span class="co">#&gt;   Total number of deaths                                      2 (13.3%)   4 (26.7%)      3 (20.0%)   </span></span>
<span id="cb47-6"><a href="#cb47-6" tabindex="-1"></a><span class="co">#&gt;   Days from last drug administration                                                                 </span></span>
<span id="cb47-7"><a href="#cb47-7" tabindex="-1"></a><span class="co">#&gt;     n                                                             2           4              3       </span></span>
<span id="cb47-8"><a href="#cb47-8" tabindex="-1"></a><span class="co">#&gt;     &lt;=30                                                      2 (100%)    1 (25.0%)      2 (66.7%)   </span></span>
<span id="cb47-9"><a href="#cb47-9" tabindex="-1"></a><span class="co">#&gt;     &gt;30                                                           0       3 (75.0%)      1 (33.3%)   </span></span>
<span id="cb47-10"><a href="#cb47-10" tabindex="-1"></a><span class="co">#&gt;   Primary cause by days from last study drug administration                                          </span></span>
<span id="cb47-11"><a href="#cb47-11" tabindex="-1"></a><span class="co">#&gt;     &lt;=30                                                                                             </span></span>
<span id="cb47-12"><a href="#cb47-12" tabindex="-1"></a><span class="co">#&gt;       n                                                           2           1              2       </span></span>
<span id="cb47-13"><a href="#cb47-13" tabindex="-1"></a><span class="co">#&gt;       Adverse Event                                           1 (50.0%)       0          1 (50.0%)   </span></span>
<span id="cb47-14"><a href="#cb47-14" tabindex="-1"></a><span class="co">#&gt;       Progressive Disease                                     1 (50.0%)       0          1 (50.0%)   </span></span>
<span id="cb47-15"><a href="#cb47-15" tabindex="-1"></a><span class="co">#&gt;       Other                                                       0        1 (100%)          0       </span></span>
<span id="cb47-16"><a href="#cb47-16" tabindex="-1"></a><span class="co">#&gt;     &gt;30                                                                                              </span></span>
<span id="cb47-17"><a href="#cb47-17" tabindex="-1"></a><span class="co">#&gt;       n                                                           0           3              1       </span></span>
<span id="cb47-18"><a href="#cb47-18" tabindex="-1"></a><span class="co">#&gt;       Adverse Event                                               0       2 (66.7%)          0       </span></span>
<span id="cb47-19"><a href="#cb47-19" tabindex="-1"></a><span class="co">#&gt;       Progressive Disease                                         0           0           1 (100%)   </span></span>
<span id="cb47-20"><a href="#cb47-20" tabindex="-1"></a><span class="co">#&gt;       Other                                                       0       1 (33.3%)          0</span></span></code></pre></div>
</div>
</div>
<div id="ecg-results-and-change-from-baseline-by-visit-egt01" class="section level3">
<h3><strong>ECG Results and Change from Baseline by Visit
(<code>EGT01</code>)</strong></h3>
<div id="ecg-results-and-change-from-baseline-by-visit" class="section level4">
<h4><strong>1. ECG Results and Change from Baseline by
Visit</strong></h4>
<p>The <strong><code>egt01</code></strong> template produces the
standard ECG results and change from baseline by visit summary.</p>
<div class="sourceCode" id="cb48"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb48-1"><a href="#cb48-1" tabindex="-1"></a><span class="fu">run</span>(egt01, syn_data)</span>
<span id="cb48-2"><a href="#cb48-2" tabindex="-1"></a><span class="co">#&gt;                                    A: Drug X                                B: Placebo                             C: Combination             </span></span>
<span id="cb48-3"><a href="#cb48-3" tabindex="-1"></a><span class="co">#&gt;                                             Change from                               Change from                              Change from    </span></span>
<span id="cb48-4"><a href="#cb48-4" tabindex="-1"></a><span class="co">#&gt;                       Value at Visit          Baseline          Value at Visit         Baseline          Value at Visit          Baseline     </span></span>
<span id="cb48-5"><a href="#cb48-5" tabindex="-1"></a><span class="co">#&gt;   Analysis Visit          (N=15)               (N=15)               (N=15)              (N=15)               (N=15)               (N=15)      </span></span>
<span id="cb48-6"><a href="#cb48-6" tabindex="-1"></a><span class="co">#&gt;   ââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb48-7"><a href="#cb48-7" tabindex="-1"></a><span class="co">#&gt;   Heart Rate                                                                                                                                  </span></span>
<span id="cb48-8"><a href="#cb48-8" tabindex="-1"></a><span class="co">#&gt;     BASELINE                                                                                                                                  </span></span>
<span id="cb48-9"><a href="#cb48-9" tabindex="-1"></a><span class="co">#&gt;       n                     15                                        15                                       15                             </span></span>
<span id="cb48-10"><a href="#cb48-10" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)      76.594 (17.889)                           69.899 (18.788)                          70.492 (18.175)                       </span></span>
<span id="cb48-11"><a href="#cb48-11" tabindex="-1"></a><span class="co">#&gt;       Median              77.531                                    77.174                                   74.111                           </span></span>
<span id="cb48-12"><a href="#cb48-12" tabindex="-1"></a><span class="co">#&gt;       Min - Max       46.50 - 106.68                            26.42 - 97.69                            45.37 - 115.49                       </span></span>
<span id="cb48-13"><a href="#cb48-13" tabindex="-1"></a><span class="co">#&gt;     WEEK 1 DAY 8                                                                                                                              </span></span>
<span id="cb48-14"><a href="#cb48-14" tabindex="-1"></a><span class="co">#&gt;       n                     15                   15                   15                  15                   15                   15        </span></span>
<span id="cb48-15"><a href="#cb48-15" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)      71.140 (23.441)      -5.454 (25.128)      70.958 (14.877)      1.059 (23.345)      67.450 (18.932)      -3.043 (23.753)  </span></span>
<span id="cb48-16"><a href="#cb48-16" tabindex="-1"></a><span class="co">#&gt;       Median              77.210               -2.152               70.033              -8.403               68.471               0.181       </span></span>
<span id="cb48-17"><a href="#cb48-17" tabindex="-1"></a><span class="co">#&gt;       Min - Max       8.53 - 102.63        -50.97 - 36.54       44.85 - 93.79       -25.34 - 60.50       38.90 - 100.05       -52.20 - 33.13  </span></span>
<span id="cb48-18"><a href="#cb48-18" tabindex="-1"></a><span class="co">#&gt;     WEEK 2 DAY 15                                                                                                                             </span></span>
<span id="cb48-19"><a href="#cb48-19" tabindex="-1"></a><span class="co">#&gt;       n                     15                   15                   15                  15                   15                   15        </span></span>
<span id="cb48-20"><a href="#cb48-20" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)      69.350 (16.083)      -7.244 (28.960)      76.096 (14.958)      6.198 (29.319)      63.694 (12.920)      -6.799 (23.949)  </span></span>
<span id="cb48-21"><a href="#cb48-21" tabindex="-1"></a><span class="co">#&gt;       Median              65.746              -11.369               75.323               0.255               61.076               -4.954      </span></span>
<span id="cb48-22"><a href="#cb48-22" tabindex="-1"></a><span class="co">#&gt;       Min - Max       47.22 - 101.44       -49.59 - 42.91       47.50 - 111.40      -37.51 - 69.34       43.25 - 86.13        -52.70 - 40.76  </span></span>
<span id="cb48-23"><a href="#cb48-23" tabindex="-1"></a><span class="co">#&gt;     WEEK 3 DAY 22                                                                                                                             </span></span>
<span id="cb48-24"><a href="#cb48-24" tabindex="-1"></a><span class="co">#&gt;       n                     15                   15                   15                  15                   15                   15        </span></span>
<span id="cb48-25"><a href="#cb48-25" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)      73.894 (24.576)      -2.700 (32.079)      67.635 (19.114)      -2.263 (29.989)     72.054 (19.308)       1.562 (27.494)  </span></span>
<span id="cb48-26"><a href="#cb48-26" tabindex="-1"></a><span class="co">#&gt;       Median              69.296               5.492                68.468              -2.093               68.686               -5.848      </span></span>
<span id="cb48-27"><a href="#cb48-27" tabindex="-1"></a><span class="co">#&gt;       Min - Max       44.15 - 131.73       -62.53 - 38.19       31.89 - 108.87      -52.26 - 66.81       32.16 - 109.86       -49.61 - 35.23  </span></span>
<span id="cb48-28"><a href="#cb48-28" tabindex="-1"></a><span class="co">#&gt;     WEEK 4 DAY 29                                                                                                                             </span></span>
<span id="cb48-29"><a href="#cb48-29" tabindex="-1"></a><span class="co">#&gt;       n                     15                   15                   15                  15                   15                   15        </span></span>
<span id="cb48-30"><a href="#cb48-30" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)      73.241 (19.256)      -3.353 (29.170)      66.524 (25.487)      -3.374 (36.024)     66.600 (22.839)      -3.892 (24.140)  </span></span>
<span id="cb48-31"><a href="#cb48-31" tabindex="-1"></a><span class="co">#&gt;       Median              68.689               0.232                66.397              -11.730              64.969               -6.827      </span></span>
<span id="cb48-32"><a href="#cb48-32" tabindex="-1"></a><span class="co">#&gt;       Min - Max       33.71 - 111.54       -55.14 - 65.04       19.66 - 111.29      -60.39 - 61.00       10.35 - 100.88       -50.72 - 26.77  </span></span>
<span id="cb48-33"><a href="#cb48-33" tabindex="-1"></a><span class="co">#&gt;     WEEK 5 DAY 36                                                                                                                             </span></span>
<span id="cb48-34"><a href="#cb48-34" tabindex="-1"></a><span class="co">#&gt;       n                     15                   15                   15                  15                   15                   15        </span></span>
<span id="cb48-35"><a href="#cb48-35" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)      61.690 (22.182)      -14.904 (30.330)     60.712 (20.025)      -9.187 (24.587)     72.683 (23.495)       2.191 (26.654)  </span></span>
<span id="cb48-36"><a href="#cb48-36" tabindex="-1"></a><span class="co">#&gt;       Median              57.925              -12.660               60.454              -16.100              77.585               14.635      </span></span>
<span id="cb48-37"><a href="#cb48-37" tabindex="-1"></a><span class="co">#&gt;       Min - Max       23.89 - 103.74       -60.00 - 57.24       32.53 - 102.02      -52.56 - 50.96       31.21 - 105.05       -42.90 - 34.64  </span></span>
<span id="cb48-38"><a href="#cb48-38" tabindex="-1"></a><span class="co">#&gt;   QT Duration                                                                                                                                 </span></span>
<span id="cb48-39"><a href="#cb48-39" tabindex="-1"></a><span class="co">#&gt;     BASELINE                                                                                                                                  </span></span>
<span id="cb48-40"><a href="#cb48-40" tabindex="-1"></a><span class="co">#&gt;       n                     15                                        15                                       15                             </span></span>
<span id="cb48-41"><a href="#cb48-41" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)     335.294 (123.231)                          363.104 (68.160)                         347.311 (86.236)                      </span></span>
<span id="cb48-42"><a href="#cb48-42" tabindex="-1"></a><span class="co">#&gt;       Median             372.731                                   386.316                                  348.254                           </span></span>
<span id="cb48-43"><a href="#cb48-43" tabindex="-1"></a><span class="co">#&gt;       Min - Max      121.28 - 554.97                           214.65 - 445.53                          170.80 - 508.54                       </span></span>
<span id="cb48-44"><a href="#cb48-44" tabindex="-1"></a><span class="co">#&gt;     WEEK 1 DAY 8                                                                                                                              </span></span>
<span id="cb48-45"><a href="#cb48-45" tabindex="-1"></a><span class="co">#&gt;       n                     15                   15                   15                  15                   15                   15        </span></span>
<span id="cb48-46"><a href="#cb48-46" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)      357.361 (85.688)     22.067 (144.166)    415.225 (105.425)    52.121 (144.259)    321.078 (107.553)    -26.233 (129.135) </span></span>
<span id="cb48-47"><a href="#cb48-47" tabindex="-1"></a><span class="co">#&gt;       Median             344.797               49.432              421.950              62.762              307.962              -17.006      </span></span>
<span id="cb48-48"><a href="#cb48-48" tabindex="-1"></a><span class="co">#&gt;       Min - Max      241.22 - 517.39      -207.23 - 245.36     234.11 - 604.72     -190.70 - 364.94     118.36 - 480.29      -363.11 - 163.67 </span></span>
<span id="cb48-49"><a href="#cb48-49" tabindex="-1"></a><span class="co">#&gt;     WEEK 2 DAY 15                                                                                                                             </span></span>
<span id="cb48-50"><a href="#cb48-50" tabindex="-1"></a><span class="co">#&gt;       n                     15                   15                   15                  15                   15                   15        </span></span>
<span id="cb48-51"><a href="#cb48-51" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)     344.883 (106.793)     9.589 (174.797)      370.548 (80.862)     7.444 (91.301)      354.129 (95.133)     6.818 (142.397)  </span></span>
<span id="cb48-52"><a href="#cb48-52" tabindex="-1"></a><span class="co">#&gt;       Median             312.236               -9.264              388.515              -9.429              365.292               39.930      </span></span>
<span id="cb48-53"><a href="#cb48-53" tabindex="-1"></a><span class="co">#&gt;       Min - Max      187.77 - 501.87      -278.91 - 372.71     204.55 - 514.43     -190.58 - 173.87     200.19 - 493.40      -279.46 - 265.56 </span></span>
<span id="cb48-54"><a href="#cb48-54" tabindex="-1"></a><span class="co">#&gt;     WEEK 3 DAY 22                                                                                                                             </span></span>
<span id="cb48-55"><a href="#cb48-55" tabindex="-1"></a><span class="co">#&gt;       n                     15                   15                   15                  15                   15                   15        </span></span>
<span id="cb48-56"><a href="#cb48-56" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)      342.062 (92.568)     6.768 (151.505)     326.684 (116.421)    -36.420 (145.415)    366.245 (99.106)     18.935 (168.417) </span></span>
<span id="cb48-57"><a href="#cb48-57" tabindex="-1"></a><span class="co">#&gt;       Median             352.930              -22.771              298.353              -78.409             329.688              -21.584      </span></span>
<span id="cb48-58"><a href="#cb48-58" tabindex="-1"></a><span class="co">#&gt;       Min - Max      199.40 - 476.04      -230.25 - 303.00     151.05 - 561.23     -205.30 - 293.76     249.42 - 580.81      -252.73 - 410.01 </span></span>
<span id="cb48-59"><a href="#cb48-59" tabindex="-1"></a><span class="co">#&gt;     WEEK 4 DAY 29                                                                                                                             </span></span>
<span id="cb48-60"><a href="#cb48-60" tabindex="-1"></a><span class="co">#&gt;       n                     15                   15                   15                  15                   15                   15        </span></span>
<span id="cb48-61"><a href="#cb48-61" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)      371.650 (44.805)     36.356 (139.308)    333.697 (110.377)    -29.407 (125.592)    333.181 (96.466)    -14.130 (107.622) </span></span>
<span id="cb48-62"><a href="#cb48-62" tabindex="-1"></a><span class="co">#&gt;       Median             375.412               58.958              308.020              -40.987             330.911              -25.820      </span></span>
<span id="cb48-63"><a href="#cb48-63" tabindex="-1"></a><span class="co">#&gt;       Min - Max      302.32 - 451.62      -214.07 - 258.04     183.09 - 531.08     -241.72 - 134.12     126.95 - 488.57      -234.92 - 152.49 </span></span>
<span id="cb48-64"><a href="#cb48-64" tabindex="-1"></a><span class="co">#&gt;     WEEK 5 DAY 36                                                                                                                             </span></span>
<span id="cb48-65"><a href="#cb48-65" tabindex="-1"></a><span class="co">#&gt;       n                     15                   15                   15                  15                   15                   15        </span></span>
<span id="cb48-66"><a href="#cb48-66" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)     345.504 (130.543)     10.210 (198.224)     309.919 (84.624)    -53.185 (105.730)    322.931 (67.801)    -24.380 (117.331) </span></span>
<span id="cb48-67"><a href="#cb48-67" tabindex="-1"></a><span class="co">#&gt;       Median             355.730              -23.213              306.219              -12.373             341.988              -26.952      </span></span>
<span id="cb48-68"><a href="#cb48-68" tabindex="-1"></a><span class="co">#&gt;       Min - Max       88.38 - 661.12      -271.06 - 539.84     189.01 - 448.58      -256.52 - 91.57     217.51 - 427.16      -291.03 - 171.19 </span></span>
<span id="cb48-69"><a href="#cb48-69" tabindex="-1"></a><span class="co">#&gt;   RR Duration                                                                                                                                 </span></span>
<span id="cb48-70"><a href="#cb48-70" tabindex="-1"></a><span class="co">#&gt;     BASELINE                                                                                                                                  </span></span>
<span id="cb48-71"><a href="#cb48-71" tabindex="-1"></a><span class="co">#&gt;       n                     15                                        15                                       15                             </span></span>
<span id="cb48-72"><a href="#cb48-72" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)     1086.908 (363.811)                        1050.034 (390.444)                       1102.659 (310.359)                     </span></span>
<span id="cb48-73"><a href="#cb48-73" tabindex="-1"></a><span class="co">#&gt;       Median             1116.849                                  1089.193                                 1250.037                          </span></span>
<span id="cb48-74"><a href="#cb48-74" tabindex="-1"></a><span class="co">#&gt;       Min - Max      626.19 - 1653.12                          414.61 - 1721.89                         385.51 - 1430.81                      </span></span>
<span id="cb48-75"><a href="#cb48-75" tabindex="-1"></a><span class="co">#&gt;     WEEK 1 DAY 8                                                                                                                              </span></span>
<span id="cb48-76"><a href="#cb48-76" tabindex="-1"></a><span class="co">#&gt;       n                     15                   15                   15                  15                   15                   15        </span></span>
<span id="cb48-77"><a href="#cb48-77" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)     968.499 (287.811)    -118.409 (546.796)   1041.186 (211.201)   -8.848 (435.281)    948.491 (213.746)    -154.168 (442.882)</span></span>
<span id="cb48-78"><a href="#cb48-78" tabindex="-1"></a><span class="co">#&gt;       Median             961.296              -147.460             1013.786             24.754              965.429              -224.054     </span></span>
<span id="cb48-79"><a href="#cb48-79" tabindex="-1"></a><span class="co">#&gt;       Min - Max      358.92 - 1593.51    -1014.82 - 911.82     714.44 - 1417.52    -618.80 - 847.31     513.35 - 1229.09     -736.69 - 843.58 </span></span>
<span id="cb48-80"><a href="#cb48-80" tabindex="-1"></a><span class="co">#&gt;     WEEK 2 DAY 15                                                                                                                             </span></span>
<span id="cb48-81"><a href="#cb48-81" tabindex="-1"></a><span class="co">#&gt;       n                     15                   15                   15                  15                   15                   15        </span></span>
<span id="cb48-82"><a href="#cb48-82" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)     932.717 (259.634)    -154.191 (331.884)   1139.332 (454.231)   89.298 (582.750)    1021.283 (233.529)   -81.376 (415.781) </span></span>
<span id="cb48-83"><a href="#cb48-83" tabindex="-1"></a><span class="co">#&gt;       Median             950.533              -205.949             1068.007             -5.449              964.616              -142.180     </span></span>
<span id="cb48-84"><a href="#cb48-84" tabindex="-1"></a><span class="co">#&gt;       Min - Max      409.68 - 1269.35     -649.69 - 473.09     486.51 - 2048.73    -846.72 - 1148.61    667.36 - 1367.25     -647.47 - 616.15 </span></span>
<span id="cb48-85"><a href="#cb48-85" tabindex="-1"></a><span class="co">#&gt;     WEEK 3 DAY 22                                                                                                                             </span></span>
<span id="cb48-86"><a href="#cb48-86" tabindex="-1"></a><span class="co">#&gt;       n                     15                   15                   15                  15                   15                   15        </span></span>
<span id="cb48-87"><a href="#cb48-87" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)     1068.865 (319.540)   -18.043 (513.412)    1110.882 (259.523)   60.848 (432.700)    1105.918 (306.185)    3.259 (516.734)  </span></span>
<span id="cb48-88"><a href="#cb48-88" tabindex="-1"></a><span class="co">#&gt;       Median             1201.998             -65.085              1163.690             51.200              1187.130              30.318      </span></span>
<span id="cb48-89"><a href="#cb48-89" tabindex="-1"></a><span class="co">#&gt;       Min - Max      380.49 - 1551.65     -832.86 - 703.74     621.41 - 1453.29    -887.06 - 822.18     446.02 - 1648.32     -984.79 - 816.30 </span></span>
<span id="cb48-90"><a href="#cb48-90" tabindex="-1"></a><span class="co">#&gt;     WEEK 4 DAY 29                                                                                                                             </span></span>
<span id="cb48-91"><a href="#cb48-91" tabindex="-1"></a><span class="co">#&gt;       n                     15                   15                   15                  15                   15                   15        </span></span>
<span id="cb48-92"><a href="#cb48-92" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)     1087.915 (205.940)    1.008 (403.039)     1161.681 (293.257)   111.647 (460.979)   992.134 (283.177)    -110.525 (334.932)</span></span>
<span id="cb48-93"><a href="#cb48-93" tabindex="-1"></a><span class="co">#&gt;       Median             1084.658             146.611              1055.223             191.008             1028.997             -112.599     </span></span>
<span id="cb48-94"><a href="#cb48-94" tabindex="-1"></a><span class="co">#&gt;       Min - Max      697.59 - 1499.17     -801.16 - 402.97     722.35 - 1762.04    -528.27 - 1191.83    497.14 - 1382.12     -597.95 - 757.99 </span></span>
<span id="cb48-95"><a href="#cb48-95" tabindex="-1"></a><span class="co">#&gt;     WEEK 5 DAY 36                                                                                                                             </span></span>
<span id="cb48-96"><a href="#cb48-96" tabindex="-1"></a><span class="co">#&gt;       n                     15                   15                   15                  15                   15                   15        </span></span>
<span id="cb48-97"><a href="#cb48-97" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)     1016.880 (424.428)   -70.027 (505.078)    1135.131 (224.684)   85.097 (497.679)    1089.527 (238.909)   -13.132 (362.606) </span></span>
<span id="cb48-98"><a href="#cb48-98" tabindex="-1"></a><span class="co">#&gt;       Median             962.584              -142.925             1158.815             -9.553              1081.015              16.706      </span></span>
<span id="cb48-99"><a href="#cb48-99" tabindex="-1"></a><span class="co">#&gt;       Min - Max      352.97 - 1843.86    -894.83 - 1162.79     714.34 - 1436.68    -843.41 - 992.34     699.72 - 1611.38     -696.03 - 561.53</span></span></code></pre></div>
</div>
</div>
<div id="ecg-abnormalities-regardless-of-abnormality-at-baseline-egt02_1" class="section level3">
<h3><strong>ECG Abnormalities (Regardless of Abnormality at Baseline)
(<code>EGT02_1</code>)</strong></h3>
<div id="ecg-abnormalities-regardless-of-abnormality-at-baseline" class="section level4">
<h4><strong>1. ECG Abnormalities (Regardless of Abnormality at
Baseline)</strong></h4>
<p>The <strong><code>egt02_1</code></strong> template produces the
standard ECG abnormalities summary where the abnormalities are
summarized regardless of the abnormality at baseline.</p>
<div class="sourceCode" id="cb49"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb49-1"><a href="#cb49-1" tabindex="-1"></a><span class="fu">run</span>(egt02_1, syn_data)</span>
<span id="cb49-2"><a href="#cb49-2" tabindex="-1"></a><span class="co">#&gt;   Assessment      A: Drug X      B: Placebo    C: Combination</span></span>
<span id="cb49-3"><a href="#cb49-3" tabindex="-1"></a><span class="co">#&gt;    Abnormality      (N=15)         (N=15)          (N=15)    </span></span>
<span id="cb49-4"><a href="#cb49-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb49-5"><a href="#cb49-5" tabindex="-1"></a><span class="co">#&gt;   Heart Rate                                                 </span></span>
<span id="cb49-6"><a href="#cb49-6" tabindex="-1"></a><span class="co">#&gt;     Low          4/15 (26.7%)    6/15 (40%)     4/15 (26.7%) </span></span>
<span id="cb49-7"><a href="#cb49-7" tabindex="-1"></a><span class="co">#&gt;     High         5/15 (33.3%)    3/15 (20%)     4/15 (26.7%) </span></span>
<span id="cb49-8"><a href="#cb49-8" tabindex="-1"></a><span class="co">#&gt;   QT Duration                                                </span></span>
<span id="cb49-9"><a href="#cb49-9" tabindex="-1"></a><span class="co">#&gt;     Low          5/15 (33.3%)    6/15 (40%)     4/15 (26.7%) </span></span>
<span id="cb49-10"><a href="#cb49-10" tabindex="-1"></a><span class="co">#&gt;     High         4/15 (26.7%)    6/15 (40%)      3/15 (20%)  </span></span>
<span id="cb49-11"><a href="#cb49-11" tabindex="-1"></a><span class="co">#&gt;   RR Duration                                                </span></span>
<span id="cb49-12"><a href="#cb49-12" tabindex="-1"></a><span class="co">#&gt;     Low           9/15 (60%)    5/15 (33.3%)     6/15 (40%)  </span></span>
<span id="cb49-13"><a href="#cb49-13" tabindex="-1"></a><span class="co">#&gt;     High          6/15 (40%)    7/15 (46.7%)     3/15 (20%)</span></span></code></pre></div>
</div>
</div>
<div id="ecg-abnormalities-among-subject-without-abnormality-at-baseline-egt02_2" class="section level3">
<h3><strong>ECG Abnormalities (Among Subject Without Abnormality at
Baseline) (<code>EGT02_2</code>)</strong></h3>
<div id="ecg-abnormalities-among-subject-without-abnormality-at-baseline" class="section level4">
<h4><strong>1. ECG Abnormalities (Among Subject Without Abnormality at
Baseline)</strong></h4>
<p>The <strong><code>egt02_2</code></strong> template produces the
standard ECG abnormalities summary where the abnormalities are
summarized among subject without abnormality at baseline.</p>
<div class="sourceCode" id="cb50"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb50-1"><a href="#cb50-1" tabindex="-1"></a><span class="fu">run</span>(egt02_2, syn_data)</span>
<span id="cb50-2"><a href="#cb50-2" tabindex="-1"></a><span class="co">#&gt;   Assessment      A: Drug X      B: Placebo    C: Combination</span></span>
<span id="cb50-3"><a href="#cb50-3" tabindex="-1"></a><span class="co">#&gt;    Abnormality      (N=15)         (N=15)          (N=15)    </span></span>
<span id="cb50-4"><a href="#cb50-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb50-5"><a href="#cb50-5" tabindex="-1"></a><span class="co">#&gt;   Heart Rate                                                 </span></span>
<span id="cb50-6"><a href="#cb50-6" tabindex="-1"></a><span class="co">#&gt;     Low          4/15 (26.7%)   5/14 (35.7%)    4/15 (26.7%) </span></span>
<span id="cb50-7"><a href="#cb50-7" tabindex="-1"></a><span class="co">#&gt;     High         3/13 (23.1%)    3/15 (20%)     3/14 (21.4%) </span></span>
<span id="cb50-8"><a href="#cb50-8" tabindex="-1"></a><span class="co">#&gt;   QT Duration                                                </span></span>
<span id="cb50-9"><a href="#cb50-9" tabindex="-1"></a><span class="co">#&gt;     Low          2/12 (16.7%)    6/15 (40%)     3/14 (21.4%) </span></span>
<span id="cb50-10"><a href="#cb50-10" tabindex="-1"></a><span class="co">#&gt;     High         3/14 (21.4%)    6/15 (40%)     2/14 (14.3%) </span></span>
<span id="cb50-11"><a href="#cb50-11" tabindex="-1"></a><span class="co">#&gt;   RR Duration                                                </span></span>
<span id="cb50-12"><a href="#cb50-12" tabindex="-1"></a><span class="co">#&gt;     Low           9/15 (60%)    3/13 (23.1%)    5/14 (35.7%) </span></span>
<span id="cb50-13"><a href="#cb50-13" tabindex="-1"></a><span class="co">#&gt;     High         4/13 (30.8%)   5/13 (38.5%)     3/15 (20%)</span></span></code></pre></div>
</div>
</div>
<div id="shift-table-of-ecg-interval-data---baseline-versus-minimummaximum-post-baseline-egt03" class="section level3">
<h3><strong>Shift Table of ECG Interval Data - Baseline versus
Minimum/Maximum Post-Baseline (<code>EGT03</code>)</strong></h3>
<div id="shift-table-of-ecg-interval-data---baseline-versus-minimum-post-baseline" class="section level4">
<h4><strong>1. Shift Table of ECG Interval Data - Baseline versus
Minimum Post-Baseline</strong></h4>
<p>The <strong><code>egt03</code></strong> template produces the
standard shift table of ECG interval data - baseline versus minimum
post-baseline summary.</p>
<div class="sourceCode" id="cb51"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb51-1"><a href="#cb51-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;HR&quot;</span>, <span class="st">&quot;adeg&quot;</span>)</span>
<span id="cb51-2"><a href="#cb51-2" tabindex="-1"></a><span class="fu">run</span>(egt03, proc_data)</span>
<span id="cb51-3"><a href="#cb51-3" tabindex="-1"></a><span class="co">#&gt;   Actual Arm Code                            Minimum Post-Baseline Assessment     </span></span>
<span id="cb51-4"><a href="#cb51-4" tabindex="-1"></a><span class="co">#&gt;     Baseline Reference Range Indicator      LOW         NORMAL      HIGH   Missing</span></span>
<span id="cb51-5"><a href="#cb51-5" tabindex="-1"></a><span class="co">#&gt;   ââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb51-6"><a href="#cb51-6" tabindex="-1"></a><span class="co">#&gt;   Heart Rate                                                                      </span></span>
<span id="cb51-7"><a href="#cb51-7" tabindex="-1"></a><span class="co">#&gt;     ARM A (N=15)                                                                  </span></span>
<span id="cb51-8"><a href="#cb51-8" tabindex="-1"></a><span class="co">#&gt;       LOW                                    0             0         0        0   </span></span>
<span id="cb51-9"><a href="#cb51-9" tabindex="-1"></a><span class="co">#&gt;       NORMAL                             4 (26.7%)     9 (60.0%)     0        0   </span></span>
<span id="cb51-10"><a href="#cb51-10" tabindex="-1"></a><span class="co">#&gt;       HIGH                                   0         2 (13.3%)     0        0   </span></span>
<span id="cb51-11"><a href="#cb51-11" tabindex="-1"></a><span class="co">#&gt;       Missing                                0             0         0        0   </span></span>
<span id="cb51-12"><a href="#cb51-12" tabindex="-1"></a><span class="co">#&gt;     ARM B (N=15)                                                                  </span></span>
<span id="cb51-13"><a href="#cb51-13" tabindex="-1"></a><span class="co">#&gt;       LOW                                    0         1 (6.7%)      0        0   </span></span>
<span id="cb51-14"><a href="#cb51-14" tabindex="-1"></a><span class="co">#&gt;       NORMAL                             4 (26.7%)    10 (66.7%)     0        0   </span></span>
<span id="cb51-15"><a href="#cb51-15" tabindex="-1"></a><span class="co">#&gt;       HIGH                                   0             0         0        0   </span></span>
<span id="cb51-16"><a href="#cb51-16" tabindex="-1"></a><span class="co">#&gt;       Missing                                0             0         0        0   </span></span>
<span id="cb51-17"><a href="#cb51-17" tabindex="-1"></a><span class="co">#&gt;     ARM C (N=15)                                                                  </span></span>
<span id="cb51-18"><a href="#cb51-18" tabindex="-1"></a><span class="co">#&gt;       LOW                                    0             0         0        0   </span></span>
<span id="cb51-19"><a href="#cb51-19" tabindex="-1"></a><span class="co">#&gt;       NORMAL                             4 (26.7%)    10 (66.7%)     0        0   </span></span>
<span id="cb51-20"><a href="#cb51-20" tabindex="-1"></a><span class="co">#&gt;       HIGH                                   0         1 (6.7%)      0        0   </span></span>
<span id="cb51-21"><a href="#cb51-21" tabindex="-1"></a><span class="co">#&gt;       Missing                                0             0         0        0</span></span></code></pre></div>
</div>
<div id="shift-table-of-ecg-interval-data---baseline-versus-maximum-post-baseline" class="section level4">
<h4><strong>2. Shift Table of ECG Interval Data - Baseline versus
Maximum Post-Baseline</strong></h4>
<p>To produce the standard shift table of ECG interval data - baseline
versus maximum post-baseline summaryâ¦.TBA</p>
</div>
</div>
<div id="ecg-actual-values-and-changes-from-baseline-by-visit-egt05_qtcat" class="section level3">
<h3><strong>ECG Actual Values and Changes from Baseline by Visit
(<code>EGT05_QTCAT</code>)</strong></h3>
<div id="ecg-actual-values-and-changes-from-baseline-by-visit" class="section level4">
<h4><strong>1. ECG Actual Values and Changes from Baseline by
Visit</strong></h4>
<p>The <strong><code>egt05_qtcat</code></strong> template produces the
standard ECG actual values and changes from baseline by visit
summary.</p>
<div class="sourceCode" id="cb52"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb52-1"><a href="#cb52-1" tabindex="-1"></a><span class="fu">run</span>(egt05_qtcat, syn_data)</span>
<span id="cb52-2"><a href="#cb52-2" tabindex="-1"></a><span class="co">#&gt;   Parameter                                                          </span></span>
<span id="cb52-3"><a href="#cb52-3" tabindex="-1"></a><span class="co">#&gt;     Analysis Visit           A: Drug X    B: Placebo   C: Combination</span></span>
<span id="cb52-4"><a href="#cb52-4" tabindex="-1"></a><span class="co">#&gt;       Category                 (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb52-5"><a href="#cb52-5" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb52-6"><a href="#cb52-6" tabindex="-1"></a><span class="co">#&gt;   QT Duration                                                        </span></span>
<span id="cb52-7"><a href="#cb52-7" tabindex="-1"></a><span class="co">#&gt;     BASELINE                                                         </span></span>
<span id="cb52-8"><a href="#cb52-8" tabindex="-1"></a><span class="co">#&gt;       Value at Visit                                                 </span></span>
<span id="cb52-9"><a href="#cb52-9" tabindex="-1"></a><span class="co">#&gt;         n                        15           15             15      </span></span>
<span id="cb52-10"><a href="#cb52-10" tabindex="-1"></a><span class="co">#&gt;         &lt;=450 msec           13 (86.7%)   15 (100%)      13 (86.7%)  </span></span>
<span id="cb52-11"><a href="#cb52-11" tabindex="-1"></a><span class="co">#&gt;         &gt;450 to &lt;=480 msec    1 (6.7%)        0              0       </span></span>
<span id="cb52-12"><a href="#cb52-12" tabindex="-1"></a><span class="co">#&gt;         &gt;480 to &lt;=500 msec       0            0           1 (6.7%)   </span></span>
<span id="cb52-13"><a href="#cb52-13" tabindex="-1"></a><span class="co">#&gt;         &gt;500 msec             1 (6.7%)        0           1 (6.7%)   </span></span>
<span id="cb52-14"><a href="#cb52-14" tabindex="-1"></a><span class="co">#&gt;     WEEK 1 DAY 8                                                     </span></span>
<span id="cb52-15"><a href="#cb52-15" tabindex="-1"></a><span class="co">#&gt;       Value at Visit                                                 </span></span>
<span id="cb52-16"><a href="#cb52-16" tabindex="-1"></a><span class="co">#&gt;         n                        15           15             15      </span></span>
<span id="cb52-17"><a href="#cb52-17" tabindex="-1"></a><span class="co">#&gt;         &lt;=450 msec           12 (80.0%)   9 (60.0%)      13 (86.7%)  </span></span>
<span id="cb52-18"><a href="#cb52-18" tabindex="-1"></a><span class="co">#&gt;         &gt;450 to &lt;=480 msec    1 (6.7%)     1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb52-19"><a href="#cb52-19" tabindex="-1"></a><span class="co">#&gt;         &gt;480 to &lt;=500 msec    1 (6.7%)    3 (20.0%)       1 (6.7%)   </span></span>
<span id="cb52-20"><a href="#cb52-20" tabindex="-1"></a><span class="co">#&gt;         &gt;500 msec             1 (6.7%)    2 (13.3%)          0       </span></span>
<span id="cb52-21"><a href="#cb52-21" tabindex="-1"></a><span class="co">#&gt;       Change from Baseline                                           </span></span>
<span id="cb52-22"><a href="#cb52-22" tabindex="-1"></a><span class="co">#&gt;         n                        15           15             15      </span></span>
<span id="cb52-23"><a href="#cb52-23" tabindex="-1"></a><span class="co">#&gt;         &lt;=30 msec            7 (46.7%)    6 (40.0%)      9 (60.0%)   </span></span>
<span id="cb52-24"><a href="#cb52-24" tabindex="-1"></a><span class="co">#&gt;         &gt;30 to &lt;=60 msec     2 (13.3%)     1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb52-25"><a href="#cb52-25" tabindex="-1"></a><span class="co">#&gt;         &gt;60 msec             6 (40.0%)    8 (53.3%)      5 (33.3%)   </span></span>
<span id="cb52-26"><a href="#cb52-26" tabindex="-1"></a><span class="co">#&gt;     WEEK 2 DAY 15                                                    </span></span>
<span id="cb52-27"><a href="#cb52-27" tabindex="-1"></a><span class="co">#&gt;       Value at Visit                                                 </span></span>
<span id="cb52-28"><a href="#cb52-28" tabindex="-1"></a><span class="co">#&gt;         n                        15           15             15      </span></span>
<span id="cb52-29"><a href="#cb52-29" tabindex="-1"></a><span class="co">#&gt;         &lt;=450 msec           11 (73.3%)   14 (93.3%)     12 (80.0%)  </span></span>
<span id="cb52-30"><a href="#cb52-30" tabindex="-1"></a><span class="co">#&gt;         &gt;450 to &lt;=480 msec   2 (13.3%)        0          2 (13.3%)   </span></span>
<span id="cb52-31"><a href="#cb52-31" tabindex="-1"></a><span class="co">#&gt;         &gt;480 to &lt;=500 msec    1 (6.7%)        0           1 (6.7%)   </span></span>
<span id="cb52-32"><a href="#cb52-32" tabindex="-1"></a><span class="co">#&gt;         &gt;500 msec             1 (6.7%)     1 (6.7%)          0       </span></span>
<span id="cb52-33"><a href="#cb52-33" tabindex="-1"></a><span class="co">#&gt;       Change from Baseline                                           </span></span>
<span id="cb52-34"><a href="#cb52-34" tabindex="-1"></a><span class="co">#&gt;         n                        15           15             15      </span></span>
<span id="cb52-35"><a href="#cb52-35" tabindex="-1"></a><span class="co">#&gt;         &lt;=30 msec            9 (60.0%)    12 (80.0%)     7 (46.7%)   </span></span>
<span id="cb52-36"><a href="#cb52-36" tabindex="-1"></a><span class="co">#&gt;         &gt;30 to &lt;=60 msec     2 (13.3%)        0          3 (20.0%)   </span></span>
<span id="cb52-37"><a href="#cb52-37" tabindex="-1"></a><span class="co">#&gt;         &gt;60 msec             4 (26.7%)    3 (20.0%)      5 (33.3%)   </span></span>
<span id="cb52-38"><a href="#cb52-38" tabindex="-1"></a><span class="co">#&gt;     WEEK 3 DAY 22                                                    </span></span>
<span id="cb52-39"><a href="#cb52-39" tabindex="-1"></a><span class="co">#&gt;       Value at Visit                                                 </span></span>
<span id="cb52-40"><a href="#cb52-40" tabindex="-1"></a><span class="co">#&gt;         n                        15           15             15      </span></span>
<span id="cb52-41"><a href="#cb52-41" tabindex="-1"></a><span class="co">#&gt;         &lt;=450 msec           12 (80.0%)   12 (80.0%)     12 (80.0%)  </span></span>
<span id="cb52-42"><a href="#cb52-42" tabindex="-1"></a><span class="co">#&gt;         &gt;450 to &lt;=480 msec   3 (20.0%)     1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb52-43"><a href="#cb52-43" tabindex="-1"></a><span class="co">#&gt;         &gt;500 msec                0        2 (13.3%)      2 (13.3%)   </span></span>
<span id="cb52-44"><a href="#cb52-44" tabindex="-1"></a><span class="co">#&gt;       Change from Baseline                                           </span></span>
<span id="cb52-45"><a href="#cb52-45" tabindex="-1"></a><span class="co">#&gt;         n                        15           15             15      </span></span>
<span id="cb52-46"><a href="#cb52-46" tabindex="-1"></a><span class="co">#&gt;         &lt;=30 msec            9 (60.0%)    11 (73.3%)     9 (60.0%)   </span></span>
<span id="cb52-47"><a href="#cb52-47" tabindex="-1"></a><span class="co">#&gt;         &gt;30 to &lt;=60 msec      1 (6.7%)     1 (6.7%)          0       </span></span>
<span id="cb52-48"><a href="#cb52-48" tabindex="-1"></a><span class="co">#&gt;         &gt;60 msec             5 (33.3%)    3 (20.0%)      6 (40.0%)   </span></span>
<span id="cb52-49"><a href="#cb52-49" tabindex="-1"></a><span class="co">#&gt;     WEEK 4 DAY 29                                                    </span></span>
<span id="cb52-50"><a href="#cb52-50" tabindex="-1"></a><span class="co">#&gt;       Value at Visit                                                 </span></span>
<span id="cb52-51"><a href="#cb52-51" tabindex="-1"></a><span class="co">#&gt;         n                        15           15             15      </span></span>
<span id="cb52-52"><a href="#cb52-52" tabindex="-1"></a><span class="co">#&gt;         &lt;=450 msec           14 (93.3%)   12 (80.0%)     13 (86.7%)  </span></span>
<span id="cb52-53"><a href="#cb52-53" tabindex="-1"></a><span class="co">#&gt;         &gt;450 to &lt;=480 msec    1 (6.7%)     1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb52-54"><a href="#cb52-54" tabindex="-1"></a><span class="co">#&gt;         &gt;480 to &lt;=500 msec       0            0           1 (6.7%)   </span></span>
<span id="cb52-55"><a href="#cb52-55" tabindex="-1"></a><span class="co">#&gt;         &gt;500 msec                0        2 (13.3%)          0       </span></span>
<span id="cb52-56"><a href="#cb52-56" tabindex="-1"></a><span class="co">#&gt;       Change from Baseline                                           </span></span>
<span id="cb52-57"><a href="#cb52-57" tabindex="-1"></a><span class="co">#&gt;         n                        15           15             15      </span></span>
<span id="cb52-58"><a href="#cb52-58" tabindex="-1"></a><span class="co">#&gt;         &lt;=30 msec            6 (40.0%)    9 (60.0%)      9 (60.0%)   </span></span>
<span id="cb52-59"><a href="#cb52-59" tabindex="-1"></a><span class="co">#&gt;         &gt;30 to &lt;=60 msec     2 (13.3%)     1 (6.7%)      2 (13.3%)   </span></span>
<span id="cb52-60"><a href="#cb52-60" tabindex="-1"></a><span class="co">#&gt;         &gt;60 msec             7 (46.7%)    5 (33.3%)      4 (26.7%)   </span></span>
<span id="cb52-61"><a href="#cb52-61" tabindex="-1"></a><span class="co">#&gt;     WEEK 5 DAY 36                                                    </span></span>
<span id="cb52-62"><a href="#cb52-62" tabindex="-1"></a><span class="co">#&gt;       Value at Visit                                                 </span></span>
<span id="cb52-63"><a href="#cb52-63" tabindex="-1"></a><span class="co">#&gt;         n                        15           15             15      </span></span>
<span id="cb52-64"><a href="#cb52-64" tabindex="-1"></a><span class="co">#&gt;         &lt;=450 msec           12 (80.0%)   15 (100%)      15 (100%)   </span></span>
<span id="cb52-65"><a href="#cb52-65" tabindex="-1"></a><span class="co">#&gt;         &gt;450 to &lt;=480 msec   2 (13.3%)        0              0       </span></span>
<span id="cb52-66"><a href="#cb52-66" tabindex="-1"></a><span class="co">#&gt;         &gt;500 msec             1 (6.7%)        0              0       </span></span>
<span id="cb52-67"><a href="#cb52-67" tabindex="-1"></a><span class="co">#&gt;       Change from Baseline                                           </span></span>
<span id="cb52-68"><a href="#cb52-68" tabindex="-1"></a><span class="co">#&gt;         n                        15           15             15      </span></span>
<span id="cb52-69"><a href="#cb52-69" tabindex="-1"></a><span class="co">#&gt;         &lt;=30 msec            9 (60.0%)    11 (73.3%)     9 (60.0%)   </span></span>
<span id="cb52-70"><a href="#cb52-70" tabindex="-1"></a><span class="co">#&gt;         &gt;30 to &lt;=60 msec         0        3 (20.0%)      2 (13.3%)   </span></span>
<span id="cb52-71"><a href="#cb52-71" tabindex="-1"></a><span class="co">#&gt;         &gt;60 msec             6 (40.0%)     1 (6.7%)      4 (26.7%)</span></span></code></pre></div>
</div>
<div id="ecg-actual-values-and-changes-from-baseline-by-visit-removing-default-analyses" class="section level4">
<h4><strong>2. ECG Actual Values and Changes from Baseline by Visit
(removing default analyses)</strong></h4>
<p>The template have two default analyses of <code>ADEG.AVALCAT1</code>
and <code>ADEG.CHGCAT1</code>. To keep only the analyses needed, this
can be achieved by modifying the parameter <code>summaryvars</code>.</p>
<div class="sourceCode" id="cb53"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb53-1"><a href="#cb53-1" tabindex="-1"></a><span class="fu">run</span>(egt05_qtcat, syn_data, <span class="at">summaryvars =</span> <span class="fu">c</span>(<span class="st">&quot;AVALCAT1&quot;</span>))</span>
<span id="cb53-2"><a href="#cb53-2" tabindex="-1"></a><span class="co">#&gt;   Parameter                                                        </span></span>
<span id="cb53-3"><a href="#cb53-3" tabindex="-1"></a><span class="co">#&gt;     Analysis Visit         A: Drug X    B: Placebo   C: Combination</span></span>
<span id="cb53-4"><a href="#cb53-4" tabindex="-1"></a><span class="co">#&gt;       Category               (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb53-5"><a href="#cb53-5" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb53-6"><a href="#cb53-6" tabindex="-1"></a><span class="co">#&gt;   QT Duration                                                      </span></span>
<span id="cb53-7"><a href="#cb53-7" tabindex="-1"></a><span class="co">#&gt;     BASELINE                                                       </span></span>
<span id="cb53-8"><a href="#cb53-8" tabindex="-1"></a><span class="co">#&gt;       n                        15           15             15      </span></span>
<span id="cb53-9"><a href="#cb53-9" tabindex="-1"></a><span class="co">#&gt;       &lt;=450 msec           13 (86.7%)   15 (100%)      13 (86.7%)  </span></span>
<span id="cb53-10"><a href="#cb53-10" tabindex="-1"></a><span class="co">#&gt;       &gt;450 to &lt;=480 msec    1 (6.7%)        0              0       </span></span>
<span id="cb53-11"><a href="#cb53-11" tabindex="-1"></a><span class="co">#&gt;       &gt;480 to &lt;=500 msec       0            0           1 (6.7%)   </span></span>
<span id="cb53-12"><a href="#cb53-12" tabindex="-1"></a><span class="co">#&gt;       &gt;500 msec             1 (6.7%)        0           1 (6.7%)   </span></span>
<span id="cb53-13"><a href="#cb53-13" tabindex="-1"></a><span class="co">#&gt;     WEEK 1 DAY 8                                                   </span></span>
<span id="cb53-14"><a href="#cb53-14" tabindex="-1"></a><span class="co">#&gt;       n                        15           15             15      </span></span>
<span id="cb53-15"><a href="#cb53-15" tabindex="-1"></a><span class="co">#&gt;       &lt;=450 msec           12 (80.0%)   9 (60.0%)      13 (86.7%)  </span></span>
<span id="cb53-16"><a href="#cb53-16" tabindex="-1"></a><span class="co">#&gt;       &gt;450 to &lt;=480 msec    1 (6.7%)     1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb53-17"><a href="#cb53-17" tabindex="-1"></a><span class="co">#&gt;       &gt;480 to &lt;=500 msec    1 (6.7%)    3 (20.0%)       1 (6.7%)   </span></span>
<span id="cb53-18"><a href="#cb53-18" tabindex="-1"></a><span class="co">#&gt;       &gt;500 msec             1 (6.7%)    2 (13.3%)          0       </span></span>
<span id="cb53-19"><a href="#cb53-19" tabindex="-1"></a><span class="co">#&gt;     WEEK 2 DAY 15                                                  </span></span>
<span id="cb53-20"><a href="#cb53-20" tabindex="-1"></a><span class="co">#&gt;       n                        15           15             15      </span></span>
<span id="cb53-21"><a href="#cb53-21" tabindex="-1"></a><span class="co">#&gt;       &lt;=450 msec           11 (73.3%)   14 (93.3%)     12 (80.0%)  </span></span>
<span id="cb53-22"><a href="#cb53-22" tabindex="-1"></a><span class="co">#&gt;       &gt;450 to &lt;=480 msec   2 (13.3%)        0          2 (13.3%)   </span></span>
<span id="cb53-23"><a href="#cb53-23" tabindex="-1"></a><span class="co">#&gt;       &gt;480 to &lt;=500 msec    1 (6.7%)        0           1 (6.7%)   </span></span>
<span id="cb53-24"><a href="#cb53-24" tabindex="-1"></a><span class="co">#&gt;       &gt;500 msec             1 (6.7%)     1 (6.7%)          0       </span></span>
<span id="cb53-25"><a href="#cb53-25" tabindex="-1"></a><span class="co">#&gt;     WEEK 3 DAY 22                                                  </span></span>
<span id="cb53-26"><a href="#cb53-26" tabindex="-1"></a><span class="co">#&gt;       n                        15           15             15      </span></span>
<span id="cb53-27"><a href="#cb53-27" tabindex="-1"></a><span class="co">#&gt;       &lt;=450 msec           12 (80.0%)   12 (80.0%)     12 (80.0%)  </span></span>
<span id="cb53-28"><a href="#cb53-28" tabindex="-1"></a><span class="co">#&gt;       &gt;450 to &lt;=480 msec   3 (20.0%)     1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb53-29"><a href="#cb53-29" tabindex="-1"></a><span class="co">#&gt;       &gt;500 msec                0        2 (13.3%)      2 (13.3%)   </span></span>
<span id="cb53-30"><a href="#cb53-30" tabindex="-1"></a><span class="co">#&gt;     WEEK 4 DAY 29                                                  </span></span>
<span id="cb53-31"><a href="#cb53-31" tabindex="-1"></a><span class="co">#&gt;       n                        15           15             15      </span></span>
<span id="cb53-32"><a href="#cb53-32" tabindex="-1"></a><span class="co">#&gt;       &lt;=450 msec           14 (93.3%)   12 (80.0%)     13 (86.7%)  </span></span>
<span id="cb53-33"><a href="#cb53-33" tabindex="-1"></a><span class="co">#&gt;       &gt;450 to &lt;=480 msec    1 (6.7%)     1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb53-34"><a href="#cb53-34" tabindex="-1"></a><span class="co">#&gt;       &gt;480 to &lt;=500 msec       0            0           1 (6.7%)   </span></span>
<span id="cb53-35"><a href="#cb53-35" tabindex="-1"></a><span class="co">#&gt;       &gt;500 msec                0        2 (13.3%)          0       </span></span>
<span id="cb53-36"><a href="#cb53-36" tabindex="-1"></a><span class="co">#&gt;     WEEK 5 DAY 36                                                  </span></span>
<span id="cb53-37"><a href="#cb53-37" tabindex="-1"></a><span class="co">#&gt;       n                        15           15             15      </span></span>
<span id="cb53-38"><a href="#cb53-38" tabindex="-1"></a><span class="co">#&gt;       &lt;=450 msec           12 (80.0%)   15 (100%)      15 (100%)   </span></span>
<span id="cb53-39"><a href="#cb53-39" tabindex="-1"></a><span class="co">#&gt;       &gt;450 to &lt;=480 msec   2 (13.3%)        0              0       </span></span>
<span id="cb53-40"><a href="#cb53-40" tabindex="-1"></a><span class="co">#&gt;       &gt;500 msec             1 (6.7%)        0              0</span></span></code></pre></div>
</div>
</div>
<div id="study-drug-exposure-ext01" class="section level3">
<h3><strong>Study Drug Exposure (<code>EXT01</code>)</strong></h3>
<div id="study-drug-exposure" class="section level4">
<h4><strong>1. Study Drug Exposure</strong></h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>ext01</code></strong> template displays total
number of doses administered and total dose administered by default</li>
<li>The template does not include the column of total by default</li>
</ol>
<div class="sourceCode" id="cb54"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb54-1"><a href="#cb54-1" tabindex="-1"></a><span class="fu">run</span>(ext01, syn_data)</span>
<span id="cb54-2"><a href="#cb54-2" tabindex="-1"></a><span class="co">#&gt;                                  A: Drug X        B: Placebo      C: Combination </span></span>
<span id="cb54-3"><a href="#cb54-3" tabindex="-1"></a><span class="co">#&gt;   PARCAT2                         (N=15)            (N=15)            (N=15)     </span></span>
<span id="cb54-4"><a href="#cb54-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb54-5"><a href="#cb54-5" tabindex="-1"></a><span class="co">#&gt;   Drug A                                                                         </span></span>
<span id="cb54-6"><a href="#cb54-6" tabindex="-1"></a><span class="co">#&gt;     Overall duration (days)                                                      </span></span>
<span id="cb54-7"><a href="#cb54-7" tabindex="-1"></a><span class="co">#&gt;       n                             11                 7                 7       </span></span>
<span id="cb54-8"><a href="#cb54-8" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)                157.5 (67.4)      115.4 (62.8)       98.6 (68.8)  </span></span>
<span id="cb54-9"><a href="#cb54-9" tabindex="-1"></a><span class="co">#&gt;       Median                       174.0             119.0             89.0      </span></span>
<span id="cb54-10"><a href="#cb54-10" tabindex="-1"></a><span class="co">#&gt;       Min - Max                53.0 - 239.0      22.0 - 219.0       1.0 - 182.0  </span></span>
<span id="cb54-11"><a href="#cb54-11" tabindex="-1"></a><span class="co">#&gt;     Total dose administered                                                      </span></span>
<span id="cb54-12"><a href="#cb54-12" tabindex="-1"></a><span class="co">#&gt;       n                             11                 7                 7       </span></span>
<span id="cb54-13"><a href="#cb54-13" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)               6567.3 (1127.1)   7028.6 (1626.1)   6377.1 (863.7) </span></span>
<span id="cb54-14"><a href="#cb54-14" tabindex="-1"></a><span class="co">#&gt;       Median                      6720.0            7200.0            6480.0     </span></span>
<span id="cb54-15"><a href="#cb54-15" tabindex="-1"></a><span class="co">#&gt;       Min - Max               4800.0 - 8400.0   5280.0 - 9360.0   5280.0 - 7440.0</span></span>
<span id="cb54-16"><a href="#cb54-16" tabindex="-1"></a><span class="co">#&gt;   Drug B                                                                         </span></span>
<span id="cb54-17"><a href="#cb54-17" tabindex="-1"></a><span class="co">#&gt;     Overall duration (days)                                                      </span></span>
<span id="cb54-18"><a href="#cb54-18" tabindex="-1"></a><span class="co">#&gt;       n                              4                 8                 8       </span></span>
<span id="cb54-19"><a href="#cb54-19" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)                142.2 (100.3)     105.9 (60.0)      158.2 (96.2)  </span></span>
<span id="cb54-20"><a href="#cb54-20" tabindex="-1"></a><span class="co">#&gt;       Median                       160.0             95.0              203.0     </span></span>
<span id="cb54-21"><a href="#cb54-21" tabindex="-1"></a><span class="co">#&gt;       Min - Max                17.0 - 232.0      37.0 - 211.0      27.0 - 249.0  </span></span>
<span id="cb54-22"><a href="#cb54-22" tabindex="-1"></a><span class="co">#&gt;     Total dose administered                                                      </span></span>
<span id="cb54-23"><a href="#cb54-23" tabindex="-1"></a><span class="co">#&gt;       n                              4                 8                 8       </span></span>
<span id="cb54-24"><a href="#cb54-24" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)               7020.0 (1148.9)   5250.0 (864.7)    5940.0 (1187.9)</span></span>
<span id="cb54-25"><a href="#cb54-25" tabindex="-1"></a><span class="co">#&gt;       Median                      6960.0            5160.0            5880.0     </span></span>
<span id="cb54-26"><a href="#cb54-26" tabindex="-1"></a><span class="co">#&gt;       Min - Max               5760.0 - 8400.0   4080.0 - 6480.0   4320.0 - 7680.0</span></span></code></pre></div>
</div>
</div>
<div id="laboratory-test-results-and-change-from-baseline-by-visit-lbt01" class="section level3">
<h3><strong>Laboratory Test Results and Change from Baseline by Visit
(<code>LBT01</code>)</strong></h3>
<div id="laboratory-test-results-and-change-from-baseline-by-visit" class="section level4">
<h4><strong>1. Laboratory Test Results and Change from Baseline by
Visit</strong></h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>lbt01</code></strong> template produces the
standard laboratory test results and change from baseline by visit.</li>
<li>To select the SI/CV/LS results and the panel
(chemistry/hematology/urinalysis/coagulation etc.) to display, user
defines individual filters and apply to input datasets prior to running
CHEVRON.</li>
</ol>
<div class="sourceCode" id="cb55"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb55-1"><a href="#cb55-1" tabindex="-1"></a>t_lb_chg <span class="ot">&lt;-</span> <span class="fu">run</span>(lbt01, syn_data)</span>
<span id="cb55-2"><a href="#cb55-2" tabindex="-1"></a><span class="fu">head</span>(t_lb_chg, <span class="dv">20</span>)</span>
<span id="cb55-3"><a href="#cb55-3" tabindex="-1"></a><span class="co">#&gt;                                                     A: Drug X                        B: Placebo                     C: Combination         </span></span>
<span id="cb55-4"><a href="#cb55-4" tabindex="-1"></a><span class="co">#&gt;                                                            Change from                       Change from                      Change from  </span></span>
<span id="cb55-5"><a href="#cb55-5" tabindex="-1"></a><span class="co">#&gt;                                          Value at Visit      Baseline      Value at Visit     Baseline      Value at Visit      Baseline   </span></span>
<span id="cb55-6"><a href="#cb55-6" tabindex="-1"></a><span class="co">#&gt;                                              (N=15)           (N=15)           (N=15)          (N=15)           (N=15)           (N=15)    </span></span>
<span id="cb55-7"><a href="#cb55-7" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb55-8"><a href="#cb55-8" tabindex="-1"></a><span class="co">#&gt;   Alanine Aminotransferase Measurement                                                                                                     </span></span>
<span id="cb55-9"><a href="#cb55-9" tabindex="-1"></a><span class="co">#&gt;     BASELINE                                                                                                                               </span></span>
<span id="cb55-10"><a href="#cb55-10" tabindex="-1"></a><span class="co">#&gt;       n                                        15                                15                               15                       </span></span>
<span id="cb55-11"><a href="#cb55-11" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)                          20.262 (4.982)                    19.371 (4.687)                   21.724 (3.857)                 </span></span>
<span id="cb55-12"><a href="#cb55-12" tabindex="-1"></a><span class="co">#&gt;       Median                                 19.216                            19.781                           22.900                     </span></span>
<span id="cb55-13"><a href="#cb55-13" tabindex="-1"></a><span class="co">#&gt;       Min - Max                          13.77 - 30.43                     11.58 - 25.59                    12.57 - 27.69                  </span></span>
<span id="cb55-14"><a href="#cb55-14" tabindex="-1"></a><span class="co">#&gt;     WEEK 1 DAY 8                                                                                                                           </span></span>
<span id="cb55-15"><a href="#cb55-15" tabindex="-1"></a><span class="co">#&gt;       n                                        15               15               15              15               15               15      </span></span>
<span id="cb55-16"><a href="#cb55-16" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)                          19.227 (4.492)   -1.036 (7.113)   21.622 (3.015)   2.251 (6.830)   20.630 (3.950)   -1.094 (4.425)</span></span>
<span id="cb55-17"><a href="#cb55-17" tabindex="-1"></a><span class="co">#&gt;       Median                                 18.666           -2.148           21.790           2.901           20.570           -0.398    </span></span>
<span id="cb55-18"><a href="#cb55-18" tabindex="-1"></a><span class="co">#&gt;       Min - Max                          12.12 - 27.32    -12.07 - 9.07    16.69 - 26.32    -6.73 - 14.36   13.21 - 27.31     -7.84 - 7.84 </span></span>
<span id="cb55-19"><a href="#cb55-19" tabindex="-1"></a><span class="co">#&gt;     WEEK 2 DAY 15                                                                                                                          </span></span>
<span id="cb55-20"><a href="#cb55-20" tabindex="-1"></a><span class="co">#&gt;       n                                        15               15               15              15               15               15      </span></span>
<span id="cb55-21"><a href="#cb55-21" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)                          19.458 (4.211)   -0.804 (6.309)   21.103 (3.831)   1.732 (5.981)   17.164 (3.089)   -4.559 (4.438)</span></span>
<span id="cb55-22"><a href="#cb55-22" tabindex="-1"></a><span class="co">#&gt;       Median                                 18.988           -2.571           20.200           2.499           16.740           -3.463    </span></span>
<span id="cb55-23"><a href="#cb55-23" tabindex="-1"></a><span class="co">#&gt;       Min - Max                          12.96 - 26.92    -12.00 - 13.14   13.42 - 29.93    -9.97 - 14.39   12.94 - 22.80    -10.95 - 1.01 </span></span>
<span id="cb55-24"><a href="#cb55-24" tabindex="-1"></a><span class="co">#&gt;     WEEK 3 DAY 22                                                                                                                          </span></span>
<span id="cb55-25"><a href="#cb55-25" tabindex="-1"></a><span class="co">#&gt;       n                                        15               15               15              15               15               15      </span></span>
<span id="cb55-26"><a href="#cb55-26" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)                          19.795 (4.272)   -0.467 (6.304)   20.822 (3.234)   1.451 (6.839)   20.165 (3.805)   -1.559 (4.042)</span></span>
<span id="cb55-27"><a href="#cb55-27" tabindex="-1"></a><span class="co">#&gt;       Median                                 18.489           0.542            21.541           2.138           20.612           -2.878</span></span></code></pre></div>
</div>
<div id="laboratory-test-results-and-change-from-baseline-by-visit-customized-precision" class="section level4">
<h4><strong>2. Laboratory Test Results and Change from Baseline by Visit
(customized precision)</strong></h4>
<p>TBA</p>
</div>
</div>
<div id="laboratory-abnormalities-lbt04" class="section level3">
<h3><strong>Laboratory Abnormalities (<code>LBT04</code>)</strong></h3>
<div id="laboratory-abnormalities" class="section level4">
<h4><strong>1. Laboratory Abnormalities</strong></h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>lbt04</code></strong> template produces the
standard laboratory abnormalities summary.</li>
<li>The template subsets to SI results by default.</li>
<li>The laboratory tests and directions of abnormality in this template
is data-driven. Table entries provide the number of patients with a
during treatment laboratory value abnormality in the direction specified
among patients without this abnormality at baseline.</li>
</ol>
<div class="sourceCode" id="cb56"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb56-1"><a href="#cb56-1" tabindex="-1"></a><span class="fu">run</span>(lbt04, syn_data)</span>
<span id="cb56-2"><a href="#cb56-2" tabindex="-1"></a><span class="co">#&gt;   Laboratory Test                           A: Drug X    B: Placebo    C: Combination</span></span>
<span id="cb56-3"><a href="#cb56-3" tabindex="-1"></a><span class="co">#&gt;       Direction of Abnormality               (N=15)        (N=15)          (N=15)    </span></span>
<span id="cb56-4"><a href="#cb56-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb56-5"><a href="#cb56-5" tabindex="-1"></a><span class="co">#&gt;   CHEMISTRY                                                                          </span></span>
<span id="cb56-6"><a href="#cb56-6" tabindex="-1"></a><span class="co">#&gt;     Alanine Aminotransferase Measurement                                             </span></span>
<span id="cb56-7"><a href="#cb56-7" tabindex="-1"></a><span class="co">#&gt;       Low                                  1/7 (14.3%)   1/3 (33.3%)        0/8      </span></span>
<span id="cb56-8"><a href="#cb56-8" tabindex="-1"></a><span class="co">#&gt;       High                                 2/7 (28.6%)       0/2        1/9 (11.1%)  </span></span>
<span id="cb56-9"><a href="#cb56-9" tabindex="-1"></a><span class="co">#&gt;     C-Reactive Protein Measurement                                                   </span></span>
<span id="cb56-10"><a href="#cb56-10" tabindex="-1"></a><span class="co">#&gt;       Low                                      0/8           0/2        2/7 (28.6%)  </span></span>
<span id="cb56-11"><a href="#cb56-11" tabindex="-1"></a><span class="co">#&gt;       High                                     0/8           0/3            0/7      </span></span>
<span id="cb56-12"><a href="#cb56-12" tabindex="-1"></a><span class="co">#&gt;     Immunoglobulin A Measurement                                                     </span></span>
<span id="cb56-13"><a href="#cb56-13" tabindex="-1"></a><span class="co">#&gt;       Low                                  2/5 (40.0%)   1/8 (12.5%)    1/6 (16.7%)  </span></span>
<span id="cb56-14"><a href="#cb56-14" tabindex="-1"></a><span class="co">#&gt;       High                                 2/5 (40.0%)   1/9 (11.1%)        0/6      </span></span>
<span id="cb56-15"><a href="#cb56-15" tabindex="-1"></a><span class="co">#&gt;   COAGULATION                                                                        </span></span>
<span id="cb56-16"><a href="#cb56-16" tabindex="-1"></a><span class="co">#&gt;     Alanine Aminotransferase Measurement                                             </span></span>
<span id="cb56-17"><a href="#cb56-17" tabindex="-1"></a><span class="co">#&gt;       Low                                      0/5       1/5 (20.0%)        0/5      </span></span>
<span id="cb56-18"><a href="#cb56-18" tabindex="-1"></a><span class="co">#&gt;       High                                     0/6       1/6 (16.7%)    1/5 (20.0%)  </span></span>
<span id="cb56-19"><a href="#cb56-19" tabindex="-1"></a><span class="co">#&gt;     C-Reactive Protein Measurement                                                   </span></span>
<span id="cb56-20"><a href="#cb56-20" tabindex="-1"></a><span class="co">#&gt;       Low                                  1/6 (16.7%)       0/5        1/4 (25.0%)  </span></span>
<span id="cb56-21"><a href="#cb56-21" tabindex="-1"></a><span class="co">#&gt;       High                                 1/5 (20.0%)   1/6 (16.7%)        0/3      </span></span>
<span id="cb56-22"><a href="#cb56-22" tabindex="-1"></a><span class="co">#&gt;     Immunoglobulin A Measurement                                                     </span></span>
<span id="cb56-23"><a href="#cb56-23" tabindex="-1"></a><span class="co">#&gt;       Low                                      0/7           0/9            0/7      </span></span>
<span id="cb56-24"><a href="#cb56-24" tabindex="-1"></a><span class="co">#&gt;       High                                 1/7 (14.3%)      0/10            0/6      </span></span>
<span id="cb56-25"><a href="#cb56-25" tabindex="-1"></a><span class="co">#&gt;   HEMATOLOGY                                                                         </span></span>
<span id="cb56-26"><a href="#cb56-26" tabindex="-1"></a><span class="co">#&gt;     Alanine Aminotransferase Measurement                                             </span></span>
<span id="cb56-27"><a href="#cb56-27" tabindex="-1"></a><span class="co">#&gt;       Low                                  1/5 (20.0%)   1/5 (20.0%)        0/4      </span></span>
<span id="cb56-28"><a href="#cb56-28" tabindex="-1"></a><span class="co">#&gt;       High                                     0/5           0/4            0/4      </span></span>
<span id="cb56-29"><a href="#cb56-29" tabindex="-1"></a><span class="co">#&gt;     C-Reactive Protein Measurement                                                   </span></span>
<span id="cb56-30"><a href="#cb56-30" tabindex="-1"></a><span class="co">#&gt;       Low                                  1/4 (25.0%)       0/2        3/9 (33.3%)  </span></span>
<span id="cb56-31"><a href="#cb56-31" tabindex="-1"></a><span class="co">#&gt;       High                                     0/4           0/5            0/9      </span></span>
<span id="cb56-32"><a href="#cb56-32" tabindex="-1"></a><span class="co">#&gt;     Immunoglobulin A Measurement                                                     </span></span>
<span id="cb56-33"><a href="#cb56-33" tabindex="-1"></a><span class="co">#&gt;       Low                                      0/2           0/3        2/8 (25.0%)  </span></span>
<span id="cb56-34"><a href="#cb56-34" tabindex="-1"></a><span class="co">#&gt;       High                                     0/4       1/4 (25.0%)        0/7</span></span></code></pre></div>
</div>
</div>
<div id="laboratory-abnormalities-with-single-and-replicated-marked-lbt05" class="section level3">
<h3><strong>Laboratory Abnormalities with Single and Replicated Marked
(<code>LBT05</code>)</strong></h3>
<div id="laboratory-abnormalities-with-single-and-replicated-marked" class="section level4">
<h4><strong>1. Laboratory Abnormalities with Single and Replicated
Marked</strong></h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>lbt05</code></strong> template produces the
standard laboratory abnormalities summary for marked abnormalities.</li>
<li>The laboratory tests and directions of abnormality in this template
is currently data-driven. The standard metadata for Safety Lab
Standardization will be incorporated in future release.</li>
</ol>
<div class="sourceCode" id="cb57"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb57-1"><a href="#cb57-1" tabindex="-1"></a><span class="fu">run</span>(lbt05, syn_data)</span>
<span id="cb57-2"><a href="#cb57-2" tabindex="-1"></a><span class="co">#&gt;   Laboratory Test                            A: Drug X   B: Placebo   C: Combination</span></span>
<span id="cb57-3"><a href="#cb57-3" tabindex="-1"></a><span class="co">#&gt;       Direction of Abnormality                (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb57-4"><a href="#cb57-4" tabindex="-1"></a><span class="co">#&gt;   ââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb57-5"><a href="#cb57-5" tabindex="-1"></a><span class="co">#&gt;   Alanine Aminotransferase Measurement (n)      15           12             13      </span></span>
<span id="cb57-6"><a href="#cb57-6" tabindex="-1"></a><span class="co">#&gt;     Low                                                                             </span></span>
<span id="cb57-7"><a href="#cb57-7" tabindex="-1"></a><span class="co">#&gt;       Single, not last                       1 (6.7%)        0           1 (7.7%)   </span></span>
<span id="cb57-8"><a href="#cb57-8" tabindex="-1"></a><span class="co">#&gt;       Last or replicated                         0       2 (16.7%)          0       </span></span>
<span id="cb57-9"><a href="#cb57-9" tabindex="-1"></a><span class="co">#&gt;       Any Abnormality                        1 (6.7%)    2 (16.7%)       1 (7.7%)   </span></span>
<span id="cb57-10"><a href="#cb57-10" tabindex="-1"></a><span class="co">#&gt;     High                                                                            </span></span>
<span id="cb57-11"><a href="#cb57-11" tabindex="-1"></a><span class="co">#&gt;       Single, not last                           0        1 (8.3%)          0       </span></span>
<span id="cb57-12"><a href="#cb57-12" tabindex="-1"></a><span class="co">#&gt;       Last or replicated                         0           0              0       </span></span>
<span id="cb57-13"><a href="#cb57-13" tabindex="-1"></a><span class="co">#&gt;       Any Abnormality                            0        1 (8.3%)          0       </span></span>
<span id="cb57-14"><a href="#cb57-14" tabindex="-1"></a><span class="co">#&gt;   C-Reactive Protein Measurement (n)            12           14             15      </span></span>
<span id="cb57-15"><a href="#cb57-15" tabindex="-1"></a><span class="co">#&gt;     Low                                                                             </span></span>
<span id="cb57-16"><a href="#cb57-16" tabindex="-1"></a><span class="co">#&gt;       Single, not last                           0           0           1 (6.7%)   </span></span>
<span id="cb57-17"><a href="#cb57-17" tabindex="-1"></a><span class="co">#&gt;       Last or replicated                     1 (8.3%)        0              0       </span></span>
<span id="cb57-18"><a href="#cb57-18" tabindex="-1"></a><span class="co">#&gt;       Any Abnormality                        1 (8.3%)        0           1 (6.7%)   </span></span>
<span id="cb57-19"><a href="#cb57-19" tabindex="-1"></a><span class="co">#&gt;     High                                                                            </span></span>
<span id="cb57-20"><a href="#cb57-20" tabindex="-1"></a><span class="co">#&gt;       Single, not last                       1 (8.3%)        0           1 (6.7%)   </span></span>
<span id="cb57-21"><a href="#cb57-21" tabindex="-1"></a><span class="co">#&gt;       Last or replicated                         0           0              0       </span></span>
<span id="cb57-22"><a href="#cb57-22" tabindex="-1"></a><span class="co">#&gt;       Any Abnormality                        1 (8.3%)        0           1 (6.7%)   </span></span>
<span id="cb57-23"><a href="#cb57-23" tabindex="-1"></a><span class="co">#&gt;   Immunoglobulin A Measurement (n)              11           14             13      </span></span>
<span id="cb57-24"><a href="#cb57-24" tabindex="-1"></a><span class="co">#&gt;     Low                                                                             </span></span>
<span id="cb57-25"><a href="#cb57-25" tabindex="-1"></a><span class="co">#&gt;       Single, not last                           0        1 (7.1%)       1 (7.7%)   </span></span>
<span id="cb57-26"><a href="#cb57-26" tabindex="-1"></a><span class="co">#&gt;       Last or replicated                         0           0              0       </span></span>
<span id="cb57-27"><a href="#cb57-27" tabindex="-1"></a><span class="co">#&gt;       Any Abnormality                            0        1 (7.1%)       1 (7.7%)   </span></span>
<span id="cb57-28"><a href="#cb57-28" tabindex="-1"></a><span class="co">#&gt;     High                                                                            </span></span>
<span id="cb57-29"><a href="#cb57-29" tabindex="-1"></a><span class="co">#&gt;       Single, not last                           0           0              0       </span></span>
<span id="cb57-30"><a href="#cb57-30" tabindex="-1"></a><span class="co">#&gt;       Last or replicated                     1 (9.1%)        0              0       </span></span>
<span id="cb57-31"><a href="#cb57-31" tabindex="-1"></a><span class="co">#&gt;       Any Abnormality                        1 (9.1%)        0              0</span></span></code></pre></div>
</div>
<div id="laboratory-abnormalities-with-single-and-replicated-marked-showing-all-categories" class="section level4">
<h4><strong>2. Laboratory Abnormalities with Single and Replicated
Marked showing all categories</strong></h4>
</div>
<div id="laboratory-abnormalities-with-single-and-replicated-marked-with-study-specific-mlas" class="section level4">
<h4><strong>3. Laboratory Abnormalities with Single and Replicated
Marked with study specific <code>MLAs</code></strong></h4>
</div>
</div>
<div id="laboratory-abnormalities-by-visit-and-baseline-status-lbt06" class="section level3">
<h3><strong>Laboratory Abnormalities by Visit and Baseline Status
(<code>LBT06</code>)</strong></h3>
<div id="laboratory-abnormalities-by-visit-and-baseline-status" class="section level4">
<h4><strong>1. Laboratory Abnormalities by Visit and Baseline
Status</strong></h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>lbt06</code></strong> template produces the
standard laboratory abnormalities by visit and baseline status
summary.</li>
</ol>
<div class="sourceCode" id="cb58"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb58-1"><a href="#cb58-1" tabindex="-1"></a><span class="fu">run</span>(lbt06, syn_data)</span>
<span id="cb58-2"><a href="#cb58-2" tabindex="-1"></a><span class="co">#&gt;   Visit                                                                            </span></span>
<span id="cb58-3"><a href="#cb58-3" tabindex="-1"></a><span class="co">#&gt;     Abnormality at Visit                  A: Drug X    B: Placebo    C: Combination</span></span>
<span id="cb58-4"><a href="#cb58-4" tabindex="-1"></a><span class="co">#&gt;               Baseline Status              (N=15)        (N=15)          (N=15)    </span></span>
<span id="cb58-5"><a href="#cb58-5" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb58-6"><a href="#cb58-6" tabindex="-1"></a><span class="co">#&gt;   Alanine Aminotransferase Measurement                                             </span></span>
<span id="cb58-7"><a href="#cb58-7" tabindex="-1"></a><span class="co">#&gt;     WEEK 1 DAY 8                                                                   </span></span>
<span id="cb58-8"><a href="#cb58-8" tabindex="-1"></a><span class="co">#&gt;       Low                                                                          </span></span>
<span id="cb58-9"><a href="#cb58-9" tabindex="-1"></a><span class="co">#&gt;                 Not low                      0/3       1/6 (16.7%)        0/3      </span></span>
<span id="cb58-10"><a href="#cb58-10" tabindex="-1"></a><span class="co">#&gt;                 Low                          0/0           0/1            0/0      </span></span>
<span id="cb58-11"><a href="#cb58-11" tabindex="-1"></a><span class="co">#&gt;                 Total                        0/3       1/7 (14.3%)        0/3      </span></span>
<span id="cb58-12"><a href="#cb58-12" tabindex="-1"></a><span class="co">#&gt;       High                                                                         </span></span>
<span id="cb58-13"><a href="#cb58-13" tabindex="-1"></a><span class="co">#&gt;                 Not high                     0/3           0/6            0/3      </span></span>
<span id="cb58-14"><a href="#cb58-14" tabindex="-1"></a><span class="co">#&gt;                 High                         0/0           0/1            0/0      </span></span>
<span id="cb58-15"><a href="#cb58-15" tabindex="-1"></a><span class="co">#&gt;                 Total                        0/3           0/7            0/3      </span></span>
<span id="cb58-16"><a href="#cb58-16" tabindex="-1"></a><span class="co">#&gt;     WEEK 2 DAY 15                                                                  </span></span>
<span id="cb58-17"><a href="#cb58-17" tabindex="-1"></a><span class="co">#&gt;       Low                                                                          </span></span>
<span id="cb58-18"><a href="#cb58-18" tabindex="-1"></a><span class="co">#&gt;                 Not low                  1/3 (33.3%)       0/2            0/3      </span></span>
<span id="cb58-19"><a href="#cb58-19" tabindex="-1"></a><span class="co">#&gt;                 Low                          0/0           0/0            0/0      </span></span>
<span id="cb58-20"><a href="#cb58-20" tabindex="-1"></a><span class="co">#&gt;                 Total                    1/3 (33.3%)       0/2            0/3      </span></span>
<span id="cb58-21"><a href="#cb58-21" tabindex="-1"></a><span class="co">#&gt;       High                                                                         </span></span>
<span id="cb58-22"><a href="#cb58-22" tabindex="-1"></a><span class="co">#&gt;                 Not high                     0/3           0/2        1/3 (33.3%)  </span></span>
<span id="cb58-23"><a href="#cb58-23" tabindex="-1"></a><span class="co">#&gt;                 High                         0/0           0/0            0/0      </span></span>
<span id="cb58-24"><a href="#cb58-24" tabindex="-1"></a><span class="co">#&gt;                 Total                        0/3           0/2        1/3 (33.3%)  </span></span>
<span id="cb58-25"><a href="#cb58-25" tabindex="-1"></a><span class="co">#&gt;     WEEK 3 DAY 22                                                                  </span></span>
<span id="cb58-26"><a href="#cb58-26" tabindex="-1"></a><span class="co">#&gt;       Low                                                                          </span></span>
<span id="cb58-27"><a href="#cb58-27" tabindex="-1"></a><span class="co">#&gt;                 Not low                      0/5       1/3 (33.3%)        0/6      </span></span>
<span id="cb58-28"><a href="#cb58-28" tabindex="-1"></a><span class="co">#&gt;                 Low                      1/1 (100%)        0/0            0/0      </span></span>
<span id="cb58-29"><a href="#cb58-29" tabindex="-1"></a><span class="co">#&gt;                 Total                    1/6 (16.7%)   1/3 (33.3%)        0/6      </span></span>
<span id="cb58-30"><a href="#cb58-30" tabindex="-1"></a><span class="co">#&gt;       High                                                                         </span></span>
<span id="cb58-31"><a href="#cb58-31" tabindex="-1"></a><span class="co">#&gt;                 Not high                  1/5 (20%)    1/3 (33.3%)        0/6      </span></span>
<span id="cb58-32"><a href="#cb58-32" tabindex="-1"></a><span class="co">#&gt;                 High                     1/1 (100%)        0/0            0/0      </span></span>
<span id="cb58-33"><a href="#cb58-33" tabindex="-1"></a><span class="co">#&gt;                 Total                    2/6 (33.3%)   1/3 (33.3%)        0/6      </span></span>
<span id="cb58-34"><a href="#cb58-34" tabindex="-1"></a><span class="co">#&gt;     WEEK 4 DAY 29                                                                  </span></span>
<span id="cb58-35"><a href="#cb58-35" tabindex="-1"></a><span class="co">#&gt;       Low                                                                          </span></span>
<span id="cb58-36"><a href="#cb58-36" tabindex="-1"></a><span class="co">#&gt;                 Not low                   1/5 (20%)        0/3            0/2      </span></span>
<span id="cb58-37"><a href="#cb58-37" tabindex="-1"></a><span class="co">#&gt;                 Low                          0/1           0/1            0/0      </span></span>
<span id="cb58-38"><a href="#cb58-38" tabindex="-1"></a><span class="co">#&gt;                 Total                    1/6 (16.7%)       0/4            0/2      </span></span>
<span id="cb58-39"><a href="#cb58-39" tabindex="-1"></a><span class="co">#&gt;       High                                                                         </span></span>
<span id="cb58-40"><a href="#cb58-40" tabindex="-1"></a><span class="co">#&gt;                 Not high                  1/5 (20%)        0/3         1/2 (50%)   </span></span>
<span id="cb58-41"><a href="#cb58-41" tabindex="-1"></a><span class="co">#&gt;                 High                         0/1           0/1            0/0      </span></span>
<span id="cb58-42"><a href="#cb58-42" tabindex="-1"></a><span class="co">#&gt;                 Total                    1/6 (16.7%)       0/4         1/2 (50%)   </span></span>
<span id="cb58-43"><a href="#cb58-43" tabindex="-1"></a><span class="co">#&gt;     WEEK 5 DAY 36                                                                  </span></span>
<span id="cb58-44"><a href="#cb58-44" tabindex="-1"></a><span class="co">#&gt;       Low                                                                          </span></span>
<span id="cb58-45"><a href="#cb58-45" tabindex="-1"></a><span class="co">#&gt;                 Not low                      0/3        1/2 (50%)         0/5      </span></span>
<span id="cb58-46"><a href="#cb58-46" tabindex="-1"></a><span class="co">#&gt;                 Low                      1/1 (100%)        0/1            0/1      </span></span>
<span id="cb58-47"><a href="#cb58-47" tabindex="-1"></a><span class="co">#&gt;                 Total                     1/4 (25%)    1/3 (33.3%)        0/6      </span></span>
<span id="cb58-48"><a href="#cb58-48" tabindex="-1"></a><span class="co">#&gt;       High                                                                         </span></span>
<span id="cb58-49"><a href="#cb58-49" tabindex="-1"></a><span class="co">#&gt;                 Not high                     0/4           0/1            0/6      </span></span>
<span id="cb58-50"><a href="#cb58-50" tabindex="-1"></a><span class="co">#&gt;                 High                         0/0           0/2            0/0      </span></span>
<span id="cb58-51"><a href="#cb58-51" tabindex="-1"></a><span class="co">#&gt;                 Total                        0/4           0/3            0/6      </span></span>
<span id="cb58-52"><a href="#cb58-52" tabindex="-1"></a><span class="co">#&gt;   C-Reactive Protein Measurement                                                   </span></span>
<span id="cb58-53"><a href="#cb58-53" tabindex="-1"></a><span class="co">#&gt;     WEEK 1 DAY 8                                                                   </span></span>
<span id="cb58-54"><a href="#cb58-54" tabindex="-1"></a><span class="co">#&gt;       Low                                                                          </span></span>
<span id="cb58-55"><a href="#cb58-55" tabindex="-1"></a><span class="co">#&gt;                 Not low                  1/7 (14.3%)       0/4        1/6 (16.7%)  </span></span>
<span id="cb58-56"><a href="#cb58-56" tabindex="-1"></a><span class="co">#&gt;                 Low                          0/1           0/0            0/0      </span></span>
<span id="cb58-57"><a href="#cb58-57" tabindex="-1"></a><span class="co">#&gt;                 Total                    1/8 (12.5%)       0/4        1/6 (16.7%)  </span></span>
<span id="cb58-58"><a href="#cb58-58" tabindex="-1"></a><span class="co">#&gt;       High                                                                         </span></span>
<span id="cb58-59"><a href="#cb58-59" tabindex="-1"></a><span class="co">#&gt;                 Not high                 1/7 (14.3%)       0/4            0/5      </span></span>
<span id="cb58-60"><a href="#cb58-60" tabindex="-1"></a><span class="co">#&gt;                 High                         0/1           0/0            0/1      </span></span>
<span id="cb58-61"><a href="#cb58-61" tabindex="-1"></a><span class="co">#&gt;                 Total                    1/8 (12.5%)       0/4            0/6      </span></span>
<span id="cb58-62"><a href="#cb58-62" tabindex="-1"></a><span class="co">#&gt;     WEEK 2 DAY 15                                                                  </span></span>
<span id="cb58-63"><a href="#cb58-63" tabindex="-1"></a><span class="co">#&gt;       Low                                                                          </span></span>
<span id="cb58-64"><a href="#cb58-64" tabindex="-1"></a><span class="co">#&gt;                 Not low                      0/7           0/0        1/3 (33.3%)  </span></span>
<span id="cb58-65"><a href="#cb58-65" tabindex="-1"></a><span class="co">#&gt;                 Low                          0/0           0/2            0/0      </span></span>
<span id="cb58-66"><a href="#cb58-66" tabindex="-1"></a><span class="co">#&gt;                 Total                        0/7           0/2        1/3 (33.3%)  </span></span>
<span id="cb58-67"><a href="#cb58-67" tabindex="-1"></a><span class="co">#&gt;       High                                                                         </span></span>
<span id="cb58-68"><a href="#cb58-68" tabindex="-1"></a><span class="co">#&gt;                 Not high                     0/5        1/2 (50%)         0/2      </span></span>
<span id="cb58-69"><a href="#cb58-69" tabindex="-1"></a><span class="co">#&gt;                 High                         0/2           0/0            0/1      </span></span>
<span id="cb58-70"><a href="#cb58-70" tabindex="-1"></a><span class="co">#&gt;                 Total                        0/7        1/2 (50%)         0/3      </span></span>
<span id="cb58-71"><a href="#cb58-71" tabindex="-1"></a><span class="co">#&gt;     WEEK 3 DAY 22                                                                  </span></span>
<span id="cb58-72"><a href="#cb58-72" tabindex="-1"></a><span class="co">#&gt;       Low                                                                          </span></span>
<span id="cb58-73"><a href="#cb58-73" tabindex="-1"></a><span class="co">#&gt;                 Not low                      0/4           0/4        2/7 (28.6%)  </span></span>
<span id="cb58-74"><a href="#cb58-74" tabindex="-1"></a><span class="co">#&gt;                 Low                          0/1           0/2            0/1      </span></span>
<span id="cb58-75"><a href="#cb58-75" tabindex="-1"></a><span class="co">#&gt;                 Total                        0/5           0/6         2/8 (25%)   </span></span>
<span id="cb58-76"><a href="#cb58-76" tabindex="-1"></a><span class="co">#&gt;       High                                                                         </span></span>
<span id="cb58-77"><a href="#cb58-77" tabindex="-1"></a><span class="co">#&gt;                 Not high                     0/5        1/5 (20%)         0/6      </span></span>
<span id="cb58-78"><a href="#cb58-78" tabindex="-1"></a><span class="co">#&gt;                 High                         0/0           0/1            0/2      </span></span>
<span id="cb58-79"><a href="#cb58-79" tabindex="-1"></a><span class="co">#&gt;                 Total                        0/5       1/6 (16.7%)        0/8      </span></span>
<span id="cb58-80"><a href="#cb58-80" tabindex="-1"></a><span class="co">#&gt;     WEEK 4 DAY 29                                                                  </span></span>
<span id="cb58-81"><a href="#cb58-81" tabindex="-1"></a><span class="co">#&gt;       Low                                                                          </span></span>
<span id="cb58-82"><a href="#cb58-82" tabindex="-1"></a><span class="co">#&gt;                 Not low                   1/2 (50%)        0/1            0/2      </span></span>
<span id="cb58-83"><a href="#cb58-83" tabindex="-1"></a><span class="co">#&gt;                 Low                          0/0           0/1            0/1      </span></span>
<span id="cb58-84"><a href="#cb58-84" tabindex="-1"></a><span class="co">#&gt;                 Total                     1/2 (50%)        0/2            0/3      </span></span>
<span id="cb58-85"><a href="#cb58-85" tabindex="-1"></a><span class="co">#&gt;       High                                                                         </span></span>
<span id="cb58-86"><a href="#cb58-86" tabindex="-1"></a><span class="co">#&gt;                 Not high                     0/2           0/2            0/3      </span></span>
<span id="cb58-87"><a href="#cb58-87" tabindex="-1"></a><span class="co">#&gt;                 High                         0/0           0/0            0/0      </span></span>
<span id="cb58-88"><a href="#cb58-88" tabindex="-1"></a><span class="co">#&gt;                 Total                        0/2           0/2            0/3      </span></span>
<span id="cb58-89"><a href="#cb58-89" tabindex="-1"></a><span class="co">#&gt;     WEEK 5 DAY 36                                                                  </span></span>
<span id="cb58-90"><a href="#cb58-90" tabindex="-1"></a><span class="co">#&gt;       Low                                                                          </span></span>
<span id="cb58-91"><a href="#cb58-91" tabindex="-1"></a><span class="co">#&gt;                 Not low                      0/2           0/2        2/6 (33.3%)  </span></span>
<span id="cb58-92"><a href="#cb58-92" tabindex="-1"></a><span class="co">#&gt;                 Low                          0/1           0/2            0/0      </span></span>
<span id="cb58-93"><a href="#cb58-93" tabindex="-1"></a><span class="co">#&gt;                 Total                        0/3           0/4        2/6 (33.3%)  </span></span>
<span id="cb58-94"><a href="#cb58-94" tabindex="-1"></a><span class="co">#&gt;       High                                                                         </span></span>
<span id="cb58-95"><a href="#cb58-95" tabindex="-1"></a><span class="co">#&gt;                 Not high                     0/3           0/4            0/6      </span></span>
<span id="cb58-96"><a href="#cb58-96" tabindex="-1"></a><span class="co">#&gt;                 High                         0/0           0/0            0/0      </span></span>
<span id="cb58-97"><a href="#cb58-97" tabindex="-1"></a><span class="co">#&gt;                 Total                        0/3           0/4            0/6      </span></span>
<span id="cb58-98"><a href="#cb58-98" tabindex="-1"></a><span class="co">#&gt;   Immunoglobulin A Measurement                                                     </span></span>
<span id="cb58-99"><a href="#cb58-99" tabindex="-1"></a><span class="co">#&gt;     WEEK 1 DAY 8                                                                   </span></span>
<span id="cb58-100"><a href="#cb58-100" tabindex="-1"></a><span class="co">#&gt;       Low                                                                          </span></span>
<span id="cb58-101"><a href="#cb58-101" tabindex="-1"></a><span class="co">#&gt;                 Not low                      0/4           0/6            0/3      </span></span>
<span id="cb58-102"><a href="#cb58-102" tabindex="-1"></a><span class="co">#&gt;                 Low                          0/2       1/1 (100%)         0/0      </span></span>
<span id="cb58-103"><a href="#cb58-103" tabindex="-1"></a><span class="co">#&gt;                 Total                        0/6       1/7 (14.3%)        0/3      </span></span>
<span id="cb58-104"><a href="#cb58-104" tabindex="-1"></a><span class="co">#&gt;       High                                                                         </span></span>
<span id="cb58-105"><a href="#cb58-105" tabindex="-1"></a><span class="co">#&gt;                 Not high                 1/6 (16.7%)       0/7            0/2      </span></span>
<span id="cb58-106"><a href="#cb58-106" tabindex="-1"></a><span class="co">#&gt;                 High                         0/0           0/0            0/1      </span></span>
<span id="cb58-107"><a href="#cb58-107" tabindex="-1"></a><span class="co">#&gt;                 Total                    1/6 (16.7%)       0/7            0/3      </span></span>
<span id="cb58-108"><a href="#cb58-108" tabindex="-1"></a><span class="co">#&gt;     WEEK 2 DAY 15                                                                  </span></span>
<span id="cb58-109"><a href="#cb58-109" tabindex="-1"></a><span class="co">#&gt;       Low                                                                          </span></span>
<span id="cb58-110"><a href="#cb58-110" tabindex="-1"></a><span class="co">#&gt;                 Not low                      0/4       1/6 (16.7%)        0/4      </span></span>
<span id="cb58-111"><a href="#cb58-111" tabindex="-1"></a><span class="co">#&gt;                 Low                          0/0           0/1            0/0      </span></span>
<span id="cb58-112"><a href="#cb58-112" tabindex="-1"></a><span class="co">#&gt;                 Total                        0/4       1/7 (14.3%)        0/4      </span></span>
<span id="cb58-113"><a href="#cb58-113" tabindex="-1"></a><span class="co">#&gt;       High                                                                         </span></span>
<span id="cb58-114"><a href="#cb58-114" tabindex="-1"></a><span class="co">#&gt;                 Not high                  1/4 (25%)        0/7            0/4      </span></span>
<span id="cb58-115"><a href="#cb58-115" tabindex="-1"></a><span class="co">#&gt;                 High                         0/0           0/0            0/0      </span></span>
<span id="cb58-116"><a href="#cb58-116" tabindex="-1"></a><span class="co">#&gt;                 Total                     1/4 (25%)        0/7            0/4      </span></span>
<span id="cb58-117"><a href="#cb58-117" tabindex="-1"></a><span class="co">#&gt;     WEEK 3 DAY 22                                                                  </span></span>
<span id="cb58-118"><a href="#cb58-118" tabindex="-1"></a><span class="co">#&gt;       Low                                                                          </span></span>
<span id="cb58-119"><a href="#cb58-119" tabindex="-1"></a><span class="co">#&gt;                 Not low                      0/4           0/5            0/8      </span></span>
<span id="cb58-120"><a href="#cb58-120" tabindex="-1"></a><span class="co">#&gt;                 Low                          0/1           0/1         1/1 (100%)  </span></span>
<span id="cb58-121"><a href="#cb58-121" tabindex="-1"></a><span class="co">#&gt;                 Total                        0/5           0/6        1/9 (11.1%)  </span></span>
<span id="cb58-122"><a href="#cb58-122" tabindex="-1"></a><span class="co">#&gt;       High                                                                         </span></span>
<span id="cb58-123"><a href="#cb58-123" tabindex="-1"></a><span class="co">#&gt;                 Not high                     0/4       1/6 (16.7%)        0/7      </span></span>
<span id="cb58-124"><a href="#cb58-124" tabindex="-1"></a><span class="co">#&gt;                 High                         0/1           0/0            0/2      </span></span>
<span id="cb58-125"><a href="#cb58-125" tabindex="-1"></a><span class="co">#&gt;                 Total                        0/5       1/6 (16.7%)        0/9      </span></span>
<span id="cb58-126"><a href="#cb58-126" tabindex="-1"></a><span class="co">#&gt;     WEEK 4 DAY 29                                                                  </span></span>
<span id="cb58-127"><a href="#cb58-127" tabindex="-1"></a><span class="co">#&gt;       Low                                                                          </span></span>
<span id="cb58-128"><a href="#cb58-128" tabindex="-1"></a><span class="co">#&gt;                 Not low                      0/1           0/5         2/4 (50%)   </span></span>
<span id="cb58-129"><a href="#cb58-129" tabindex="-1"></a><span class="co">#&gt;                 Low                          0/1           0/1            0/0      </span></span>
<span id="cb58-130"><a href="#cb58-130" tabindex="-1"></a><span class="co">#&gt;                 Total                        0/2           0/6         2/4 (50%)   </span></span>
<span id="cb58-131"><a href="#cb58-131" tabindex="-1"></a><span class="co">#&gt;       High                                                                         </span></span>
<span id="cb58-132"><a href="#cb58-132" tabindex="-1"></a><span class="co">#&gt;                 Not high                 1/1 (100%)    1/6 (16.7%)        0/4      </span></span>
<span id="cb58-133"><a href="#cb58-133" tabindex="-1"></a><span class="co">#&gt;                 High                         0/1           0/0            0/0      </span></span>
<span id="cb58-134"><a href="#cb58-134" tabindex="-1"></a><span class="co">#&gt;                 Total                     1/2 (50%)    1/6 (16.7%)        0/4      </span></span>
<span id="cb58-135"><a href="#cb58-135" tabindex="-1"></a><span class="co">#&gt;     WEEK 5 DAY 36                                                                  </span></span>
<span id="cb58-136"><a href="#cb58-136" tabindex="-1"></a><span class="co">#&gt;       Low                                                                          </span></span>
<span id="cb58-137"><a href="#cb58-137" tabindex="-1"></a><span class="co">#&gt;                 Not low                  2/7 (28.6%)       0/4        1/6 (16.7%)  </span></span>
<span id="cb58-138"><a href="#cb58-138" tabindex="-1"></a><span class="co">#&gt;                 Low                          0/0           0/1            0/0      </span></span>
<span id="cb58-139"><a href="#cb58-139" tabindex="-1"></a><span class="co">#&gt;                 Total                    2/7 (28.6%)       0/5        1/6 (16.7%)  </span></span>
<span id="cb58-140"><a href="#cb58-140" tabindex="-1"></a><span class="co">#&gt;       High                                                                         </span></span>
<span id="cb58-141"><a href="#cb58-141" tabindex="-1"></a><span class="co">#&gt;                 Not high                     0/5           0/5            0/6      </span></span>
<span id="cb58-142"><a href="#cb58-142" tabindex="-1"></a><span class="co">#&gt;                 High                         0/2           0/0            0/0      </span></span>
<span id="cb58-143"><a href="#cb58-143" tabindex="-1"></a><span class="co">#&gt;                 Total                        0/7           0/5            0/6</span></span></code></pre></div>
</div>
</div>
<div id="laboratory-test-results-with-highest-nci-ctcae-grade-post-baseline-lbt07" class="section level3">
<h3><strong>Laboratory Test Results with Highest <code>NCI CTCAE</code>
Grade Post-Baseline (<code>LBT07</code>)</strong></h3>
<div id="laboratory-test-results-with-highest-nci-ctcae-grade-post-baseline" class="section level4">
<h4><strong>1. Laboratory Test Results with Highest
<code>NCI CTCAE</code> Grade Post-Baseline</strong></h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>lbt07</code></strong> template produces the
standard laboratory test results with highest <code>NCI CTCAE</code>
grade post-baseline summary.</li>
<li>The laboratory tests and grades in this template is currently
data-driven. The standard metadata for possible lab tests and
corresponding <code>NCI CTCAE</code> grade will be incorporated in
future release.</li>
</ol>
<div class="sourceCode" id="cb59"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb59-1"><a href="#cb59-1" tabindex="-1"></a><span class="fu">run</span>(lbt07, syn_data)</span>
<span id="cb59-2"><a href="#cb59-2" tabindex="-1"></a><span class="co">#&gt;   Parameter                                                                         </span></span>
<span id="cb59-3"><a href="#cb59-3" tabindex="-1"></a><span class="co">#&gt;     Direction of Abnormality                 A: Drug X   B: Placebo   C: Combination</span></span>
<span id="cb59-4"><a href="#cb59-4" tabindex="-1"></a><span class="co">#&gt;               Highest NCI CTCAE Grade         (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb59-5"><a href="#cb59-5" tabindex="-1"></a><span class="co">#&gt;   ââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb59-6"><a href="#cb59-6" tabindex="-1"></a><span class="co">#&gt;   Alanine Aminotransferase Measurement (n)      15           15             15      </span></span>
<span id="cb59-7"><a href="#cb59-7" tabindex="-1"></a><span class="co">#&gt;     LOW                                                                             </span></span>
<span id="cb59-8"><a href="#cb59-8" tabindex="-1"></a><span class="co">#&gt;               1                              3 (20.0%)   2 (13.3%)      2 (13.3%)   </span></span>
<span id="cb59-9"><a href="#cb59-9" tabindex="-1"></a><span class="co">#&gt;               2                                  0        1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb59-10"><a href="#cb59-10" tabindex="-1"></a><span class="co">#&gt;               3                              5 (33.3%)   3 (20.0%)      2 (13.3%)   </span></span>
<span id="cb59-11"><a href="#cb59-11" tabindex="-1"></a><span class="co">#&gt;               4                              1 (6.7%)    2 (13.3%)          0       </span></span>
<span id="cb59-12"><a href="#cb59-12" tabindex="-1"></a><span class="co">#&gt;               Any                            9 (60.0%)   8 (53.3%)      5 (33.3%)   </span></span>
<span id="cb59-13"><a href="#cb59-13" tabindex="-1"></a><span class="co">#&gt;     HIGH                                                                            </span></span>
<span id="cb59-14"><a href="#cb59-14" tabindex="-1"></a><span class="co">#&gt;               1                              3 (20.0%)   2 (13.3%)      3 (20.0%)   </span></span>
<span id="cb59-15"><a href="#cb59-15" tabindex="-1"></a><span class="co">#&gt;               2                              2 (13.3%)       0          4 (26.7%)   </span></span>
<span id="cb59-16"><a href="#cb59-16" tabindex="-1"></a><span class="co">#&gt;               3                              1 (6.7%)     1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb59-17"><a href="#cb59-17" tabindex="-1"></a><span class="co">#&gt;               4                                  0        1 (6.7%)          0       </span></span>
<span id="cb59-18"><a href="#cb59-18" tabindex="-1"></a><span class="co">#&gt;               Any                            6 (40.0%)   4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb59-19"><a href="#cb59-19" tabindex="-1"></a><span class="co">#&gt;   C-Reactive Protein Measurement (n)            15           15             15      </span></span>
<span id="cb59-20"><a href="#cb59-20" tabindex="-1"></a><span class="co">#&gt;     LOW                                                                             </span></span>
<span id="cb59-21"><a href="#cb59-21" tabindex="-1"></a><span class="co">#&gt;               1                              2 (13.3%)    1 (6.7%)      3 (20.0%)   </span></span>
<span id="cb59-22"><a href="#cb59-22" tabindex="-1"></a><span class="co">#&gt;               2                                  0       2 (13.3%)      2 (13.3%)   </span></span>
<span id="cb59-23"><a href="#cb59-23" tabindex="-1"></a><span class="co">#&gt;               3                              2 (13.3%)       0          4 (26.7%)   </span></span>
<span id="cb59-24"><a href="#cb59-24" tabindex="-1"></a><span class="co">#&gt;               4                              1 (6.7%)        0           1 (6.7%)   </span></span>
<span id="cb59-25"><a href="#cb59-25" tabindex="-1"></a><span class="co">#&gt;               Any                            5 (33.3%)   3 (20.0%)      10 (66.7%)  </span></span>
<span id="cb59-26"><a href="#cb59-26" tabindex="-1"></a><span class="co">#&gt;     HIGH                                                                            </span></span>
<span id="cb59-27"><a href="#cb59-27" tabindex="-1"></a><span class="co">#&gt;               1                              1 (6.7%)        0              0       </span></span>
<span id="cb59-28"><a href="#cb59-28" tabindex="-1"></a><span class="co">#&gt;               2                              3 (20.0%)       0              0       </span></span>
<span id="cb59-29"><a href="#cb59-29" tabindex="-1"></a><span class="co">#&gt;               3                              1 (6.7%)        0           1 (6.7%)   </span></span>
<span id="cb59-30"><a href="#cb59-30" tabindex="-1"></a><span class="co">#&gt;               4                              1 (6.7%)     1 (6.7%)          0       </span></span>
<span id="cb59-31"><a href="#cb59-31" tabindex="-1"></a><span class="co">#&gt;               Any                            6 (40.0%)    1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb59-32"><a href="#cb59-32" tabindex="-1"></a><span class="co">#&gt;   Immunoglobulin A Measurement (n)              15           15             15      </span></span>
<span id="cb59-33"><a href="#cb59-33" tabindex="-1"></a><span class="co">#&gt;     LOW                                                                             </span></span>
<span id="cb59-34"><a href="#cb59-34" tabindex="-1"></a><span class="co">#&gt;               1                              2 (13.3%)    1 (6.7%)          0       </span></span>
<span id="cb59-35"><a href="#cb59-35" tabindex="-1"></a><span class="co">#&gt;               2                              1 (6.7%)     1 (6.7%)      2 (13.3%)   </span></span>
<span id="cb59-36"><a href="#cb59-36" tabindex="-1"></a><span class="co">#&gt;               3                              2 (13.3%)    1 (6.7%)      4 (26.7%)   </span></span>
<span id="cb59-37"><a href="#cb59-37" tabindex="-1"></a><span class="co">#&gt;               4                              1 (6.7%)    2 (13.3%)      2 (13.3%)   </span></span>
<span id="cb59-38"><a href="#cb59-38" tabindex="-1"></a><span class="co">#&gt;               Any                            6 (40.0%)   5 (33.3%)      8 (53.3%)   </span></span>
<span id="cb59-39"><a href="#cb59-39" tabindex="-1"></a><span class="co">#&gt;     HIGH                                                                            </span></span>
<span id="cb59-40"><a href="#cb59-40" tabindex="-1"></a><span class="co">#&gt;               1                              4 (26.7%)   2 (13.3%)          0       </span></span>
<span id="cb59-41"><a href="#cb59-41" tabindex="-1"></a><span class="co">#&gt;               2                              1 (6.7%)     1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb59-42"><a href="#cb59-42" tabindex="-1"></a><span class="co">#&gt;               3                              1 (6.7%)     1 (6.7%)          0       </span></span>
<span id="cb59-43"><a href="#cb59-43" tabindex="-1"></a><span class="co">#&gt;               4                                  0        1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb59-44"><a href="#cb59-44" tabindex="-1"></a><span class="co">#&gt;               Any                            6 (40.0%)   5 (33.3%)      2 (13.3%)</span></span></code></pre></div>
</div>
</div>
<div id="laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-lbt14" class="section level3">
<h3><strong>Laboratory Test Results Shift Table - Highest
<code>NCI-CTCAE</code> Grade Post-Baseline by Baseline
<code>NCI-CTCAE</code> Grade (<code>LBT14</code>)</strong></h3>
<div id="laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-high" class="section level4">
<h4><strong>1. Laboratory Test Results Shift Table - Highest
<code>NCI-CTCAE</code> Grade Post-Baseline by Baseline
<code>NCI-CTCAE</code> Grade (High)</strong></h4>
<p>To produce the standard laboratory test results shift table - highest
<code>NCI-CTCAE</code> grade post-baseline by baseline
<code>NCI-CTCAE</code> grade summary for high abnormalities, use the
<strong><code>lbt14</code></strong> template and set the parameter
<em><code>direction</code></em> to <code>high</code>.</p>
<div class="sourceCode" id="cb60"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb60-1"><a href="#cb60-1" tabindex="-1"></a><span class="fu">run</span>(lbt14, syn_data, <span class="at">direction =</span> <span class="st">&quot;high&quot;</span>)</span>
<span id="cb60-2"><a href="#cb60-2" tabindex="-1"></a><span class="co">#&gt;   Baseline Toxicity Grade                 A: Drug X   B: Placebo   C: Combination</span></span>
<span id="cb60-3"><a href="#cb60-3" tabindex="-1"></a><span class="co">#&gt;           Post-baseline NCI-CTCAE Grade    (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb60-4"><a href="#cb60-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb60-5"><a href="#cb60-5" tabindex="-1"></a><span class="co">#&gt;   Alanine Aminotransferase Measurement                                           </span></span>
<span id="cb60-6"><a href="#cb60-6" tabindex="-1"></a><span class="co">#&gt;     Not High                                 14           13             15      </span></span>
<span id="cb60-7"><a href="#cb60-7" tabindex="-1"></a><span class="co">#&gt;             Not High                      9 (60.0%)   9 (60.0%)      7 (46.7%)   </span></span>
<span id="cb60-8"><a href="#cb60-8" tabindex="-1"></a><span class="co">#&gt;             1                             2 (13.3%)   2 (13.3%)      3 (20.0%)   </span></span>
<span id="cb60-9"><a href="#cb60-9" tabindex="-1"></a><span class="co">#&gt;             2                             2 (13.3%)       0          4 (26.7%)   </span></span>
<span id="cb60-10"><a href="#cb60-10" tabindex="-1"></a><span class="co">#&gt;             3                             1 (6.7%)     1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb60-11"><a href="#cb60-11" tabindex="-1"></a><span class="co">#&gt;             4                                 0        1 (6.7%)          0       </span></span>
<span id="cb60-12"><a href="#cb60-12" tabindex="-1"></a><span class="co">#&gt;     1                                         1           0              0       </span></span>
<span id="cb60-13"><a href="#cb60-13" tabindex="-1"></a><span class="co">#&gt;             1                             1 (6.7%)        0              0       </span></span>
<span id="cb60-14"><a href="#cb60-14" tabindex="-1"></a><span class="co">#&gt;     2                                         0           1              0       </span></span>
<span id="cb60-15"><a href="#cb60-15" tabindex="-1"></a><span class="co">#&gt;             Not High                          0        1 (6.7%)          0       </span></span>
<span id="cb60-16"><a href="#cb60-16" tabindex="-1"></a><span class="co">#&gt;     3                                         0           1              0       </span></span>
<span id="cb60-17"><a href="#cb60-17" tabindex="-1"></a><span class="co">#&gt;             Not High                          0        1 (6.7%)          0       </span></span>
<span id="cb60-18"><a href="#cb60-18" tabindex="-1"></a><span class="co">#&gt;   C-Reactive Protein Measurement                                                 </span></span>
<span id="cb60-19"><a href="#cb60-19" tabindex="-1"></a><span class="co">#&gt;     Not High                                 13           13             13      </span></span>
<span id="cb60-20"><a href="#cb60-20" tabindex="-1"></a><span class="co">#&gt;             Not High                      7 (46.7%)   12 (80.0%)     12 (80.0%)  </span></span>
<span id="cb60-21"><a href="#cb60-21" tabindex="-1"></a><span class="co">#&gt;             1                             1 (6.7%)        0              0       </span></span>
<span id="cb60-22"><a href="#cb60-22" tabindex="-1"></a><span class="co">#&gt;             2                             3 (20.0%)       0              0       </span></span>
<span id="cb60-23"><a href="#cb60-23" tabindex="-1"></a><span class="co">#&gt;             3                             1 (6.7%)        0           1 (6.7%)   </span></span>
<span id="cb60-24"><a href="#cb60-24" tabindex="-1"></a><span class="co">#&gt;             4                             1 (6.7%)     1 (6.7%)          0       </span></span>
<span id="cb60-25"><a href="#cb60-25" tabindex="-1"></a><span class="co">#&gt;     1                                         1           1              1       </span></span>
<span id="cb60-26"><a href="#cb60-26" tabindex="-1"></a><span class="co">#&gt;             Not High                      1 (6.7%)     1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb60-27"><a href="#cb60-27" tabindex="-1"></a><span class="co">#&gt;     2                                         1           1              1       </span></span>
<span id="cb60-28"><a href="#cb60-28" tabindex="-1"></a><span class="co">#&gt;             Not High                      1 (6.7%)     1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb60-29"><a href="#cb60-29" tabindex="-1"></a><span class="co">#&gt;   Immunoglobulin A Measurement                                                   </span></span>
<span id="cb60-30"><a href="#cb60-30" tabindex="-1"></a><span class="co">#&gt;     Not High                                 12           15             13      </span></span>
<span id="cb60-31"><a href="#cb60-31" tabindex="-1"></a><span class="co">#&gt;             Not High                      6 (40.0%)   10 (66.7%)     11 (73.3%)  </span></span>
<span id="cb60-32"><a href="#cb60-32" tabindex="-1"></a><span class="co">#&gt;             1                             4 (26.7%)   2 (13.3%)          0       </span></span>
<span id="cb60-33"><a href="#cb60-33" tabindex="-1"></a><span class="co">#&gt;             2                             1 (6.7%)     1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb60-34"><a href="#cb60-34" tabindex="-1"></a><span class="co">#&gt;             3                             1 (6.7%)     1 (6.7%)          0       </span></span>
<span id="cb60-35"><a href="#cb60-35" tabindex="-1"></a><span class="co">#&gt;             4                                 0        1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb60-36"><a href="#cb60-36" tabindex="-1"></a><span class="co">#&gt;     1                                         1           0              2       </span></span>
<span id="cb60-37"><a href="#cb60-37" tabindex="-1"></a><span class="co">#&gt;             Not High                      1 (6.7%)        0          2 (13.3%)   </span></span>
<span id="cb60-38"><a href="#cb60-38" tabindex="-1"></a><span class="co">#&gt;     3                                         1           0              0       </span></span>
<span id="cb60-39"><a href="#cb60-39" tabindex="-1"></a><span class="co">#&gt;             Not High                      1 (6.7%)        0              0       </span></span>
<span id="cb60-40"><a href="#cb60-40" tabindex="-1"></a><span class="co">#&gt;     4                                         1           0              0       </span></span>
<span id="cb60-41"><a href="#cb60-41" tabindex="-1"></a><span class="co">#&gt;             Not High                      1 (6.7%)        0              0</span></span></code></pre></div>
</div>
<div id="laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-low" class="section level4">
<h4><strong>2. Laboratory Test Results Shift Table - Highest
<code>NCI-CTCAE</code> Grade Post-Baseline by Baseline
<code>NCI-CTCAE</code> Grade (Low)</strong></h4>
<p>To produce the standard laboratory test results shift table - highest
<code>NCI-CTCAE</code> grade post-baseline by baseline
<code>NCI-CTCAE</code> grade summary for high abnormalities, use the
<strong><code>lbt14</code></strong> template and the argument
<code>direction</code> is <code>low</code> by default.</p>
<div class="sourceCode" id="cb61"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb61-1"><a href="#cb61-1" tabindex="-1"></a><span class="fu">run</span>(lbt14, syn_data)</span>
<span id="cb61-2"><a href="#cb61-2" tabindex="-1"></a><span class="co">#&gt;   Baseline Toxicity Grade                 A: Drug X   B: Placebo   C: Combination</span></span>
<span id="cb61-3"><a href="#cb61-3" tabindex="-1"></a><span class="co">#&gt;           Post-baseline NCI-CTCAE Grade    (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb61-4"><a href="#cb61-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb61-5"><a href="#cb61-5" tabindex="-1"></a><span class="co">#&gt;   Alanine Aminotransferase Measurement                                           </span></span>
<span id="cb61-6"><a href="#cb61-6" tabindex="-1"></a><span class="co">#&gt;     Not Low                                  13           13             14      </span></span>
<span id="cb61-7"><a href="#cb61-7" tabindex="-1"></a><span class="co">#&gt;             Not Low                       6 (40.0%)   5 (33.3%)      9 (60.0%)   </span></span>
<span id="cb61-8"><a href="#cb61-8" tabindex="-1"></a><span class="co">#&gt;             1                             3 (20.0%)   2 (13.3%)      2 (13.3%)   </span></span>
<span id="cb61-9"><a href="#cb61-9" tabindex="-1"></a><span class="co">#&gt;             2                                 0        1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb61-10"><a href="#cb61-10" tabindex="-1"></a><span class="co">#&gt;             3                             3 (20.0%)   3 (20.0%)      2 (13.3%)   </span></span>
<span id="cb61-11"><a href="#cb61-11" tabindex="-1"></a><span class="co">#&gt;             4                             1 (6.7%)    2 (13.3%)          0       </span></span>
<span id="cb61-12"><a href="#cb61-12" tabindex="-1"></a><span class="co">#&gt;     1                                         1           1              0       </span></span>
<span id="cb61-13"><a href="#cb61-13" tabindex="-1"></a><span class="co">#&gt;             Not Low                           0        1 (6.7%)          0       </span></span>
<span id="cb61-14"><a href="#cb61-14" tabindex="-1"></a><span class="co">#&gt;             3                             1 (6.7%)        0              0       </span></span>
<span id="cb61-15"><a href="#cb61-15" tabindex="-1"></a><span class="co">#&gt;     2                                         0           0              1       </span></span>
<span id="cb61-16"><a href="#cb61-16" tabindex="-1"></a><span class="co">#&gt;             Not Low                           0           0           1 (6.7%)   </span></span>
<span id="cb61-17"><a href="#cb61-17" tabindex="-1"></a><span class="co">#&gt;     3                                         0           1              0       </span></span>
<span id="cb61-18"><a href="#cb61-18" tabindex="-1"></a><span class="co">#&gt;             Not Low                           0        1 (6.7%)          0       </span></span>
<span id="cb61-19"><a href="#cb61-19" tabindex="-1"></a><span class="co">#&gt;     4                                         1           0              0       </span></span>
<span id="cb61-20"><a href="#cb61-20" tabindex="-1"></a><span class="co">#&gt;             3                             1 (6.7%)        0              0       </span></span>
<span id="cb61-21"><a href="#cb61-21" tabindex="-1"></a><span class="co">#&gt;   C-Reactive Protein Measurement                                                 </span></span>
<span id="cb61-22"><a href="#cb61-22" tabindex="-1"></a><span class="co">#&gt;     Not Low                                  14           11             13      </span></span>
<span id="cb61-23"><a href="#cb61-23" tabindex="-1"></a><span class="co">#&gt;             Not Low                       9 (60.0%)   9 (60.0%)      4 (26.7%)   </span></span>
<span id="cb61-24"><a href="#cb61-24" tabindex="-1"></a><span class="co">#&gt;             1                             2 (13.3%)    1 (6.7%)      3 (20.0%)   </span></span>
<span id="cb61-25"><a href="#cb61-25" tabindex="-1"></a><span class="co">#&gt;             2                                 0        1 (6.7%)      2 (13.3%)   </span></span>
<span id="cb61-26"><a href="#cb61-26" tabindex="-1"></a><span class="co">#&gt;             3                             2 (13.3%)       0          3 (20.0%)   </span></span>
<span id="cb61-27"><a href="#cb61-27" tabindex="-1"></a><span class="co">#&gt;             4                             1 (6.7%)        0           1 (6.7%)   </span></span>
<span id="cb61-28"><a href="#cb61-28" tabindex="-1"></a><span class="co">#&gt;     1                                         0           1              0       </span></span>
<span id="cb61-29"><a href="#cb61-29" tabindex="-1"></a><span class="co">#&gt;             Not Low                           0        1 (6.7%)          0       </span></span>
<span id="cb61-30"><a href="#cb61-30" tabindex="-1"></a><span class="co">#&gt;     2                                         0           1              0       </span></span>
<span id="cb61-31"><a href="#cb61-31" tabindex="-1"></a><span class="co">#&gt;             2                                 0        1 (6.7%)          0       </span></span>
<span id="cb61-32"><a href="#cb61-32" tabindex="-1"></a><span class="co">#&gt;     3                                         1           1              1       </span></span>
<span id="cb61-33"><a href="#cb61-33" tabindex="-1"></a><span class="co">#&gt;             Not Low                       1 (6.7%)     1 (6.7%)          0       </span></span>
<span id="cb61-34"><a href="#cb61-34" tabindex="-1"></a><span class="co">#&gt;             3                                 0           0           1 (6.7%)   </span></span>
<span id="cb61-35"><a href="#cb61-35" tabindex="-1"></a><span class="co">#&gt;     4                                         0           1              1       </span></span>
<span id="cb61-36"><a href="#cb61-36" tabindex="-1"></a><span class="co">#&gt;             Not Low                           0        1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb61-37"><a href="#cb61-37" tabindex="-1"></a><span class="co">#&gt;   Immunoglobulin A Measurement                                                   </span></span>
<span id="cb61-38"><a href="#cb61-38" tabindex="-1"></a><span class="co">#&gt;     Not Low                                  13           14             13      </span></span>
<span id="cb61-39"><a href="#cb61-39" tabindex="-1"></a><span class="co">#&gt;             Not Low                       7 (46.7%)   10 (66.7%)     7 (46.7%)   </span></span>
<span id="cb61-40"><a href="#cb61-40" tabindex="-1"></a><span class="co">#&gt;             1                             2 (13.3%)    1 (6.7%)          0       </span></span>
<span id="cb61-41"><a href="#cb61-41" tabindex="-1"></a><span class="co">#&gt;             2                             1 (6.7%)        0          2 (13.3%)   </span></span>
<span id="cb61-42"><a href="#cb61-42" tabindex="-1"></a><span class="co">#&gt;             3                             2 (13.3%)    1 (6.7%)      4 (26.7%)   </span></span>
<span id="cb61-43"><a href="#cb61-43" tabindex="-1"></a><span class="co">#&gt;             4                             1 (6.7%)    2 (13.3%)          0       </span></span>
<span id="cb61-44"><a href="#cb61-44" tabindex="-1"></a><span class="co">#&gt;     1                                         1           1              0       </span></span>
<span id="cb61-45"><a href="#cb61-45" tabindex="-1"></a><span class="co">#&gt;             Not Low                       1 (6.7%)        0              0       </span></span>
<span id="cb61-46"><a href="#cb61-46" tabindex="-1"></a><span class="co">#&gt;             2                                 0        1 (6.7%)          0       </span></span>
<span id="cb61-47"><a href="#cb61-47" tabindex="-1"></a><span class="co">#&gt;     3                                         1           0              1       </span></span>
<span id="cb61-48"><a href="#cb61-48" tabindex="-1"></a><span class="co">#&gt;             Not Low                       1 (6.7%)        0              0       </span></span>
<span id="cb61-49"><a href="#cb61-49" tabindex="-1"></a><span class="co">#&gt;             4                                 0           0           1 (6.7%)   </span></span>
<span id="cb61-50"><a href="#cb61-50" tabindex="-1"></a><span class="co">#&gt;     4                                         0           0              1       </span></span>
<span id="cb61-51"><a href="#cb61-51" tabindex="-1"></a><span class="co">#&gt;             4                                 0           0           1 (6.7%)</span></span></code></pre></div>
</div>
<div id="laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-high-without-patients-with-missing-baseline" class="section level4">
<h4><strong>3. Laboratory Test Results Shift Table - Highest
<code>NCI-CTCAE</code> Grade Post-Baseline by Baseline
<code>NCI-CTCAE</code> Grade (High) Without Patients with Missing
Baseline</strong></h4>
<p>To exclude patients with missing baseline grade, set the argument
<code>gr_missing</code> to <code>excl</code>.</p>
<div class="sourceCode" id="cb62"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb62-1"><a href="#cb62-1" tabindex="-1"></a><span class="fu">run</span>(lbt14, syn_data, <span class="at">direction =</span> <span class="st">&quot;high&quot;</span>, <span class="at">gr_missing =</span> <span class="st">&quot;excl&quot;</span>)</span>
<span id="cb62-2"><a href="#cb62-2" tabindex="-1"></a><span class="co">#&gt;   Baseline Toxicity Grade                 A: Drug X   B: Placebo   C: Combination</span></span>
<span id="cb62-3"><a href="#cb62-3" tabindex="-1"></a><span class="co">#&gt;           Post-baseline NCI-CTCAE Grade    (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb62-4"><a href="#cb62-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb62-5"><a href="#cb62-5" tabindex="-1"></a><span class="co">#&gt;   Alanine Aminotransferase Measurement                                           </span></span>
<span id="cb62-6"><a href="#cb62-6" tabindex="-1"></a><span class="co">#&gt;     Not High                                 14           13             15      </span></span>
<span id="cb62-7"><a href="#cb62-7" tabindex="-1"></a><span class="co">#&gt;             Not High                      9 (60.0%)   9 (60.0%)      7 (46.7%)   </span></span>
<span id="cb62-8"><a href="#cb62-8" tabindex="-1"></a><span class="co">#&gt;             1                             2 (13.3%)   2 (13.3%)      3 (20.0%)   </span></span>
<span id="cb62-9"><a href="#cb62-9" tabindex="-1"></a><span class="co">#&gt;             2                             2 (13.3%)       0          4 (26.7%)   </span></span>
<span id="cb62-10"><a href="#cb62-10" tabindex="-1"></a><span class="co">#&gt;             3                             1 (6.7%)     1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb62-11"><a href="#cb62-11" tabindex="-1"></a><span class="co">#&gt;             4                                 0        1 (6.7%)          0       </span></span>
<span id="cb62-12"><a href="#cb62-12" tabindex="-1"></a><span class="co">#&gt;     1                                         1           0              0       </span></span>
<span id="cb62-13"><a href="#cb62-13" tabindex="-1"></a><span class="co">#&gt;             1                             1 (6.7%)        0              0       </span></span>
<span id="cb62-14"><a href="#cb62-14" tabindex="-1"></a><span class="co">#&gt;     2                                         0           1              0       </span></span>
<span id="cb62-15"><a href="#cb62-15" tabindex="-1"></a><span class="co">#&gt;             Not High                          0        1 (6.7%)          0       </span></span>
<span id="cb62-16"><a href="#cb62-16" tabindex="-1"></a><span class="co">#&gt;     3                                         0           1              0       </span></span>
<span id="cb62-17"><a href="#cb62-17" tabindex="-1"></a><span class="co">#&gt;             Not High                          0        1 (6.7%)          0       </span></span>
<span id="cb62-18"><a href="#cb62-18" tabindex="-1"></a><span class="co">#&gt;   C-Reactive Protein Measurement                                                 </span></span>
<span id="cb62-19"><a href="#cb62-19" tabindex="-1"></a><span class="co">#&gt;     Not High                                 13           13             13      </span></span>
<span id="cb62-20"><a href="#cb62-20" tabindex="-1"></a><span class="co">#&gt;             Not High                      7 (46.7%)   12 (80.0%)     12 (80.0%)  </span></span>
<span id="cb62-21"><a href="#cb62-21" tabindex="-1"></a><span class="co">#&gt;             1                             1 (6.7%)        0              0       </span></span>
<span id="cb62-22"><a href="#cb62-22" tabindex="-1"></a><span class="co">#&gt;             2                             3 (20.0%)       0              0       </span></span>
<span id="cb62-23"><a href="#cb62-23" tabindex="-1"></a><span class="co">#&gt;             3                             1 (6.7%)        0           1 (6.7%)   </span></span>
<span id="cb62-24"><a href="#cb62-24" tabindex="-1"></a><span class="co">#&gt;             4                             1 (6.7%)     1 (6.7%)          0       </span></span>
<span id="cb62-25"><a href="#cb62-25" tabindex="-1"></a><span class="co">#&gt;     1                                         1           1              1       </span></span>
<span id="cb62-26"><a href="#cb62-26" tabindex="-1"></a><span class="co">#&gt;             Not High                      1 (6.7%)     1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb62-27"><a href="#cb62-27" tabindex="-1"></a><span class="co">#&gt;     2                                         1           1              1       </span></span>
<span id="cb62-28"><a href="#cb62-28" tabindex="-1"></a><span class="co">#&gt;             Not High                      1 (6.7%)     1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb62-29"><a href="#cb62-29" tabindex="-1"></a><span class="co">#&gt;   Immunoglobulin A Measurement                                                   </span></span>
<span id="cb62-30"><a href="#cb62-30" tabindex="-1"></a><span class="co">#&gt;     Not High                                 12           15             13      </span></span>
<span id="cb62-31"><a href="#cb62-31" tabindex="-1"></a><span class="co">#&gt;             Not High                      6 (40.0%)   10 (66.7%)     11 (73.3%)  </span></span>
<span id="cb62-32"><a href="#cb62-32" tabindex="-1"></a><span class="co">#&gt;             1                             4 (26.7%)   2 (13.3%)          0       </span></span>
<span id="cb62-33"><a href="#cb62-33" tabindex="-1"></a><span class="co">#&gt;             2                             1 (6.7%)     1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb62-34"><a href="#cb62-34" tabindex="-1"></a><span class="co">#&gt;             3                             1 (6.7%)     1 (6.7%)          0       </span></span>
<span id="cb62-35"><a href="#cb62-35" tabindex="-1"></a><span class="co">#&gt;             4                                 0        1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb62-36"><a href="#cb62-36" tabindex="-1"></a><span class="co">#&gt;     1                                         1           0              2       </span></span>
<span id="cb62-37"><a href="#cb62-37" tabindex="-1"></a><span class="co">#&gt;             Not High                      1 (6.7%)        0          2 (13.3%)   </span></span>
<span id="cb62-38"><a href="#cb62-38" tabindex="-1"></a><span class="co">#&gt;     3                                         1           0              0       </span></span>
<span id="cb62-39"><a href="#cb62-39" tabindex="-1"></a><span class="co">#&gt;             Not High                      1 (6.7%)        0              0       </span></span>
<span id="cb62-40"><a href="#cb62-40" tabindex="-1"></a><span class="co">#&gt;     4                                         1           0              0       </span></span>
<span id="cb62-41"><a href="#cb62-41" tabindex="-1"></a><span class="co">#&gt;             Not High                      1 (6.7%)        0              0</span></span></code></pre></div>
</div>
<div id="laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-low-with-missing-baseline-considered-as-grade-0" class="section level4">
<h4><strong>4. Laboratory Test Results Shift Table - Highest
<code>NCI-CTCAE</code> Grade Post-Baseline by Baseline
<code>NCI-CTCAE</code> Grade (Low) with Missing Baseline Considered as
Grade 0</strong></h4>
<p>To count patients with missing baseline grade as grade 0, set the
argument <code>gr_missing</code> to <code>gr_0</code>.</p>
<div class="sourceCode" id="cb63"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb63-1"><a href="#cb63-1" tabindex="-1"></a><span class="fu">run</span>(lbt14, syn_data, <span class="at">gr_missing =</span> <span class="st">&quot;gr_0&quot;</span>)</span>
<span id="cb63-2"><a href="#cb63-2" tabindex="-1"></a><span class="co">#&gt;   Baseline Toxicity Grade                 A: Drug X   B: Placebo   C: Combination</span></span>
<span id="cb63-3"><a href="#cb63-3" tabindex="-1"></a><span class="co">#&gt;           Post-baseline NCI-CTCAE Grade    (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb63-4"><a href="#cb63-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb63-5"><a href="#cb63-5" tabindex="-1"></a><span class="co">#&gt;   Alanine Aminotransferase Measurement                                           </span></span>
<span id="cb63-6"><a href="#cb63-6" tabindex="-1"></a><span class="co">#&gt;     1                                         1           1              0       </span></span>
<span id="cb63-7"><a href="#cb63-7" tabindex="-1"></a><span class="co">#&gt;             Not Low                           0        1 (6.7%)          0       </span></span>
<span id="cb63-8"><a href="#cb63-8" tabindex="-1"></a><span class="co">#&gt;             3                             1 (6.7%)        0              0       </span></span>
<span id="cb63-9"><a href="#cb63-9" tabindex="-1"></a><span class="co">#&gt;     2                                         0           0              1       </span></span>
<span id="cb63-10"><a href="#cb63-10" tabindex="-1"></a><span class="co">#&gt;             1                                 0           0           1 (6.7%)   </span></span>
<span id="cb63-11"><a href="#cb63-11" tabindex="-1"></a><span class="co">#&gt;     3                                         0           1              0       </span></span>
<span id="cb63-12"><a href="#cb63-12" tabindex="-1"></a><span class="co">#&gt;             1                                 0        1 (6.7%)          0       </span></span>
<span id="cb63-13"><a href="#cb63-13" tabindex="-1"></a><span class="co">#&gt;     4                                         1           0              0       </span></span>
<span id="cb63-14"><a href="#cb63-14" tabindex="-1"></a><span class="co">#&gt;             3                             1 (6.7%)        0              0       </span></span>
<span id="cb63-15"><a href="#cb63-15" tabindex="-1"></a><span class="co">#&gt;     Not Low                                  13           13             14      </span></span>
<span id="cb63-16"><a href="#cb63-16" tabindex="-1"></a><span class="co">#&gt;             Not Low                       6 (40.0%)   5 (33.3%)      9 (60.0%)   </span></span>
<span id="cb63-17"><a href="#cb63-17" tabindex="-1"></a><span class="co">#&gt;             1                             3 (20.0%)   2 (13.3%)      2 (13.3%)   </span></span>
<span id="cb63-18"><a href="#cb63-18" tabindex="-1"></a><span class="co">#&gt;             2                                 0        1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb63-19"><a href="#cb63-19" tabindex="-1"></a><span class="co">#&gt;             3                             3 (20.0%)   3 (20.0%)      2 (13.3%)   </span></span>
<span id="cb63-20"><a href="#cb63-20" tabindex="-1"></a><span class="co">#&gt;             4                             1 (6.7%)    2 (13.3%)          0       </span></span>
<span id="cb63-21"><a href="#cb63-21" tabindex="-1"></a><span class="co">#&gt;   C-Reactive Protein Measurement                                                 </span></span>
<span id="cb63-22"><a href="#cb63-22" tabindex="-1"></a><span class="co">#&gt;     1                                         0           1              0       </span></span>
<span id="cb63-23"><a href="#cb63-23" tabindex="-1"></a><span class="co">#&gt;             1                                 0        1 (6.7%)          0       </span></span>
<span id="cb63-24"><a href="#cb63-24" tabindex="-1"></a><span class="co">#&gt;     2                                         0           1              0       </span></span>
<span id="cb63-25"><a href="#cb63-25" tabindex="-1"></a><span class="co">#&gt;             3                                 0        1 (6.7%)          0       </span></span>
<span id="cb63-26"><a href="#cb63-26" tabindex="-1"></a><span class="co">#&gt;     3                                         1           1              1       </span></span>
<span id="cb63-27"><a href="#cb63-27" tabindex="-1"></a><span class="co">#&gt;             Not Low                       1 (6.7%)     1 (6.7%)          0       </span></span>
<span id="cb63-28"><a href="#cb63-28" tabindex="-1"></a><span class="co">#&gt;             3                                 0           0           1 (6.7%)   </span></span>
<span id="cb63-29"><a href="#cb63-29" tabindex="-1"></a><span class="co">#&gt;     4                                         0           1              1       </span></span>
<span id="cb63-30"><a href="#cb63-30" tabindex="-1"></a><span class="co">#&gt;             1                                 0        1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb63-31"><a href="#cb63-31" tabindex="-1"></a><span class="co">#&gt;     Not Low                                  14           11             13      </span></span>
<span id="cb63-32"><a href="#cb63-32" tabindex="-1"></a><span class="co">#&gt;             Not Low                       9 (60.0%)   9 (60.0%)      4 (26.7%)   </span></span>
<span id="cb63-33"><a href="#cb63-33" tabindex="-1"></a><span class="co">#&gt;             1                             2 (13.3%)    1 (6.7%)      3 (20.0%)   </span></span>
<span id="cb63-34"><a href="#cb63-34" tabindex="-1"></a><span class="co">#&gt;             2                                 0        1 (6.7%)      2 (13.3%)   </span></span>
<span id="cb63-35"><a href="#cb63-35" tabindex="-1"></a><span class="co">#&gt;             3                             2 (13.3%)       0          3 (20.0%)   </span></span>
<span id="cb63-36"><a href="#cb63-36" tabindex="-1"></a><span class="co">#&gt;             4                             1 (6.7%)        0           1 (6.7%)   </span></span>
<span id="cb63-37"><a href="#cb63-37" tabindex="-1"></a><span class="co">#&gt;   Immunoglobulin A Measurement                                                   </span></span>
<span id="cb63-38"><a href="#cb63-38" tabindex="-1"></a><span class="co">#&gt;     1                                         1           1              0       </span></span>
<span id="cb63-39"><a href="#cb63-39" tabindex="-1"></a><span class="co">#&gt;             Not Low                       1 (6.7%)        0              0       </span></span>
<span id="cb63-40"><a href="#cb63-40" tabindex="-1"></a><span class="co">#&gt;             2                                 0        1 (6.7%)          0       </span></span>
<span id="cb63-41"><a href="#cb63-41" tabindex="-1"></a><span class="co">#&gt;     3                                         1           0              1       </span></span>
<span id="cb63-42"><a href="#cb63-42" tabindex="-1"></a><span class="co">#&gt;             Not Low                       1 (6.7%)        0              0       </span></span>
<span id="cb63-43"><a href="#cb63-43" tabindex="-1"></a><span class="co">#&gt;             4                                 0           0           1 (6.7%)   </span></span>
<span id="cb63-44"><a href="#cb63-44" tabindex="-1"></a><span class="co">#&gt;     4                                         0           0              1       </span></span>
<span id="cb63-45"><a href="#cb63-45" tabindex="-1"></a><span class="co">#&gt;             Not Low                           0           0           1 (6.7%)   </span></span>
<span id="cb63-46"><a href="#cb63-46" tabindex="-1"></a><span class="co">#&gt;     Not Low                                  13           14             13      </span></span>
<span id="cb63-47"><a href="#cb63-47" tabindex="-1"></a><span class="co">#&gt;             Not Low                       7 (46.7%)   10 (66.7%)     7 (46.7%)   </span></span>
<span id="cb63-48"><a href="#cb63-48" tabindex="-1"></a><span class="co">#&gt;             1                             2 (13.3%)    1 (6.7%)          0       </span></span>
<span id="cb63-49"><a href="#cb63-49" tabindex="-1"></a><span class="co">#&gt;             2                             1 (6.7%)        0          2 (13.3%)   </span></span>
<span id="cb63-50"><a href="#cb63-50" tabindex="-1"></a><span class="co">#&gt;             3                             2 (13.3%)    1 (6.7%)      4 (26.7%)   </span></span>
<span id="cb63-51"><a href="#cb63-51" tabindex="-1"></a><span class="co">#&gt;             4                             1 (6.7%)    2 (13.3%)          0</span></span></code></pre></div>
</div>
<div id="laboratory-test-results-shift-table---highest-nci-ctcae-grade-post-baseline-by-baseline-nci-ctcae-grade-with-fill-in-of-grades" class="section level4">
<h4><strong>4. Laboratory Test Results Shift Table - Highest
<code>NCI-CTCAE</code> Grade Post-Baseline by Baseline
<code>NCI-CTCAE</code> Grade (with fill in of grades)</strong></h4>
<p>To display all possible grades even if they do not occur in the data,
set the argument <code>prune_0</code> to <code>FALSE</code>.</p>
<div class="sourceCode" id="cb64"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb64-1"><a href="#cb64-1" tabindex="-1"></a><span class="fu">run</span>(lbt14, syn_data, <span class="at">direction =</span> <span class="st">&quot;high&quot;</span>, <span class="at">prune_0 =</span> <span class="cn">FALSE</span>)</span>
<span id="cb64-2"><a href="#cb64-2" tabindex="-1"></a><span class="co">#&gt;   Baseline Toxicity Grade                 A: Drug X   B: Placebo   C: Combination</span></span>
<span id="cb64-3"><a href="#cb64-3" tabindex="-1"></a><span class="co">#&gt;           Post-baseline NCI-CTCAE Grade    (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb64-4"><a href="#cb64-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb64-5"><a href="#cb64-5" tabindex="-1"></a><span class="co">#&gt;   Alanine Aminotransferase Measurement                                           </span></span>
<span id="cb64-6"><a href="#cb64-6" tabindex="-1"></a><span class="co">#&gt;     Not High                                 14           13             15      </span></span>
<span id="cb64-7"><a href="#cb64-7" tabindex="-1"></a><span class="co">#&gt;             Not High                      9 (60.0%)   9 (60.0%)      7 (46.7%)   </span></span>
<span id="cb64-8"><a href="#cb64-8" tabindex="-1"></a><span class="co">#&gt;             1                             2 (13.3%)   2 (13.3%)      3 (20.0%)   </span></span>
<span id="cb64-9"><a href="#cb64-9" tabindex="-1"></a><span class="co">#&gt;             2                             2 (13.3%)       0          4 (26.7%)   </span></span>
<span id="cb64-10"><a href="#cb64-10" tabindex="-1"></a><span class="co">#&gt;             3                             1 (6.7%)     1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb64-11"><a href="#cb64-11" tabindex="-1"></a><span class="co">#&gt;             4                                 0        1 (6.7%)          0       </span></span>
<span id="cb64-12"><a href="#cb64-12" tabindex="-1"></a><span class="co">#&gt;             Missing                           0           0              0       </span></span>
<span id="cb64-13"><a href="#cb64-13" tabindex="-1"></a><span class="co">#&gt;     1                                         1           0              0       </span></span>
<span id="cb64-14"><a href="#cb64-14" tabindex="-1"></a><span class="co">#&gt;             Not High                          0           0              0       </span></span>
<span id="cb64-15"><a href="#cb64-15" tabindex="-1"></a><span class="co">#&gt;             1                             1 (6.7%)        0              0       </span></span>
<span id="cb64-16"><a href="#cb64-16" tabindex="-1"></a><span class="co">#&gt;             2                                 0           0              0       </span></span>
<span id="cb64-17"><a href="#cb64-17" tabindex="-1"></a><span class="co">#&gt;             3                                 0           0              0       </span></span>
<span id="cb64-18"><a href="#cb64-18" tabindex="-1"></a><span class="co">#&gt;             4                                 0           0              0       </span></span>
<span id="cb64-19"><a href="#cb64-19" tabindex="-1"></a><span class="co">#&gt;             Missing                           0           0              0       </span></span>
<span id="cb64-20"><a href="#cb64-20" tabindex="-1"></a><span class="co">#&gt;     2                                         0           1              0       </span></span>
<span id="cb64-21"><a href="#cb64-21" tabindex="-1"></a><span class="co">#&gt;             Not High                          0        1 (6.7%)          0       </span></span>
<span id="cb64-22"><a href="#cb64-22" tabindex="-1"></a><span class="co">#&gt;             1                                 0           0              0       </span></span>
<span id="cb64-23"><a href="#cb64-23" tabindex="-1"></a><span class="co">#&gt;             2                                 0           0              0       </span></span>
<span id="cb64-24"><a href="#cb64-24" tabindex="-1"></a><span class="co">#&gt;             3                                 0           0              0       </span></span>
<span id="cb64-25"><a href="#cb64-25" tabindex="-1"></a><span class="co">#&gt;             4                                 0           0              0       </span></span>
<span id="cb64-26"><a href="#cb64-26" tabindex="-1"></a><span class="co">#&gt;             Missing                           0           0              0       </span></span>
<span id="cb64-27"><a href="#cb64-27" tabindex="-1"></a><span class="co">#&gt;     3                                         0           1              0       </span></span>
<span id="cb64-28"><a href="#cb64-28" tabindex="-1"></a><span class="co">#&gt;             Not High                          0        1 (6.7%)          0       </span></span>
<span id="cb64-29"><a href="#cb64-29" tabindex="-1"></a><span class="co">#&gt;             1                                 0           0              0       </span></span>
<span id="cb64-30"><a href="#cb64-30" tabindex="-1"></a><span class="co">#&gt;             2                                 0           0              0       </span></span>
<span id="cb64-31"><a href="#cb64-31" tabindex="-1"></a><span class="co">#&gt;             3                                 0           0              0       </span></span>
<span id="cb64-32"><a href="#cb64-32" tabindex="-1"></a><span class="co">#&gt;             4                                 0           0              0       </span></span>
<span id="cb64-33"><a href="#cb64-33" tabindex="-1"></a><span class="co">#&gt;             Missing                           0           0              0       </span></span>
<span id="cb64-34"><a href="#cb64-34" tabindex="-1"></a><span class="co">#&gt;     4                                         0           0              0       </span></span>
<span id="cb64-35"><a href="#cb64-35" tabindex="-1"></a><span class="co">#&gt;             Not High                          0           0              0       </span></span>
<span id="cb64-36"><a href="#cb64-36" tabindex="-1"></a><span class="co">#&gt;             1                                 0           0              0       </span></span>
<span id="cb64-37"><a href="#cb64-37" tabindex="-1"></a><span class="co">#&gt;             2                                 0           0              0       </span></span>
<span id="cb64-38"><a href="#cb64-38" tabindex="-1"></a><span class="co">#&gt;             3                                 0           0              0       </span></span>
<span id="cb64-39"><a href="#cb64-39" tabindex="-1"></a><span class="co">#&gt;             4                                 0           0              0       </span></span>
<span id="cb64-40"><a href="#cb64-40" tabindex="-1"></a><span class="co">#&gt;             Missing                           0           0              0       </span></span>
<span id="cb64-41"><a href="#cb64-41" tabindex="-1"></a><span class="co">#&gt;     Missing                                   0           0              0       </span></span>
<span id="cb64-42"><a href="#cb64-42" tabindex="-1"></a><span class="co">#&gt;             Not High                          0           0              0       </span></span>
<span id="cb64-43"><a href="#cb64-43" tabindex="-1"></a><span class="co">#&gt;             1                                 0           0              0       </span></span>
<span id="cb64-44"><a href="#cb64-44" tabindex="-1"></a><span class="co">#&gt;             2                                 0           0              0       </span></span>
<span id="cb64-45"><a href="#cb64-45" tabindex="-1"></a><span class="co">#&gt;             3                                 0           0              0       </span></span>
<span id="cb64-46"><a href="#cb64-46" tabindex="-1"></a><span class="co">#&gt;             4                                 0           0              0       </span></span>
<span id="cb64-47"><a href="#cb64-47" tabindex="-1"></a><span class="co">#&gt;             Missing                           0           0              0       </span></span>
<span id="cb64-48"><a href="#cb64-48" tabindex="-1"></a><span class="co">#&gt;   C-Reactive Protein Measurement                                                 </span></span>
<span id="cb64-49"><a href="#cb64-49" tabindex="-1"></a><span class="co">#&gt;     Not High                                 13           13             13      </span></span>
<span id="cb64-50"><a href="#cb64-50" tabindex="-1"></a><span class="co">#&gt;             Not High                      7 (46.7%)   12 (80.0%)     12 (80.0%)  </span></span>
<span id="cb64-51"><a href="#cb64-51" tabindex="-1"></a><span class="co">#&gt;             1                             1 (6.7%)        0              0       </span></span>
<span id="cb64-52"><a href="#cb64-52" tabindex="-1"></a><span class="co">#&gt;             2                             3 (20.0%)       0              0       </span></span>
<span id="cb64-53"><a href="#cb64-53" tabindex="-1"></a><span class="co">#&gt;             3                             1 (6.7%)        0           1 (6.7%)   </span></span>
<span id="cb64-54"><a href="#cb64-54" tabindex="-1"></a><span class="co">#&gt;             4                             1 (6.7%)     1 (6.7%)          0       </span></span>
<span id="cb64-55"><a href="#cb64-55" tabindex="-1"></a><span class="co">#&gt;             Missing                           0           0              0       </span></span>
<span id="cb64-56"><a href="#cb64-56" tabindex="-1"></a><span class="co">#&gt;     1                                         1           1              1       </span></span>
<span id="cb64-57"><a href="#cb64-57" tabindex="-1"></a><span class="co">#&gt;             Not High                      1 (6.7%)     1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb64-58"><a href="#cb64-58" tabindex="-1"></a><span class="co">#&gt;             1                                 0           0              0       </span></span>
<span id="cb64-59"><a href="#cb64-59" tabindex="-1"></a><span class="co">#&gt;             2                                 0           0              0       </span></span>
<span id="cb64-60"><a href="#cb64-60" tabindex="-1"></a><span class="co">#&gt;             3                                 0           0              0       </span></span>
<span id="cb64-61"><a href="#cb64-61" tabindex="-1"></a><span class="co">#&gt;             4                                 0           0              0       </span></span>
<span id="cb64-62"><a href="#cb64-62" tabindex="-1"></a><span class="co">#&gt;             Missing                           0           0              0       </span></span>
<span id="cb64-63"><a href="#cb64-63" tabindex="-1"></a><span class="co">#&gt;     2                                         1           1              1       </span></span>
<span id="cb64-64"><a href="#cb64-64" tabindex="-1"></a><span class="co">#&gt;             Not High                      1 (6.7%)     1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb64-65"><a href="#cb64-65" tabindex="-1"></a><span class="co">#&gt;             1                                 0           0              0       </span></span>
<span id="cb64-66"><a href="#cb64-66" tabindex="-1"></a><span class="co">#&gt;             2                                 0           0              0       </span></span>
<span id="cb64-67"><a href="#cb64-67" tabindex="-1"></a><span class="co">#&gt;             3                                 0           0              0       </span></span>
<span id="cb64-68"><a href="#cb64-68" tabindex="-1"></a><span class="co">#&gt;             4                                 0           0              0       </span></span>
<span id="cb64-69"><a href="#cb64-69" tabindex="-1"></a><span class="co">#&gt;             Missing                           0           0              0       </span></span>
<span id="cb64-70"><a href="#cb64-70" tabindex="-1"></a><span class="co">#&gt;     3                                         0           0              0       </span></span>
<span id="cb64-71"><a href="#cb64-71" tabindex="-1"></a><span class="co">#&gt;             Not High                          0           0              0       </span></span>
<span id="cb64-72"><a href="#cb64-72" tabindex="-1"></a><span class="co">#&gt;             1                                 0           0              0       </span></span>
<span id="cb64-73"><a href="#cb64-73" tabindex="-1"></a><span class="co">#&gt;             2                                 0           0              0       </span></span>
<span id="cb64-74"><a href="#cb64-74" tabindex="-1"></a><span class="co">#&gt;             3                                 0           0              0       </span></span>
<span id="cb64-75"><a href="#cb64-75" tabindex="-1"></a><span class="co">#&gt;             4                                 0           0              0       </span></span>
<span id="cb64-76"><a href="#cb64-76" tabindex="-1"></a><span class="co">#&gt;             Missing                           0           0              0       </span></span>
<span id="cb64-77"><a href="#cb64-77" tabindex="-1"></a><span class="co">#&gt;     4                                         0           0              0       </span></span>
<span id="cb64-78"><a href="#cb64-78" tabindex="-1"></a><span class="co">#&gt;             Not High                          0           0              0       </span></span>
<span id="cb64-79"><a href="#cb64-79" tabindex="-1"></a><span class="co">#&gt;             1                                 0           0              0       </span></span>
<span id="cb64-80"><a href="#cb64-80" tabindex="-1"></a><span class="co">#&gt;             2                                 0           0              0       </span></span>
<span id="cb64-81"><a href="#cb64-81" tabindex="-1"></a><span class="co">#&gt;             3                                 0           0              0       </span></span>
<span id="cb64-82"><a href="#cb64-82" tabindex="-1"></a><span class="co">#&gt;             4                                 0           0              0       </span></span>
<span id="cb64-83"><a href="#cb64-83" tabindex="-1"></a><span class="co">#&gt;             Missing                           0           0              0       </span></span>
<span id="cb64-84"><a href="#cb64-84" tabindex="-1"></a><span class="co">#&gt;     Missing                                   0           0              0       </span></span>
<span id="cb64-85"><a href="#cb64-85" tabindex="-1"></a><span class="co">#&gt;             Not High                          0           0              0       </span></span>
<span id="cb64-86"><a href="#cb64-86" tabindex="-1"></a><span class="co">#&gt;             1                                 0           0              0       </span></span>
<span id="cb64-87"><a href="#cb64-87" tabindex="-1"></a><span class="co">#&gt;             2                                 0           0              0       </span></span>
<span id="cb64-88"><a href="#cb64-88" tabindex="-1"></a><span class="co">#&gt;             3                                 0           0              0       </span></span>
<span id="cb64-89"><a href="#cb64-89" tabindex="-1"></a><span class="co">#&gt;             4                                 0           0              0       </span></span>
<span id="cb64-90"><a href="#cb64-90" tabindex="-1"></a><span class="co">#&gt;             Missing                           0           0              0       </span></span>
<span id="cb64-91"><a href="#cb64-91" tabindex="-1"></a><span class="co">#&gt;   Immunoglobulin A Measurement                                                   </span></span>
<span id="cb64-92"><a href="#cb64-92" tabindex="-1"></a><span class="co">#&gt;     Not High                                 12           15             13      </span></span>
<span id="cb64-93"><a href="#cb64-93" tabindex="-1"></a><span class="co">#&gt;             Not High                      6 (40.0%)   10 (66.7%)     11 (73.3%)  </span></span>
<span id="cb64-94"><a href="#cb64-94" tabindex="-1"></a><span class="co">#&gt;             1                             4 (26.7%)   2 (13.3%)          0       </span></span>
<span id="cb64-95"><a href="#cb64-95" tabindex="-1"></a><span class="co">#&gt;             2                             1 (6.7%)     1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb64-96"><a href="#cb64-96" tabindex="-1"></a><span class="co">#&gt;             3                             1 (6.7%)     1 (6.7%)          0       </span></span>
<span id="cb64-97"><a href="#cb64-97" tabindex="-1"></a><span class="co">#&gt;             4                                 0        1 (6.7%)       1 (6.7%)   </span></span>
<span id="cb64-98"><a href="#cb64-98" tabindex="-1"></a><span class="co">#&gt;             Missing                           0           0              0       </span></span>
<span id="cb64-99"><a href="#cb64-99" tabindex="-1"></a><span class="co">#&gt;     1                                         1           0              2       </span></span>
<span id="cb64-100"><a href="#cb64-100" tabindex="-1"></a><span class="co">#&gt;             Not High                      1 (6.7%)        0          2 (13.3%)   </span></span>
<span id="cb64-101"><a href="#cb64-101" tabindex="-1"></a><span class="co">#&gt;             1                                 0           0              0       </span></span>
<span id="cb64-102"><a href="#cb64-102" tabindex="-1"></a><span class="co">#&gt;             2                                 0           0              0       </span></span>
<span id="cb64-103"><a href="#cb64-103" tabindex="-1"></a><span class="co">#&gt;             3                                 0           0              0       </span></span>
<span id="cb64-104"><a href="#cb64-104" tabindex="-1"></a><span class="co">#&gt;             4                                 0           0              0       </span></span>
<span id="cb64-105"><a href="#cb64-105" tabindex="-1"></a><span class="co">#&gt;             Missing                           0           0              0       </span></span>
<span id="cb64-106"><a href="#cb64-106" tabindex="-1"></a><span class="co">#&gt;     2                                         0           0              0       </span></span>
<span id="cb64-107"><a href="#cb64-107" tabindex="-1"></a><span class="co">#&gt;             Not High                          0           0              0       </span></span>
<span id="cb64-108"><a href="#cb64-108" tabindex="-1"></a><span class="co">#&gt;             1                                 0           0              0       </span></span>
<span id="cb64-109"><a href="#cb64-109" tabindex="-1"></a><span class="co">#&gt;             2                                 0           0              0       </span></span>
<span id="cb64-110"><a href="#cb64-110" tabindex="-1"></a><span class="co">#&gt;             3                                 0           0              0       </span></span>
<span id="cb64-111"><a href="#cb64-111" tabindex="-1"></a><span class="co">#&gt;             4                                 0           0              0       </span></span>
<span id="cb64-112"><a href="#cb64-112" tabindex="-1"></a><span class="co">#&gt;             Missing                           0           0              0       </span></span>
<span id="cb64-113"><a href="#cb64-113" tabindex="-1"></a><span class="co">#&gt;     3                                         1           0              0       </span></span>
<span id="cb64-114"><a href="#cb64-114" tabindex="-1"></a><span class="co">#&gt;             Not High                      1 (6.7%)        0              0       </span></span>
<span id="cb64-115"><a href="#cb64-115" tabindex="-1"></a><span class="co">#&gt;             1                                 0           0              0       </span></span>
<span id="cb64-116"><a href="#cb64-116" tabindex="-1"></a><span class="co">#&gt;             2                                 0           0              0       </span></span>
<span id="cb64-117"><a href="#cb64-117" tabindex="-1"></a><span class="co">#&gt;             3                                 0           0              0       </span></span>
<span id="cb64-118"><a href="#cb64-118" tabindex="-1"></a><span class="co">#&gt;             4                                 0           0              0       </span></span>
<span id="cb64-119"><a href="#cb64-119" tabindex="-1"></a><span class="co">#&gt;             Missing                           0           0              0       </span></span>
<span id="cb64-120"><a href="#cb64-120" tabindex="-1"></a><span class="co">#&gt;     4                                         1           0              0       </span></span>
<span id="cb64-121"><a href="#cb64-121" tabindex="-1"></a><span class="co">#&gt;             Not High                      1 (6.7%)        0              0       </span></span>
<span id="cb64-122"><a href="#cb64-122" tabindex="-1"></a><span class="co">#&gt;             1                                 0           0              0       </span></span>
<span id="cb64-123"><a href="#cb64-123" tabindex="-1"></a><span class="co">#&gt;             2                                 0           0              0       </span></span>
<span id="cb64-124"><a href="#cb64-124" tabindex="-1"></a><span class="co">#&gt;             3                                 0           0              0       </span></span>
<span id="cb64-125"><a href="#cb64-125" tabindex="-1"></a><span class="co">#&gt;             4                                 0           0              0       </span></span>
<span id="cb64-126"><a href="#cb64-126" tabindex="-1"></a><span class="co">#&gt;             Missing                           0           0              0       </span></span>
<span id="cb64-127"><a href="#cb64-127" tabindex="-1"></a><span class="co">#&gt;     Missing                                   0           0              0       </span></span>
<span id="cb64-128"><a href="#cb64-128" tabindex="-1"></a><span class="co">#&gt;             Not High                          0           0              0       </span></span>
<span id="cb64-129"><a href="#cb64-129" tabindex="-1"></a><span class="co">#&gt;             1                                 0           0              0       </span></span>
<span id="cb64-130"><a href="#cb64-130" tabindex="-1"></a><span class="co">#&gt;             2                                 0           0              0       </span></span>
<span id="cb64-131"><a href="#cb64-131" tabindex="-1"></a><span class="co">#&gt;             3                                 0           0              0       </span></span>
<span id="cb64-132"><a href="#cb64-132" tabindex="-1"></a><span class="co">#&gt;             4                                 0           0              0       </span></span>
<span id="cb64-133"><a href="#cb64-133" tabindex="-1"></a><span class="co">#&gt;             Missing                           0           0              0</span></span></code></pre></div>
</div>
</div>
<div id="medical-history-mht01" class="section level3">
<h3><strong>Medical History (<code>MHT01</code>)</strong></h3>
<div id="medical-history" class="section level4">
<h4><strong>1. Medical History</strong></h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>mht01</code></strong> template displays medical
conditions by MedDRA system organ class and Preferred Name by
default.</li>
<li>The default treatment variable is <code>&quot;ADSL.ARM&quot;</code>.</li>
<li>The user is expected to use filter to subset medical conditions
prior to or on entering study.</li>
<li>By default, the template produces the overall âtotal number of
conditionsâ as well as the âtotal number of conditionsâ per body system
after the summary of patients. 5ï¼This template currently does not
support sorting MedDRA system organ class and preferred names by order
of frequency.</li>
</ol>
<div class="sourceCode" id="cb65"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb65-1"><a href="#cb65-1" tabindex="-1"></a><span class="fu">run</span>(mht01, syn_data)</span>
<span id="cb65-2"><a href="#cb65-2" tabindex="-1"></a><span class="co">#&gt;   MedDRA System Organ Class                                A: Drug X    B: Placebo   C: Combination</span></span>
<span id="cb65-3"><a href="#cb65-3" tabindex="-1"></a><span class="co">#&gt;     MedDRA Preferred Term                                    (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb65-4"><a href="#cb65-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb65-5"><a href="#cb65-5" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with at least one condition     13 (86.7%)   14 (93.3%)     15 (100%)   </span></span>
<span id="cb65-6"><a href="#cb65-6" tabindex="-1"></a><span class="co">#&gt;   Total number of conditions                                   58           59             99      </span></span>
<span id="cb65-7"><a href="#cb65-7" tabindex="-1"></a><span class="co">#&gt;   cl A                                                                                             </span></span>
<span id="cb65-8"><a href="#cb65-8" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one condition   7 (46.7%)    6 (40.0%)      10 (66.7%)  </span></span>
<span id="cb65-9"><a href="#cb65-9" tabindex="-1"></a><span class="co">#&gt;     Total number of conditions                                 8            11             16      </span></span>
<span id="cb65-10"><a href="#cb65-10" tabindex="-1"></a><span class="co">#&gt;     trm A_2/2                                              5 (33.3%)    6 (40.0%)      6 (40.0%)   </span></span>
<span id="cb65-11"><a href="#cb65-11" tabindex="-1"></a><span class="co">#&gt;     trm A_1/2                                              3 (20.0%)     1 (6.7%)      6 (40.0%)   </span></span>
<span id="cb65-12"><a href="#cb65-12" tabindex="-1"></a><span class="co">#&gt;   cl B                                                                                             </span></span>
<span id="cb65-13"><a href="#cb65-13" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one condition   12 (80.0%)   11 (73.3%)     12 (80.0%)  </span></span>
<span id="cb65-14"><a href="#cb65-14" tabindex="-1"></a><span class="co">#&gt;     Total number of conditions                                 24           21             32      </span></span>
<span id="cb65-15"><a href="#cb65-15" tabindex="-1"></a><span class="co">#&gt;     trm B_3/3                                              8 (53.3%)    6 (40.0%)      7 (46.7%)   </span></span>
<span id="cb65-16"><a href="#cb65-16" tabindex="-1"></a><span class="co">#&gt;     trm B_1/3                                              5 (33.3%)    6 (40.0%)      8 (53.3%)   </span></span>
<span id="cb65-17"><a href="#cb65-17" tabindex="-1"></a><span class="co">#&gt;     trm B_2/3                                              5 (33.3%)    6 (40.0%)      5 (33.3%)   </span></span>
<span id="cb65-18"><a href="#cb65-18" tabindex="-1"></a><span class="co">#&gt;   cl C                                                                                             </span></span>
<span id="cb65-19"><a href="#cb65-19" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one condition   8 (53.3%)    6 (40.0%)      11 (73.3%)  </span></span>
<span id="cb65-20"><a href="#cb65-20" tabindex="-1"></a><span class="co">#&gt;     Total number of conditions                                 10           13             22      </span></span>
<span id="cb65-21"><a href="#cb65-21" tabindex="-1"></a><span class="co">#&gt;     trm C_2/2                                              6 (40.0%)    4 (26.7%)      8 (53.3%)   </span></span>
<span id="cb65-22"><a href="#cb65-22" tabindex="-1"></a><span class="co">#&gt;     trm C_1/2                                              4 (26.7%)    4 (26.7%)      5 (33.3%)   </span></span>
<span id="cb65-23"><a href="#cb65-23" tabindex="-1"></a><span class="co">#&gt;   cl D                                                                                             </span></span>
<span id="cb65-24"><a href="#cb65-24" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one condition   10 (66.7%)   7 (46.7%)      13 (86.7%)  </span></span>
<span id="cb65-25"><a href="#cb65-25" tabindex="-1"></a><span class="co">#&gt;     Total number of conditions                                 16           14             29      </span></span>
<span id="cb65-26"><a href="#cb65-26" tabindex="-1"></a><span class="co">#&gt;     trm D_1/3                                              4 (26.7%)    4 (26.7%)      7 (46.7%)   </span></span>
<span id="cb65-27"><a href="#cb65-27" tabindex="-1"></a><span class="co">#&gt;     trm D_2/3                                              6 (40.0%)    2 (13.3%)      7 (46.7%)   </span></span>
<span id="cb65-28"><a href="#cb65-28" tabindex="-1"></a><span class="co">#&gt;     trm D_3/3                                              2 (13.3%)    5 (33.3%)      7 (46.7%)</span></span></code></pre></div>
</div>
<div id="medical-history-showing-additional-column-all-patients" class="section level4">
<h4><strong>2. Medical History showing additional column âAll
Patientsâ</strong></h4>
<div class="sourceCode" id="cb66"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb66-1"><a href="#cb66-1" tabindex="-1"></a><span class="fu">run</span>(mht01, syn_data, <span class="at">lbl_overall =</span> <span class="st">&quot;All Patients&quot;</span>)</span>
<span id="cb66-2"><a href="#cb66-2" tabindex="-1"></a><span class="co">#&gt;   MedDRA System Organ Class                                A: Drug X    B: Placebo   C: Combination   All Patients</span></span>
<span id="cb66-3"><a href="#cb66-3" tabindex="-1"></a><span class="co">#&gt;     MedDRA Preferred Term                                    (N=15)       (N=15)         (N=15)          (N=45)   </span></span>
<span id="cb66-4"><a href="#cb66-4" tabindex="-1"></a><span class="co">#&gt;   ââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb66-5"><a href="#cb66-5" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with at least one condition     13 (86.7%)   14 (93.3%)     15 (100%)       42 (93.3%) </span></span>
<span id="cb66-6"><a href="#cb66-6" tabindex="-1"></a><span class="co">#&gt;   Total number of conditions                                   58           59             99             216     </span></span>
<span id="cb66-7"><a href="#cb66-7" tabindex="-1"></a><span class="co">#&gt;   cl A                                                                                                            </span></span>
<span id="cb66-8"><a href="#cb66-8" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one condition   7 (46.7%)    6 (40.0%)      10 (66.7%)      23 (51.1%) </span></span>
<span id="cb66-9"><a href="#cb66-9" tabindex="-1"></a><span class="co">#&gt;     Total number of conditions                                 8            11             16              35     </span></span>
<span id="cb66-10"><a href="#cb66-10" tabindex="-1"></a><span class="co">#&gt;     trm A_2/2                                              5 (33.3%)    6 (40.0%)      6 (40.0%)       17 (37.8%) </span></span>
<span id="cb66-11"><a href="#cb66-11" tabindex="-1"></a><span class="co">#&gt;     trm A_1/2                                              3 (20.0%)     1 (6.7%)      6 (40.0%)       10 (22.2%) </span></span>
<span id="cb66-12"><a href="#cb66-12" tabindex="-1"></a><span class="co">#&gt;   cl B                                                                                                            </span></span>
<span id="cb66-13"><a href="#cb66-13" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one condition   12 (80.0%)   11 (73.3%)     12 (80.0%)      35 (77.8%) </span></span>
<span id="cb66-14"><a href="#cb66-14" tabindex="-1"></a><span class="co">#&gt;     Total number of conditions                                 24           21             32              77     </span></span>
<span id="cb66-15"><a href="#cb66-15" tabindex="-1"></a><span class="co">#&gt;     trm B_3/3                                              8 (53.3%)    6 (40.0%)      7 (46.7%)       21 (46.7%) </span></span>
<span id="cb66-16"><a href="#cb66-16" tabindex="-1"></a><span class="co">#&gt;     trm B_1/3                                              5 (33.3%)    6 (40.0%)      8 (53.3%)       19 (42.2%) </span></span>
<span id="cb66-17"><a href="#cb66-17" tabindex="-1"></a><span class="co">#&gt;     trm B_2/3                                              5 (33.3%)    6 (40.0%)      5 (33.3%)       16 (35.6%) </span></span>
<span id="cb66-18"><a href="#cb66-18" tabindex="-1"></a><span class="co">#&gt;   cl C                                                                                                            </span></span>
<span id="cb66-19"><a href="#cb66-19" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one condition   8 (53.3%)    6 (40.0%)      11 (73.3%)      25 (55.6%) </span></span>
<span id="cb66-20"><a href="#cb66-20" tabindex="-1"></a><span class="co">#&gt;     Total number of conditions                                 10           13             22              45     </span></span>
<span id="cb66-21"><a href="#cb66-21" tabindex="-1"></a><span class="co">#&gt;     trm C_2/2                                              6 (40.0%)    4 (26.7%)      8 (53.3%)       18 (40.0%) </span></span>
<span id="cb66-22"><a href="#cb66-22" tabindex="-1"></a><span class="co">#&gt;     trm C_1/2                                              4 (26.7%)    4 (26.7%)      5 (33.3%)       13 (28.9%) </span></span>
<span id="cb66-23"><a href="#cb66-23" tabindex="-1"></a><span class="co">#&gt;   cl D                                                                                                            </span></span>
<span id="cb66-24"><a href="#cb66-24" tabindex="-1"></a><span class="co">#&gt;     Total number of patients with at least one condition   10 (66.7%)   7 (46.7%)      13 (86.7%)      30 (66.7%) </span></span>
<span id="cb66-25"><a href="#cb66-25" tabindex="-1"></a><span class="co">#&gt;     Total number of conditions                                 16           14             29              59     </span></span>
<span id="cb66-26"><a href="#cb66-26" tabindex="-1"></a><span class="co">#&gt;     trm D_1/3                                              4 (26.7%)    4 (26.7%)      7 (46.7%)       15 (33.3%) </span></span>
<span id="cb66-27"><a href="#cb66-27" tabindex="-1"></a><span class="co">#&gt;     trm D_2/3                                              6 (40.0%)    2 (13.3%)      7 (46.7%)       15 (33.3%) </span></span>
<span id="cb66-28"><a href="#cb66-28" tabindex="-1"></a><span class="co">#&gt;     trm D_3/3                                              2 (13.3%)    5 (33.3%)      7 (46.7%)       14 (31.1%)</span></span></code></pre></div>
</div>
</div>
<div id="major-protocol-deviations-pdt01" class="section level3">
<h3><strong>Major Protocol Deviations (<code>PDT01</code>)</strong></h3>
<div id="major-protocol-deviations" class="section level4">
<h4><strong>1. Major Protocol Deviations</strong></h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>pdt01</code></strong> template produces the
standard major protocol deviations output.</li>
<li>Users are expected to filter <code>addv</code> to only include
records where <code>DVCAT == &quot;MAJOR&quot;</code> in pre-processing.</li>
</ol>
<div class="sourceCode" id="cb67"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb67-1"><a href="#cb67-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> syn_data</span>
<span id="cb67-2"><a href="#cb67-2" tabindex="-1"></a>proc_data<span class="sc">$</span>addv <span class="ot">&lt;-</span> proc_data<span class="sc">$</span>addv <span class="sc">%&gt;%</span></span>
<span id="cb67-3"><a href="#cb67-3" tabindex="-1"></a>  <span class="fu">filter</span>(DVCAT <span class="sc">==</span> <span class="st">&quot;MAJOR&quot;</span>)</span>
<span id="cb67-4"><a href="#cb67-4" tabindex="-1"></a></span>
<span id="cb67-5"><a href="#cb67-5" tabindex="-1"></a><span class="fu">run</span>(pdt01, proc_data)</span>
<span id="cb67-6"><a href="#cb67-6" tabindex="-1"></a><span class="co">#&gt;   Category                                                              A: Drug X   B: Placebo   C: Combination</span></span>
<span id="cb67-7"><a href="#cb67-7" tabindex="-1"></a><span class="co">#&gt;     Description                                                          (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb67-8"><a href="#cb67-8" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb67-9"><a href="#cb67-9" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with at least one major protocol deviation   3 (20.0%)   3 (20.0%)          0       </span></span>
<span id="cb67-10"><a href="#cb67-10" tabindex="-1"></a><span class="co">#&gt;   Total number of major protocol deviations                                 3           4              0       </span></span>
<span id="cb67-11"><a href="#cb67-11" tabindex="-1"></a><span class="co">#&gt;   EXCLUSION CRITERIA                                                                                           </span></span>
<span id="cb67-12"><a href="#cb67-12" tabindex="-1"></a><span class="co">#&gt;     Active or untreated or other excluded cns metastases                    0        1 (6.7%)          0       </span></span>
<span id="cb67-13"><a href="#cb67-13" tabindex="-1"></a><span class="co">#&gt;     Pregnancy criteria                                                      0        1 (6.7%)          0       </span></span>
<span id="cb67-14"><a href="#cb67-14" tabindex="-1"></a><span class="co">#&gt;   INCLUSION CRITERIA                                                                                           </span></span>
<span id="cb67-15"><a href="#cb67-15" tabindex="-1"></a><span class="co">#&gt;     Ineligible cancer type or current cancer stage                      2 (13.3%)       0              0       </span></span>
<span id="cb67-16"><a href="#cb67-16" tabindex="-1"></a><span class="co">#&gt;   MEDICATION                                                                                                   </span></span>
<span id="cb67-17"><a href="#cb67-17" tabindex="-1"></a><span class="co">#&gt;     Received prohibited concomitant medication                              0        1 (6.7%)          0       </span></span>
<span id="cb67-18"><a href="#cb67-18" tabindex="-1"></a><span class="co">#&gt;   PROCEDURAL                                                                                                   </span></span>
<span id="cb67-19"><a href="#cb67-19" tabindex="-1"></a><span class="co">#&gt;     Eligibility-related test not done/out of window                         0        1 (6.7%)          0       </span></span>
<span id="cb67-20"><a href="#cb67-20" tabindex="-1"></a><span class="co">#&gt;     Failure to sign updated ICF within two visits                       1 (6.7%)        0              0</span></span></code></pre></div>
</div>
</div>
<div id="reasons-for-major-protocol-deviations-related-to-epidemicpandemic-pdt02" class="section level3">
<h3><strong>Reasons for Major Protocol Deviations Related to
Epidemic/Pandemic (<code>PDT02</code>)</strong></h3>
<div id="reasons-for-major-protocol-deviations-related-to-epidemicpandemic" class="section level4">
<h4><strong>1. Reasons for Major Protocol Deviations Related to
Epidemic/Pandemic</strong></h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>pdt02</code></strong> template produces the
reasons for major protocol deviations related to epidemic/pandemic
summary.</li>
<li>By default, <code>ADDV.DVREAS</code> provides the reason and
<code>ADDV.DVTERM</code> provides the description.</li>
<li>By default, <code>addv</code> has been filtered to include only
records that meet the condition
<code>AEPRELFL == &quot;Y&quot; &amp; DVCAT == &quot;MAJOR&quot;</code>.</li>
</ol>
<div class="sourceCode" id="cb68"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb68-1"><a href="#cb68-1" tabindex="-1"></a><span class="fu">run</span>(pdt02, syn_data)</span>
<span id="cb68-2"><a href="#cb68-2" tabindex="-1"></a><span class="co">#&gt;   Primary Reason                                                                                     A: Drug X   B: Placebo   C: Combination</span></span>
<span id="cb68-3"><a href="#cb68-3" tabindex="-1"></a><span class="co">#&gt;     Description                                                                                       (N=15)       (N=15)         (N=15)    </span></span>
<span id="cb68-4"><a href="#cb68-4" tabindex="-1"></a><span class="co">#&gt;   ââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb68-5"><a href="#cb68-5" tabindex="-1"></a><span class="co">#&gt;   Total number of patients with at least one major protocol deviation related to epidemic/pandemic   1 (6.7%)        0              0       </span></span>
<span id="cb68-6"><a href="#cb68-6" tabindex="-1"></a><span class="co">#&gt;   Total number of major protocol deviations related to epidemic/pandemic                                 1           0              0       </span></span>
<span id="cb68-7"><a href="#cb68-7" tabindex="-1"></a><span class="co">#&gt;   Site action due to epidemic/pandemic                                                               1 (6.7%)        0              0       </span></span>
<span id="cb68-8"><a href="#cb68-8" tabindex="-1"></a><span class="co">#&gt;     Failure to sign updated ICF within two visits                                                    1 (6.7%)        0              0</span></span></code></pre></div>
</div>
</div>
<div id="duration-of-exposure-for-risk-management-plan-rmpt01" class="section level3">
<h3><strong>Duration of Exposure for Risk Management Plan
(<code>RMPT01</code>)</strong></h3>
<div id="duration-of-exposure-for-risk-management-plan" class="section level4">
<h4><strong>1. Duration of Exposure for Risk Management
Plan</strong></h4>
<p>The <strong><code>rmpt01</code></strong> template produces the
standard duration of exposure output for the Risk Management Plan
(<code>RMP</code>).</p>
<p>Person time is the sum of exposure across all patients in days.</p>
<div class="sourceCode" id="cb69"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb69-1"><a href="#cb69-1" tabindex="-1"></a><span class="fu">run</span>(rmpt01, syn_data)</span>
<span id="cb69-2"><a href="#cb69-2" tabindex="-1"></a><span class="co">#&gt;                                        Patients     Person time</span></span>
<span id="cb69-3"><a href="#cb69-3" tabindex="-1"></a><span class="co">#&gt;   Duration of exposure                  (N=45)        (N=45)   </span></span>
<span id="cb69-4"><a href="#cb69-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb69-5"><a href="#cb69-5" tabindex="-1"></a><span class="co">#&gt;   &lt; 1 month                            4 (8.9%)         67     </span></span>
<span id="cb69-6"><a href="#cb69-6" tabindex="-1"></a><span class="co">#&gt;   1 to &lt;3 months                      13 (28.9%)        837    </span></span>
<span id="cb69-7"><a href="#cb69-7" tabindex="-1"></a><span class="co">#&gt;   3 to &lt;6 months                      13 (28.9%)       1728    </span></span>
<span id="cb69-8"><a href="#cb69-8" tabindex="-1"></a><span class="co">#&gt;   &gt;=6 months                          15 (33.3%)       3281    </span></span>
<span id="cb69-9"><a href="#cb69-9" tabindex="-1"></a><span class="co">#&gt;   Total patients number/person time   45 (100.0%)      5913</span></span></code></pre></div>
</div>
</div>
<div id="extent-of-exposure-by-age-group-and-gender-for-risk-management-plan-rmpt03" class="section level3">
<h3><strong>Extent of Exposure by Age Group and Gender for Risk
Management Plan (<code>RMPT03</code>)</strong></h3>
<div id="extent-of-exposure-by-age-group-and-gender-for-risk-management-plan" class="section level4">
<h4><strong>1. Extent of Exposure by Age Group and Gender for Risk
Management Plan</strong></h4>
<p>The <strong><code>rmpt03</code></strong> template produces the
standard extent of exposure by age group and gender output for the Risk
Management Plan (<code>RMP</code>).</p>
<p>By default, the <code>AGEGR1</code> variable is used as the age
group. If <code>AGEGR1</code> is available in <code>ADSL</code> only but
not in <code>ADEX</code>, it needs to be added to <code>ADEX</code>
first.</p>
<div class="sourceCode" id="cb70"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb70-1"><a href="#cb70-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> syn_data</span>
<span id="cb70-2"><a href="#cb70-2" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">propagate</span>(proc_data, <span class="st">&quot;adsl&quot;</span>, <span class="st">&quot;AGEGR1&quot;</span>, <span class="st">&quot;USUBJID&quot;</span>)</span>
<span id="cb70-3"><a href="#cb70-3" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb70-4"><a href="#cb70-4" tabindex="-1"></a><span class="co">#&gt; Updating: adae with: AGEGR1</span></span>
<span id="cb70-5"><a href="#cb70-5" tabindex="-1"></a><span class="co">#&gt; Updating: adsaftte with: AGEGR1</span></span>
<span id="cb70-6"><a href="#cb70-6" tabindex="-1"></a><span class="co">#&gt; Updating: adcm with: AGEGR1</span></span>
<span id="cb70-7"><a href="#cb70-7" tabindex="-1"></a><span class="co">#&gt; Updating: addv with: AGEGR1</span></span>
<span id="cb70-8"><a href="#cb70-8" tabindex="-1"></a><span class="co">#&gt; Updating: adeg with: AGEGR1</span></span>
<span id="cb70-9"><a href="#cb70-9" tabindex="-1"></a><span class="co">#&gt; Updating: adex with: AGEGR1</span></span>
<span id="cb70-10"><a href="#cb70-10" tabindex="-1"></a><span class="co">#&gt; Updating: adlb with: AGEGR1</span></span>
<span id="cb70-11"><a href="#cb70-11" tabindex="-1"></a><span class="co">#&gt; Updating: admh with: AGEGR1</span></span>
<span id="cb70-12"><a href="#cb70-12" tabindex="-1"></a><span class="co">#&gt; Skipping: adrs</span></span>
<span id="cb70-13"><a href="#cb70-13" tabindex="-1"></a><span class="co">#&gt; Updating: adsub with: AGEGR1</span></span>
<span id="cb70-14"><a href="#cb70-14" tabindex="-1"></a><span class="co">#&gt; Skipping: adtte</span></span>
<span id="cb70-15"><a href="#cb70-15" tabindex="-1"></a><span class="co">#&gt; Updating: advs with: AGEGR1</span></span>
<span id="cb70-16"><a href="#cb70-16" tabindex="-1"></a><span class="fu">run</span>(rmpt03, proc_data)</span>
<span id="cb70-17"><a href="#cb70-17" tabindex="-1"></a><span class="co">#&gt;                                                   F                           M                      All Genders       </span></span>
<span id="cb70-18"><a href="#cb70-18" tabindex="-1"></a><span class="co">#&gt;                                        Patients     Person time    Patients     Person time    Patients     Person time</span></span>
<span id="cb70-19"><a href="#cb70-19" tabindex="-1"></a><span class="co">#&gt;   Age Group                             (N=30)        (N=30)        (N=15)        (N=15)        (N=45)        (N=45)   </span></span>
<span id="cb70-20"><a href="#cb70-20" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb70-21"><a href="#cb70-21" tabindex="-1"></a><span class="co">#&gt;   &lt;65                                 30 (100.0%)      4088       15 (100.0%)      1825       45 (100.0%)      5913    </span></span>
<span id="cb70-22"><a href="#cb70-22" tabindex="-1"></a><span class="co">#&gt;   Total patients number/person time   30 (100.0%)      4088       15 (100.0%)      1825       45 (100.0%)      5913</span></span></code></pre></div>
<p>Any other study specific age group can be used by editing the
parameter <code>summaryvars</code>. For all <code>RMP</code> tables, if
the variable specified per <code>summaryvars</code> is unavailable in
<code>ADEX</code>, it needs to be added to <code>ADEX</code> first.</p>
<div class="sourceCode" id="cb71"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb71-1"><a href="#cb71-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> syn_data</span>
<span id="cb71-2"><a href="#cb71-2" tabindex="-1"></a>proc_data<span class="sc">$</span>adsl <span class="ot">&lt;-</span> proc_data<span class="sc">$</span>adsl <span class="sc">%&gt;%</span></span>
<span id="cb71-3"><a href="#cb71-3" tabindex="-1"></a>  <span class="fu">mutate</span>(</span>
<span id="cb71-4"><a href="#cb71-4" tabindex="-1"></a>    <span class="at">AGEGR2 =</span> <span class="fu">with_label</span>(</span>
<span id="cb71-5"><a href="#cb71-5" tabindex="-1"></a>      <span class="fu">factor</span>(<span class="fu">case_when</span>(</span>
<span id="cb71-6"><a href="#cb71-6" tabindex="-1"></a>        AAGE <span class="sc">&lt;</span> <span class="dv">18</span> <span class="sc">~</span> <span class="st">&quot;&lt;18&quot;</span>,</span>
<span id="cb71-7"><a href="#cb71-7" tabindex="-1"></a>        AAGE <span class="sc">&gt;=</span> <span class="dv">18</span> <span class="sc">&amp;</span> AAGE <span class="sc">&lt;=</span> <span class="dv">65</span> <span class="sc">~</span> <span class="st">&quot;18 - 65&quot;</span>,</span>
<span id="cb71-8"><a href="#cb71-8" tabindex="-1"></a>        AAGE <span class="sc">&gt;</span> <span class="dv">65</span> <span class="sc">~</span> <span class="st">&quot;&gt;65&quot;</span>,</span>
<span id="cb71-9"><a href="#cb71-9" tabindex="-1"></a>      ), <span class="at">levels =</span> <span class="fu">c</span>(<span class="st">&quot;&lt;18&quot;</span>, <span class="st">&quot;18 - 65&quot;</span>, <span class="st">&quot;&gt;65&quot;</span>)),</span>
<span id="cb71-10"><a href="#cb71-10" tabindex="-1"></a>      <span class="st">&quot;Age Group 2&quot;</span></span>
<span id="cb71-11"><a href="#cb71-11" tabindex="-1"></a>    )</span>
<span id="cb71-12"><a href="#cb71-12" tabindex="-1"></a>  )</span>
<span id="cb71-13"><a href="#cb71-13" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">propagate</span>(proc_data, <span class="st">&quot;adsl&quot;</span>, <span class="st">&quot;AGEGR2&quot;</span>, <span class="st">&quot;USUBJID&quot;</span>)</span>
<span id="cb71-14"><a href="#cb71-14" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb71-15"><a href="#cb71-15" tabindex="-1"></a><span class="co">#&gt; Updating: adae with: AGEGR2</span></span>
<span id="cb71-16"><a href="#cb71-16" tabindex="-1"></a><span class="co">#&gt; Updating: adsaftte with: AGEGR2</span></span>
<span id="cb71-17"><a href="#cb71-17" tabindex="-1"></a><span class="co">#&gt; Updating: adcm with: AGEGR2</span></span>
<span id="cb71-18"><a href="#cb71-18" tabindex="-1"></a><span class="co">#&gt; Updating: addv with: AGEGR2</span></span>
<span id="cb71-19"><a href="#cb71-19" tabindex="-1"></a><span class="co">#&gt; Updating: adeg with: AGEGR2</span></span>
<span id="cb71-20"><a href="#cb71-20" tabindex="-1"></a><span class="co">#&gt; Updating: adex with: AGEGR2</span></span>
<span id="cb71-21"><a href="#cb71-21" tabindex="-1"></a><span class="co">#&gt; Updating: adlb with: AGEGR2</span></span>
<span id="cb71-22"><a href="#cb71-22" tabindex="-1"></a><span class="co">#&gt; Updating: admh with: AGEGR2</span></span>
<span id="cb71-23"><a href="#cb71-23" tabindex="-1"></a><span class="co">#&gt; Updating: adrs with: AGEGR2</span></span>
<span id="cb71-24"><a href="#cb71-24" tabindex="-1"></a><span class="co">#&gt; Updating: adsub with: AGEGR2</span></span>
<span id="cb71-25"><a href="#cb71-25" tabindex="-1"></a><span class="co">#&gt; Updating: adtte with: AGEGR2</span></span>
<span id="cb71-26"><a href="#cb71-26" tabindex="-1"></a><span class="co">#&gt; Updating: advs with: AGEGR2</span></span>
<span id="cb71-27"><a href="#cb71-27" tabindex="-1"></a><span class="fu">run</span>(rmpt03, proc_data, <span class="at">summaryvars =</span> <span class="st">&quot;AGEGR2&quot;</span>)</span>
<span id="cb71-28"><a href="#cb71-28" tabindex="-1"></a><span class="co">#&gt;                                                   F                           M                      All Genders       </span></span>
<span id="cb71-29"><a href="#cb71-29" tabindex="-1"></a><span class="co">#&gt;                                        Patients     Person time    Patients     Person time    Patients     Person time</span></span>
<span id="cb71-30"><a href="#cb71-30" tabindex="-1"></a><span class="co">#&gt;   Age Group 2                           (N=30)        (N=30)        (N=15)        (N=15)        (N=45)        (N=45)   </span></span>
<span id="cb71-31"><a href="#cb71-31" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb71-32"><a href="#cb71-32" tabindex="-1"></a><span class="co">#&gt;   18 - 65                             30 (100.0%)      4088       15 (100.0%)      1825       45 (100.0%)      5913    </span></span>
<span id="cb71-33"><a href="#cb71-33" tabindex="-1"></a><span class="co">#&gt;   Total patients number/person time   30 (100.0%)      4088       15 (100.0%)      1825       45 (100.0%)      5913</span></span></code></pre></div>
</div>
</div>
<div id="extent-of-exposure-by-ethnic-origin-for-risk-management-plan-rmpt04" class="section level3">
<h3><strong>Extent of Exposure by Ethnic Origin for Risk Management Plan
(<code>RMPT04</code>)</strong></h3>
<div id="extent-of-exposure-by-ethnic-origin-for-risk-management-plan" class="section level4">
<h4><strong>1. Extent of Exposure by Ethnic Origin for Risk Management
Plan</strong></h4>
<p>The <strong><code>rmpt04</code></strong> template produces the
standard extent of exposure by ethnic origin output for the Risk
Management Plan (<code>RMP</code>).</p>
<div class="sourceCode" id="cb72"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb72-1"><a href="#cb72-1" tabindex="-1"></a><span class="fu">run</span>(rmpt04, syn_data)</span>
<span id="cb72-2"><a href="#cb72-2" tabindex="-1"></a><span class="co">#&gt;                                        Patients     Person time</span></span>
<span id="cb72-3"><a href="#cb72-3" tabindex="-1"></a><span class="co">#&gt;   ETHNIC                                (N=45)        (N=45)   </span></span>
<span id="cb72-4"><a href="#cb72-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb72-5"><a href="#cb72-5" tabindex="-1"></a><span class="co">#&gt;   NOT REPORTED                         2 (4.4%)         49     </span></span>
<span id="cb72-6"><a href="#cb72-6" tabindex="-1"></a><span class="co">#&gt;   HISPANIC OR LATINO                   2 (4.4%)         309    </span></span>
<span id="cb72-7"><a href="#cb72-7" tabindex="-1"></a><span class="co">#&gt;   NOT HISPANIC OR LATINO              41 (91.1%)       5555    </span></span>
<span id="cb72-8"><a href="#cb72-8" tabindex="-1"></a><span class="co">#&gt;   Total patients number/person time   45 (100.0%)      5913</span></span></code></pre></div>
</div>
</div>
<div id="extent-of-exposure-by-race-for-risk-management-plan-rmpt05" class="section level3">
<h3><strong>Extent of Exposure by Race for Risk Management Plan
(<code>RMPT05</code>)</strong></h3>
<div id="extent-of-exposure-by-race-for-risk-management-plan" class="section level4">
<h4><strong>1. Extent of Exposure by Race for Risk Management
Plan</strong></h4>
<p>The <strong><code>rmpt05</code></strong> template produces the
standard extent of exposure by race output for the Risk Management Plan
(<code>RMP</code>).</p>
<div class="sourceCode" id="cb73"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb73-1"><a href="#cb73-1" tabindex="-1"></a><span class="fu">run</span>(rmpt05, syn_data)</span>
<span id="cb73-2"><a href="#cb73-2" tabindex="-1"></a><span class="co">#&gt;                                        Patients     Person time</span></span>
<span id="cb73-3"><a href="#cb73-3" tabindex="-1"></a><span class="co">#&gt;   RACE                                  (N=45)        (N=45)   </span></span>
<span id="cb73-4"><a href="#cb73-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb73-5"><a href="#cb73-5" tabindex="-1"></a><span class="co">#&gt;   ASIAN                               26 (57.8%)       3309    </span></span>
<span id="cb73-6"><a href="#cb73-6" tabindex="-1"></a><span class="co">#&gt;   BLACK OR AFRICAN AMERICAN            9 (20.0%)       1139    </span></span>
<span id="cb73-7"><a href="#cb73-7" tabindex="-1"></a><span class="co">#&gt;   WHITE                                7 (15.6%)       1231    </span></span>
<span id="cb73-8"><a href="#cb73-8" tabindex="-1"></a><span class="co">#&gt;   AMERICAN INDIAN OR ALASKA NATIVE     3 (6.7%)         234    </span></span>
<span id="cb73-9"><a href="#cb73-9" tabindex="-1"></a><span class="co">#&gt;   Total patients number/person time   45 (100.0%)      5913</span></span></code></pre></div>
</div>
</div>
<div id="best-overall-response-rspt01" class="section level3">
<h3><strong>Best Overall Response (<code>RSPT01</code>)</strong></h3>
<div id="best-overall-response" class="section level4">
<h4><strong>1. Best Overall Response</strong></h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>rspt01</code></strong> template produces the
standard best overall response output.</li>
<li>The template syntax is built based on <code>RECIST 1.1</code>. By
default, the subjects with response results of <code>&quot;CR&quot;</code> or
<code>&quot;PR&quot;</code> are considered as responders.</li>
<li>Users are expected to pre-process the input analysis data and select
the parameter to be analyzed, i.e., best overall response by
investigator or best overall response by <code>BICR</code>.</li>
<li>Unstratified analysis is provided by default.</li>
</ol>
<div class="sourceCode" id="cb74"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb74-1"><a href="#cb74-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;BESRSPI&quot;</span>, <span class="st">&quot;adrs&quot;</span>)</span>
<span id="cb74-2"><a href="#cb74-2" tabindex="-1"></a></span>
<span id="cb74-3"><a href="#cb74-3" tabindex="-1"></a><span class="fu">run</span>(rspt01, proc_data, <span class="at">ref_group =</span> <span class="cn">NULL</span>, <span class="at">perform_analysis =</span> <span class="st">&quot;unstrat&quot;</span>, <span class="at">strata =</span> <span class="cn">NULL</span>)</span>
<span id="cb74-4"><a href="#cb74-4" tabindex="-1"></a><span class="co">#&gt; Warning in stats::prop.test(tbl, correct = FALSE): Chi-squared approximation</span></span>
<span id="cb74-5"><a href="#cb74-5" tabindex="-1"></a><span class="co">#&gt; may be incorrect</span></span>
<span id="cb74-6"><a href="#cb74-6" tabindex="-1"></a><span class="co">#&gt;                                           A: Drug X         B: Placebo        C: Combination  </span></span>
<span id="cb74-7"><a href="#cb74-7" tabindex="-1"></a><span class="co">#&gt;                                            (N=15)             (N=15)              (N=15)      </span></span>
<span id="cb74-8"><a href="#cb74-8" tabindex="-1"></a><span class="co">#&gt;   ââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb74-9"><a href="#cb74-9" tabindex="-1"></a><span class="co">#&gt;   Responders                             15 (100.0%)        14 (93.3%)          15 (100.0%)   </span></span>
<span id="cb74-10"><a href="#cb74-10" tabindex="-1"></a><span class="co">#&gt;   95% CI (Wald, with correction)        (96.7, 100.0)      (77.4, 100.0)       (96.7, 100.0)  </span></span>
<span id="cb74-11"><a href="#cb74-11" tabindex="-1"></a><span class="co">#&gt;   Unstratified Analysis                                                                       </span></span>
<span id="cb74-12"><a href="#cb74-12" tabindex="-1"></a><span class="co">#&gt;     Difference in Response rate (%)                            -6.7                 0.0       </span></span>
<span id="cb74-13"><a href="#cb74-13" tabindex="-1"></a><span class="co">#&gt;       95% CI (Wald, with correction)                       (-26.0, 12.6)        (-6.7, 6.7)   </span></span>
<span id="cb74-14"><a href="#cb74-14" tabindex="-1"></a><span class="co">#&gt;     p-value (Chi-Squared Test)                                0.3091              1.0000      </span></span>
<span id="cb74-15"><a href="#cb74-15" tabindex="-1"></a><span class="co">#&gt;   Odds Ratio (95% CI)                                    0.00 (0.00 - Inf)   1.00 (0.00 - Inf)</span></span>
<span id="cb74-16"><a href="#cb74-16" tabindex="-1"></a><span class="co">#&gt;   Complete Response (CR)                 15 (100.0%)        11 (73.3%)          14 (93.3%)    </span></span>
<span id="cb74-17"><a href="#cb74-17" tabindex="-1"></a><span class="co">#&gt;     95% CI (Wald, with correction)     (96.67, 100.00)    (47.62, 99.05)      (77.38, 100.00) </span></span>
<span id="cb74-18"><a href="#cb74-18" tabindex="-1"></a><span class="co">#&gt;   Partial Response (PR)                   0 (0.0%)           3 (20.0%)           1 (6.7%)     </span></span>
<span id="cb74-19"><a href="#cb74-19" tabindex="-1"></a><span class="co">#&gt;     95% CI (Wald, with correction)      (0.00, 3.33)       (0.00, 43.58)       (0.00, 22.62)  </span></span>
<span id="cb74-20"><a href="#cb74-20" tabindex="-1"></a><span class="co">#&gt;   Stable Disease (SD)                     0 (0.0%)           1 (6.7%)            0 (0.0%)     </span></span>
<span id="cb74-21"><a href="#cb74-21" tabindex="-1"></a><span class="co">#&gt;     95% CI (Wald, with correction)      (0.00, 3.33)       (0.00, 22.62)       (0.00, 3.33)</span></span></code></pre></div>
</div>
<div id="id_1" class="section level4">
<h4><strong>2. Best Overall Response (Ordering of treatment
groups)</strong></h4>
<ol style="list-style-type: decimal">
<li>By default, the first level or value of <code>arm_var</code>
(default to <code>&quot;ADSL.ARM&quot;</code> unless specified) is treated as the
reference group without specification.</li>
<li>To apply user-defined reference group, please provide the value from
the treatment variable to the argument <code>ref_group</code>, e.g.,
<code>ref_group = &quot;PLACEBO&quot;</code>.</li>
<li>Since <code>rtables</code> displays the reference group at the very
left column, the order of displayed treatment groups may not be exactly
the same as the order factorized, depending on which group is selected
as the reference group. See below for examples:</li>
</ol>
<table>
<colgroup>
<col width="25%" />
<col width="13%" />
<col width="25%" />
<col width="36%" />
</colgroup>
<thead>
<tr class="header">
<th align="center">Factorized <code>trt</code> order</th>
<th align="center"><code>ref_group</code></th>
<th align="center">Displayed <code>trt</code> order</th>
<th align="center">Reference group used in analysis</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="center">ARM C, ARM B, ARM A</td>
<td align="center">NULL</td>
<td align="center">ARM C, ARM B, ARM A</td>
<td align="center">ARM C</td>
</tr>
<tr class="even">
<td align="center">NULL</td>
<td align="center">ARM B</td>
<td align="center">ARM B, ARM A, ARM C</td>
<td align="center">ARM B</td>
</tr>
<tr class="odd">
<td align="center">ARM C, ARM B, ARM A</td>
<td align="center">ARM B</td>
<td align="center">ARM B, ARM C, ARM A</td>
<td align="center">ARM B</td>
</tr>
</tbody>
</table>
</div>
<div id="best-overall-response-selecting-sections-to-display" class="section level4">
<h4><strong>3. Best Overall Response (selecting sections to
display)</strong></h4>
<ol style="list-style-type: decimal">
<li>The section of <code>Odds Ratio</code> can be suppressed with the
argument <code>odds_ratio = FALSE</code>.</li>
<li>The section of <code>Difference in response rate</code> can be
suppressed with the argument <code>perform_analysis = NULL</code>.</li>
</ol>
<div class="sourceCode" id="cb75"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb75-1"><a href="#cb75-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;BESRSPI&quot;</span>, <span class="st">&quot;adrs&quot;</span>)</span>
<span id="cb75-2"><a href="#cb75-2" tabindex="-1"></a></span>
<span id="cb75-3"><a href="#cb75-3" tabindex="-1"></a><span class="fu">run</span>(rspt01, proc_data, <span class="at">odds_ratio =</span> <span class="cn">FALSE</span>, <span class="at">perform_analysis =</span> <span class="cn">NULL</span>)</span>
<span id="cb75-4"><a href="#cb75-4" tabindex="-1"></a><span class="co">#&gt;                                         A: Drug X        B: Placebo     C: Combination </span></span>
<span id="cb75-5"><a href="#cb75-5" tabindex="-1"></a><span class="co">#&gt;                                          (N=15)            (N=15)           (N=15)     </span></span>
<span id="cb75-6"><a href="#cb75-6" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb75-7"><a href="#cb75-7" tabindex="-1"></a><span class="co">#&gt;   Responders                           15 (100.0%)       14 (93.3%)       15 (100.0%)  </span></span>
<span id="cb75-8"><a href="#cb75-8" tabindex="-1"></a><span class="co">#&gt;   95% CI (Wald, with correction)      (96.7, 100.0)    (77.4, 100.0)     (96.7, 100.0) </span></span>
<span id="cb75-9"><a href="#cb75-9" tabindex="-1"></a><span class="co">#&gt;   Complete Response (CR)               15 (100.0%)       11 (73.3%)       14 (93.3%)   </span></span>
<span id="cb75-10"><a href="#cb75-10" tabindex="-1"></a><span class="co">#&gt;     95% CI (Wald, with correction)   (96.67, 100.00)   (47.62, 99.05)   (77.38, 100.00)</span></span>
<span id="cb75-11"><a href="#cb75-11" tabindex="-1"></a><span class="co">#&gt;   Partial Response (PR)                 0 (0.0%)         3 (20.0%)         1 (6.7%)    </span></span>
<span id="cb75-12"><a href="#cb75-12" tabindex="-1"></a><span class="co">#&gt;     95% CI (Wald, with correction)    (0.00, 3.33)     (0.00, 43.58)     (0.00, 22.62) </span></span>
<span id="cb75-13"><a href="#cb75-13" tabindex="-1"></a><span class="co">#&gt;   Stable Disease (SD)                   0 (0.0%)          1 (6.7%)         0 (0.0%)    </span></span>
<span id="cb75-14"><a href="#cb75-14" tabindex="-1"></a><span class="co">#&gt;     95% CI (Wald, with correction)    (0.00, 3.33)     (0.00, 22.62)     (0.00, 3.33)</span></span></code></pre></div>
</div>
<div id="best-overall-response-with-stratified-analysis" class="section level4">
<h4><strong>4. Best Overall Response (with stratified
analysis)</strong></h4>
<ol style="list-style-type: decimal">
<li>A stratified analysis can be added by specifying the argument
<code>perform_analysis = &quot;strat&quot;</code> and providing the stratification
variable to the argument <code>strata</code> . The argument
<code>strata</code> is expected if <code>perform_analysis</code> is set
to include stratified analysis.</li>
<li>The stratification variables are expected to be available in
<code>adrs</code>.</li>
<li>If both unstratified and stratified analysis are required, use
<code>perform_analysis = c(&quot;unstrat&quot;, &quot;strat&quot;)</code></li>
</ol>
<div class="sourceCode" id="cb76"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb76-1"><a href="#cb76-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;BESRSPI&quot;</span>, <span class="st">&quot;adrs&quot;</span>)</span>
<span id="cb76-2"><a href="#cb76-2" tabindex="-1"></a></span>
<span id="cb76-3"><a href="#cb76-3" tabindex="-1"></a><span class="fu">run</span>(rspt01, proc_data, <span class="at">perform_analysis =</span> <span class="st">&quot;strat&quot;</span>, <span class="at">strata =</span> <span class="fu">c</span>(<span class="st">&quot;STRATA1&quot;</span>, <span class="st">&quot;STRATA2&quot;</span>))</span>
<span id="cb76-4"><a href="#cb76-4" tabindex="-1"></a><span class="co">#&gt; Warning in prop_diff_cmh(rsp, grp, strata, conf_level): Less than 5</span></span>
<span id="cb76-5"><a href="#cb76-5" tabindex="-1"></a><span class="co">#&gt; observations in some strata.</span></span>
<span id="cb76-6"><a href="#cb76-6" tabindex="-1"></a></span>
<span id="cb76-7"><a href="#cb76-7" tabindex="-1"></a><span class="co">#&gt; Warning in prop_diff_cmh(rsp, grp, strata, conf_level): Less than 5</span></span>
<span id="cb76-8"><a href="#cb76-8" tabindex="-1"></a><span class="co">#&gt; observations in some strata.</span></span>
<span id="cb76-9"><a href="#cb76-9" tabindex="-1"></a><span class="co">#&gt; Warning in prop_cmh(tbl): &lt;5 data points in some strata. CMH test may be</span></span>
<span id="cb76-10"><a href="#cb76-10" tabindex="-1"></a><span class="co">#&gt; incorrect.</span></span>
<span id="cb76-11"><a href="#cb76-11" tabindex="-1"></a></span>
<span id="cb76-12"><a href="#cb76-12" tabindex="-1"></a><span class="co">#&gt; Warning in prop_cmh(tbl): &lt;5 data points in some strata. CMH test may be</span></span>
<span id="cb76-13"><a href="#cb76-13" tabindex="-1"></a><span class="co">#&gt; incorrect.</span></span>
<span id="cb76-14"><a href="#cb76-14" tabindex="-1"></a><span class="co">#&gt;                                                 A: Drug X         B: Placebo        C: Combination  </span></span>
<span id="cb76-15"><a href="#cb76-15" tabindex="-1"></a><span class="co">#&gt;                                                  (N=15)             (N=15)              (N=15)      </span></span>
<span id="cb76-16"><a href="#cb76-16" tabindex="-1"></a><span class="co">#&gt;   ââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb76-17"><a href="#cb76-17" tabindex="-1"></a><span class="co">#&gt;   Responders                                   15 (100.0%)        14 (93.3%)          15 (100.0%)   </span></span>
<span id="cb76-18"><a href="#cb76-18" tabindex="-1"></a><span class="co">#&gt;   95% CI (Wald, with correction)              (96.7, 100.0)      (77.4, 100.0)       (96.7, 100.0)  </span></span>
<span id="cb76-19"><a href="#cb76-19" tabindex="-1"></a><span class="co">#&gt;   Stratified Analysis                                                                               </span></span>
<span id="cb76-20"><a href="#cb76-20" tabindex="-1"></a><span class="co">#&gt;     Difference in Response rate (%)                                  -6.8                 0.0       </span></span>
<span id="cb76-21"><a href="#cb76-21" tabindex="-1"></a><span class="co">#&gt;       95% CI (CMH, without correction)                           (-18.8, 5.3)         (0.0, 0.0)    </span></span>
<span id="cb76-22"><a href="#cb76-22" tabindex="-1"></a><span class="co">#&gt;     p-value (Cochran-Mantel-Haenszel Test)                          0.3613                NE        </span></span>
<span id="cb76-23"><a href="#cb76-23" tabindex="-1"></a><span class="co">#&gt;   Odds Ratio (95% CI)                                          0.00 (0.00 - Inf)   1.00 (0.00 - Inf)</span></span>
<span id="cb76-24"><a href="#cb76-24" tabindex="-1"></a><span class="co">#&gt;   Complete Response (CR)                       15 (100.0%)        11 (73.3%)          14 (93.3%)    </span></span>
<span id="cb76-25"><a href="#cb76-25" tabindex="-1"></a><span class="co">#&gt;     95% CI (Wald, with correction)           (96.67, 100.00)    (47.62, 99.05)      (77.38, 100.00) </span></span>
<span id="cb76-26"><a href="#cb76-26" tabindex="-1"></a><span class="co">#&gt;   Partial Response (PR)                         0 (0.0%)           3 (20.0%)           1 (6.7%)     </span></span>
<span id="cb76-27"><a href="#cb76-27" tabindex="-1"></a><span class="co">#&gt;     95% CI (Wald, with correction)            (0.00, 3.33)       (0.00, 43.58)       (0.00, 22.62)  </span></span>
<span id="cb76-28"><a href="#cb76-28" tabindex="-1"></a><span class="co">#&gt;   Stable Disease (SD)                           0 (0.0%)           1 (6.7%)            0 (0.0%)     </span></span>
<span id="cb76-29"><a href="#cb76-29" tabindex="-1"></a><span class="co">#&gt;     95% CI (Wald, with correction)            (0.00, 3.33)       (0.00, 22.62)       (0.00, 3.33)</span></span></code></pre></div>
</div>
<div id="best-overall-response-modifying-analysis-details-like-type-of-confidence-interval-alpha-level-test-for-p-value" class="section level4">
<h4><strong>5. Best Overall Response (modifying analysis details like
type of confidence interval, alpha level, test for
p-value)</strong></h4>
<ol style="list-style-type: decimal">
<li>The level of the confidence intervals is defined by the argument
<code>conf_level</code>.</li>
<li>The methods to construct confidence interval and p-value are
controlled by the argument <code>methods</code>. It is a named list with
five optional sub-arguments. For example,
<code>methods = list(prop_conf_method = &quot;wald&quot;, diff_conf_method = &quot;wald&quot;, strat_diff_conf_method = &quot;ha&quot;, diff_pval_method = &quot;fisher&quot;, strat_diff_pval_method = &quot;schouten&quot;)</code></li>
</ol>
<p>See table below for what each argument controls and the available
method options:</p>
<table>
<colgroup>
<col width="23%" />
<col width="41%" />
<col width="35%" />
</colgroup>
<thead>
<tr class="header">
<th align="center">Arguments</th>
<th align="center">Methods Controlled</th>
<th align="center">Methods Options</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="center"><code>prop_conf_method</code></td>
<td align="center">proportion confidence interval</td>
<td align="center"><code>&quot;waldcc&quot;</code> (default), <code>&quot;wald&quot;</code>,
etc.</td>
</tr>
<tr class="even">
<td align="center"><code>diff_conf_method</code></td>
<td align="center">unstratified difference confidence interval</td>
<td align="center"><code>&quot;waldcc&quot;</code> (default), <code>&quot;wald&quot;</code>,
etc.</td>
</tr>
<tr class="odd">
<td align="center"><code>diff_pval_method</code></td>
<td align="center">unstratified p-value for odds ratio</td>
<td align="center"><code>&quot;chisq&quot;</code> (default),
<code>&quot;fisher&quot;</code></td>
</tr>
<tr class="even">
<td align="center"><code>strat_diff_conf_method</code></td>
<td align="center">stratified difference confidence interval</td>
<td align="center"><code>&quot;cmh&quot;</code> (default), <code>&quot;ha&quot;</code></td>
</tr>
<tr class="odd">
<td align="center"><code>strat_diff_pval_method</code></td>
<td align="center">stratified p-value for odds ratio</td>
<td align="center"><code>&quot;cmh&quot;</code> (default),
<code>&quot;schouten&quot;</code></td>
</tr>
</tbody>
</table>
<p>See in the table below the method options for estimates of
proportions and the associated statistical methods:</p>
<table>
<thead>
<tr class="header">
<th align="center">Method Options</th>
<th align="center">Statistical Methods</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="center"><code>&quot;clopper-pearson&quot;</code></td>
<td align="center">Clopper-Pearson</td>
</tr>
<tr class="even">
<td align="center"><code>&quot;wald&quot;</code></td>
<td align="center">Wald, without correction</td>
</tr>
<tr class="odd">
<td align="center"><code>&quot;waldcc&quot;</code></td>
<td align="center">Wald, with correction</td>
</tr>
<tr class="even">
<td align="center"><code>&quot;wilson&quot;</code></td>
<td align="center">Wilson, without correction</td>
</tr>
<tr class="odd">
<td align="center"><code>&quot;strat_wilson&quot;</code></td>
<td align="center">Stratified Wilson, without correction</td>
</tr>
<tr class="even">
<td align="center"><code>&quot;wilsonc&quot;</code></td>
<td align="center">Wilson, with correction</td>
</tr>
<tr class="odd">
<td align="center"><code>&quot;strat_wilsonc&quot;</code></td>
<td align="center">Stratified Wilson, with correction</td>
</tr>
<tr class="even">
<td align="center"><code>&quot;agresti-coull&quot;</code></td>
<td align="center">Agresti-Coull</td>
</tr>
<tr class="odd">
<td align="center"><code>&quot;jeffreys&quot;</code></td>
<td align="center">Jeffreys</td>
</tr>
</tbody>
</table>
<p>See in the table below the method options for estimates of proportion
difference and the associated statistical methods:</p>
<table>
<thead>
<tr class="header">
<th align="center">Method Options</th>
<th align="center">Statistical Methods</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="center"><code>&quot;cmh&quot;</code></td>
<td align="center"><code>CMH</code>, without correction</td>
</tr>
<tr class="even">
<td align="center"><code>&quot;wald&quot;</code></td>
<td align="center">Wald, with correction</td>
</tr>
<tr class="odd">
<td align="center"><code>&quot;waldcc&quot;</code></td>
<td align="center">Wald, without correction</td>
</tr>
<tr class="even">
<td align="center"><code>&quot;ha&quot;</code></td>
<td align="center">Anderson-Hauck</td>
</tr>
<tr class="odd">
<td align="center"><code>&quot;newcombe&quot;</code></td>
<td align="center">Newcombe, without correction</td>
</tr>
<tr class="even">
<td align="center"><code>&quot;newcombecc&quot;</code></td>
<td align="center">Newcombe, with correction</td>
</tr>
<tr class="odd">
<td align="center"><code>&quot;strat_wilsonc&quot;</code></td>
<td align="center">Stratified Wilson, with correction</td>
</tr>
<tr class="even">
<td align="center"><code>&quot;strat_newcombe&quot;</code></td>
<td align="center">Stratified Newcombe, without correction</td>
</tr>
<tr class="odd">
<td align="center"><code>&quot;strat_newcombecc&quot;</code></td>
<td align="center">Stratified Newcombe, with correction</td>
</tr>
</tbody>
</table>
<p>See in the table below the method options for testing proportion
difference and the associated statistical methods:</p>
<table>
<thead>
<tr class="header">
<th align="center">Method Options</th>
<th align="center">Statistical Methods</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="center"><code>&quot;chisq&quot;</code></td>
<td align="center">Chi-Squared test</td>
</tr>
<tr class="even">
<td align="center"><code>&quot;fisher&quot;</code></td>
<td align="center">the Fisherâs exact test</td>
</tr>
<tr class="odd">
<td align="center"><code>&quot;cmh&quot;</code></td>
<td align="center">stratified Cochran-Mantel-Haenszel test</td>
</tr>
<tr class="even">
<td align="center"><code>&quot;shouten&quot;</code></td>
<td align="center">Chi-Squared test with Schouten correction</td>
</tr>
</tbody>
</table>
<p>An example:</p>
<div class="sourceCode" id="cb77"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb77-1"><a href="#cb77-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;BESRSPI&quot;</span>, <span class="st">&quot;adrs&quot;</span>)</span>
<span id="cb77-2"><a href="#cb77-2" tabindex="-1"></a></span>
<span id="cb77-3"><a href="#cb77-3" tabindex="-1"></a><span class="fu">run</span>(rspt01, proc_data,</span>
<span id="cb77-4"><a href="#cb77-4" tabindex="-1"></a>  <span class="at">conf_level =</span> <span class="fl">0.90</span>,</span>
<span id="cb77-5"><a href="#cb77-5" tabindex="-1"></a>  <span class="at">methods =</span> <span class="fu">list</span>(</span>
<span id="cb77-6"><a href="#cb77-6" tabindex="-1"></a>    <span class="at">prop_conf_method =</span> <span class="st">&quot;wald&quot;</span>,</span>
<span id="cb77-7"><a href="#cb77-7" tabindex="-1"></a>    <span class="at">diff_conf_method =</span> <span class="st">&quot;wald&quot;</span>,</span>
<span id="cb77-8"><a href="#cb77-8" tabindex="-1"></a>    <span class="at">diff_pval_method =</span> <span class="st">&quot;fisher&quot;</span></span>
<span id="cb77-9"><a href="#cb77-9" tabindex="-1"></a>  )</span>
<span id="cb77-10"><a href="#cb77-10" tabindex="-1"></a>)</span>
<span id="cb77-11"><a href="#cb77-11" tabindex="-1"></a><span class="co">#&gt;                                              A: Drug X          B: Placebo        C: Combination  </span></span>
<span id="cb77-12"><a href="#cb77-12" tabindex="-1"></a><span class="co">#&gt;                                                (N=15)             (N=15)              (N=15)      </span></span>
<span id="cb77-13"><a href="#cb77-13" tabindex="-1"></a><span class="co">#&gt;   ââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb77-14"><a href="#cb77-14" tabindex="-1"></a><span class="co">#&gt;   Responders                                15 (100.0%)         14 (93.3%)          15 (100.0%)   </span></span>
<span id="cb77-15"><a href="#cb77-15" tabindex="-1"></a><span class="co">#&gt;   90% CI (Wald, without correction)        (100.0, 100.0)      (82.7, 100.0)      (100.0, 100.0)  </span></span>
<span id="cb77-16"><a href="#cb77-16" tabindex="-1"></a><span class="co">#&gt;   Unstratified Analysis                                                                           </span></span>
<span id="cb77-17"><a href="#cb77-17" tabindex="-1"></a><span class="co">#&gt;     Difference in Response rate (%)                                -6.7                 0.0       </span></span>
<span id="cb77-18"><a href="#cb77-18" tabindex="-1"></a><span class="co">#&gt;       90% CI (Wald, without correction)                        (-17.3, 3.9)         (0.0, 0.0)    </span></span>
<span id="cb77-19"><a href="#cb77-19" tabindex="-1"></a><span class="co">#&gt;     p-value (Fisher&#39;s Exact Test)                                 1.0000              1.0000      </span></span>
<span id="cb77-20"><a href="#cb77-20" tabindex="-1"></a><span class="co">#&gt;   Odds Ratio (95% CI)                                        0.00 (0.00 - Inf)   1.00 (0.00 - Inf)</span></span>
<span id="cb77-21"><a href="#cb77-21" tabindex="-1"></a><span class="co">#&gt;   Complete Response (CR)                    15 (100.0%)         11 (73.3%)          14 (93.3%)    </span></span>
<span id="cb77-22"><a href="#cb77-22" tabindex="-1"></a><span class="co">#&gt;     90% CI (Wald, without correction)     (100.00, 100.00)    (54.55, 92.11)      (82.74, 100.00) </span></span>
<span id="cb77-23"><a href="#cb77-23" tabindex="-1"></a><span class="co">#&gt;   Partial Response (PR)                       0 (0.0%)           3 (20.0%)           1 (6.7%)     </span></span>
<span id="cb77-24"><a href="#cb77-24" tabindex="-1"></a><span class="co">#&gt;     90% CI (Wald, without correction)       (0.00, 0.00)       (3.01, 36.99)       (0.00, 17.26)  </span></span>
<span id="cb77-25"><a href="#cb77-25" tabindex="-1"></a><span class="co">#&gt;   Stable Disease (SD)                         0 (0.0%)           1 (6.7%)            0 (0.0%)     </span></span>
<span id="cb77-26"><a href="#cb77-26" tabindex="-1"></a><span class="co">#&gt;     90% CI (Wald, without correction)       (0.00, 0.00)       (0.00, 17.26)       (0.00, 0.00)</span></span></code></pre></div>
</div>
<div id="best-overall-response-modifying-the-definition-of-overall-response" class="section level4">
<h4><strong>6. Best Overall Response (modifying the definition of
overall response)</strong></h4>
<p>The following example shows how to customize the definition of
responder, e.g, consider only complete response as response.</p>
<div class="sourceCode" id="cb78"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb78-1"><a href="#cb78-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;BESRSPI&quot;</span>, <span class="st">&quot;adrs&quot;</span>)</span>
<span id="cb78-2"><a href="#cb78-2" tabindex="-1"></a></span>
<span id="cb78-3"><a href="#cb78-3" tabindex="-1"></a><span class="fu">preprocess</span>(rspt01) <span class="ot">&lt;-</span> <span class="cf">function</span>(adam_db, ...) {</span>
<span id="cb78-4"><a href="#cb78-4" tabindex="-1"></a>  adam_db<span class="sc">$</span>adrs <span class="ot">&lt;-</span> adam_db<span class="sc">$</span>adrs <span class="sc">%&gt;%</span></span>
<span id="cb78-5"><a href="#cb78-5" tabindex="-1"></a>    <span class="fu">mutate</span>(<span class="at">RSP_LAB =</span> tern<span class="sc">::</span><span class="fu">d_onco_rsp_label</span>(.data<span class="sc">$</span>AVALC)) <span class="sc">%&gt;%</span></span>
<span id="cb78-6"><a href="#cb78-6" tabindex="-1"></a>    <span class="fu">mutate</span>(<span class="at">IS_RSP =</span> .data<span class="sc">$</span>AVALC <span class="sc">%in%</span> <span class="fu">c</span>(<span class="st">&quot;CR&quot;</span>))</span>
<span id="cb78-7"><a href="#cb78-7" tabindex="-1"></a>  adam_db</span>
<span id="cb78-8"><a href="#cb78-8" tabindex="-1"></a>}</span>
<span id="cb78-9"><a href="#cb78-9" tabindex="-1"></a></span>
<span id="cb78-10"><a href="#cb78-10" tabindex="-1"></a><span class="fu">run</span>(rspt01, proc_data)</span>
<span id="cb78-11"><a href="#cb78-11" tabindex="-1"></a><span class="co">#&gt; Warning in stats::prop.test(tbl, correct = FALSE): Chi-squared approximation</span></span>
<span id="cb78-12"><a href="#cb78-12" tabindex="-1"></a><span class="co">#&gt; may be incorrect</span></span>
<span id="cb78-13"><a href="#cb78-13" tabindex="-1"></a></span>
<span id="cb78-14"><a href="#cb78-14" tabindex="-1"></a><span class="co">#&gt; Warning in stats::prop.test(tbl, correct = FALSE): Chi-squared approximation</span></span>
<span id="cb78-15"><a href="#cb78-15" tabindex="-1"></a><span class="co">#&gt; may be incorrect</span></span>
<span id="cb78-16"><a href="#cb78-16" tabindex="-1"></a><span class="co">#&gt;                                           A: Drug X         B: Placebo        C: Combination  </span></span>
<span id="cb78-17"><a href="#cb78-17" tabindex="-1"></a><span class="co">#&gt;                                            (N=15)             (N=15)              (N=15)      </span></span>
<span id="cb78-18"><a href="#cb78-18" tabindex="-1"></a><span class="co">#&gt;   ââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb78-19"><a href="#cb78-19" tabindex="-1"></a><span class="co">#&gt;   Responders                             15 (100.0%)        11 (73.3%)          14 (93.3%)    </span></span>
<span id="cb78-20"><a href="#cb78-20" tabindex="-1"></a><span class="co">#&gt;   95% CI (Wald, with correction)        (96.7, 100.0)      (47.6, 99.0)        (77.4, 100.0)  </span></span>
<span id="cb78-21"><a href="#cb78-21" tabindex="-1"></a><span class="co">#&gt;   Unstratified Analysis                                                                       </span></span>
<span id="cb78-22"><a href="#cb78-22" tabindex="-1"></a><span class="co">#&gt;     Difference in Response rate (%)                            -26.7               -6.7       </span></span>
<span id="cb78-23"><a href="#cb78-23" tabindex="-1"></a><span class="co">#&gt;       95% CI (Wald, with correction)                       (-55.7, 2.4)        (-26.0, 12.6)  </span></span>
<span id="cb78-24"><a href="#cb78-24" tabindex="-1"></a><span class="co">#&gt;     p-value (Chi-Squared Test)                                0.0317              0.3091      </span></span>
<span id="cb78-25"><a href="#cb78-25" tabindex="-1"></a><span class="co">#&gt;   Odds Ratio (95% CI)                                    0.00 (0.00 - Inf)   0.00 (0.00 - Inf)</span></span>
<span id="cb78-26"><a href="#cb78-26" tabindex="-1"></a><span class="co">#&gt;   Complete Response (CR)                 15 (100.0%)        11 (73.3%)          14 (93.3%)    </span></span>
<span id="cb78-27"><a href="#cb78-27" tabindex="-1"></a><span class="co">#&gt;     95% CI (Wald, with correction)     (96.67, 100.00)    (47.62, 99.05)      (77.38, 100.00) </span></span>
<span id="cb78-28"><a href="#cb78-28" tabindex="-1"></a><span class="co">#&gt;   Partial Response (PR)                   0 (0.0%)           3 (20.0%)           1 (6.7%)     </span></span>
<span id="cb78-29"><a href="#cb78-29" tabindex="-1"></a><span class="co">#&gt;     95% CI (Wald, with correction)      (0.00, 3.33)       (0.00, 43.58)       (0.00, 22.62)  </span></span>
<span id="cb78-30"><a href="#cb78-30" tabindex="-1"></a><span class="co">#&gt;   Stable Disease (SD)                     0 (0.0%)           1 (6.7%)            0 (0.0%)     </span></span>
<span id="cb78-31"><a href="#cb78-31" tabindex="-1"></a><span class="co">#&gt;     95% CI (Wald, with correction)      (0.00, 3.33)       (0.00, 22.62)       (0.00, 3.33)</span></span></code></pre></div>
</div>
</div>
<div id="time-to-event-summary-ttet01" class="section level3">
<h3><strong>Time-to-event Summary (<code>TTET01</code>)</strong></h3>
<div id="time-to-event-summary" class="section level4">
<h4><strong>1. Time-to-event Summary</strong></h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>ttet01</code></strong> template produces the
standard time-to-event summary.</li>
<li>Users are expected to subset the parameter of interest
(e.g.Â <code>PARAMCD == &quot;PFS&quot;</code>) in pre-processing.</li>
<li>Please see the section of <a href="#id_1">Best Overall Response
(Ordering of treatment groups)</a> to find out more about the ordering
of treatment groups and reference group.</li>
<li>Unstratified analysis is provided by default.</li>
<li>Survival estimations and difference in survival are both provided by
default.</li>
</ol>
<div class="sourceCode" id="cb79"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb79-1"><a href="#cb79-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;PFS&quot;</span>, <span class="st">&quot;adtte&quot;</span>)</span>
<span id="cb79-2"><a href="#cb79-2" tabindex="-1"></a></span>
<span id="cb79-3"><a href="#cb79-3" tabindex="-1"></a><span class="fu">run</span>(ttet01, proc_data)</span>
<span id="cb79-4"><a href="#cb79-4" tabindex="-1"></a><span class="co">#&gt;                                        A: Drug X        B: Placebo      C: Combination </span></span>
<span id="cb79-5"><a href="#cb79-5" tabindex="-1"></a><span class="co">#&gt;                                         (N=15)            (N=15)            (N=15)     </span></span>
<span id="cb79-6"><a href="#cb79-6" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb79-7"><a href="#cb79-7" tabindex="-1"></a><span class="co">#&gt;   Patients with event (%)             10 (66.7%)        11 (73.3%)        11 (73.3%)   </span></span>
<span id="cb79-8"><a href="#cb79-8" tabindex="-1"></a><span class="co">#&gt;     Earliest contributing event                                                        </span></span>
<span id="cb79-9"><a href="#cb79-9" tabindex="-1"></a><span class="co">#&gt;       Death                                5                 6                 4       </span></span>
<span id="cb79-10"><a href="#cb79-10" tabindex="-1"></a><span class="co">#&gt;       Disease Progression                  5                 5                 7       </span></span>
<span id="cb79-11"><a href="#cb79-11" tabindex="-1"></a><span class="co">#&gt;   Patients without event (%)           5 (33.3%)         4 (26.7%)         4 (26.7%)   </span></span>
<span id="cb79-12"><a href="#cb79-12" tabindex="-1"></a><span class="co">#&gt;   Time to Event (MONTHS)                                                               </span></span>
<span id="cb79-13"><a href="#cb79-13" tabindex="-1"></a><span class="co">#&gt;     Median                               17.2              18.1              12.6      </span></span>
<span id="cb79-14"><a href="#cb79-14" tabindex="-1"></a><span class="co">#&gt;       95% CI                         (11.9, 24.4)       (6.5, 34.1)       (7.1, 15.6)  </span></span>
<span id="cb79-15"><a href="#cb79-15" tabindex="-1"></a><span class="co">#&gt;     25% and 75%-ile                   11.9, 24.4         6.5, 34.1         7.1, 15.5   </span></span>
<span id="cb79-16"><a href="#cb79-16" tabindex="-1"></a><span class="co">#&gt;     Range                           1.2 to 46.9 {1}   1.0 to 50.5 {2}     1.9 to 28.9  </span></span>
<span id="cb79-17"><a href="#cb79-17" tabindex="-1"></a><span class="co">#&gt;   Unstratified Analysis                                                                </span></span>
<span id="cb79-18"><a href="#cb79-18" tabindex="-1"></a><span class="co">#&gt;     p-value (log-rank)                                    0.8668            0.1419     </span></span>
<span id="cb79-19"><a href="#cb79-19" tabindex="-1"></a><span class="co">#&gt;     Hazard Ratio                                           0.93              1.95      </span></span>
<span id="cb79-20"><a href="#cb79-20" tabindex="-1"></a><span class="co">#&gt;     95% CI                                             (0.39, 2.22)      (0.79, 4.80)  </span></span>
<span id="cb79-21"><a href="#cb79-21" tabindex="-1"></a><span class="co">#&gt;   6 MONTHS                                                                             </span></span>
<span id="cb79-22"><a href="#cb79-22" tabindex="-1"></a><span class="co">#&gt;     Patients remaining at risk            10                11                10       </span></span>
<span id="cb79-23"><a href="#cb79-23" tabindex="-1"></a><span class="co">#&gt;     Event Free Rate (%)                  78.32             78.57             80.00     </span></span>
<span id="cb79-24"><a href="#cb79-24" tabindex="-1"></a><span class="co">#&gt;     95% CI                          (56.47, 100.00)   (57.08, 100.00)   (59.76, 100.00)</span></span>
<span id="cb79-25"><a href="#cb79-25" tabindex="-1"></a><span class="co">#&gt;     Difference in Event Free Rate                          0.25              1.68      </span></span>
<span id="cb79-26"><a href="#cb79-26" tabindex="-1"></a><span class="co">#&gt;       95% CI                                          (-30.40, 30.90)   (-28.11, 31.47)</span></span>
<span id="cb79-27"><a href="#cb79-27" tabindex="-1"></a><span class="co">#&gt;       p-value (Z-test)                                    0.9873            0.9121     </span></span>
<span id="cb79-28"><a href="#cb79-28" tabindex="-1"></a><span class="co">#&gt;   12 MONTHS                                                                            </span></span>
<span id="cb79-29"><a href="#cb79-29" tabindex="-1"></a><span class="co">#&gt;     Patients remaining at risk             8                 6                 7       </span></span>
<span id="cb79-30"><a href="#cb79-30" tabindex="-1"></a><span class="co">#&gt;     Event Free Rate (%)                  69.62             55.10             62.22     </span></span>
<span id="cb79-31"><a href="#cb79-31" tabindex="-1"></a><span class="co">#&gt;     95% CI                          (44.40, 94.84)    (27.89, 82.31)    (35.39, 89.06) </span></span>
<span id="cb79-32"><a href="#cb79-32" tabindex="-1"></a><span class="co">#&gt;     Difference in Event Free Rate                         -14.52             -7.40     </span></span>
<span id="cb79-33"><a href="#cb79-33" tabindex="-1"></a><span class="co">#&gt;       95% CI                                          (-51.62, 22.58)   (-44.22, 29.43)</span></span>
<span id="cb79-34"><a href="#cb79-34" tabindex="-1"></a><span class="co">#&gt;       p-value (Z-test)                                    0.4431            0.6938     </span></span>
<span id="cb79-35"><a href="#cb79-35" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb79-36"><a href="#cb79-36" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb79-37"><a href="#cb79-37" tabindex="-1"></a><span class="co">#&gt;   {1} - Censored observation: range maximum</span></span>
<span id="cb79-38"><a href="#cb79-38" tabindex="-1"></a><span class="co">#&gt;   {2} - Censored observations: range minimum &amp; maximum</span></span>
<span id="cb79-39"><a href="#cb79-39" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span></code></pre></div>
</div>
<div id="time-to-event-summary-selecting-sections-to-display" class="section level4">
<h4><strong>2. Time-to-event Summary (selecting sections to
display)</strong></h4>
<p>To suspend the section of earliest contributing events, use
<code>summarize_event = FALSE</code>.</p>
<div class="sourceCode" id="cb80"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb80-1"><a href="#cb80-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;PFS&quot;</span>, <span class="st">&quot;adtte&quot;</span>)</span>
<span id="cb80-2"><a href="#cb80-2" tabindex="-1"></a></span>
<span id="cb80-3"><a href="#cb80-3" tabindex="-1"></a><span class="fu">run</span>(ttet01, proc_data, <span class="at">summarize_event =</span> <span class="cn">FALSE</span>)</span>
<span id="cb80-4"><a href="#cb80-4" tabindex="-1"></a><span class="co">#&gt;                                        A: Drug X        B: Placebo      C: Combination </span></span>
<span id="cb80-5"><a href="#cb80-5" tabindex="-1"></a><span class="co">#&gt;                                         (N=15)            (N=15)            (N=15)     </span></span>
<span id="cb80-6"><a href="#cb80-6" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb80-7"><a href="#cb80-7" tabindex="-1"></a><span class="co">#&gt;   Patients with event (%)             10 (66.7%)        11 (73.3%)        11 (73.3%)   </span></span>
<span id="cb80-8"><a href="#cb80-8" tabindex="-1"></a><span class="co">#&gt;   Patients without event (%)           5 (33.3%)         4 (26.7%)         4 (26.7%)   </span></span>
<span id="cb80-9"><a href="#cb80-9" tabindex="-1"></a><span class="co">#&gt;   Time to Event (MONTHS)                                                               </span></span>
<span id="cb80-10"><a href="#cb80-10" tabindex="-1"></a><span class="co">#&gt;     Median                               17.2              18.1              12.6      </span></span>
<span id="cb80-11"><a href="#cb80-11" tabindex="-1"></a><span class="co">#&gt;       95% CI                         (11.9, 24.4)       (6.5, 34.1)       (7.1, 15.6)  </span></span>
<span id="cb80-12"><a href="#cb80-12" tabindex="-1"></a><span class="co">#&gt;     25% and 75%-ile                   11.9, 24.4         6.5, 34.1         7.1, 15.5   </span></span>
<span id="cb80-13"><a href="#cb80-13" tabindex="-1"></a><span class="co">#&gt;     Range                           1.2 to 46.9 {1}   1.0 to 50.5 {2}     1.9 to 28.9  </span></span>
<span id="cb80-14"><a href="#cb80-14" tabindex="-1"></a><span class="co">#&gt;   Unstratified Analysis                                                                </span></span>
<span id="cb80-15"><a href="#cb80-15" tabindex="-1"></a><span class="co">#&gt;     p-value (log-rank)                                    0.8668            0.1419     </span></span>
<span id="cb80-16"><a href="#cb80-16" tabindex="-1"></a><span class="co">#&gt;     Hazard Ratio                                           0.93              1.95      </span></span>
<span id="cb80-17"><a href="#cb80-17" tabindex="-1"></a><span class="co">#&gt;     95% CI                                             (0.39, 2.22)      (0.79, 4.80)  </span></span>
<span id="cb80-18"><a href="#cb80-18" tabindex="-1"></a><span class="co">#&gt;   6 MONTHS                                                                             </span></span>
<span id="cb80-19"><a href="#cb80-19" tabindex="-1"></a><span class="co">#&gt;     Patients remaining at risk            10                11                10       </span></span>
<span id="cb80-20"><a href="#cb80-20" tabindex="-1"></a><span class="co">#&gt;     Event Free Rate (%)                  78.32             78.57             80.00     </span></span>
<span id="cb80-21"><a href="#cb80-21" tabindex="-1"></a><span class="co">#&gt;     95% CI                          (56.47, 100.00)   (57.08, 100.00)   (59.76, 100.00)</span></span>
<span id="cb80-22"><a href="#cb80-22" tabindex="-1"></a><span class="co">#&gt;     Difference in Event Free Rate                          0.25              1.68      </span></span>
<span id="cb80-23"><a href="#cb80-23" tabindex="-1"></a><span class="co">#&gt;       95% CI                                          (-30.40, 30.90)   (-28.11, 31.47)</span></span>
<span id="cb80-24"><a href="#cb80-24" tabindex="-1"></a><span class="co">#&gt;       p-value (Z-test)                                    0.9873            0.9121     </span></span>
<span id="cb80-25"><a href="#cb80-25" tabindex="-1"></a><span class="co">#&gt;   12 MONTHS                                                                            </span></span>
<span id="cb80-26"><a href="#cb80-26" tabindex="-1"></a><span class="co">#&gt;     Patients remaining at risk             8                 6                 7       </span></span>
<span id="cb80-27"><a href="#cb80-27" tabindex="-1"></a><span class="co">#&gt;     Event Free Rate (%)                  69.62             55.10             62.22     </span></span>
<span id="cb80-28"><a href="#cb80-28" tabindex="-1"></a><span class="co">#&gt;     95% CI                          (44.40, 94.84)    (27.89, 82.31)    (35.39, 89.06) </span></span>
<span id="cb80-29"><a href="#cb80-29" tabindex="-1"></a><span class="co">#&gt;     Difference in Event Free Rate                         -14.52             -7.40     </span></span>
<span id="cb80-30"><a href="#cb80-30" tabindex="-1"></a><span class="co">#&gt;       95% CI                                          (-51.62, 22.58)   (-44.22, 29.43)</span></span>
<span id="cb80-31"><a href="#cb80-31" tabindex="-1"></a><span class="co">#&gt;       p-value (Z-test)                                    0.4431            0.6938     </span></span>
<span id="cb80-32"><a href="#cb80-32" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb80-33"><a href="#cb80-33" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb80-34"><a href="#cb80-34" tabindex="-1"></a><span class="co">#&gt;   {1} - Censored observation: range maximum</span></span>
<span id="cb80-35"><a href="#cb80-35" tabindex="-1"></a><span class="co">#&gt;   {2} - Censored observations: range minimum &amp; maximum</span></span>
<span id="cb80-36"><a href="#cb80-36" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span></code></pre></div>
<p>To select either survival estimations or difference in survival or
both, please specify in the argument <code>method</code>. -
<code>surv</code> calls out the analysis of patients remaining at risk,
event free rate and corresponding 95% confidence interval of the rates.
- <code>surv_diff</code> calls out the analysis of difference in event
free rate, the 95% confidence interval of the difference and its
corresponding p-value. - <code>both</code> calls out both.</p>
<div class="sourceCode" id="cb81"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb81-1"><a href="#cb81-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;PFS&quot;</span>, <span class="st">&quot;adtte&quot;</span>)</span>
<span id="cb81-2"><a href="#cb81-2" tabindex="-1"></a></span>
<span id="cb81-3"><a href="#cb81-3" tabindex="-1"></a><span class="fu">run</span>(ttet01, proc_data, <span class="at">method =</span> <span class="st">&quot;surv&quot;</span>)</span>
<span id="cb81-4"><a href="#cb81-4" tabindex="-1"></a><span class="co">#&gt;                                      A: Drug X        B: Placebo      C: Combination </span></span>
<span id="cb81-5"><a href="#cb81-5" tabindex="-1"></a><span class="co">#&gt;                                       (N=15)            (N=15)            (N=15)     </span></span>
<span id="cb81-6"><a href="#cb81-6" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb81-7"><a href="#cb81-7" tabindex="-1"></a><span class="co">#&gt;   Patients with event (%)           10 (66.7%)        11 (73.3%)        11 (73.3%)   </span></span>
<span id="cb81-8"><a href="#cb81-8" tabindex="-1"></a><span class="co">#&gt;     Earliest contributing event                                                      </span></span>
<span id="cb81-9"><a href="#cb81-9" tabindex="-1"></a><span class="co">#&gt;       Death                              5                 6                 4       </span></span>
<span id="cb81-10"><a href="#cb81-10" tabindex="-1"></a><span class="co">#&gt;       Disease Progression                5                 5                 7       </span></span>
<span id="cb81-11"><a href="#cb81-11" tabindex="-1"></a><span class="co">#&gt;   Patients without event (%)         5 (33.3%)         4 (26.7%)         4 (26.7%)   </span></span>
<span id="cb81-12"><a href="#cb81-12" tabindex="-1"></a><span class="co">#&gt;   Time to Event (MONTHS)                                                             </span></span>
<span id="cb81-13"><a href="#cb81-13" tabindex="-1"></a><span class="co">#&gt;     Median                             17.2              18.1              12.6      </span></span>
<span id="cb81-14"><a href="#cb81-14" tabindex="-1"></a><span class="co">#&gt;       95% CI                       (11.9, 24.4)       (6.5, 34.1)       (7.1, 15.6)  </span></span>
<span id="cb81-15"><a href="#cb81-15" tabindex="-1"></a><span class="co">#&gt;     25% and 75%-ile                 11.9, 24.4         6.5, 34.1         7.1, 15.5   </span></span>
<span id="cb81-16"><a href="#cb81-16" tabindex="-1"></a><span class="co">#&gt;     Range                         1.2 to 46.9 {1}   1.0 to 50.5 {2}     1.9 to 28.9  </span></span>
<span id="cb81-17"><a href="#cb81-17" tabindex="-1"></a><span class="co">#&gt;   Unstratified Analysis                                                              </span></span>
<span id="cb81-18"><a href="#cb81-18" tabindex="-1"></a><span class="co">#&gt;     p-value (log-rank)                                  0.8668            0.1419     </span></span>
<span id="cb81-19"><a href="#cb81-19" tabindex="-1"></a><span class="co">#&gt;     Hazard Ratio                                         0.93              1.95      </span></span>
<span id="cb81-20"><a href="#cb81-20" tabindex="-1"></a><span class="co">#&gt;     95% CI                                           (0.39, 2.22)      (0.79, 4.80)  </span></span>
<span id="cb81-21"><a href="#cb81-21" tabindex="-1"></a><span class="co">#&gt;   6 MONTHS                                                                           </span></span>
<span id="cb81-22"><a href="#cb81-22" tabindex="-1"></a><span class="co">#&gt;     Patients remaining at risk          10                11                10       </span></span>
<span id="cb81-23"><a href="#cb81-23" tabindex="-1"></a><span class="co">#&gt;     Event Free Rate (%)                78.32             78.57             80.00     </span></span>
<span id="cb81-24"><a href="#cb81-24" tabindex="-1"></a><span class="co">#&gt;     95% CI                        (56.47, 100.00)   (57.08, 100.00)   (59.76, 100.00)</span></span>
<span id="cb81-25"><a href="#cb81-25" tabindex="-1"></a><span class="co">#&gt;   12 MONTHS                                                                          </span></span>
<span id="cb81-26"><a href="#cb81-26" tabindex="-1"></a><span class="co">#&gt;     Patients remaining at risk           8                 6                 7       </span></span>
<span id="cb81-27"><a href="#cb81-27" tabindex="-1"></a><span class="co">#&gt;     Event Free Rate (%)                69.62             55.10             62.22     </span></span>
<span id="cb81-28"><a href="#cb81-28" tabindex="-1"></a><span class="co">#&gt;     95% CI                        (44.40, 94.84)    (27.89, 82.31)    (35.39, 89.06) </span></span>
<span id="cb81-29"><a href="#cb81-29" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb81-30"><a href="#cb81-30" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb81-31"><a href="#cb81-31" tabindex="-1"></a><span class="co">#&gt;   {1} - Censored observation: range maximum</span></span>
<span id="cb81-32"><a href="#cb81-32" tabindex="-1"></a><span class="co">#&gt;   {2} - Censored observations: range minimum &amp; maximum</span></span>
<span id="cb81-33"><a href="#cb81-33" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span></code></pre></div>
</div>
<div id="time-to-event-summary-modifying-analysis-details-like-confidence-interval-type-ties-and-alpha-level" class="section level4">
<h4><strong>3. Time-to-event Summary (modifying analysis details like
confidence interval type, ties, and alpha level)</strong></h4>
<ol style="list-style-type: decimal">
<li>The level of the confidence intervals is defined by the argument
<code>conf_level</code>.</li>
<li>The type of confidence interval is defined in the argument
<code>conf_type</code>. Options are <code>&quot;plain&quot;</code> (default),
<code>&quot;log&quot;</code> and <code>&quot;log-log&quot;</code>.</li>
<li>Handling of ties is specified in the argument <code>ties</code>.
Options are <code>&quot;efron&quot;</code> (default),<code>&quot;breslow&quot;</code> or
<code>&quot;exact&quot;</code>.</li>
</ol>
<div class="sourceCode" id="cb82"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb82-1"><a href="#cb82-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;PFS&quot;</span>, <span class="st">&quot;adtte&quot;</span>)</span>
<span id="cb82-2"><a href="#cb82-2" tabindex="-1"></a></span>
<span id="cb82-3"><a href="#cb82-3" tabindex="-1"></a><span class="fu">run</span>(ttet01, proc_data, <span class="at">conf_level =</span> <span class="fl">0.90</span>, <span class="at">conf_type =</span> <span class="st">&quot;log-log&quot;</span>, <span class="at">ties =</span> <span class="st">&quot;efron&quot;</span>)</span>
<span id="cb82-4"><a href="#cb82-4" tabindex="-1"></a><span class="co">#&gt;                                        A: Drug X        B: Placebo      C: Combination </span></span>
<span id="cb82-5"><a href="#cb82-5" tabindex="-1"></a><span class="co">#&gt;                                         (N=15)            (N=15)            (N=15)     </span></span>
<span id="cb82-6"><a href="#cb82-6" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb82-7"><a href="#cb82-7" tabindex="-1"></a><span class="co">#&gt;   Patients with event (%)             10 (66.7%)        11 (73.3%)        11 (73.3%)   </span></span>
<span id="cb82-8"><a href="#cb82-8" tabindex="-1"></a><span class="co">#&gt;     Earliest contributing event                                                        </span></span>
<span id="cb82-9"><a href="#cb82-9" tabindex="-1"></a><span class="co">#&gt;       Death                                5                 6                 4       </span></span>
<span id="cb82-10"><a href="#cb82-10" tabindex="-1"></a><span class="co">#&gt;       Disease Progression                  5                 5                 7       </span></span>
<span id="cb82-11"><a href="#cb82-11" tabindex="-1"></a><span class="co">#&gt;   Patients without event (%)           5 (33.3%)         4 (26.7%)         4 (26.7%)   </span></span>
<span id="cb82-12"><a href="#cb82-12" tabindex="-1"></a><span class="co">#&gt;   Time to Event (MONTHS)                                                               </span></span>
<span id="cb82-13"><a href="#cb82-13" tabindex="-1"></a><span class="co">#&gt;     Median                               17.2              18.1              12.6      </span></span>
<span id="cb82-14"><a href="#cb82-14" tabindex="-1"></a><span class="co">#&gt;       90% CI                         (11.9, 20.6)       (6.5, 29.5)       (7.1, 15.5)  </span></span>
<span id="cb82-15"><a href="#cb82-15" tabindex="-1"></a><span class="co">#&gt;     25% and 75%-ile                   11.9, 24.4         6.5, 34.1         7.1, 15.5   </span></span>
<span id="cb82-16"><a href="#cb82-16" tabindex="-1"></a><span class="co">#&gt;     Range                           1.2 to 46.9 {1}   1.0 to 50.5 {2}     1.9 to 28.9  </span></span>
<span id="cb82-17"><a href="#cb82-17" tabindex="-1"></a><span class="co">#&gt;   Unstratified Analysis                                                                </span></span>
<span id="cb82-18"><a href="#cb82-18" tabindex="-1"></a><span class="co">#&gt;     p-value (log-rank)                                    0.8668            0.1419     </span></span>
<span id="cb82-19"><a href="#cb82-19" tabindex="-1"></a><span class="co">#&gt;     Hazard Ratio                                           0.93              1.95      </span></span>
<span id="cb82-20"><a href="#cb82-20" tabindex="-1"></a><span class="co">#&gt;     90% CI                                             (0.45, 1.93)      (0.91, 4.15)  </span></span>
<span id="cb82-21"><a href="#cb82-21" tabindex="-1"></a><span class="co">#&gt;   6 MONTHS                                                                             </span></span>
<span id="cb82-22"><a href="#cb82-22" tabindex="-1"></a><span class="co">#&gt;     Patients remaining at risk            10                11                10       </span></span>
<span id="cb82-23"><a href="#cb82-23" tabindex="-1"></a><span class="co">#&gt;     Event Free Rate (%)                  78.32             78.57             80.00     </span></span>
<span id="cb82-24"><a href="#cb82-24" tabindex="-1"></a><span class="co">#&gt;     90% CI                          (52.89, 91.05)    (53.54, 91.11)    (56.11, 91.74) </span></span>
<span id="cb82-25"><a href="#cb82-25" tabindex="-1"></a><span class="co">#&gt;     Difference in Event Free Rate                          0.25              1.68      </span></span>
<span id="cb82-26"><a href="#cb82-26" tabindex="-1"></a><span class="co">#&gt;       90% CI                                          (-25.47, 25.97)   (-23.32, 26.68)</span></span>
<span id="cb82-27"><a href="#cb82-27" tabindex="-1"></a><span class="co">#&gt;       p-value (Z-test)                                    0.9873            0.9121     </span></span>
<span id="cb82-28"><a href="#cb82-28" tabindex="-1"></a><span class="co">#&gt;   12 MONTHS                                                                            </span></span>
<span id="cb82-29"><a href="#cb82-29" tabindex="-1"></a><span class="co">#&gt;     Patients remaining at risk             8                 6                 7       </span></span>
<span id="cb82-30"><a href="#cb82-30" tabindex="-1"></a><span class="co">#&gt;     Event Free Rate (%)                  69.62             55.10             62.22     </span></span>
<span id="cb82-31"><a href="#cb82-31" tabindex="-1"></a><span class="co">#&gt;     90% CI                          (43.24, 85.52)    (30.28, 74.28)    (36.15, 80.15) </span></span>
<span id="cb82-32"><a href="#cb82-32" tabindex="-1"></a><span class="co">#&gt;     Difference in Event Free Rate                         -14.52             -7.40     </span></span>
<span id="cb82-33"><a href="#cb82-33" tabindex="-1"></a><span class="co">#&gt;       90% CI                                          (-45.65, 16.62)   (-38.30, 23.51)</span></span>
<span id="cb82-34"><a href="#cb82-34" tabindex="-1"></a><span class="co">#&gt;       p-value (Z-test)                                    0.4431            0.6938     </span></span>
<span id="cb82-35"><a href="#cb82-35" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb82-36"><a href="#cb82-36" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb82-37"><a href="#cb82-37" tabindex="-1"></a><span class="co">#&gt;   {1} - Censored observation: range maximum</span></span>
<span id="cb82-38"><a href="#cb82-38" tabindex="-1"></a><span class="co">#&gt;   {2} - Censored observations: range minimum &amp; maximum</span></span>
<span id="cb82-39"><a href="#cb82-39" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span></code></pre></div>
</div>
<div id="time-to-event-summary-with-stratified-analysis" class="section level4">
<h4><strong>4. Time-to-event Summary (with stratified
analysis)</strong></h4>
<ol style="list-style-type: decimal">
<li>A stratified analysis can be added by specifying the argument
<code>perform_analysis = &quot;strat&quot;</code> and providing the stratification
variable to the argument <code>strata</code> . The argument
<code>strata</code> is expected if <code>perform_analysis</code> is set
to include stratified analysis.</li>
<li>The stratification variables are expected to be available in
<code>adrs</code>.</li>
<li>If unstratified and stratified analysis are both required, users can
use <code>perform_analysis = c(&quot;unstrat&quot;, &quot;strat&quot;)</code>.</li>
</ol>
<div class="sourceCode" id="cb83"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb83-1"><a href="#cb83-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;PFS&quot;</span>, <span class="st">&quot;adtte&quot;</span>)</span>
<span id="cb83-2"><a href="#cb83-2" tabindex="-1"></a></span>
<span id="cb83-3"><a href="#cb83-3" tabindex="-1"></a><span class="fu">run</span>(ttet01, proc_data, <span class="at">perform_analysis =</span> <span class="st">&quot;strat&quot;</span>, <span class="at">strata =</span> <span class="st">&quot;STRATA1&quot;</span>)</span>
<span id="cb83-4"><a href="#cb83-4" tabindex="-1"></a><span class="co">#&gt;                                        A: Drug X        B: Placebo      C: Combination </span></span>
<span id="cb83-5"><a href="#cb83-5" tabindex="-1"></a><span class="co">#&gt;                                         (N=15)            (N=15)            (N=15)     </span></span>
<span id="cb83-6"><a href="#cb83-6" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb83-7"><a href="#cb83-7" tabindex="-1"></a><span class="co">#&gt;   Patients with event (%)             10 (66.7%)        11 (73.3%)        11 (73.3%)   </span></span>
<span id="cb83-8"><a href="#cb83-8" tabindex="-1"></a><span class="co">#&gt;     Earliest contributing event                                                        </span></span>
<span id="cb83-9"><a href="#cb83-9" tabindex="-1"></a><span class="co">#&gt;       Death                                5                 6                 4       </span></span>
<span id="cb83-10"><a href="#cb83-10" tabindex="-1"></a><span class="co">#&gt;       Disease Progression                  5                 5                 7       </span></span>
<span id="cb83-11"><a href="#cb83-11" tabindex="-1"></a><span class="co">#&gt;   Patients without event (%)           5 (33.3%)         4 (26.7%)         4 (26.7%)   </span></span>
<span id="cb83-12"><a href="#cb83-12" tabindex="-1"></a><span class="co">#&gt;   Time to Event (MONTHS)                                                               </span></span>
<span id="cb83-13"><a href="#cb83-13" tabindex="-1"></a><span class="co">#&gt;     Median                               17.2              18.1              12.6      </span></span>
<span id="cb83-14"><a href="#cb83-14" tabindex="-1"></a><span class="co">#&gt;       95% CI                         (11.9, 24.4)       (6.5, 34.1)       (7.1, 15.6)  </span></span>
<span id="cb83-15"><a href="#cb83-15" tabindex="-1"></a><span class="co">#&gt;     25% and 75%-ile                   11.9, 24.4         6.5, 34.1         7.1, 15.5   </span></span>
<span id="cb83-16"><a href="#cb83-16" tabindex="-1"></a><span class="co">#&gt;     Range                           1.2 to 46.9 {1}   1.0 to 50.5 {2}     1.9 to 28.9  </span></span>
<span id="cb83-17"><a href="#cb83-17" tabindex="-1"></a><span class="co">#&gt;   Stratified Analysis                                                                  </span></span>
<span id="cb83-18"><a href="#cb83-18" tabindex="-1"></a><span class="co">#&gt;     p-value (log-rank)                                    0.6624            0.2020     </span></span>
<span id="cb83-19"><a href="#cb83-19" tabindex="-1"></a><span class="co">#&gt;     Hazard Ratio                                           0.82              1.90      </span></span>
<span id="cb83-20"><a href="#cb83-20" tabindex="-1"></a><span class="co">#&gt;     95% CI                                             (0.33, 2.02)      (0.70, 5.15)  </span></span>
<span id="cb83-21"><a href="#cb83-21" tabindex="-1"></a><span class="co">#&gt;   6 MONTHS                                                                             </span></span>
<span id="cb83-22"><a href="#cb83-22" tabindex="-1"></a><span class="co">#&gt;     Patients remaining at risk            10                11                10       </span></span>
<span id="cb83-23"><a href="#cb83-23" tabindex="-1"></a><span class="co">#&gt;     Event Free Rate (%)                  78.32             78.57             80.00     </span></span>
<span id="cb83-24"><a href="#cb83-24" tabindex="-1"></a><span class="co">#&gt;     95% CI                          (56.47, 100.00)   (57.08, 100.00)   (59.76, 100.00)</span></span>
<span id="cb83-25"><a href="#cb83-25" tabindex="-1"></a><span class="co">#&gt;     Difference in Event Free Rate                          0.25              1.68      </span></span>
<span id="cb83-26"><a href="#cb83-26" tabindex="-1"></a><span class="co">#&gt;       95% CI                                          (-30.40, 30.90)   (-28.11, 31.47)</span></span>
<span id="cb83-27"><a href="#cb83-27" tabindex="-1"></a><span class="co">#&gt;       p-value (Z-test)                                    0.9873            0.9121     </span></span>
<span id="cb83-28"><a href="#cb83-28" tabindex="-1"></a><span class="co">#&gt;   12 MONTHS                                                                            </span></span>
<span id="cb83-29"><a href="#cb83-29" tabindex="-1"></a><span class="co">#&gt;     Patients remaining at risk             8                 6                 7       </span></span>
<span id="cb83-30"><a href="#cb83-30" tabindex="-1"></a><span class="co">#&gt;     Event Free Rate (%)                  69.62             55.10             62.22     </span></span>
<span id="cb83-31"><a href="#cb83-31" tabindex="-1"></a><span class="co">#&gt;     95% CI                          (44.40, 94.84)    (27.89, 82.31)    (35.39, 89.06) </span></span>
<span id="cb83-32"><a href="#cb83-32" tabindex="-1"></a><span class="co">#&gt;     Difference in Event Free Rate                         -14.52             -7.40     </span></span>
<span id="cb83-33"><a href="#cb83-33" tabindex="-1"></a><span class="co">#&gt;       95% CI                                          (-51.62, 22.58)   (-44.22, 29.43)</span></span>
<span id="cb83-34"><a href="#cb83-34" tabindex="-1"></a><span class="co">#&gt;       p-value (Z-test)                                    0.4431            0.6938     </span></span>
<span id="cb83-35"><a href="#cb83-35" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb83-36"><a href="#cb83-36" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb83-37"><a href="#cb83-37" tabindex="-1"></a><span class="co">#&gt;   {1} - Censored observation: range maximum</span></span>
<span id="cb83-38"><a href="#cb83-38" tabindex="-1"></a><span class="co">#&gt;   {2} - Censored observations: range minimum &amp; maximum</span></span>
<span id="cb83-39"><a href="#cb83-39" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span></code></pre></div>
</div>
<div id="time-to-event-summary-modifying-time-point-for-the-survival-at-xx-months-analysis" class="section level4">
<h4><strong>5. Time-to-event Summary (modifying time point for the
âsurvival at xx monthsâ analysis)</strong></h4>
<p>The time point for the âsurvival at xx monthsâ analysis can be
modified by specifying the argument <code>time_point</code>. By default,
the function takes <code>AVAL</code> from <code>adtte</code> in days and
converts it to months. The survival estimates are then summarized in
month, and the numeric values should be provided in months to
<code>time_point</code>.</p>
<div class="sourceCode" id="cb84"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb84-1"><a href="#cb84-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;PFS&quot;</span>, <span class="st">&quot;adtte&quot;</span>)</span>
<span id="cb84-2"><a href="#cb84-2" tabindex="-1"></a></span>
<span id="cb84-3"><a href="#cb84-3" tabindex="-1"></a><span class="fu">run</span>(ttet01, proc_data, <span class="at">perform_analysis =</span> <span class="st">&quot;unstrat&quot;</span>, <span class="at">time_point =</span> <span class="fu">c</span>(<span class="dv">3</span>, <span class="dv">6</span>))</span>
<span id="cb84-4"><a href="#cb84-4" tabindex="-1"></a><span class="co">#&gt;                                        A: Drug X        B: Placebo      C: Combination </span></span>
<span id="cb84-5"><a href="#cb84-5" tabindex="-1"></a><span class="co">#&gt;                                         (N=15)            (N=15)            (N=15)     </span></span>
<span id="cb84-6"><a href="#cb84-6" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb84-7"><a href="#cb84-7" tabindex="-1"></a><span class="co">#&gt;   Patients with event (%)             10 (66.7%)        11 (73.3%)        11 (73.3%)   </span></span>
<span id="cb84-8"><a href="#cb84-8" tabindex="-1"></a><span class="co">#&gt;     Earliest contributing event                                                        </span></span>
<span id="cb84-9"><a href="#cb84-9" tabindex="-1"></a><span class="co">#&gt;       Death                                5                 6                 4       </span></span>
<span id="cb84-10"><a href="#cb84-10" tabindex="-1"></a><span class="co">#&gt;       Disease Progression                  5                 5                 7       </span></span>
<span id="cb84-11"><a href="#cb84-11" tabindex="-1"></a><span class="co">#&gt;   Patients without event (%)           5 (33.3%)         4 (26.7%)         4 (26.7%)   </span></span>
<span id="cb84-12"><a href="#cb84-12" tabindex="-1"></a><span class="co">#&gt;   Time to Event (MONTHS)                                                               </span></span>
<span id="cb84-13"><a href="#cb84-13" tabindex="-1"></a><span class="co">#&gt;     Median                               17.2              18.1              12.6      </span></span>
<span id="cb84-14"><a href="#cb84-14" tabindex="-1"></a><span class="co">#&gt;       95% CI                         (11.9, 24.4)       (6.5, 34.1)       (7.1, 15.6)  </span></span>
<span id="cb84-15"><a href="#cb84-15" tabindex="-1"></a><span class="co">#&gt;     25% and 75%-ile                   11.9, 24.4         6.5, 34.1         7.1, 15.5   </span></span>
<span id="cb84-16"><a href="#cb84-16" tabindex="-1"></a><span class="co">#&gt;     Range                           1.2 to 46.9 {1}   1.0 to 50.5 {2}     1.9 to 28.9  </span></span>
<span id="cb84-17"><a href="#cb84-17" tabindex="-1"></a><span class="co">#&gt;   Unstratified Analysis                                                                </span></span>
<span id="cb84-18"><a href="#cb84-18" tabindex="-1"></a><span class="co">#&gt;     p-value (log-rank)                                    0.8668            0.1419     </span></span>
<span id="cb84-19"><a href="#cb84-19" tabindex="-1"></a><span class="co">#&gt;     Hazard Ratio                                           0.93              1.95      </span></span>
<span id="cb84-20"><a href="#cb84-20" tabindex="-1"></a><span class="co">#&gt;     95% CI                                             (0.39, 2.22)      (0.79, 4.80)  </span></span>
<span id="cb84-21"><a href="#cb84-21" tabindex="-1"></a><span class="co">#&gt;   3 MONTHS                                                                             </span></span>
<span id="cb84-22"><a href="#cb84-22" tabindex="-1"></a><span class="co">#&gt;     Patients remaining at risk            12                12                12       </span></span>
<span id="cb84-23"><a href="#cb84-23" tabindex="-1"></a><span class="co">#&gt;     Event Free Rate (%)                  86.15             85.71             80.00     </span></span>
<span id="cb84-24"><a href="#cb84-24" tabindex="-1"></a><span class="co">#&gt;     95% CI                          (68.31, 100.00)   (67.38, 100.00)   (59.76, 100.00)</span></span>
<span id="cb84-25"><a href="#cb84-25" tabindex="-1"></a><span class="co">#&gt;     Difference in Event Free Rate                          -0.44             -6.15     </span></span>
<span id="cb84-26"><a href="#cb84-26" tabindex="-1"></a><span class="co">#&gt;       95% CI                                          (-26.02, 25.14)   (-33.14, 20.83)</span></span>
<span id="cb84-27"><a href="#cb84-27" tabindex="-1"></a><span class="co">#&gt;       p-value (Z-test)                                    0.9731            0.6549     </span></span>
<span id="cb84-28"><a href="#cb84-28" tabindex="-1"></a><span class="co">#&gt;   6 MONTHS                                                                             </span></span>
<span id="cb84-29"><a href="#cb84-29" tabindex="-1"></a><span class="co">#&gt;     Patients remaining at risk            10                11                10       </span></span>
<span id="cb84-30"><a href="#cb84-30" tabindex="-1"></a><span class="co">#&gt;     Event Free Rate (%)                  78.32             78.57             80.00     </span></span>
<span id="cb84-31"><a href="#cb84-31" tabindex="-1"></a><span class="co">#&gt;     95% CI                          (56.47, 100.00)   (57.08, 100.00)   (59.76, 100.00)</span></span>
<span id="cb84-32"><a href="#cb84-32" tabindex="-1"></a><span class="co">#&gt;     Difference in Event Free Rate                          0.25              1.68      </span></span>
<span id="cb84-33"><a href="#cb84-33" tabindex="-1"></a><span class="co">#&gt;       95% CI                                          (-30.40, 30.90)   (-28.11, 31.47)</span></span>
<span id="cb84-34"><a href="#cb84-34" tabindex="-1"></a><span class="co">#&gt;       p-value (Z-test)                                    0.9873            0.9121     </span></span>
<span id="cb84-35"><a href="#cb84-35" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb84-36"><a href="#cb84-36" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb84-37"><a href="#cb84-37" tabindex="-1"></a><span class="co">#&gt;   {1} - Censored observation: range maximum</span></span>
<span id="cb84-38"><a href="#cb84-38" tabindex="-1"></a><span class="co">#&gt;   {2} - Censored observations: range minimum &amp; maximum</span></span>
<span id="cb84-39"><a href="#cb84-39" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span></code></pre></div>
<p>The following example shows how to specify the time point in
<strong>user-defined unit</strong>.</p>
<div class="sourceCode" id="cb85"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb85-1"><a href="#cb85-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;PFS&quot;</span>, <span class="st">&quot;adtte&quot;</span>)</span>
<span id="cb85-2"><a href="#cb85-2" tabindex="-1"></a></span>
<span id="cb85-3"><a href="#cb85-3" tabindex="-1"></a><span class="fu">preprocess</span>(ttet01) <span class="ot">&lt;-</span> <span class="cf">function</span>(adam_db, <span class="at">dataset =</span> <span class="st">&quot;adtte&quot;</span>,</span>
<span id="cb85-4"><a href="#cb85-4" tabindex="-1"></a>                               ...) {</span>
<span id="cb85-5"><a href="#cb85-5" tabindex="-1"></a>  adam_db[[dataset]] <span class="ot">&lt;-</span> adam_db[[dataset]] <span class="sc">%&gt;%</span></span>
<span id="cb85-6"><a href="#cb85-6" tabindex="-1"></a>    <span class="fu">mutate</span>(</span>
<span id="cb85-7"><a href="#cb85-7" tabindex="-1"></a>      <span class="at">AVALU =</span> <span class="st">&quot;DAYS&quot;</span>,</span>
<span id="cb85-8"><a href="#cb85-8" tabindex="-1"></a>      <span class="at">IS_EVENT =</span> .data<span class="sc">$</span>CNSR <span class="sc">==</span> <span class="dv">0</span>,</span>
<span id="cb85-9"><a href="#cb85-9" tabindex="-1"></a>      <span class="at">IS_NOT_EVENT =</span> .data<span class="sc">$</span>CNSR <span class="sc">==</span> <span class="dv">1</span>,</span>
<span id="cb85-10"><a href="#cb85-10" tabindex="-1"></a>      <span class="at">EVNT1 =</span> <span class="fu">factor</span>(</span>
<span id="cb85-11"><a href="#cb85-11" tabindex="-1"></a>        <span class="fu">case_when</span>(</span>
<span id="cb85-12"><a href="#cb85-12" tabindex="-1"></a>          IS_EVENT <span class="sc">==</span> <span class="cn">TRUE</span> <span class="sc">~</span> <span class="fu">render_safe</span>(<span class="st">&quot;{Patient_label} with event (%)&quot;</span>),</span>
<span id="cb85-13"><a href="#cb85-13" tabindex="-1"></a>          IS_EVENT <span class="sc">==</span> <span class="cn">FALSE</span> <span class="sc">~</span> <span class="fu">render_safe</span>(<span class="st">&quot;{Patient_label} without event (%)&quot;</span>)</span>
<span id="cb85-14"><a href="#cb85-14" tabindex="-1"></a>        ),</span>
<span id="cb85-15"><a href="#cb85-15" tabindex="-1"></a>        <span class="at">levels =</span> <span class="fu">render_safe</span>(<span class="fu">c</span>(<span class="st">&quot;{Patient_label} with event (%)&quot;</span>, <span class="st">&quot;{Patient_label} without event (%)&quot;</span>))</span>
<span id="cb85-16"><a href="#cb85-16" tabindex="-1"></a>      ),</span>
<span id="cb85-17"><a href="#cb85-17" tabindex="-1"></a>      <span class="at">EVNTDESC =</span> <span class="fu">factor</span>(.data<span class="sc">$</span>EVNTDESC)</span>
<span id="cb85-18"><a href="#cb85-18" tabindex="-1"></a>    )</span>
<span id="cb85-19"><a href="#cb85-19" tabindex="-1"></a></span>
<span id="cb85-20"><a href="#cb85-20" tabindex="-1"></a>  adam_db</span>
<span id="cb85-21"><a href="#cb85-21" tabindex="-1"></a>}</span>
<span id="cb85-22"><a href="#cb85-22" tabindex="-1"></a></span>
<span id="cb85-23"><a href="#cb85-23" tabindex="-1"></a><span class="fu">run</span>(ttet01, proc_data, <span class="at">perform_analysis =</span> <span class="st">&quot;unstrat&quot;</span>, <span class="at">time_point =</span> <span class="fu">c</span>(<span class="dv">91</span>, <span class="dv">183</span>))</span>
<span id="cb85-24"><a href="#cb85-24" tabindex="-1"></a><span class="co">#&gt;                                         A: Drug X            B: Placebo       C: Combination </span></span>
<span id="cb85-25"><a href="#cb85-25" tabindex="-1"></a><span class="co">#&gt;                                           (N=15)               (N=15)             (N=15)     </span></span>
<span id="cb85-26"><a href="#cb85-26" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb85-27"><a href="#cb85-27" tabindex="-1"></a><span class="co">#&gt;   Patients with event (%)               10 (66.7%)           11 (73.3%)         11 (73.3%)   </span></span>
<span id="cb85-28"><a href="#cb85-28" tabindex="-1"></a><span class="co">#&gt;     Earliest contributing event                                                              </span></span>
<span id="cb85-29"><a href="#cb85-29" tabindex="-1"></a><span class="co">#&gt;       Death                                 5                    6                   4       </span></span>
<span id="cb85-30"><a href="#cb85-30" tabindex="-1"></a><span class="co">#&gt;       Disease Progression                   5                    5                   7       </span></span>
<span id="cb85-31"><a href="#cb85-31" tabindex="-1"></a><span class="co">#&gt;   Patients without event (%)            5 (33.3%)            4 (26.7%)           4 (26.7%)   </span></span>
<span id="cb85-32"><a href="#cb85-32" tabindex="-1"></a><span class="co">#&gt;   Time to Event (DAYS)                                                                       </span></span>
<span id="cb85-33"><a href="#cb85-33" tabindex="-1"></a><span class="co">#&gt;     Median                                523.9                549.7               382.9     </span></span>
<span id="cb85-34"><a href="#cb85-34" tabindex="-1"></a><span class="co">#&gt;       95% CI                          (363.0, 743.3)      (196.5, 1037.2)     (215.4, 474.4) </span></span>
<span id="cb85-35"><a href="#cb85-35" tabindex="-1"></a><span class="co">#&gt;     25% and 75%-ile                    363.0, 743.3        196.5, 1037.2       215.4, 470.5  </span></span>
<span id="cb85-36"><a href="#cb85-36" tabindex="-1"></a><span class="co">#&gt;     Range                           38.0 to 1426.9 {1}   30.0 to 1537.5 {2}    57.3 to 880.2 </span></span>
<span id="cb85-37"><a href="#cb85-37" tabindex="-1"></a><span class="co">#&gt;   Unstratified Analysis                                                                      </span></span>
<span id="cb85-38"><a href="#cb85-38" tabindex="-1"></a><span class="co">#&gt;     p-value (log-rank)                                         0.8668             0.1419     </span></span>
<span id="cb85-39"><a href="#cb85-39" tabindex="-1"></a><span class="co">#&gt;     Hazard Ratio                                                0.93               1.95      </span></span>
<span id="cb85-40"><a href="#cb85-40" tabindex="-1"></a><span class="co">#&gt;     95% CI                                                  (0.39, 2.22)       (0.79, 4.80)  </span></span>
<span id="cb85-41"><a href="#cb85-41" tabindex="-1"></a><span class="co">#&gt;   91 DAYS                                                                                    </span></span>
<span id="cb85-42"><a href="#cb85-42" tabindex="-1"></a><span class="co">#&gt;     Patients remaining at risk              12                   12                 12       </span></span>
<span id="cb85-43"><a href="#cb85-43" tabindex="-1"></a><span class="co">#&gt;     Event Free Rate (%)                   86.15                85.71               80.00     </span></span>
<span id="cb85-44"><a href="#cb85-44" tabindex="-1"></a><span class="co">#&gt;     95% CI                           (68.31, 100.00)      (67.38, 100.00)     (59.76, 100.00)</span></span>
<span id="cb85-45"><a href="#cb85-45" tabindex="-1"></a><span class="co">#&gt;     Difference in Event Free Rate                              -0.44               -6.15     </span></span>
<span id="cb85-46"><a href="#cb85-46" tabindex="-1"></a><span class="co">#&gt;       95% CI                                              (-26.02, 25.14)     (-33.14, 20.83)</span></span>
<span id="cb85-47"><a href="#cb85-47" tabindex="-1"></a><span class="co">#&gt;       p-value (Z-test)                                         0.9731             0.6549     </span></span>
<span id="cb85-48"><a href="#cb85-48" tabindex="-1"></a><span class="co">#&gt;   183 DAYS                                                                                   </span></span>
<span id="cb85-49"><a href="#cb85-49" tabindex="-1"></a><span class="co">#&gt;     Patients remaining at risk              10                   11                 10       </span></span>
<span id="cb85-50"><a href="#cb85-50" tabindex="-1"></a><span class="co">#&gt;     Event Free Rate (%)                   78.32                78.57               80.00     </span></span>
<span id="cb85-51"><a href="#cb85-51" tabindex="-1"></a><span class="co">#&gt;     95% CI                           (56.47, 100.00)      (57.08, 100.00)     (59.76, 100.00)</span></span>
<span id="cb85-52"><a href="#cb85-52" tabindex="-1"></a><span class="co">#&gt;     Difference in Event Free Rate                               0.25               1.68      </span></span>
<span id="cb85-53"><a href="#cb85-53" tabindex="-1"></a><span class="co">#&gt;       95% CI                                              (-30.40, 30.90)     (-28.11, 31.47)</span></span>
<span id="cb85-54"><a href="#cb85-54" tabindex="-1"></a><span class="co">#&gt;       p-value (Z-test)                                         0.9873             0.9121     </span></span>
<span id="cb85-55"><a href="#cb85-55" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb85-56"><a href="#cb85-56" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb85-57"><a href="#cb85-57" tabindex="-1"></a><span class="co">#&gt;   {1} - Censored observation: range maximum</span></span>
<span id="cb85-58"><a href="#cb85-58" tabindex="-1"></a><span class="co">#&gt;   {2} - Censored observations: range minimum &amp; maximum</span></span>
<span id="cb85-59"><a href="#cb85-59" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span></code></pre></div>
</div>
<div id="time-to-event-summary-modifying-the-p-value-method-for-testing-hazard-ratio" class="section level4">
<h4><strong>6. Time-to-event Summary (modifying the p-value method for
testing hazard ratio)</strong></h4>
<p>The default p-value method for testing hazard ratio is âlog-rankâ.
Alternative methods can be requested by specifying the argument
<code>pval_method</code> and options include, <code>log-rank</code>
(default), <code>wald</code> or <code>likelihood</code>. The syntax
currently does not allow requesting more than one p-value.</p>
<p>Note that <code>ttet01</code> has been modified in the previous
example (i.e., <code>preprocess(ttet01)</code> has been overridden); to
access the default template, try <code>chevron::ttet01</code>.</p>
<div class="sourceCode" id="cb86"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb86-1"><a href="#cb86-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;PFS&quot;</span>, <span class="st">&quot;adtte&quot;</span>)</span>
<span id="cb86-2"><a href="#cb86-2" tabindex="-1"></a></span>
<span id="cb86-3"><a href="#cb86-3" tabindex="-1"></a><span class="fu">run</span>(chevron<span class="sc">::</span>ttet01, proc_data, <span class="at">pval_method =</span> <span class="st">&quot;wald&quot;</span>)</span>
<span id="cb86-4"><a href="#cb86-4" tabindex="-1"></a><span class="co">#&gt;                                        A: Drug X        B: Placebo      C: Combination </span></span>
<span id="cb86-5"><a href="#cb86-5" tabindex="-1"></a><span class="co">#&gt;                                         (N=15)            (N=15)            (N=15)     </span></span>
<span id="cb86-6"><a href="#cb86-6" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb86-7"><a href="#cb86-7" tabindex="-1"></a><span class="co">#&gt;   Patients with event (%)             10 (66.7%)        11 (73.3%)        11 (73.3%)   </span></span>
<span id="cb86-8"><a href="#cb86-8" tabindex="-1"></a><span class="co">#&gt;     Earliest contributing event                                                        </span></span>
<span id="cb86-9"><a href="#cb86-9" tabindex="-1"></a><span class="co">#&gt;       Death                                5                 6                 4       </span></span>
<span id="cb86-10"><a href="#cb86-10" tabindex="-1"></a><span class="co">#&gt;       Disease Progression                  5                 5                 7       </span></span>
<span id="cb86-11"><a href="#cb86-11" tabindex="-1"></a><span class="co">#&gt;   Patients without event (%)           5 (33.3%)         4 (26.7%)         4 (26.7%)   </span></span>
<span id="cb86-12"><a href="#cb86-12" tabindex="-1"></a><span class="co">#&gt;   Time to Event (MONTHS)                                                               </span></span>
<span id="cb86-13"><a href="#cb86-13" tabindex="-1"></a><span class="co">#&gt;     Median                               17.2              18.1              12.6      </span></span>
<span id="cb86-14"><a href="#cb86-14" tabindex="-1"></a><span class="co">#&gt;       95% CI                         (11.9, 24.4)       (6.5, 34.1)       (7.1, 15.6)  </span></span>
<span id="cb86-15"><a href="#cb86-15" tabindex="-1"></a><span class="co">#&gt;     25% and 75%-ile                   11.9, 24.4         6.5, 34.1         7.1, 15.5   </span></span>
<span id="cb86-16"><a href="#cb86-16" tabindex="-1"></a><span class="co">#&gt;     Range                           1.2 to 46.9 {1}   1.0 to 50.5 {2}     1.9 to 28.9  </span></span>
<span id="cb86-17"><a href="#cb86-17" tabindex="-1"></a><span class="co">#&gt;   Unstratified Analysis                                                                </span></span>
<span id="cb86-18"><a href="#cb86-18" tabindex="-1"></a><span class="co">#&gt;     p-value (wald)                                        0.8669            0.1476     </span></span>
<span id="cb86-19"><a href="#cb86-19" tabindex="-1"></a><span class="co">#&gt;     Hazard Ratio                                           0.93              1.95      </span></span>
<span id="cb86-20"><a href="#cb86-20" tabindex="-1"></a><span class="co">#&gt;     95% CI                                             (0.39, 2.22)      (0.79, 4.80)  </span></span>
<span id="cb86-21"><a href="#cb86-21" tabindex="-1"></a><span class="co">#&gt;   6 MONTHS                                                                             </span></span>
<span id="cb86-22"><a href="#cb86-22" tabindex="-1"></a><span class="co">#&gt;     Patients remaining at risk            10                11                10       </span></span>
<span id="cb86-23"><a href="#cb86-23" tabindex="-1"></a><span class="co">#&gt;     Event Free Rate (%)                  78.32             78.57             80.00     </span></span>
<span id="cb86-24"><a href="#cb86-24" tabindex="-1"></a><span class="co">#&gt;     95% CI                          (56.47, 100.00)   (57.08, 100.00)   (59.76, 100.00)</span></span>
<span id="cb86-25"><a href="#cb86-25" tabindex="-1"></a><span class="co">#&gt;     Difference in Event Free Rate                          0.25              1.68      </span></span>
<span id="cb86-26"><a href="#cb86-26" tabindex="-1"></a><span class="co">#&gt;       95% CI                                          (-30.40, 30.90)   (-28.11, 31.47)</span></span>
<span id="cb86-27"><a href="#cb86-27" tabindex="-1"></a><span class="co">#&gt;       p-value (Z-test)                                    0.9873            0.9121     </span></span>
<span id="cb86-28"><a href="#cb86-28" tabindex="-1"></a><span class="co">#&gt;   12 MONTHS                                                                            </span></span>
<span id="cb86-29"><a href="#cb86-29" tabindex="-1"></a><span class="co">#&gt;     Patients remaining at risk             8                 6                 7       </span></span>
<span id="cb86-30"><a href="#cb86-30" tabindex="-1"></a><span class="co">#&gt;     Event Free Rate (%)                  69.62             55.10             62.22     </span></span>
<span id="cb86-31"><a href="#cb86-31" tabindex="-1"></a><span class="co">#&gt;     95% CI                          (44.40, 94.84)    (27.89, 82.31)    (35.39, 89.06) </span></span>
<span id="cb86-32"><a href="#cb86-32" tabindex="-1"></a><span class="co">#&gt;     Difference in Event Free Rate                         -14.52             -7.40     </span></span>
<span id="cb86-33"><a href="#cb86-33" tabindex="-1"></a><span class="co">#&gt;       95% CI                                          (-51.62, 22.58)   (-44.22, 29.43)</span></span>
<span id="cb86-34"><a href="#cb86-34" tabindex="-1"></a><span class="co">#&gt;       p-value (Z-test)                                    0.4431            0.6938     </span></span>
<span id="cb86-35"><a href="#cb86-35" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb86-36"><a href="#cb86-36" tabindex="-1"></a><span class="co">#&gt; </span></span>
<span id="cb86-37"><a href="#cb86-37" tabindex="-1"></a><span class="co">#&gt;   {1} - Censored observation: range maximum</span></span>
<span id="cb86-38"><a href="#cb86-38" tabindex="-1"></a><span class="co">#&gt;   {2} - Censored observations: range minimum &amp; maximum</span></span>
<span id="cb86-39"><a href="#cb86-39" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span></code></pre></div>
</div>
</div>
<div id="vital-signs-vst01" class="section level3">
<h3><strong>Vital Signs (<code>VST01</code>)</strong></h3>
<div id="vital-sign-results-and-change-from-baseline-by-visit" class="section level4">
<h4><strong>1. Vital Sign Results and Change from Baseline by
Visit</strong></h4>
<div class="sourceCode" id="cb87"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb87-1"><a href="#cb87-1" tabindex="-1"></a>t_vs_chg <span class="ot">&lt;-</span> <span class="fu">run</span>(vst01, syn_data)</span>
<span id="cb87-2"><a href="#cb87-2" tabindex="-1"></a><span class="fu">head</span>(t_vs_chg, <span class="dv">20</span>)</span>
<span id="cb87-3"><a href="#cb87-3" tabindex="-1"></a><span class="co">#&gt;                                         A: Drug X                        B: Placebo                       C: Combination         </span></span>
<span id="cb87-4"><a href="#cb87-4" tabindex="-1"></a><span class="co">#&gt;                                                Change from                       Change from                        Change from  </span></span>
<span id="cb87-5"><a href="#cb87-5" tabindex="-1"></a><span class="co">#&gt;                              Value at Visit      Baseline      Value at Visit      Baseline      Value at Visit      Baseline    </span></span>
<span id="cb87-6"><a href="#cb87-6" tabindex="-1"></a><span class="co">#&gt;                                  (N=15)           (N=15)           (N=15)           (N=15)           (N=15)           (N=15)     </span></span>
<span id="cb87-7"><a href="#cb87-7" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb87-8"><a href="#cb87-8" tabindex="-1"></a><span class="co">#&gt;   Diastolic Blood Pressure                                                                                                       </span></span>
<span id="cb87-9"><a href="#cb87-9" tabindex="-1"></a><span class="co">#&gt;     SCREENING                                                                                                                    </span></span>
<span id="cb87-10"><a href="#cb87-10" tabindex="-1"></a><span class="co">#&gt;       n                            15               0                15               0                15                0       </span></span>
<span id="cb87-11"><a href="#cb87-11" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)              47.754 (6.827)      NE (NE)       52.552 (8.234)      NE (NE)       52.587 (5.051)       NE (NE)    </span></span>
<span id="cb87-12"><a href="#cb87-12" tabindex="-1"></a><span class="co">#&gt;       Median                     47.973             NE             54.453             NE             53.344             NE       </span></span>
<span id="cb87-13"><a href="#cb87-13" tabindex="-1"></a><span class="co">#&gt;       Min - Max              32.28 - 58.80       NE - NE       34.09 - 62.76       NE - NE       43.31 - 60.87        NE - NE    </span></span>
<span id="cb87-14"><a href="#cb87-14" tabindex="-1"></a><span class="co">#&gt;     BASELINE                                                                                                                     </span></span>
<span id="cb87-15"><a href="#cb87-15" tabindex="-1"></a><span class="co">#&gt;       n                            15                                15                                15                        </span></span>
<span id="cb87-16"><a href="#cb87-16" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)              48.453 (8.983)                    53.244 (6.030)                    51.260 (7.901)                  </span></span>
<span id="cb87-17"><a href="#cb87-17" tabindex="-1"></a><span class="co">#&gt;       Median                     47.331                            53.581                            51.140                      </span></span>
<span id="cb87-18"><a href="#cb87-18" tabindex="-1"></a><span class="co">#&gt;       Min - Max              34.23 - 64.64                     43.38 - 62.65                     36.42 - 64.62                   </span></span>
<span id="cb87-19"><a href="#cb87-19" tabindex="-1"></a><span class="co">#&gt;     WEEK 1 DAY 8                                                                                                                 </span></span>
<span id="cb87-20"><a href="#cb87-20" tabindex="-1"></a><span class="co">#&gt;       n                            15               15               15               15               15               15       </span></span>
<span id="cb87-21"><a href="#cb87-21" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)              49.591 (8.543)   1.138 (11.242)   51.644 (6.469)   -1.601 (8.747)   50.330 (7.611)   -0.929 (10.007)</span></span>
<span id="cb87-22"><a href="#cb87-22" tabindex="-1"></a><span class="co">#&gt;       Median                     46.979           -1.626           53.081           1.291            51.223           -0.990     </span></span>
<span id="cb87-23"><a href="#cb87-23" tabindex="-1"></a><span class="co">#&gt;       Min - Max              37.02 - 62.15    -13.13 - 19.07   38.36 - 63.15    -21.18 - 11.45   38.02 - 61.47    -22.06 - 16.72 </span></span>
<span id="cb87-24"><a href="#cb87-24" tabindex="-1"></a><span class="co">#&gt;     WEEK 2 DAY 15                                                                                                                </span></span>
<span id="cb87-25"><a href="#cb87-25" tabindex="-1"></a><span class="co">#&gt;       n                            15               15               15               15               15               15       </span></span>
<span id="cb87-26"><a href="#cb87-26" tabindex="-1"></a><span class="co">#&gt;       Mean (SD)              49.903 (5.791)   1.450 (8.476)    48.989 (6.919)   -4.255 (8.332)   47.709 (6.784)   -3.551 (10.892)</span></span>
<span id="cb87-27"><a href="#cb87-27" tabindex="-1"></a><span class="co">#&gt;       Median                     50.599           0.692            49.800           -3.891           48.715           -4.062</span></span></code></pre></div>
</div>
</div>
<div id="vital-signs-abnormalities-regardless-of-abnormality-at-baseline-vst02_1" class="section level3">
<h3><strong>Vital Signs Abnormalities (Regardless of Abnormality at
Baseline) (<code>VST02_1</code>)</strong></h3>
<div id="vital-sign-abnormalities-regardless-of-abnormality-at-baseline" class="section level4">
<h4><strong>1. Vital Sign Abnormalities (Regardless of Abnormality at
Baseline)</strong></h4>
<div class="sourceCode" id="cb88"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb88-1"><a href="#cb88-1" tabindex="-1"></a><span class="fu">run</span>(vst02_1, syn_data)</span>
<span id="cb88-2"><a href="#cb88-2" tabindex="-1"></a><span class="co">#&gt;   Assessment                  A: Drug X      B: Placebo     C: Combination</span></span>
<span id="cb88-3"><a href="#cb88-3" tabindex="-1"></a><span class="co">#&gt;    Abnormality                  (N=15)         (N=15)           (N=15)    </span></span>
<span id="cb88-4"><a href="#cb88-4" tabindex="-1"></a><span class="co">#&gt;   ââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb88-5"><a href="#cb88-5" tabindex="-1"></a><span class="co">#&gt;   Diastolic Blood Pressure                                                </span></span>
<span id="cb88-6"><a href="#cb88-6" tabindex="-1"></a><span class="co">#&gt;     Low                       6/15 (40%)    10/15 (66.7%)     9/15 (60%)  </span></span>
<span id="cb88-7"><a href="#cb88-7" tabindex="-1"></a><span class="co">#&gt;     High                      6/15 (40%)    8/15 (53.3%)     12/15 (80%)  </span></span>
<span id="cb88-8"><a href="#cb88-8" tabindex="-1"></a><span class="co">#&gt;   Pulse Rate                                                              </span></span>
<span id="cb88-9"><a href="#cb88-9" tabindex="-1"></a><span class="co">#&gt;     Low                      8/15 (53.3%)   5/15 (33.3%)     7/15 (46.7%) </span></span>
<span id="cb88-10"><a href="#cb88-10" tabindex="-1"></a><span class="co">#&gt;     High                     7/15 (46.7%)   8/15 (53.3%)     7/15 (46.7%) </span></span>
<span id="cb88-11"><a href="#cb88-11" tabindex="-1"></a><span class="co">#&gt;   Respiratory Rate                                                        </span></span>
<span id="cb88-12"><a href="#cb88-12" tabindex="-1"></a><span class="co">#&gt;     Low                      7/15 (46.7%)   7/15 (46.7%)     5/15 (33.3%) </span></span>
<span id="cb88-13"><a href="#cb88-13" tabindex="-1"></a><span class="co">#&gt;     High                     7/15 (46.7%)   4/15 (26.7%)     8/15 (53.3%) </span></span>
<span id="cb88-14"><a href="#cb88-14" tabindex="-1"></a><span class="co">#&gt;   Systolic Blood Pressure                                                 </span></span>
<span id="cb88-15"><a href="#cb88-15" tabindex="-1"></a><span class="co">#&gt;     Low                      7/15 (46.7%)   10/15 (66.7%)    4/15 (26.7%) </span></span>
<span id="cb88-16"><a href="#cb88-16" tabindex="-1"></a><span class="co">#&gt;     High                     8/15 (53.3%)   8/15 (53.3%)      6/15 (40%)  </span></span>
<span id="cb88-17"><a href="#cb88-17" tabindex="-1"></a><span class="co">#&gt;   Temperature                                                             </span></span>
<span id="cb88-18"><a href="#cb88-18" tabindex="-1"></a><span class="co">#&gt;     Low                       6/15 (40%)    8/15 (53.3%)      9/15 (60%)  </span></span>
<span id="cb88-19"><a href="#cb88-19" tabindex="-1"></a><span class="co">#&gt;     High                      9/15 (60%)     9/15 (60%)       9/15 (60%)  </span></span>
<span id="cb88-20"><a href="#cb88-20" tabindex="-1"></a><span class="co">#&gt;   Weight                                                                  </span></span>
<span id="cb88-21"><a href="#cb88-21" tabindex="-1"></a><span class="co">#&gt;     Low                      12/15 (80%)    7/15 (46.7%)      9/15 (60%)  </span></span>
<span id="cb88-22"><a href="#cb88-22" tabindex="-1"></a><span class="co">#&gt;     High                     7/15 (46.7%)   10/15 (66.7%)     9/15 (60%)</span></span></code></pre></div>
</div>
</div>
<div id="vital-signs-abnormalities-among-subject-without-abnormality-at-baseline-vst02_2" class="section level3">
<h3><strong>Vital Signs Abnormalities (Among Subject Without Abnormality
at Baseline) (<code>VST02_2</code>)</strong></h3>
<div id="vital-sign-abnormalities-among-subject-without-abnormality-at-baseline" class="section level4">
<h4><strong>1. Vital Sign Abnormalities (Among Subject Without
Abnormality at Baseline)</strong></h4>
<div class="sourceCode" id="cb89"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb89-1"><a href="#cb89-1" tabindex="-1"></a><span class="fu">run</span>(vst02_2, syn_data)</span>
<span id="cb89-2"><a href="#cb89-2" tabindex="-1"></a><span class="co">#&gt;   Assessment                  A: Drug X      B: Placebo    C: Combination</span></span>
<span id="cb89-3"><a href="#cb89-3" tabindex="-1"></a><span class="co">#&gt;    Abnormality                  (N=15)         (N=15)          (N=15)    </span></span>
<span id="cb89-4"><a href="#cb89-4" tabindex="-1"></a><span class="co">#&gt;   âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb89-5"><a href="#cb89-5" tabindex="-1"></a><span class="co">#&gt;   Diastolic Blood Pressure                                               </span></span>
<span id="cb89-6"><a href="#cb89-6" tabindex="-1"></a><span class="co">#&gt;     Low                      4/13 (30.8%)    5/10 (50%)     7/13 (53.8%) </span></span>
<span id="cb89-7"><a href="#cb89-7" tabindex="-1"></a><span class="co">#&gt;     High                     5/14 (35.7%)    7/14 (50%)      9/12 (75%)  </span></span>
<span id="cb89-8"><a href="#cb89-8" tabindex="-1"></a><span class="co">#&gt;   Pulse Rate                                                             </span></span>
<span id="cb89-9"><a href="#cb89-9" tabindex="-1"></a><span class="co">#&gt;     Low                      5/12 (41.7%)   3/13 (23.1%)    6/14 (42.9%) </span></span>
<span id="cb89-10"><a href="#cb89-10" tabindex="-1"></a><span class="co">#&gt;     High                     7/15 (46.7%)   5/12 (41.7%)    6/14 (42.9%) </span></span>
<span id="cb89-11"><a href="#cb89-11" tabindex="-1"></a><span class="co">#&gt;   Respiratory Rate                                                       </span></span>
<span id="cb89-12"><a href="#cb89-12" tabindex="-1"></a><span class="co">#&gt;     Low                      5/13 (38.5%)   6/14 (42.9%)    5/15 (33.3%) </span></span>
<span id="cb89-13"><a href="#cb89-13" tabindex="-1"></a><span class="co">#&gt;     High                     6/14 (42.9%)   4/15 (26.7%)    8/15 (53.3%) </span></span>
<span id="cb89-14"><a href="#cb89-14" tabindex="-1"></a><span class="co">#&gt;   Systolic Blood Pressure                                                </span></span>
<span id="cb89-15"><a href="#cb89-15" tabindex="-1"></a><span class="co">#&gt;     Low                      5/13 (38.5%)   9/14 (64.3%)    4/15 (26.7%) </span></span>
<span id="cb89-16"><a href="#cb89-16" tabindex="-1"></a><span class="co">#&gt;     High                      7/14 (50%)    8/15 (53.3%)    4/13 (30.8%) </span></span>
<span id="cb89-17"><a href="#cb89-17" tabindex="-1"></a><span class="co">#&gt;   Temperature                                                            </span></span>
<span id="cb89-18"><a href="#cb89-18" tabindex="-1"></a><span class="co">#&gt;     Low                      4/13 (30.8%)   6/13 (46.2%)     9/15 (60%)  </span></span>
<span id="cb89-19"><a href="#cb89-19" tabindex="-1"></a><span class="co">#&gt;     High                      9/15 (60%)    8/14 (57.1%)    7/13 (53.8%) </span></span>
<span id="cb89-20"><a href="#cb89-20" tabindex="-1"></a><span class="co">#&gt;   Weight                                                                 </span></span>
<span id="cb89-21"><a href="#cb89-21" tabindex="-1"></a><span class="co">#&gt;     Low                       9/12 (75%)     2/10 (20%)     7/13 (53.8%) </span></span>
<span id="cb89-22"><a href="#cb89-22" tabindex="-1"></a><span class="co">#&gt;     High                     4/12 (33.3%)   9/14 (64.3%)    7/13 (53.8%)</span></span></code></pre></div>
</div>
</div>
</div>
<div id="listings" class="section level2">
<h2><strong>LISTINGS</strong></h2>
<div id="glossary-of-adverse-event-preferred-terms-and-investigator-specified-terms-ael01_nollt" class="section level3">
<h3><strong>Glossary of Adverse Event Preferred Terms and
Investigator-Specified Terms (<code>AEL01_NOLLT</code>)</strong></h3>
<div id="glossary-of-adverse-event-preferred-terms-and-investigator-specified-terms" class="section level4">
<h4><strong>1. Glossary of Adverse Event Preferred Terms and
Investigator-Specified Terms</strong></h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>ael01_nollt</code></strong> template produces the
standard glossary of adverse event preferred terms and
investigator-specified terms.</li>
<li>The example below uses <code>head</code> function to print only the
first 10 lines of the output.</li>
</ol>
<div class="sourceCode" id="cb90"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb90-1"><a href="#cb90-1" tabindex="-1"></a>l_ae_nollt <span class="ot">&lt;-</span> <span class="fu">run</span>(ael01_nollt, syn_data)</span>
<span id="cb90-2"><a href="#cb90-2" tabindex="-1"></a><span class="fu">head</span>(l_ae_nollt, <span class="dv">10</span>)</span>
<span id="cb90-3"><a href="#cb90-3" tabindex="-1"></a><span class="co">#&gt; MedDRA System Organ Class   MedDRA Preferred Term   Reported Term for the Adverse Event</span></span>
<span id="cb90-4"><a href="#cb90-4" tabindex="-1"></a><span class="co">#&gt; âââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââââ</span></span>
<span id="cb90-5"><a href="#cb90-5" tabindex="-1"></a><span class="co">#&gt; cl A.1                      dcd A.1.1.1.1           trm A.1.1.1.1                      </span></span>
<span id="cb90-6"><a href="#cb90-6" tabindex="-1"></a><span class="co">#&gt;                             dcd A.1.1.1.2           trm A.1.1.1.2                      </span></span>
<span id="cb90-7"><a href="#cb90-7" tabindex="-1"></a><span class="co">#&gt; cl B.1                      dcd B.1.1.1.1           trm B.1.1.1.1                      </span></span>
<span id="cb90-8"><a href="#cb90-8" tabindex="-1"></a><span class="co">#&gt; cl B.2                      dcd B.2.1.2.1           trm B.2.1.2.1                      </span></span>
<span id="cb90-9"><a href="#cb90-9" tabindex="-1"></a><span class="co">#&gt;                             dcd B.2.2.3.1           trm B.2.2.3.1                      </span></span>
<span id="cb90-10"><a href="#cb90-10" tabindex="-1"></a><span class="co">#&gt; cl C.1                      dcd C.1.1.1.3           trm C.1.1.1.3                      </span></span>
<span id="cb90-11"><a href="#cb90-11" tabindex="-1"></a><span class="co">#&gt; cl C.2                      dcd C.2.1.2.1           trm C.2.1.2.1                      </span></span>
<span id="cb90-12"><a href="#cb90-12" tabindex="-1"></a><span class="co">#&gt; cl D.1                      dcd D.1.1.1.1           trm D.1.1.1.1                      </span></span>
<span id="cb90-13"><a href="#cb90-13" tabindex="-1"></a><span class="co">#&gt;                             dcd D.1.1.4.2           trm D.1.1.4.2                      </span></span>
<span id="cb90-14"><a href="#cb90-14" tabindex="-1"></a><span class="co">#&gt; cl D.2                      dcd D.2.1.5.3           trm D.2.1.5.3</span></span></code></pre></div>
</div>
</div>
</div>
<div id="graphics" class="section level2">
<h2><strong>Graphics</strong></h2>
<div id="kaplan-meier-plot-kmg01" class="section level3">
<h3><strong>Kaplan-Meier Plot (<code>KMG01</code>)</strong></h3>
<div id="kaplan-meier-plot-without-comparative-statistics" class="section level4">
<h4><strong>1. Kaplan-Meier Plot (without comparative
statistics)</strong></h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>kmg01</code></strong> template produces the
standard Kaplan-Meier Plot.</li>
<li>Users are expected to select a particular parameter for
analysis.</li>
<li>Users are expected to select the treatment groups to compare,
otherwise, all treatment groups available in the input datasets will be
plotted.</li>
<li>The comparative statistics are not included by default.</li>
<li>The estimation of median survival time per treatment group by
default.</li>
<li>By default, the <code>run</code> function will not render the plot.
For viewing and testing purpose, the users can include the argument
<code>draw = TRUE</code> to view the plot in the <code>Plots</code>
tab.</li>
<li>More arguments in the <code>g_km</code> and
<code>control_coxph</code> functions can be passed through, please use
the Help to find out more information.</li>
</ol>
<div class="sourceCode" id="cb91"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb91-1"><a href="#cb91-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;OS&quot;</span>, <span class="st">&quot;adtte&quot;</span>)</span>
<span id="cb91-2"><a href="#cb91-2" tabindex="-1"></a><span class="fu">run</span>(kmg01, proc_data, <span class="at">dataset =</span> <span class="st">&quot;adtte&quot;</span>, <span class="at">draw =</span> <span class="cn">TRUE</span>)</span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<pre><code>#&gt; gTree[GRID.gTree.140]</code></pre>
</div>
<div id="kaplan-meier-plot-with-comparative-statistics" class="section level4">
<h4><strong>2. Kaplan-Meier Plot (with comparative
statistics)</strong></h4>
<p>To enable the comparative statistics (hazard ratio and p-value), the
argument <code>annot_coxph</code> needs to be set to TRUE. The compare
group is determined by the levels in the factorized variable of
treatment group and the first level is used as reference group in the
statistics.</p>
<div class="sourceCode" id="cb93"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb93-1"><a href="#cb93-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;OS&quot;</span>, <span class="st">&quot;adtte&quot;</span>)</span>
<span id="cb93-2"><a href="#cb93-2" tabindex="-1"></a><span class="fu">run</span>(kmg01, proc_data, <span class="at">dataset =</span> <span class="st">&quot;adtte&quot;</span>, <span class="at">draw =</span> <span class="cn">TRUE</span>, <span class="at">annot_coxph =</span> <span class="cn">TRUE</span>)</span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<pre><code>#&gt; gTree[GRID.gTree.294]</code></pre>
</div>
<div id="kaplan-meier-plot-without-censoring-marks" class="section level4">
<h4><strong>3. Kaplan-Meier Plot (without censoring marks)</strong></h4>
<p>To suppress the censoring marks, set the argument
<code>cencor_show</code> to FALSE.</p>
<div class="sourceCode" id="cb95"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb95-1"><a href="#cb95-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;OS&quot;</span>, <span class="st">&quot;adtte&quot;</span>)</span>
<span id="cb95-2"><a href="#cb95-2" tabindex="-1"></a><span class="fu">run</span>(kmg01, proc_data, <span class="at">dataset =</span> <span class="st">&quot;adtte&quot;</span>, <span class="at">draw =</span> <span class="cn">TRUE</span>, <span class="at">censor_show =</span> <span class="cn">FALSE</span>)</span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<pre><code>#&gt; gTree[GRID.gTree.408]</code></pre>
</div>
<div id="kaplan-meier-plot-without-estimation-of-median-survival-time" class="section level4">
<h4><strong>4. Kaplan-Meier Plot (without estimation of median survival
time)</strong></h4>
<div class="sourceCode" id="cb97"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb97-1"><a href="#cb97-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;OS&quot;</span>, <span class="st">&quot;adtte&quot;</span>)</span>
<span id="cb97-2"><a href="#cb97-2" tabindex="-1"></a><span class="fu">run</span>(kmg01, proc_data, <span class="at">dataset =</span> <span class="st">&quot;adtte&quot;</span>, <span class="at">draw =</span> <span class="cn">TRUE</span>, <span class="at">annot_surv_method =</span> <span class="cn">FALSE</span>)</span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<pre><code>#&gt; gTree[GRID.gTree.536]</code></pre>
</div>
<div id="kaplan-meier-plot-with-statistical-annotation-of-either-median-or-min-of-survival-time" class="section level4">
<h4><strong>5. Kaplan-Meier Plot (with statistical annotation of either
median or min of survival time)</strong></h4>
<p>To add the statistics annotation, use the function
<code>annot_stats</code>. Options are <code>min</code> or
<code>median</code>.</p>
<div class="sourceCode" id="cb99"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb99-1"><a href="#cb99-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;OS&quot;</span>, <span class="st">&quot;adtte&quot;</span>)</span>
<span id="cb99-2"><a href="#cb99-2" tabindex="-1"></a><span class="fu">run</span>(kmg01, proc_data, <span class="at">dataset =</span> <span class="st">&quot;adtte&quot;</span>, <span class="at">draw =</span> <span class="cn">TRUE</span>, <span class="at">annot_stats =</span> <span class="st">&quot;median&quot;</span>)</span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<pre><code>#&gt; gTree[GRID.gTree.665]
run(kmg01, proc_data, dataset = &quot;adtte&quot;, draw = TRUE, annot_stats = c(&quot;min&quot;, &quot;median&quot;))</code></pre>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<pre><code>#&gt; gTree[GRID.gTree.795]</code></pre>
</div>
<div id="kaplan-meier-plot-without-the-table-of-patient-at-risk" class="section level4">
<h4><strong>6. Kaplan-Meier Plot (without the table of patient at
risk)</strong></h4>
<div class="sourceCode" id="cb102"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb102-1"><a href="#cb102-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;OS&quot;</span>, <span class="st">&quot;adtte&quot;</span>)</span>
<span id="cb102-2"><a href="#cb102-2" tabindex="-1"></a><span class="fu">run</span>(kmg01, proc_data, <span class="at">dataset =</span> <span class="st">&quot;adtte&quot;</span>, <span class="at">draw =</span> <span class="cn">TRUE</span>, <span class="at">annot_at_risk =</span> <span class="cn">FALSE</span>)</span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<pre><code>#&gt; gTree[GRID.gTree.908]</code></pre>
</div>
</div>
<div id="mean-plot-mng01" class="section level3">
<h3><strong>Mean Plot (<code>MNG01</code>)</strong></h3>
<div id="plot-of-mean-and-confidence-interval-with-table-section" class="section level4">
<h4><strong>1. Plot of Mean and Confidence Interval (with Table
Section)</strong></h4>
<ol style="list-style-type: decimal">
<li>The <strong><code>mng01</code></strong> template produces the
standard mean plot.</li>
<li>Note that the template <code>mng01</code> is quite general. The
users are expected to specify the analysis dataset and the visit
variable in the <code>run</code> function, and select the parameters
prior to the <code>run</code> function.</li>
<li>The table of summary statistics is included by default.</li>
<li>The variable Analysis Value <code>AVAL</code> is used for plotting
by default.</li>
<li>If the input dataset contains results of the same analyses in
multiple units,(e.g.Â SI/CV units in <code>ADLB</code>), please make sure
that the parameters in appropriate units are selected in advance.</li>
</ol>
<div class="sourceCode" id="cb104"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb104-1"><a href="#cb104-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;DIABP&quot;</span>, <span class="st">&quot;advs&quot;</span>)</span>
<span id="cb104-2"><a href="#cb104-2" tabindex="-1"></a><span class="fu">run</span>(mng01, proc_data, <span class="at">dataset =</span> <span class="st">&quot;advs&quot;</span>, <span class="at">x_var =</span> <span class="fu">c</span>(<span class="st">&quot;AVISIT&quot;</span>, <span class="st">&quot;AVISITN&quot;</span>), <span class="at">draw =</span> <span class="cn">TRUE</span>)</span>
<span id="cb104-3"><a href="#cb104-3" tabindex="-1"></a><span class="co">#&gt; $`Diastolic Blood Pressure`</span></span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<pre><code>#&gt; 
#&gt; attr(,&quot;class&quot;)
#&gt; [1] &quot;gg_list&quot; &quot;list&quot;</code></pre>
</div>
<div id="plot-of-mean-and-confidence-interval-of-change-from-baseline-of-vital-signs" class="section level4">
<h4><strong>2. Plot of Mean and Confidence Interval of Change from
Baseline of Vital Signs</strong></h4>
<div class="sourceCode" id="cb106"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb106-1"><a href="#cb106-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;DIABP&quot;</span>, <span class="st">&quot;advs&quot;</span>)</span>
<span id="cb106-2"><a href="#cb106-2" tabindex="-1"></a><span class="fu">run</span>(mng01, proc_data, <span class="at">dataset =</span> <span class="st">&quot;advs&quot;</span>, <span class="at">x_var =</span> <span class="fu">c</span>(<span class="st">&quot;AVISIT&quot;</span>, <span class="st">&quot;AVISITN&quot;</span>), <span class="at">y_var =</span> <span class="st">&quot;CHG&quot;</span>, <span class="at">draw =</span> <span class="cn">TRUE</span>)</span>
<span id="cb106-3"><a href="#cb106-3" tabindex="-1"></a><span class="co">#&gt; `geom_line()`: Each group consists of only one observation.</span></span>
<span id="cb106-4"><a href="#cb106-4" tabindex="-1"></a><span class="co">#&gt; â¹ Do you need to adjust the group aesthetic?</span></span>
<span id="cb106-5"><a href="#cb106-5" tabindex="-1"></a><span class="co">#&gt; $`Diastolic Blood Pressure`</span></span></code></pre></div>
<p><img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAASAAAAEgCAIAAACb4TnXAAAACXBIWXMAAA7DAAAOwwHHb6hkAAAgAElEQVR4nO2dd1wTyfvHJyEgTYFIkyqIICBSbBTPgh4HiIhgQ9ATULEA4llOxF4QRe8Ue7s7+VlQwEMEbAgiRcVTQVBA6UUNvYeQsr8/5m6/MQlFJITIvF/5YzI7O/PsJp+d2Wdn5yFgGAYQCAR/IAraAATiewYJDIHgI0hgCAQfQQJDIPgIEhgCwUeQwBAIPoIExsmcOXMI/yEpKWlpaXnu3Dl8K41GIxAIWVlZX1ttdXV1S0tLFwWYTCaBQHj+/PlXNaGvr49bKyoqqqend+bMGY4Kv9ZUboYOHfro0SOOzAULFuBNE4lEDQ0NX1/f5ubmb2/ue4IkaAMGIrNmzdq/fz8AoK6uLjk52cfHJz8//7fffgMAiIiIbNq0SUFB4WvrdHZ2dnJy2rhxY7clv7aJ5cuXr169GgBApVLj4+PXrl07YsQIJyenr7WwF0ydOvXw4cOw6Xv37p06dYpKpV68eLEfmhYWkMB4IC8vP3nyZJi2s7MzMjL6+eef16xZM3r0aBKJFBISwtfWv7YJNTU13Nrp06cnJCTEx8f3j8DIZDJ706KioidPnuQQWFtbm6SkZD8Y028NfRVoiNg9rq6u6urqYWFh4MshYkFBgZOTk5KS0rBhw6ZPn44P6u7cuWNqaiopKamlpXXs2DEAwMSJE1NTUzdt2mRnZwcAqK2tXbp06YgRI1RUVNzd3WtqatibY2+iurp68eLFCgoKo0aN2rZtG5PJ7NZaAoGgpqbGkdlZi53lFxQU2NraysrKmpqaxsTE9PBEycrKtrW1QSPh6PSnn35ydXUFADQ1Na1evVpTU1NGRmbOnDkVFRWdnSuema2trQQC4e3bt7BAfn4+gUBobGzseUMCA0N8iYODw+LFizkyHR0dlyxZgmFYe3s7ACAzMxPDMH19/RkzZjx69CgxMXHq1KkTJ07EMKy0tFRMTGzr1q0vXryAw6f09HQMw6ZMmXLkyBEMw1gs1sSJEydNmpSUlJSUlDRp0iS4I4PBAAA8e/YMb4LJZJqYmPz0009paWlXrlxRUlL65ZdfOAwbM2aMp6fnP//8888//6SkpAQEBGhoaBQWFrJX2FmLneW3traqqKjMmjUrOTk5KipKXV2dSCQmJCRwND1//nwnJyeYplKp0dHRmpqa1tbWMAcAYGFhceXKlfLycgzDrK2tp0+fnpycnJGRsWTJEgMDg/r6ep7nimcmvH3NycmBlefl5QEAGhoaethQH/wtegsSGCc8BbZixYrp06djbAJjsVhHjhwpKiqCBcLCwuTl5TEMS0hIIBAIBQUFMD82NrakpARjE1hSUpKIiEhpaSksUFJSIiIikpyczC2wuLg4KSmpuro6WPKvv/7y9PTkMGzMmDEcV8wFCxbAXfAKO2uxs/wLFy7Iyck1NjbC/OjoaAAAT4FxNG1kZAS1jWEYACAoKAimnz17Jioqiv/RGQyGkpLSxYsXeZ4rnpldC6zbhjr9sfkPugfrEVVVVSoqKuw5BAJh3bp1MTExly5dysvLS0xMFBERAQBYWlqam5sbGhra2dlZW1s7OTmpq6uz75ibm6ulpaWhoQG/ampqampq5ubmWllZcTSanZ09duxYOTk5+PXnn3/++eefuW3bvn37vn37YLqwsNDd3d3d3T0uLq7bFlksFs/8vLy8SZMmDRs2DObPmjWrs9OCOzkAAMOHD9fW1iYS/3fTYWZmhhtAp9PZ3TYMBuPjx49LlizhPleKiorcma2trZ3Z0JOGutiX36B7sO7BMCwnJ2fUqFHsmS0tLRYWFiEhITIyMsuXL//9999hvoSERFpaWkJCwtixY//8808dHR3YA7DXxlE/kUiEvQ0HdDodirbnjBo1KiAgICEhgf0f2VmLneVzNDpkyJDOzIBODoiOjg67ugAA0tLSMCEjI6OsrExnA8OwHTt28DxX3Z5AAACdTv+qhro4Y/wGCax7bt68WVpaunTpUvbMpKSkd+/ePXjwYPPmzQ4ODiTSv2OBxMTE4ODgKVOm7Nu379WrV3Z2dtA7gqOvr19SUoLffJeXl5eUlBgaGnK3a2BgkJOTgz9ZunDhwqRJk7q1trm5mcFgEAiEblvsIj8jIwNvNz09vSfOlS4wNDSkUCi5ubnwa2Vlpbm5+Zs3b3ieqy5OYENDA0x09pCws4a+xfhvRYDD04GJg4ODjY0NdBs8fPhw+/btoqKiGzZsgFvxG6S0tDQAwMWLF8vKyqKiojQ1NSUlJaurqxMTE4lE4okTJ3Jycm7evCknJ3fgwAEMw6ZOnbpu3br6+noWizVhwgQLC4vU1NSUlBQLC4sJEyawWCzuezA6na6npzdnzpwXL16Eh4erqqpu3LiRw1p2J0dGRsbx48fV1dWh74HdycGzxc7yW1tbR4wYYWNjk5aWFhcXp6urKykp2bWTgxsAQGpqKv7V2dlZV1f37t27jx49mjZtmqGhIYPB4HmuOjuBCgoKs2fPzsnJSUxMhMNa/B6s24a+5f/wjSCBceLg4IBffcTFxc3Nzc+cOYNvZfciHjhwQFlZmUwmz58/Py8vT19fH3rhjh07pq2tPWTIEE1NzYCAADhQuXjx4vDhw52dnTEMq66uXrJkiZKSkrKyspubW3V1NcbLi4hhWEVFxbx588hk8ogRI/z9/alUKoe1HE4OeXl5d3f32tpa9go7a7GL/A8fPtjY2MjIyBgZGd26dWvs2LHfKLDW1tY1a9aoqanJyso6OTlBx09n54pn5r1798aMGUMkEkkk0tmzZzsTWGcNCQoCht5oRggPNBqNRqPhDpiBDxIYAsFHkJMDgeAjSGAIBB9BAkMg+AgSGALBR5DAEAg+ggSGQPARJDAEgo8ggSEQfAQJDIHgI0hgCAQfQQJDIPgIEhgCwUeQwBAIPoIEhkDwESQwBIKPIIEhEHwECQyB4CNIYAgEH0ECQyD4CBIYAsFHkMAQCD6CBIZA8JFOBdZ1ANKysjIikThs2DC4SiYCgeBJL3uw8PBwaWnplpaW+Pj4vjWon2EymcrKysbGxl0Xk5CQEBcXl5CQkJGRmTVr1rt377696eTk5KFDh5aVlcGv7969Gzp0KHfNu3fvzsrKqqysJBAIV65cwfOPHj3q6+v7tY1GRUXRaDT86+TJk/E4y7C2Gzdu3Lx5szfH8yUGp3u/b21tLYFAgCcchsnu4oTLyckNGTIE/kBjxoy5ffs2AODly5cWFha9twAAAMDly5fXrFnTix3Zf7JeCuz69esLFy6cMGFCeHg4zwJtbW29q/nrMHAGBs7fUsHjx4/JZHJZWVl+fn7XJfPz86lUKlzL+ocffqitrcU3dXR09KLpadOmubu7w781hmHe3t4BAQEGBgbsZWpqajIzM6H+SSTSli1b8AAIveD9+/deXl7sg47i4uKampr29vb29nYYIMbFxeXChQs8o718Ld+iMQBAa2srlUptbGzU09Pz8fHpouSbN2+oVGpdXd3KlSvd3Nyampq+qeFvg+MnI4LOQ6F2Rl5eXmZm5sKFC+fOnRsbGwuDo0E44nmKioqePn1aXV1dSkrK2tq6srLS399fWVlZUVExNDT0m46DXVrfoLEbN24sX77cyckpIiICz7Szs9uzZw/P8kOHDl23bt1PP/10+vTply9fOjg4rF+/fvbs2cnJyT/++CMsExUVhYdiuXz58siRI/X19X/55ReO+CwAgEOHDr169er27dsXLlxobW3dsmULR4HDhw97eHjAtKysrKOj4/bt23t3pAsWLDA1NYVhVyEtLS0EAmH48OFDhgwZMmQIDBBDIpFmzpzJ3lX2gm+UFjuioqJLliwpLy+HX7v4aSQlJX18fDo6OgoLC9nzg4ODNTU1yWTyjBkzPn/+DDMvX748evRoNTW1zZs3w9gxDx8+NDIyGjlypJeXF97J19XVzZ49W0FBYdasWXgYmmvXro0ePVpVVdXDw4M7cBnHTwawTkKhsocO4GDnzp1kMplOp+fk5MD28E3gy3ieJBJJW1s7JSXl8ePHKioqEhISO3bsyMvLW7FihYiISE9je7ZSsYrPnB/9eZwf7jJ0ZtcVw2Bt5eXl8fHx48aNw/NzcnLKysrYS4qLi7OHEfjzzz/nzZv3zz//SEhInD17lsFgPH78eNasWXBrZGSku7s7hmEFBQUaGhqVlZVVVVU6Ojowk4M7d+6oqakpKirCaA8caGtrf/78GcOwiooKeXn52tpaJSWlf/75B8OwI0eO+Pj49OgEfnkgMGYChmFZWVkKCgrjxo0bPny4o6Pjp0+fYH5SUtKcOXN6UlsjDatoxCoasVb6vzlVrZj+qS8+sEBV678FmmnYx8ZuqoWhomFUlNbWVnd3dzy6DfdPIysrm5eXh2EYlUo9duyYhIREXV3dP//8Y25ujmFYfn7+0KFDS0pKaDTaokWLYCzM7OxsdXX1srIyCoWir6//8OFDCoUiJyf35s0bBoOxfPnytWvXYhj2119/iYiIJCQk0Ol0Pz+/2bNnYxj2/v17RUXFvLy8jo6OBQsWBAQEcBjP8ZORMAzz8vJydnbW0tICAFRUVPzyyy9dX1TCw8OdnZ1JJJKhoeGoUaPCw8NhfwWZM2eOm5sb/nXPnj1TpkwBAMybN+/Ro0d79+4FAAQGBl68eLGyslJWVrbrtgAAIPQaCIvtvtiPXMPl6GNAV6OLPRISEoyMjNTU1JSUlMrLy/Pz8/X09AAAPKN1saOgoPDp0ycAAJlM9vb27qzYrVu3Fi5cCENj/vzzzzxHofb29kQi0cDAgPs+sLGxsaamRklJCc8hk8lBQUFr1659+vRp1xb2hLa2tilTppw8eVJBQcHDw8PHxycyMhIAMHr06JcvX/akhk0PQGoZAAA464P9MwAAwP4aZ5kfrwAAwNAh4LkXAADsTQGx+eDd2u4rl5KSIhAITCZTQkICd7bx/GnMzMyIRGJHR4eysvL//d//4TFBAQBaWlolJSVkMrmqqopAIMDRY2Rk5M8//wwjj165ckVcXDwmJmbGjBlGRkYAAB8fH1tb21OnTgEApk+fPnPmTADAvn375OXlGQxGTEzMwoUL4f8kICDAzc0tKCgIb477JyN1Fgq1M16+fPn+/ftNmzbBjtjKyio8PLyhoQGXCh7PE4IHUJWTk9PU1MTT3Z9gHOvJoI5rVB37hDPHYSpnjmI36r1x48azZ89GjBgBAGhpaYmIiOjhAKympgbupaqqyr0V+y+eRmVlJX7IKioqPAV27NgxFRWVwsLCmJgYR0dH9k21tbVqamoc5T08PC5dunThwgWO/OvXr7P/0gCACxcumJubd3EU5ubmt27dgmlfX18bGxvc1B7e6TmPAbISAABg91/0z1Zed6MOekBt6L/p2TpAjMCjDDetra0iIiIsFismJmbixIkUCkVSUpJnyVevXsF/PE/27t0bFRWlpqYmIiIycuRIAEBlZeXEiRPhVvh3jYiISE9PNzU1hZn4nxaPrzts2DApKana2tpPnz6xb4XXWRzun4zU0tLyww8/kEikhQsXLl++fM6cOZs2berisK9fvw4AWLVqFXtmdHT08uXLYRqP58kNe9jFr2CSIZjEdd3iFthh/6+qtaOj4/bt2x8+fIA9TExMzI4dO3oosISEBBMTEwAAe9BUFosFE7iQFBUV8UE/nmCnoKBg7969aWlphYWFa9asmTp1KnuXTiaTKysrOXYhEAinT5/+8ccf8YE+xNXVlX0c0RMyMjIAADBqppiYmLi4OMynUCg9jA9kqwNsdbovxt5lTdME0zS/wkgikejk5CQvL//q1Ss4FPoqwsPD//nnn+zsbFlZ2ZCQkLq6OvDl75KcnEyn0xUVFRcsWAD9Am1tbTDIOgAAv/d7//59W1ubgoKCsrIy7vitrKxUVlZmb477JyN2FgqVJxiG3bhxY+nSpeyDTjhK/Noj/1be3erqaw+4f/++trY2Htp81qxZ79+/h9rIy8vj/mdD2trazp8/Hx8fv3btF6OcoUOHvnz5sqamprW19caNGzBzzpw5N27cqKqqqq+v/7//+z+OquDg3MfHx9DQ0NHR0dzcnGNwLisrKysrW11dzbGjsbGxq6srHMPgXL9+3ehLnj171vUZKC0tnT9/fklJCZPJPHnypJOTE8x///49vHz0gndreX96DYZh8fHxnz590tHRAV3+NDypqalRUFAYNmxYTU3N5cuXYXDnuXPn/vXXX58/f66trfX19W1oaLC3t4+IiMjOzu7o6Ni4cSN+bpOSkp48eQLPj7OzM5FIdHBwuHnzZmFhIYPBCA4O5hh08PjJOguFytPJkZycDABITExkz9y1axeJRILBEcGX4QZJJNLjx49hevv27ba2tjANRyA5OTnd3O3yEzc3t507d7Ln2NnZ7du3D8MwW1vb3bt3s28SFxeXlJSUlpYeNmzYjBkzsrOzMQzD76QxDGOxWOvXr1dXV5eTk1u+fDnuzzhx4oSqqurEiRM3b968atUq9jpPnjypo6ODB62srKwcNmzY3bt32cusX78+NjYW+++OGc9vbGxUVlb+RicHhmGHDx/W0tJSUVH5+eefGxv/dT4cOXLk7NmzX1tzHwKdHFJSUtLS0hISEhoaGlevXoWbuH8a3MnBDv7T1NbWLly4UEdHZ+bMmefOnRsxYgR0EZ0+fVpLS0tZWdnf35/FYmEYFhkZqaurq6Cg4OjoCEOE/vXXX/PmzZs8ebKiouLs2bMpFAqsPCwsTEdHR1VVddmyZc3NzRxNc/xkAOskFCpPga1evXrkyJHQIJyCggIAAPxJhEhg/UBmZub27dsxDGOxWK6urmFhYV9bw8ePH2HU2X6DyWTOnDmTRqP1Z6PfExw/GYpwyUfodPrWrVvT0tLodPqMGTMOHz7Mfs/WQ7Zt2+bu7s7xAJp//P333y0tLdyP7BA9h/0nQwIb6LBYLBaL1fW9cR/S0dEhKiraS3cUAgDw5U+GBIZA8BH0ugoCwUeQwBAIPoIEhkDwESQwBIKPIIEhEHwECQyB4CNIYAgEH0ECQyD4CBIYAsFHkMAQCD6CBIZA8BEkMASCjyCBIRB8BAkMgeAjSGAIBB9BAkMg+AgSGALBR5DAEAg+ggSGQPARJDAEgo8ggSEQfAQJDIHgI0hgCAQfQQJDIPgIEhgCwUf6aUHmgcCzZ8+uXr1aV1c3atQoX19fBQUF7jL79+9nDzktxNAZoIkzfHBvkBgCJMX7oJ7vGgzDhg0bFhgYyL1psAisqqrq2LFje/fu1dDQuHTp0pkzZ3bu3MldrLa29ujRo70I0TDgSM8CK3gHC/86VrkAf7fuiw1umEzm5s2beW4aLAJ79+7duHHjdHV1AQBz58799ddfBW0RnzHTB/fPdFWgoQUs2gy2rQDTxndVbJhU39o12BgsAjM3N58wYQJMFxYWjho1quvyQo+4GFBX6qqAlAQAAAyX6aYY4tsYLALDAxCnpKT8+eefW7duxTelp6efOfPvxZ5EIlGp1O9hiNgdhPZ2cQA6OjqYVKqgbRF6mEwmHqGbg8EiMABAc3Pz8ePHa2pq9uzZo6n5v0DcMjIy+vr6MF1cXEwikQaDwERnrQYAiAWcoNt/dWRxBAcEAqGziGqDRWB0On3nzp1GRkaBgYEc58LQ0NDQ0BCmN2zYICoq+v0LzMAZT4oaL+pFCHkEO0QisTOBfe//pP94+vQpi8V6/fr18uXLL1682FmHPihgU1enOYg+YrAI7MOHD8XFxaWlpfX19TExMa6uroK2CDEoGCxDRFNT0/z8/MOHDwMAUlNTExISBG2RcFNZ+YZCyWfPMTCwFRcfCgB49SqCPV9GVnWUtiUA4DMl72NlNvsmPT1rKanh/DdWkAwWgVVVVamrq8O0urp6dXU1vqmoqCglJQWm29vbMQz7zuNWv40iGLqwZ2Bvo8BXHnJuXkL60z/YczQ0JgwZIg0AFhv/xQPuMXoztbUsAAAFBSmJScfZNykojJaUJH+d8QOSLv4wg0Vgzc3NEhISMC0hIdHU1IRvys/PP3HiBEzr6+u3trZ+/06OjDBCfbPUT+sAAC0ZYaD1qydVTRj/s6nJF8NsMTGp1tZWAMC6NQ8BAB8Kkh48DPLyiJKUJMP8sYbO+mMc2HcRFZVs/fqmByDITQ+kpaUpFApMU6lUaWlpfJOdnZ2dnR1Mb9iwQVpa+vsXGACggwUAAEc3sp+Kr6HTvWCFnz7LAgDIZCUJCdludxF2mExmZ/+ZwSIwJSWl2NhYX1/furo6eXl5OTk5QVv03bJ3/1g8HXL034dsO7fnCMgcATNYBDZixIiKigp/f//Jkyf7+PgI2hz+U1kF7qZ1VaCNBgAAiS9AZVVXxYx1wUTDvjRskDFYBJafn29oaBgdHX3jxg1jY+OMjAxBW8RnKqvAxb+7KSMpAZ68BCmvAAAdRFI7aQgAQJxBE2MxAABtJHEGUQQsJkhPMCQSAACgiQYAAEQCkBYDAAA6C1DpAAAgJgLESQAAQKUDkUEwuP4qBovA4GRfeHuQnJxcW1uLb6LT6dT/5uN9P/7DSWPBs7CeF//7LdiTDAAAW63AMmMAANgQC1LKAADgQTNQGwZqqGDqnwAAoDcc/L0IAAAeFYFfHgAAwJoJwHcSAADsSgYTVfryIL4DBovAupjsm5CQsGPHDpjW19dvbGwcFE6OLzGSIR74QQQAMFqO2djIAgC4jSHZahIAAKJ0RmMjll8tAoD0WpN2XTKzsZEBABgl9e8uWjKsxkYmAMBJS0RWHMvlVX9jY2P/HUy/w2QymUwmz03fs8Du379/+/ZtAMDKlStNTU07m+xramoaHBwM03///beMjMwgFJiMDDBQ+yJnqswXX4e2AwDAdB3xsYr/22X0iC/KWH65y5f1d75N+GEymSIiIry3YYODjo4Of3//S5cusVisLor5+/szmcx+s0qI0D/176eHZOfE7dln2NZWz0+jBgoMBmPDhg08Nw2WS/XTp08lJCQ8PT1pNFpcXJygzUEMFr7nISI7BQUFOTk5jo6O8Ov169evXLkiWJOECIPTX6TfrQUJj37jmCq1bk3s8OEjAcD27jfCM0OOThmjN3PhguMAgLT0i48Sj7Hv4rn8qpqaMV8tFziDRWCenp6enp7Pnj0LDw+nUqnnzp0TtEVCA7u68JyHc2eR5dTZM/+btktwsN/Fni8jqwoTo0ZNkRD/4k5MTu7L277vkcEiMABAfX399evXV61aFRoayp7/4sWLP//8E6ZpNBqNRhuETo4uGcKdJS+vJy+vx5FJo9EAAIaGjjzz5WS15GS1eG4SdrqYizhY/kkYhh0/ftzDw2Po0KGCtkWYML3EQ11d5CM4+J57MHY3/cePH1VVVU1MTMrKyjiKTZw4ceLEiTC9YcOGIUOGoB4M593afxNUOihqANqyQEIU34g09i+DdLLvTz/99NNPP8F0cnLy8+fPExMTWSxWe3u7q6vr2bNnv++HM32LhCgw5LEUMqIbvmeBsePv7w8TZWVlBw4cQE4ODvJqQGo5AACYqwL4KPl+IShvAgCARYZgqBhgYuDPTAAAIIsDZ30AACiqB4klAABgqgzGjwAAgKQSoCIN9OQFYP+AZbAIrOdUVlYOwiHi00Jw8SUAALBMgRwdAACiM8DrzwAAYCYFlKRAAw2cTQQiRDBSFkweBgAAL8vBxacAALDAACizAADg7itgqACktQVzCAKks3lSAAAC9t1Mb+0Lbt68WVBQIGgrBiI0Gu3jx48qKipDhqBbLx6MHj16wYIF3PlIYIgekZOTs3z58rCwMAMDA0HbIkwMurEQAtGfIIEhEHwEDRERPYJKpZaUlIwcORJfnAvRE5DAEAg+goaICAQfQQJDIPgIEhgCwUeQwBDdkJ2dDedwCtoQoQQ5ORBdgWGYp6dnR0eHtLT0okWLpk+fPgjnkX0LSGCIbggPD//06ZOVlVV4eHhbW9uiRYumTZuGZNZDkMAQ3dDa2rpq1arff/9dUVHxzp07Fy5cUFVVXbRo0dSpU5HMugUJDMGbN2/eEAgEIyMjAMDVq1ebm5vnzp27e/fuVatWUanUsLAwERGRPXv2KCoqdlvVYAYJDMGbV69eHT16dOvWrUZGRs3NzWvXrpWQkFi9erWZmRkAgMlkZmdnm5iYCNrMgY7I7t27BW0DYiAyYsQILS2tkJAQXV1ddXX15uZmSUlJF5d/Q2MSiURlZWXBWigUoDE0olPMzMw2btwYHBycnZ3t5OT04sWLyspKQRslZKAeDPE/3rx5c+7cuZqaGiKRKCcnRyQS8X7MyMhIQkLi6dOnU6ZMEbSZwgRaMgDxPxgMRlZWVkNDQ2pqamVlpa6urqGh4dixY318fIKDg729vYcNGyZoG4UM5ORAfAHu2xg1atS7d+9ycnJycnJKS0uJRCKLxTp16hRyG34VSGAITtj9hzCnvb09Nze3qalp2rRpgrVN6EACQ/CAW2OI3oG8iAgesPsPBW2LcIN6MESnwH4MTpIStC3CChIYois+ffo0YsSI7sshOgEJDIHgI+geDIHgI0hgCAQfQQJDIPgIEhgCwUeQwBAIPoIEhkDwESQwBIKPIIEhEHwECQyB4CNIYAgEH0ECQyD4CBIYAsFHkMAQCD6CBIZA8BEkMASCj6Bl276go6ODyWQK2gqE8CEiIiImJsadjwT2BUwmk8FgCNoKxPcDGiIiEHwECYwHTCZzypQpc+fO7bqYsbHxuHHjjI2NJ0yY4OHhUVBQ8O1NZ2RkmJmZffr0CX4tKCgwMzPrk5oRAgEJjAcZGRkyMjIfP34sLi7uuuS9e/eysrKSk5NnzZrl5ubW0NCAb6LT6b1oetKkSY6Ojvv27QMAYBi2a9euVatW6ejo9KIqxEAACYwHd+/enTdv3qxZs+7du4dnrly58uTJkzzLS0lJubm5TZky5dq1a2/fvvX29j5w4IC3t3dGRoanpycsc6vjNbMAACAASURBVP/+/S1btsB0dHS0tbW1vb39wYMH8UycTZs2vXv37tGjRzdv3qRSqStWrODDISL6CSQwThgMRkJCgoODg52dHbvAtmzZgkfH4smUKVNyc3MBAM+fP9fR0blw4QLPYuXl5cePHw8PD79y5UpSUhJ3AWlp6d27d+/bty80NDQoKIhEQo4oIQYJjJOnT5/q6uoqKytbWlp++vQJHyWOHj266xUCyWRyVVUVAEBGRmbRokUiIiI8iz148MDOzk5RUZFMJs+bN49nmalTpxIIhFGjRo0ZM+bbjgYhYJDAOImPj8/MzPzhhx9mzJjR1tbG3ol1TX19PVwBt+t1cCkUipKSEkx3VjIsLExRUbG8vDwxMfFrbEcMONDw4wvodPqjR48ePHgA//qJiYnHjx9fs2ZNT/ZNT0+HHQ6R+L/LFovFggm8JySTydXV1TCNJ9gpKys7efLk9evXy8vLd+/ePXHixKFDh37DMSEECerBviAlJUVdXR3vWCwtLUtKSqA2ioqKKBQKz73a29tv3LiRnJy8ZMkS9nxpaemcnJz6+noqlRofHw8zra2t4+Pja2trm5qaYmJiOKrCMCwwMNDd3X306NHW1tYmJiYHDx7s44NE9CNIYF8QFxc3ffp0/Ku4uPjkyZPhKPHgwYMREREc5e3t7c3MzKZMmRIfH/9///d/cnJy7Fv19fWdnZ2dnZ2nTZtmaGgIM3V1db28vJydnb28vGbMmCEhIcG+y7Vr1ygUCt5nbt++/cGDBykpKX19oIh+Aq1N/wVUKpXfU6Xy8vLu37+/fv16DMM2bdo0derUbp9oIwY+JBKJ41oJQT1Yf6Ojo0OlUhcuXOji4qKoqDhnzhxBW4TgI6gH+4J+6MEQ3yWd9WDIi/gFJBKJ3QeIQPSQTv82GGLAExsbO2bMmJEjRwYFBQnalv7m8OHDGhoaGhoae/fuhTnCdTYGncCKioq2bdt24MCB5cuXb9u2rbCwUNAWdUNDQ4OqquqHDx9aWlpMTU1TUlIEbVH/ERsbq6urW1pa+unTJ0tLy1u3bgnd2RiMw6Hs7GwrK6s//vhj5MiR0dHRgjanG+Lj46dMmaKjoyMlJeXp6RkeHi5oi/qP1NRUR0dHDQ0NZWVlNze3iIgIoTsbg1Fg4uLiU6ZMIRAIEyZMaG1tFbQ53VBeXj5y5EiY1tTUrKysFKg5/YqRkdG9e/coFEpdXV1UVNSnT5+E7mwMRieHmpoanIkrFP4MfLIVpHevmQkprq6ur1+/NjExGTZs2LRp0z5+/Ch0Z0MI/mGDHDU1tfLycpguLy9XV1cXrD39CZPJ3L9//6dPn/Lz8w0NDbW1tYXubAiTwKqqqhwdHf/44w/2zG3btrm7uwvKJH5QWFhIIBDwuYv29va3bt26cOECnU4PCwuzs7MTFxdfvHixYI3sH4qLi42MjBoaGurq6s6dO7d8+XJ7e/ukpKSPHz/Cs+Hs7CxoG7tBmAQGABATE3v27Bn+tampqaioSID28AkxMTF/f/+Ojg4AAJlMNjMz279/v7Gx8ezZs1taWoyNje/evdve3i5oM/lLXFyco6NjTU2NhobGtGnTAgMDzczMyGTy6dOnx48fLyUllZeXx/5nGJgImcCkpKSGDx+OiwouEYNvzczM9PX1XbFiRWhoKBydR0ZGenl5LVmyJDAwsL6+HhaTkJAICgry8PC4efOmm5tb/x9Ft2hoaIwbN+7YsWPwq4qKym+//fbu3bsdO3ZERkb6+fkZGRndv39fsEbylcbGRm9v7zt37pSXl+vo6Jw5cwb/pURFRYcNG1ZQUJCXl3fv3r2///5bsKZ2jZAJDABgaWn59OlTmH769KmFhQVMNzY2Hj58eNOmTefPn8cw7NKlS5WVlREREQcPHgwLC5OVlX306BEsKRRu+qNHjx45cgRfXgrS2tqanJw8d+5cFxeXqKgoQdnWD3Thjuf23QvQzm4RPoGZm5unp6cDANrb20tLS/GX6p8/f25kZKSpqUkkEmfPnp2amqqsrHzx4kVFRUXoi29ra4MlhcJNr6mpuXbtWo4lceLi4mbOnCktLT1v3rw7d+4MfB9ar+nCHc/tuxeMiT1D+Nz0CgoKQ4YMqaioKC0tNTMzw13ttbW1eXl5/v7+8Ku8vDwAIDw8/OnTp8OHDycSifiL+sLipv/1118NDAzg1QQSGRn58OFDLS0tAEBjY+OjR49sbW0FZyAf6cIdz+2773frvgLhExgAwNLSMj09vayszNraGs+UlZW1srJatWoVAIBGo1VUVDx58qSgoODEiRNSUlK3bt1qaWkRnMm9QUJC4siRI76+vpqamgAAKpX68OHDkpISGRkZAMCBAweioqK+V4GpqallZ2fDNIc7HvruQ0JCAADHjx8XFxcXjIk946sv4f3jK3/8+LG3t7enp+eFCxfwi9mBAwfq6+sdHR3DwsJu376dm5trbGyM7zJ+/Pi0tLTS0tLc3Nw//vgjLi6uqalJRkZGUlKyqakpMTExPz/f19d38+bNZWVl+GIyOTk5WVlZfWj5t1NWVlZQUADd9C4uLrKysjExMc+ePbt7966JiQmRSIRuejs7u+jo6IEcqsLPz6+z8dv79++73penO/7t27cdHR3cvvteW3j16lXuVRv6lt6MkfjtKy8uLj5//vyePXvOnj1bVlZ29+5dmF9TUyMrKxsVFRUVFSUrK2toaEihUIKCglpaWk6dOiUvL+/t7b179+5du3bV1tZ6eHhYW1uTSKTVq1eHhIQoKyu/e/du8eLFhw4dUlBQCAsLy8zM7EOb+xYCgYC76UNDQ+ElJjIycvbs2Xfu3IFuen19fRKJ9OTJE0Eby5vCwsLW1laeC93V1dX9+OOP3Pl//fWXvr6+kpLSggULiETi6dOnR40aJSYm9vz5cxsbmzNnzowdO7a4uHj06NEeHh76+vrQd3/r1i01NbURI0asWbOG43ITFxenr6+vpaWFr2sSEhKiqampqakJ105euHDhqVOnOIajfczXzg6mUCjLli3bunUrPg/94cOHhw4dcnNzg19fv37t4+Pj5eV1/Pjxjo4ODMMiIiI8PT1dXV23bdtWV1eHdTelPSIi4siRIzCdlpa2detWDMOoVKq7uzuHMadPn05PT8cw7PDhw9nZ2QwGY9euXTQajaNYY2Pj4sWLq6ur8Zz79+9fuXIFwzAfH5/MzMyvPQl8paCgQEdHx8XF5dChQzBn/vz5kZGRMD1v3rwrV65YWVlFR0cLzsbu8fLyevbsGXf+xo0blZWVZWVlOfJfv36toqJSWlra3Ny8aNEiX19fDMPIZDKTyeyilcTERBMTk6ampvr6elNT06tXr+KbuOfdc8/NxzBsz5494eHhfXDAndDLu3y++soZDAb233vWRCIRrm32+fNnAICfn5+bm9v+/fvhQy1HR8fbt2/7+vqKi4vr6+vfu3fP2tqaO0xTUVGRhoYGdHtAbGxsBuYTMBxhd9Onp6ebmJhw569bt47nqKysrGzlypUaGhrS0tKurq4fPnyoqqqC3qkuWhEXF9+zZ8/QoUNlZWXNzMzYfcLcjn6e/v0JEybwdZTYS4Hx1VduZmb26tWrkpKSxsbGmJgY6Jyg0WgGBga7d+8OCwuTlJQ8d+4cAEBVVTU4OPjEiRO+vr40Gu3ly5c//PADt7UUCoVMJvfuSAWFULvpqVQqnU4fMmQI9yYtLS1dXV3ufEdHx927dwMAmpqafv/99/nz5xcVFbW0tIwbN05BQcHV1ZU9sAaOhYWFo6PjnTt35s6dW1RUxD6DjNvRz9O/r6uri3tT+EEvBYb7yl++fMnTV+7v73/y5EncV+7p6bl///6amhq8hi585bq6up6enkePHt2xY4exsbG0tDQAQE9PLyAggEwmi4iIODg4cN9B3bx5c/78+bm5uevWrfP29k5NTcU3ycvL19XVsReur68f+Guh/frrr6mpqTzd9DNmzIBuegGa1wVVVVX4Fe3ixYumpqampqY9+R/fuHFj/Pjxixcv9vLykpaW9vf3z8jIyM/P7+jo2LZtW2d7TZo0ycPDo7m5mb0v4nb0u7q62trampiYWFhYjBo1SkpKCgCgqKjY2NjYy+PsAb130/PPV97R0WFpaTlr1iwAQEZGBrxRhn4nePEjkUiioqLsu1AolNraWgMDg40bN+7YsWPo0KH+/v6WlpZQvdra2sXFxTU1NfgoMTk5OSsri2d3N3AQXje9uro6vkjrihUrehIgBsMwDw+PqqqqpKQkNTU1AMCYMWP09fVFRETExcWXL1/OcwHW2NhYOTk5KysrJyenurq6yMhIfOTP7ejn6d8vLi7GH5Dyg94/abWwsEhJSenMV85gMHj6ynuyZlNTU5OPj09NTQ2VSo2KirKxsQEAVFdXBwcHV1VVsVis2NhYc3Nz9l2uXr2Kr6pLJBKJRCKB8L8Fs+Tk5BwcHA4ePFhWVsZkMrOysm7evGlvb9/rY+83oJseTjuEbnqoLgDAQHbTE4lEBQWFHvYM0PkeHR1dUlISFxcH1QUAOHfunI2NTVtbW1NT09WrV6dNmwYL02g0fN/a2tqtW7fW1dXB7mvs2LF4hdyOfp7+/ffv3+MeBH7Q+x5MVVWVxWIZGhqyhxFRVFT09vYODg5uaWnR09Nbv349ACA/P3/16tVwDcBr165NnTq1s8gjEHl5eRcXlw0bNkhJSdna2sJ+xsrKikKhBAYG0ul0ExMT9otifn6+jIwM7Og8PT337NnDZDKXLl3K3oqbm5u4uHhQUFBdXZ2iouLKlSsnTpzY62PvT0JDQ6G3ALrp8XxTU1Popp8xY4bgrOuUuXPnJiQkdB3wCQDAZDLHjh2bl5eXkpKSmpoqKSkJ86dOnRofH//582cjI6P29nYHB4edO3fCwjk5OfgyyUuXLn3z5o2pqSmDwbC1tQ0ICMAr1NPTO336tK2tLYPBcHV1hQ8GoH9fXl4ezs0HADx69AiP4cYP0LqICAQfGdCT8RAIYQcJDIHgI0hgCAQfQQJDIPgIEhgCwUeQwBAIPiKUL1zyDxS+CNE7UAA+BEIAIIEhEHwECewLGhoaxowZM27cOGNjYxMTk8WLFxcUFHRWeOLEiUZGRsbGxuPGjbOzs4Nz29++fbto0aJvNCM6Ohq+u4EQdpDAePD69eusrKx//vlHS0sLvlveGTExMVlZWRkZGQsXLty0aZPQrauD4DdIYJ1CIpHmzJmDv1O8cuXKkydP8iwpLi7u5uZGp9PLysrY88+fPz9jxoxJkyYtW7YMvpcNAIiOjraxsZk2bdrhw4fhXPj09HRHR0dra+vAwEC4DgcAoLGxcdWqVRYWFh4eHvBtbgBAbGysjY3N1KlTAwICqFQqP44a0bcggXVKe3t7dHQ0Pld9y5Ytnc0Np9Fo4eHhJBIJf9UCAFBSUnLu3LmrV6+mpaXJy8vfunULAPD+/fvjx49fvnz51q1bycnJz58/r62t9ff3P3LkyMOHD1ksVnBwMNz9wYMHHh4eKSkpOjo6u3btAgCUlpYePHjw3LlziYmJVCr17Nmz/D1+RF+A3PQ8MDU1JRAITCZTXFz85s2bMHP06NHcJefNm0ckEul0ury8/KFDh4YNG4ZvUlNTS0xMlJGRqa2tJRAIcFmEBw8eODk5wTdrQkJCxMTEEhMTzc3N4Yuk7u7uK1as2LlzJwBg0qRJ8D2l9evXm5ubMxiMxMREW1tbuOroqlWrNm/evGHDBr6fC8S3gQTGg9evX4uIiLBYrMTExPnz56enp3e2uuXff/8N//E8OXXq1IMHD5SUlERERFRVVQEAFAoFvhQIADAwMAAA3Lt37/Xr1/PmzYOZ+DpneEJaWlpCQqKhoaGqqgrPVFFRqaqq6oNDRfAZJLBOIRKJs2bNkpOTe/v27fjx479297i4uJycnDt37gwdOvTSpUvw9d7hw4fjC5NkZGQwGIzhw4f/9NNP27dvBwC0t7fjK0zi910lJSXt7e1kMllBQQFfJppCoSgoKHz7MSL4DboH6xQMw548eVJdXa2hoQEAKCoqwteZ6AkNDQ1kMllKSqq+vj46OhquADVz5sy///67urq6oaFh//79zc3N06ZNu3///vv37+l0enBw8NWrV+Huz58/f/HiBZPJvHLlio2NDZFInD59+r1798rLyxkMxvnz59mXQkEMWFAPxoMJEyYQCAQWiyUnJxcUFAT7ioMHDxobG/v4+PSwEicnp8zMTFtbW1VVVXd395MnTzo4OBgZGXl5ebm6utJoNHt7exsbGwKBsH37dj8/v6amJhMTE3xpF2tr65CQkMrKyrFjxwYFBQEAtLW1N2/e7OXlRaPRzM3N165dy6fDR/QhaMmAL0BzERG9A81FRCAEABoifgGBQBjgQcMQAxMCgcB7A/+WvUf0FbGxsWPGjBk5cmRQUJCgbelvDh8+rKGhoaGhsXfvXpgjXGdj0Ams68AuAxDuKCGCtqj/4I6HInRnYzAOh4QiCDpOF+HAv3u446EI3dkYjAITiiDoOF2EA//u4Y6HInRnYzA6OYQlCDqki3Dg3z3c8c6F7mwIwT9skKOmplZeXg7THOHAv3tgPJRPnz7l5+cbGhpqa2sL3dkQJoH1T/x1gVNYWEggEGAQdACAvb39rVu3Lly4AKOE2NnZwSDogjWyf+COh8IzOPpARpgEBvgff32AICYmhgdBJ5PJZmZm+/fvNzY2nj17dktLCwyC3t7eLmgz+c7o0aPV1NTk5eWVlJRUVFSMjY3JZDKMmWJsbFxSUgLnmhEIBBjxdAAiZAKTkpIaPnw4LqqMjAwYhAaSmZnp6+u7YsWK0NBQODqPjIz08vJasmRJYGAgDOsMAJCQkAgKCvLw8Lh58+bAjNSsoaExbty4Y8eOwa8qKiq//fbbu3fvduzYERkZ6efnZ2RkBIOGfd8kJSXV19fX19dXV1fX1dXduHEDAODk5PTmzZt3797R6XQ8RLq3t7egjeWNkAkM8Dn++sBB2IOg9wldxDjvSYj0gcBAt48bvsZfHzgIdRD0vqKLGOc9CZE+EBA+gfE1/vqAQniDoH8L3EHTecY473mIdMEilM/B+Bd/fUAhvEHQvwX2oOldxDjvSYj0gcBXX8L7x1f++PFjb29vT0/PCxcu4M8WDxw4UF9f7+joGBYWdvv27c7ir+fm5vKMv56fn+/r67t58+aysrLExES4V05OTlZWVh9a/u2UlZUVFBRANz0Mgh4TE/Ps2TMYBJ1IJEI3/UAOgu7n58dx99g7uohxzjNE+vv373vRytWrV9n7xr6lN2MkfvvKi4uLz58/v2fPnrNnz5aVld29exfm19TUyMrKRkVFRUVFycrKGhoaUiiUoKCglpaWU6dOycvLe3t77969e9euXbW1tR4eHtbW1iQSafXq1SEhIcrKyu/evVu8ePGhQ4cUFBTCwsIyMzP70Oa+hUAg4G760NBQeImBQdDv3LkD3fT6+vowCLqgjeWksLCwtbUVX58Hx9jYmPAfHF717du3q6mpjRgxYs2aNfCSAXO2bt3a1NRkamo6ZsyY4cOH4zHOi4uLV69ebWlpaWRkpK+vLyMjs3Pnzrq6OhjpnIPs7GxLS0tlZeVFixbBykNCQjQ1NTU1NeGqsgsXLjx16hTHHJE+42tnB1MolGXLlm3duhWfh/7w4cNDhw65ubnBr69fv/bx8fHy8jp+/HhHRweGYREREZ6enq6urtu2baurq8O6m9IeERFx5MgRmE5LS9u6dSuGYVQq1d3dncOY06dPp6enYxh2+PDh7OxsBoOxa9cuGo3GUayxsXHx4sXV1dV4zv37969cuYJhmI+PT2Zm5teeBL5SUFCgo6Pj4uJy6NAhmDN//vzIyEiYnjdv3pUrV6ysrKKjowVnY1d4eXk9e/aMO59MJuNedXYSExNNTEyamprq6+tNTU2vXr3KndNtoxs3blRWVpaVleXIp9Fompqaz58/p9FoLi4uly9f5p6hj2HYnj17wsPDe3W43dDLu3y++soZDAb230IGRCIRrokLV1ny8/Nzc3Pbv38/fKjl6Oh4+/ZtX19fcXFxfX39e/fuWVtbi4mJcVhbVFSkoaEB3R4QGxubgfkEDEd43fTp6ekmJiYcmV141bl98V145ztj3bp1PId58fHxpqamkyZNEhMTu379+vz587ln6AMAJkyYwKdRYi8FxldfuZmZ2atXr0pKShobG2NiYqBzgkajGRgY7N69OywsTFJSEo4xVFVVg4ODT5w44evrS6PRXr58+cMPP3BbS6FQyGRy745UUAipm55KpdLp9CFDhnDkd+FV5/bFd+Gd7wwtLS24eCsHxcXFLBZr8uTJioqKCxcubG9v556hDwDQ1dXFnZZ9Sy8Fxldfua6urqen59GjR3fs2GFsbCwtLQ0A0NPTCwgIIJPJIiIiDg4O3HdQN2/enD9/fm5u7rp167y9vVNTU/FN8vLydXV17IXr6+tTUlJ6d+z9hjC66auqqvBrGbvDvVuvOrcvnqd3Hofbm8+TlpaWtLS0y5cvFxcXS0tLb9u2zdXV1dbW1sTExMLCYtSoUVJSUgAARUVFuHBln9N7Nz3/fOUdHR2WlpazZs0CAGRkZMDbZeggglcpEokkKirKvguFQqmtrTUwMNi4ceOOHTuGDh3q7+9vaWkJ1autrV1cXFxTU4OPEpOTk7Oysnh2dwMHYXTTq6ur46tHsjvcGQxGZ151bl+8jIxMZ955HPbKu0BZWXnmzJlwhLV48eL9+/fDGfohISEAgOPHj8M1m4uLi5WUlPriBHDS+yetFhYWKSkpnfnKGQwGT195TxZFa2pq8vHxqampoVKpUVFRNjY2AIDq6urg4OCqqioWixUbG2tubs6+y9WrV5csWfLvIRGJRCKRQPjfinRycnIODg4HDx4sKytjMplZWVk3b960t7fv9bH3G9BND6cdQjc9VBcAYGC66YlEooKCAndvwNOrDh3u3L74zrzzNBqt55bAyh0cHJKTk3Nzc1taWsLCwqZMmcI9Qx8A8P79e9yP0Lf0vgdTVVVlsViGhoZwpAdRVFT09vYODg5uaWnR09Nbv349ACA/P3/16tWKiopz5sy5du3a1KlT2XfhRl5e3sXFZcOGDVJSUra2trCfsbKyolAogYGBdDrdxMSE/eqVn58vIyMDOzpPT889e/YwmcylS5eyt+Lm5iYuLh4UFFRXV6eoqLhy5cqJEyf2+tj7k9DQUOgzgG56PN/U1BS66fH4LwOEuXPnJiQkcESiWb169efPn42MjNrb2x0cHHbu3Akd7nl5eUuXLn3z5o2pqSmDwbC1tQ0ICBAXF+fIgYVzcnIMDQ17YgNeuZ6e3pkzZ5ycnJqbm21sbHbv3i0lJeXh4aGvry8vLx8YGAgniz969MjT05MfZwMtPIpA8JEBPRkPgRB2kMAQCD6CBIZA8BEkMASCjyCBIRB8BAkMgeAjQvnCJf9A8cEQvQPFB0MgBAASGALBR5DAOMEwLCwszNHR0dTUdPbs2V2s69bzkl0THR29e/dujsxXr14tW7as55WwWCx/f/9e7IjgK+gejJPTp08nJyf/9ttvI0eOzMzM/OWXXxQVFS0tLb+lZC/Q1dXdvn17z8tjGJaUlNSLHRF8BfVgX1BfX//XX3+Fhobq6OiQSKQJEyb4+vq+ePECALBy5cqTJ0/2pGRsbKyNjc3UqVMDAgKoVCoAIC8vb8GCBe7u7paWlitWrHj48KGzs/OPP/6ILzfS2Ni4atUqCwsLDw8P+O52UVHR/v374b7Lli3z8fGZNm3asmXLcnNz4S7nz5+fMWPGpEmTli1bVl1d7efn19HRsWDBAnzHzizhWRuCTyCBfcHbt29Hjx6trKyM5yxYsAC+E7Blyxb2GeK5ubk8S5aWlh48ePDcuXOJiYlUKvXs2bNwa3Z2tr+/f2JiYkVFxfnz52/cuLFlyxZ864MHDzw8PFJSUnR0dHbt2sVhVUZGhq2t7ePHj/X09OB6XiUlJefOnbt69WpaWpq8vPytW7dCQ0PFxMTgC/CQzizhrg3BP5DAvqCyslJBQYHnptGjR7OvlFRRUcGzZGJioq2trZaWFolEWrVqVUJCAsxXV1efMGGCuLi4sbHxnDlzREVFLSwsPn78CLdOmjTJwsKCRCKtX78+LS2N41GBpKSkra0tgUCYPn16c3MzAEBNTS0xMVFFRaWpqYlAIPBctaIzS7hrQ/APdA/2BcrKynCNHZzq6uqMjAz2F7G6LllVVYXrUEVFpaqqCqbxFyWJRKKcnBwAgP11NXwXaWlpCQkJjoWgoUjAl8srnDp16sGDB0pKSiIiIqqqqtzH0pklPGtD8Al0ir/AwMAgLy+PfS2n2NjY27dvc5fU19fnWVJBQQHeRAEAKBRKZ/0hB/guJSUl7e3tHEv0EAgEjvJxcXE5OTl37ty5cePGzJkzedbZmSXctSH4BxLYFygoKLi7u/v5+X348IHBYDx9+vTMmTNwMYKioiJ8tYkuSk6fPv3evXvl5eUMBuP8+fPsC5Z0wfPnz1+8eMFkMq9cuWJjY9Nt39LQ0EAmk6WkpOrr66Ojo+HyUkwmk331zN5Zguhb0BCREz8/P0lJSR8fn+rqalVV1cDAwOnTpwMADh48aGxs7OPj023JzZs3e3l50Wg0c3PztWvX9qRRa2vrkJCQysrKsWPHBgUFdVveyckpMzPT1tZWVVXV3d395MmTDg4OkydPdnR0xHfX1tbuhSWIvgUtGfAFaC4ioneguYgIhABAAkMg+AgaIiIQfAT1YEJAXFycvr6+lpbWgA0zxz84Qg0BoTsb/AjZMpDpOnLSAKShoUFVVfXDhw8tLS2mpqYpKSmCtqj/4A41JHRnYzD2YF1EThqAxMfHT5kyRUdHR0pKytPTMzw8XNAW9R/coYaE7mwMRoF1ETlpAFJeXj5y5EiY1tTUrKys5m4qigAADH1JREFUFKg5/Qp3qCGhOxuD8UFzF5GTBiAcoU0HYEww/uHq6vr69WsTE5Nhw4ZNmzbt48ePQnc2hOAfNshRU1MrLy+H6fLycnV1dcHa05/AUEOfPn3Kz883NDTU1tYWurMhTAKrqqpydHTkeIVp27Zt7u7ugjKJHxQWFhIIhPj4ePjV3t7+1q1bFy5coNPpYWFhdnZ24uLiPQn6+B2Ahxp68eIFDDVkb2+flJT08eNHeDacnZ0FbWM3CJPAAABiYmLPnj3DvzY1NRUVFQnQHj4hJibm7+/f0dEBACCTyWZmZvv37zc2Np49e3ZLS4uxsfHdu3fb29sFbSbfGT16tIeHh56enpWVFQw1RCaTT58+bWtra2xsXFJSYmNjQyAQCAQCDCk8ABGyezApKanhw4cXFRVpa2sDADIyMszMzN68eQO3ZmZmXrp0iUqljhs3bs2aNaKiopGRkXfv3qVSqVpaWps2bYIvYklISAQFBX348EFFRcXLy0uQx9MJGhoa48aNO3bsGIzRrKKi8ssvv8D3qZ2dnf38/M6cOXP//v25c+cK2lK+U1tbSyQSpaSk8CCXTk5OTk5OAIDhw4czmcwBfiM9oI3jiaWl5dOnT2H66dOneGDCxsbGw4cPb9q06fz58xiGXbp0qbKyMiIi4uDBg2FhYbKysnhEY6Fw0x89evTIkSPs75sBAFpbW5OTk+fOnevi4hIVFSUo2/qTdevW8YzRXFVVNXz48AGuLiCMAjM3N4dxwdvb20tLS2H4XQDA8+fPjYyMNDU1iUTi7NmzU1NTlZWVL168qKioCH3xbW1tsKRQuOk1NTXXrl0LezCcuLi4mTNnSktLz5s3786dOwPfh/btaGlpwcDcHBQVFbW0tIwbN05BQcHV1ZXjHfCBg5ANEQEACgoKQ4YMqaioKC0tNTMzw69htbW1eXl5cG1AAACMdx4eHv706VN4qcOjXAuLm/7XX381MDCAVxNIZGTkw4cPtbS0AACNjY2PHj0aaEHQv52LFy+eOnUKABAWFmZkZNRZMWlpaX9/fz8/v7a2tpUrV27btu306dP9aGaP+dqpHxQKZc6cOZcuXWLPDAgIcHNz67PpJRiWlJS0atUqDw+P8+fPM5lMmOnn5zfnPzZt2hQSEvLy5cuamhrYdHx8/Llz5zAMy8/Pb29vLygoSExM3LJlS0tLC4ZhkZGRO3bs8PHxcXFxcXFxefToEYZhmZmZCxcuzMzM7EPLv53ExEQAQFxcHIZhkZGRZmZmqqqqmzZtamtrk5WVraioGDJkyKJFi/bv379ixQpBG9sVvr6+Hz9+/PZ6GhoaZGVlOTLpdDqDwYDpmJgYCwuLXtR85cqV27dvf6t9XdKbSzi/XXnFxcXnz5/fs2fP2bNny8rK8MUDa2pqZGVlo6KiTpw4QaVSc3NzFRUVg4KCWlpaTp06ZWpqmpaWFhcXl5WV9ccff8TFxTU1NcnIyEhKSjY1NUVHR5eWlm7ZsuXQoUMKCgphYWGZmZl9aHPfQiAQoBfRxcVFVlYWLq1x9+5dExOT5ORk6EWcOXNmdHQ0k8kUtLG8KSwsbG1tZV+HC7J9+3Y1NbURI0asWbOGw/i//vpLX19fSUlpwYIFcMh34sQJDQ0NPT29trY2fDz89u3bjo6Oc+fO2djYtLW1RUREuLu7v3v3jnvuL3eFHFOHFy5ceOrUKY6H131LbwSGu/LgV+jKw7dmZmb6+vquWLEiNDQUnpTIyEgvL68lS5YEBgbW19cDAIqLiwMDA4OCgjw8PAIDAzn0+fLly/HjxysrK4uJidnZ2aWmpgIAoFeaQCCIiopqampiGGZoaHjnzp2ffvpJWlq6ra2tpqZm5cqVly9fjomJqa2t9fDwsLa2JpFIq1evPnjwYHt7O4vFotFoRCJRQkJiyZIlb9++7e1J4zskEgl6EQEAoaGh8B8QGRk5e/bsyMhIPz8/IyOjz58/k0ikJ0+eCNpY3hw8eHDVqlUcmUlJSXFxcbm5ubm5uc+fP79x4wa+KTMzMzAw8P79+4WFhSIiIjt37nz79u3evXufP3/++vVrFot16dIlAACTyRw7dmxxcfHq1astLS0NDQ1dXV3t7e0LCgoiIiLgX6WzCuPi4i5evJiSkvL8+fN79+79/fffoqKiVlZW7ItJ9j1f2+VRKJRly5bFxMRcuXIF5uzdu/fJkydwnNbQ0ODq6lpSUsJkMo8dO3bmzJmKioqFCxdSKBQ6nX748OGIiAgMw4qKiubMmfP48WMWi3X+/PmjR4+yN3H9+vWQkBCYfvr0qZeXF4ZhxcXF7u7uvr6+S5Ys2bdvX11dHYZhFRUVv/76q4+PT2hoKIPBiI2NTU5O5rb59evXW7Zs4Xk4Pj4+A22IWFBQoKOjU1JSoqCgAIdY8+fPj4yMxDCspaWFTCY3Nzf/9ttvS5cuFbSlXaGvr9/e3s6RmZ6ejg/JvLy8oL8Xcvv27V27dsF0dHS0ra3tu3fvRowY0djYyGAw7O3t4fifg2vXri1atAimT5w4sW7dui4q3Lp166ZNm2DOqVOnXF1dMQyLi4tbsmTJtx5t5/TyLp+vrjwzM7NXr16VlJQ0NjbGxMS0tLQAAGg0moGBwe7du8PCwiQlJeGDRVVV1eDg4BMnTvj6+tJotJcvX/7www/c1lIoFI6F0AY+Qu1FpFKpdDp9yJAhHPkWFhaOjo537tyZO3duUVER+3wUR0dHGAGjqanp999/nz9/vr6+/s8//6yoqKigoAA9GdwNdTH3l7tC7qnDAABdXd3s7Ow+Pfov6KXAcFfey5cvebry/P39T548ibvyPD099+/fX1NTg9fQhStPV1fX09Pz6NGjO3bsMDY2lpaWBgDo6ekFBASQyWQREREHBwfuO6ibN2/Onz8/Nzd33bp13t7e7KMFeXn5uro69sL19fUpKSm9O/Z+49dff01NTeXpRZwxYwb0IgrQvC6oqqrCr2gXL140NTU1NTXF/8eTJk3y8PBobm7mfsB148aN8ePHL1682MvLKy0tLSoq6vHjxxkZGWJiYr///jt3Q93O/WWv0NXV1dbW1sTExMLCYtSoUVJSUgAARUXFxsbGPjlqnvTeTW9paZmenl5WVsa+4J6srKyVlRUcfNNotIqKiidPnhQUFJw4cUJKSurWrVuwO+qajo4OS0vLWbNmAQAyMjLgjfL79+8BAPCRCIlEEhUVZd+FQqHU1tYaGBhs3Lhxx44dQ4cO9ff3t7S0hOrV1tYuLi6uqamBggcAJCcnZ2Vl8ezuBg4SEhJHjhzx9fXV1NQEAFCp1IcPH5aUlMBFgg8cOBAVFTUw3fTq6ur4GpIrVqxYsWIFTMfGxsrJyVlZWTk5OdXV1UVGRuLzMzAM8/DwqKqqSkpKUlNTg4WdnJzMzc0BAOvWrQsJCfnll184GlJTU8N1yzH3l7tCOHU4JCQEAHD8+HFxcXEAQHFxMf78hh/0/kGQhYVFSkpKbm6usbExnjl+/Pi0tLTS0lIGg8HtyktMTOzJomhNTU0+Pj41NTVUKjUqKsrGxgYAUF1dHRwcXFVVxWKxYmNj4XnHuXr1KlweFABAJBKJRCKB8L/lRuTk5BwcHA4ePFhWVsZkMrOysm7evGlvb9/rY+83oBfx/v374D8vIr4Et52d3YD1IhKJRAUFBe6eoba2duvWrXV1dbD7Gjt2LPjPKxgdHV1SUhIXFwfFAAAwNjaOj4//9OlTc3NzeHi4qakpLEyj0fAKec797axCfOpwXV0dnDoMAHj//j0+GYgf9L4HU1VVZbFYhoaG7GusKyoqent7BwcHt7S06Onpwbgk+fn5q1evVlRUnDNnzrVr16ZOncq+Czfy8vIuLi4bNmyQkpKytbWF/YyVlRWFQgkMDKTT6SYmJvhFEdYvIyMDOzpPT889e/YwmcylS5eyt+Lm5iYuLh4UFFRXV6eoqLhy5cqJEyf2+tj7k9DQUBMTE/CfFxHPNzU1hV7EGTNmCM66Tpk7d25CQgJ7PBoAwNKlS9+8eWNqaspgMGxtbQMCAqBXMC8vLyUlJTU1VVJSEpacOnXq/fv38/PzJ0+eTKfTf/zxxwMHDsDCOTk5hoaGsBg+95fBYLi6uv74449dV+jh4aGvry8vLw+nDgMAHj165OnpyccTwT//CWIw09zc7Ozs3OfVXrhwoaqqqq9qq66u5qsLEcMwtGwbAsFHBvRkPARC2EECQyD4CBIYAsFHkMAQCD6CBIZA8BEkMASCjyCBIRB8BAkMgeAjSGAIBB/5fzcaJbGSnrzLAAAAAElFTkSuQmCC" /><!-- --></p>
<pre><code>#&gt; 
#&gt; attr(,&quot;class&quot;)
#&gt; [1] &quot;gg_list&quot; &quot;list&quot;</code></pre>
</div>
<div id="plot-of-mean--sd-changing-the-statistics" class="section level4">
<h4><strong>3. Plot of Mean (+/-SD) (Changing the
Statistics)</strong></h4>
<p>To change the statistics, use the argument <code>interval_fun</code>.
Options are <code>mean_ci</code>, <code>mean_sei</code>,
<code>mean_sdi</code>, <code>median_ci</code>,
<code>quantiles</code>,<code>range</code>.</p>
<div class="sourceCode" id="cb108"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb108-1"><a href="#cb108-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;DIABP&quot;</span>, <span class="st">&quot;advs&quot;</span>)</span>
<span id="cb108-2"><a href="#cb108-2" tabindex="-1"></a><span class="fu">run</span>(mng01, proc_data, <span class="at">dataset =</span> <span class="st">&quot;advs&quot;</span>, <span class="at">x_var =</span> <span class="fu">c</span>(<span class="st">&quot;AVISIT&quot;</span>, <span class="st">&quot;AVISITN&quot;</span>), <span class="at">interval_fun =</span> <span class="st">&quot;mean_sdi&quot;</span>, <span class="at">draw =</span> <span class="cn">TRUE</span>)</span>
<span id="cb108-3"><a href="#cb108-3" tabindex="-1"></a><span class="co">#&gt; $`Diastolic Blood Pressure`</span></span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<pre><code>#&gt; 
#&gt; attr(,&quot;class&quot;)
#&gt; [1] &quot;gg_list&quot; &quot;list&quot;</code></pre>
</div>
<div id="plot-of-mean-and-confidence-interval-modify-alpha-level" class="section level4">
<h4><strong>4. Plot of Mean and Confidence Interval (Modify Alpha
Level)</strong></h4>
<p>To change the alpha level of the confidence interval, use the
argument
<code>control = control_analyze_vars(conf_level = &lt;0.xx&gt;)</code>.
Note that this is only in effect when <code>interval_fun</code> is set
to <code>mean_ci</code>.</p>
<div class="sourceCode" id="cb110"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb110-1"><a href="#cb110-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;DIABP&quot;</span>, <span class="st">&quot;advs&quot;</span>)</span>
<span id="cb110-2"><a href="#cb110-2" tabindex="-1"></a><span class="fu">run</span>(</span>
<span id="cb110-3"><a href="#cb110-3" tabindex="-1"></a>  mng01, proc_data,</span>
<span id="cb110-4"><a href="#cb110-4" tabindex="-1"></a>  <span class="at">dataset =</span> <span class="st">&quot;advs&quot;</span>, <span class="at">x_var =</span> <span class="fu">c</span>(<span class="st">&quot;AVISIT&quot;</span>, <span class="st">&quot;AVISITN&quot;</span>),</span>
<span id="cb110-5"><a href="#cb110-5" tabindex="-1"></a>  <span class="at">interval_fun =</span> <span class="st">&quot;mean_ci&quot;</span>, <span class="at">draw =</span> <span class="cn">TRUE</span>, <span class="at">control =</span> tern<span class="sc">::</span><span class="fu">control_analyze_vars</span>(<span class="at">conf_level =</span> <span class="fl">0.80</span>)</span>
<span id="cb110-6"><a href="#cb110-6" tabindex="-1"></a>)</span>
<span id="cb110-7"><a href="#cb110-7" tabindex="-1"></a><span class="co">#&gt; $`Diastolic Blood Pressure`</span></span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<pre><code>#&gt; 
#&gt; attr(,&quot;class&quot;)
#&gt; [1] &quot;gg_list&quot; &quot;list&quot;</code></pre>
</div>
<div id="plot-of-mean-and-confidence-interval-with-number-of-patients-only" class="section level4">
<h4><strong>5. Plot of Mean and Confidence Interval ï¼With Number of
Patients Only)</strong></h4>
<div class="sourceCode" id="cb112"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb112-1"><a href="#cb112-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;DIABP&quot;</span>, <span class="st">&quot;advs&quot;</span>)</span>
<span id="cb112-2"><a href="#cb112-2" tabindex="-1"></a><span class="fu">run</span>(mng01, proc_data, <span class="at">dataset =</span> <span class="st">&quot;advs&quot;</span>, <span class="at">x_var =</span> <span class="fu">c</span>(<span class="st">&quot;AVISIT&quot;</span>, <span class="st">&quot;AVISITN&quot;</span>), <span class="at">table =</span> <span class="st">&quot;n&quot;</span>, <span class="at">draw =</span> <span class="cn">TRUE</span>)</span>
<span id="cb112-3"><a href="#cb112-3" tabindex="-1"></a><span class="co">#&gt; $`Diastolic Blood Pressure`</span></span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<pre><code>#&gt; 
#&gt; attr(,&quot;class&quot;)
#&gt; [1] &quot;gg_list&quot; &quot;list&quot;</code></pre>
</div>
<div id="plot-of-mean-and-confidence-interval-without-table-section" class="section level4">
<h4><strong>6. Plot of Mean and Confidence Interval (without Table
Section)</strong></h4>
<div class="sourceCode" id="cb114"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb114-1"><a href="#cb114-1" tabindex="-1"></a>proc_data <span class="ot">&lt;-</span> <span class="fu">log_filter</span>(syn_data, PARAMCD <span class="sc">==</span> <span class="st">&quot;DIABP&quot;</span>, <span class="st">&quot;advs&quot;</span>)</span>
<span id="cb114-2"><a href="#cb114-2" tabindex="-1"></a><span class="fu">run</span>(mng01, proc_data, <span class="at">dataset =</span> <span class="st">&quot;advs&quot;</span>, <span class="at">x_var =</span> <span class="fu">c</span>(<span class="st">&quot;AVISIT&quot;</span>, <span class="st">&quot;AVISITN&quot;</span>), <span class="at">table =</span> <span class="cn">NULL</span>, <span class="at">draw =</span> <span class="cn">TRUE</span>)</span>
<span id="cb114-3"><a href="#cb114-3" tabindex="-1"></a><span class="co">#&gt; $`Diastolic Blood Pressure`</span></span></code></pre></div>
<p><img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAASAAAAEgCAIAAACb4TnXAAAACXBIWXMAAA7DAAAOwwHHb6hkAAAgAElEQVR4nO3dd1wT9/8H8HcWhACBACFhyRDZqFBBrFupCwdatRWpe1TF1jrqqFpHtVpHtY7qF/xWrf4sbqmirfvrQitUhggKiiB7ywohyf3+OIgRAgH1EgLv58PHw8vnPrn75JIXd/fJ5T40giAAIUQNuqYbgFBbhgFDiEIYMIQohAFDiEIYMIQohAFDiEJUBWzEiBG0OhwO5+OPP96/f798bnV1NY1Gi42Nbeli8/Pzy8vLm6gglUppNNr9+/dbtApXV1d5a1kslrOz86+//lpvgS1takOGhoZXr16tVzhu3Dj5qul0eocOHebPn19WVvb+q0OtAZO6Rfv7+//www8AUFRUdPPmzZCQkOTk5O3btwMAg8FYvHgxn89v6TLHjBkTGBi4aNEilTVbuoopU6Z8+eWXAFBVVRUZGTl37lwLC4vAwMCWtvAd9OnT56effiJXfenSpT179lRVVYWFhalh1YhqFAbMzMyse/fu5PTQoUM9PT0nT548Z86cTp06MZnMLVu2ULdqAGjpKqytreWt7dev35UrVyIjI9UTMBMTE8VVs1is3bt31wtYZWUlh8NRQ2PUtqJ2Qn3nYBMmTLCxsTl8+DC8fYiYkpISGBgoEAi4XG6/fv3kB3V//vmnl5cXh8Oxt7ffsWMHAPj4+Ny+fXvx4sVDhw4FgMLCwi+++MLCwsLS0jI4OLigoEBxdYqryM/P//zzz/l8fseOHVesWCGVSlW2lkajWVtb1ytsbI2NlaekpAwZMsTY2NjLyysiIqKZG8rY2LiyspJsJHl0Onjw4AkTJgDA69evv/zyS1tbWyMjoxEjRrx69aqxbaW0sKKigkajPX78mKyQnJxMo9FKS0ubvyLUYgQ1hg8f/vnnn9crHDlyZFBQEEEQIpEIAB49ekQQhKura//+/a9evXrt2rU+ffr4+PgQBPHy5UsdHZ1ly5b9888/5OHT3bt3CYLo1avX1q1bCYKQyWQ+Pj6+vr7Xr1+/fv26r68v+USJRAIAUVFR8lVIpdKuXbsOHjz4zp07R44cEQgECxcurNcwFxeXadOmPXz48OHDh7du3Vq+fHmHDh1SU1MVF9jYGhsrr6iosLS09Pf3v3nz5qlTp2xsbOh0+pUrV+qteuzYsYGBgeR0VVXV2bNnbW1tBwwYQJYAQI8ePY4cOZKRkUEQxIABA/r163fz5s0HDx4EBQW5ubkVFxcr3VZKC8nT14SEBHLhSUlJAFBSUtLMFX2Aj0X7o9aAzZgxo1+/foRCwGQy2datW58/f05WOHz4sJmZGUEQV65codFoKSkpZPn58+fT0tIIhYBdv36dwWC8fPmSrJCWlsZgMG7evNkwYBcuXNDX1y8qKiJrHjx4cNq0afUa5uLiUu/vzrhx48inyBfY2BobKw8NDeXxeKWlpWT52bNnAUBpwOqt2tPTk8w2QRAAsHHjRnI6KiqKxWLJP+gSiUQgEISFhSndVkoLmw6YyhU1+majxlF4DtZQXl6epaWlYgmNRps3b15ERMSBAweSkpKuXbvGYDAA4OOPP/bz83N3dx86dOiAAQMCAwNtbGwUn/jkyRN7e/sOHTqQD21tbW1tbZ88edKzZ896K42Pj/fw8ODxeOTDyZMnT548uWHbVq5cuX79enI6NTU1ODg4ODj4woULKtcok8mUliclJfn6+nK5XLLc39+/sc0i7+QAAFNTUwcHBzr9zaG7t7e3vAE1NTWK3TYSiSQrKysoKKjhtjI3N29YWFFR0VgbmrOiJp6LGqO+czCCIBISEjp27KhYWF5e3qNHjy1bthgZGU2ZMuXnn38my/X09O7cuXPlyhUPD4/ffvvN0dGR3AMoLq3e8ul0Orm3qaempoYMbfN17Nhx+fLlV65cUfxENrbGxsrrrVRXV7exZpCdHCRHR0fFdAGAgYEBOWFkZCQUCmsUEASxatUqpdtK5QYEgJqamhatqIkthhqjvoAdP3785cuXX3zxhWLh9evXExMT//777yVLlgwfPpzJrN2jXrt2bdOmTb169Vq/fn1MTMzQoUPJ3hE5V1fXtLQ0+cl3RkZGWlqau7t7w/W6ubklJCTIv1kKDQ319fVV2dqysjKJREKj0VSusYnyBw8eyNd79+7d5nSuNMHd3T03N/fJkyfkw8zMTD8/v7i4OKXbqokNWFJSQk409iVhYyt6n8a3XxQdeg4fPnzQoEFkt8Hly5dXrlzJYrG++eYbcq78BOnOnTsAEBYWlp6efurUKVtbWw6Hk5+ff+3aNTqdvmvXroSEhOPHj/N4vA0bNhAE0adPn3nz5hUXF8tksm7duvXo0eP27du3bt3q0aNHt27dZDJZw3OwmpoaZ2fnESNG/PPPP3/88YeVldWiRYvqtVaxk+PBgwc7d+60sbEh+x4UOzmUrrGx8oqKCgsLi0GDBt25c+fChQtOTk4cDqfpTo6GAOD27dvyh2PGjHFycrp48eLVq1f79u3r7u4ukUiUbqvGNiCfzw8ICEhISLh27Rp5WCs/B1O5ovf5PLRbFAZMnmE2m+3n5/frr7/K5yr2Im7YsEEoFJqYmIwdOzYpKcnV1ZXshduxY4eDg4Ourq6tre3y5cvJA5WwsDBTU9MxY8YQBJGfnx8UFCQQCIRC4cSJE/Pz8wllvYgEQbx69Wr06NEmJiYWFhYLFiyoqqqq19p6nRxmZmbBwcGFhYWKC2xsjU2UP3v2bNCgQUZGRp6enqdPn/bw8HjPgFVUVMyZM8fa2trY2DgwMJDs+GlsWyktvHTpkouLC51OZzKZ+/btayxgja0ItRSNwF80tz/V1dXV1dXyDhhEHQwYQhTCq+kRohAGDCEKYcAQohAGDCEKYcAQohAGDCEKYcAQohAGDCEKYcAQohAGDCEKYcAQohAGDCEKYcAQohAGDCEKYcAQohAGDCEKYcAQohAGDCEKYcAQohAGDCEKYcAQohAGDCEKYcAQohAGDCEKaUHApFKpUCjs0qVL09X09PTYbLaenp6RkZG/v39iYuL7r/rmzZuGhobp6enkw8TERENDw4ZLXrNmTWxsbGZmJo1GO3LkiLx827Zt8+fPb+lKT506VV1dLX/YvXt3+Sjp5NLCw8OPHz/+Lq+njtved39uYWEhjUYjNzU5vH0Tm5rH4+nq6pJvjYuLy7lz5wAgOjq6R48e794CAAA4dOjQnDlz3uGJan6z6ABQWVn5Dg1tLrcxtf/e1Y0bN0xMTNLT05OTk5uumZycXFVVRd6Jvnfv3oWFhfJZYrH4HVbdt2/f4OBgcksRBDF79uzly5e7ubkp1ikoKHj06BGZfyaT+e2338qHL3kHT58+nT59OnljfdKLFy8KCgpEIpFIJCKHd/r0009DQ0OVjtXUfO+TMQCoqKioqqoqLS11dnYOCQlpomZcXFxVVVVRUdHMmTMnTpz4+vXr91rx+1H/m0WXD8vLYrH27t1rY2Ojr68/YMCAzMzMBQsWCIVCc3PzX3755V3WXy9X75qx8PDwKVOmBAYGnjhxQl44dOjQtWvXKq1vaGg4b968wYMH7927Nzo6evjw4V9//XVAQMDNmzc/+eQTss6pU6fkAykdOnTIzs7O1dV14cKF9UZXAoDNmzfHxMScO3cuNDS0oqLi22+/rVfhp59+mjp1KjltbGw8cuTIlStXvtsrHTdunJeXFzloMqm8vJxGo5mamurq6urq6pLDOzGZzIEDByr+9W0RebTeM2MAwGKxgoKCMjIyyIdNvCkcDickJEQsFqempiqWb9q0ydbW1sTEpH///jk5OWThoUOHOnXqZG1tvWTJEnLMp8uXL3t6etrZ2U2fPl2+xygqKgoICODz+f7+/vLho/7v//6vU6dOVlZWU6dObTjgoPrfLJAPy8tkMh0cHG7dunXjxg1LS0s9Pb1Vq1YlJSXNmDGDwWCoGKK3oooIO1P/n+vo+v8a1kl+2fTgFORQixkZGZGRkZ07d5aXJyQkpKenK9Zks9mKg4D89ttvo0ePfvjwoZ6e3r59+yQSyY0bN/z9/cm5J0+eDA4OJggiJSWlQ4cOmZmZeXl5jo6OZGE9f/75p7W1tbm5OTlWSz0ODg45OTkEQbx69crMzKywsFAgEDx8+JAgiK1bt4aEhDT9Ahtis9nkiCcEQcTGxvL5/M6dO5uamo4cOTI7O5ssv379+ogRI5peTlwOERZDhMUQcTl1LySZcN3z1j+ywpmk2grJBURYjIrmkUO8k6MZVVRUBAcHy0elavimGBsbJyUlEQRRVVW1Y8cOPT29oqKihw8f+vn5EQSRnJxsaGiYlpZWXV392WefkWPYxsfH29jYpKen5+bmurq6Xr58OTc3l8fjxcXFSSSSKVOmzJ07lyCIgwcPMhiMK1eu1NTUfPXVVwEBAQRBPH361NzcPCkpSSwWjxs3bvny5fUar/43izlx4kR5BNeuXdurVy8AGD169NWrV9etWwcA3333XVhYWGZmprGxcaNxzi6EbYcbnSvXsE5WAaya0cQzrly54unpaW1tLRAIMjIykpOTnZ2dAUDpWHuK+Hx+dnY2AJiYmMyePbuxaqdPnx4/fjw5sO3kyZOVHoUOGzaMTqe7ubk1PA8sLS0tKCgQCATyEhMTk40bN86dO/fevXtNt7A5Kisre/XqtXv3bj6fP3Xq1JCQkJMnTwJAp06doqOjm37ugX/h7+cAAEMdYdsgAIAfbtevs+0eAIAeCwKdAQD+eAx/JMBUL9Wn5vr6+jQaTSqV6unp3b9/nyxU+qZ4e3vT6XSxWCwUCn///Xf5WL4AYG9vn5aWZmJikpeXR6PRyKPHkydPTp48mRwx+MiRI2w2OyIion///p6engAQEhIyZMiQPXv2AEC/fv0GDhwIAOvXrzczM5NIJBEREePHjyc/IcuXL584ceLGjRvlq9PIm/XWGM3ycZB5PJ6tra18WvWybQRwcH39wikNBh1tWMfBqukFh4eHR0VFWVhYAEB5efmJEyeauU8vKCggn2VlpWQVRN2YMpmZmfJXamlpqTRgO3bssLS0TE1NjYiIGDlypOKswsJCa2vrevWnTp164MCB0NDQeuXHjh1TfL8BIDQ01M/Pr4lX4efnd/r0aXJ6/vz5gwYNkjdV5cnD0l4Q1BkAwLZulKLXIiXVDgYCh1U7PbcbDHFsVsdXRUUFg8GQyWQRERE+Pj65ubkcDkdpzZiYGPITr9S6detOnTplbW3NYDDs7OwAIDMz08fHh5xLDht94sSJu3fvenl5kYXyT6l8XGwul6uvr19YWJidna04l/wLK6eRN6vRQdAVR09VTYcJvg3+eiWern/e1bBOk8Ri8blz5549e0buYSIiIlatWtXMgF25cqVr164AoDjksUwmIyfkQTI3N5cf+ssnFKWkpKxbt+7OnTupqalz5szp06eP4p7cxMQkMzOz3lNoNNrevXs/+eQT+eE+acKECeTpbvM9ePAAAMgxb3V0dNhsNlmem5urcnQvCwOwMFC9iilnIXFu7bQZB8yUx0Q5Op0eGBhoZmYWExNDHvu0yB9//PHw4cP4+HhjY+MtW7YUFRXB2+/IzZs3a2pqzM3Nx40bR3YEVFZWJiUlkXPl535Pnz6trKzk8/lCoVDe5ZuZmSkUChVXp5E3i+Ju+sTTbybk0832119/OTg4kOkCAH9//6dPn5LZSEpKarixSJWVlf/5z38iIyPnzp2rWG5oaBgdHV1QUFBRUREeHk4WjhgxIjw8PC8vr7i4+Pfff6+3KIIgpk+fHhIS4u7uPnLkSD8/v4ULFypWMDY2NjY2zs/Pr/fELl26TJgwgTySkTt27Jjn26KiopreAi9fvhw7dmxaWppUKt29e3dgYCBZ/vTpU/LPR4skzlX+750RBBEZGZmdne3o6AhNvilKFRQU8Pl8LpdbUFBw6NAhclD2UaNGHTx4MCcnp7CwcP78+SUlJcOGDTtx4kR8fLxYLF60aJF8q16/fv1///sfuWXGjBlDp9OHDx9+/Pjx1NRUiUSyadOmeocbmnmz5KdrTCbzxo0b5PTKlSuHDBlCTpOHIgkJCS09/3t/EydOXL16tWLJ0KFD169fTxDEkCFD1qxZoziLzWZzOBwDAwMul9u/f//4+HiCIOTn0wRByGSyr7/+2sbGhsfjTZkyRd6fsWvXLisrKx8fnyVLlsyaNUtxmbt373Z0dJQPOZuZmcnlci9evKhY5+uvvz5//jxRd94sLy8tLRUKhe953kwQxE8//WRvb29paTl58uTS0lKycOvWrfv27Wvpkj8IspNDX1/fwMBAT0+vQ4cOR48eJWc1fFPknRyK5G9KYWHh+PHjHR0dBw4cuH//fgsLC7K/Ye/evfb29kKhcMGCBTKZjCCIkydPOjk58fn8kSNHkkP7Hjx4cPTo0d27dzc3Nw8ICMjNzSUXfvjwYUdHRysrq0mTJpWVldVbtfrfrFYdMDV49OjRypUrCYKQyWQTJkw4fPhwS5eQlZVFjhmtNlKpdODAgdXV1epcadug/jfrzTkYuYMmrV//pjfCyMiIaLvDzLq5uVVWVvr5+dXU1PTv31+xT7WZLCwsnJ2dExMT630BTZ1z585NnjxZR0dHPatrS9T/ZuEYzR+ATCaTyWS1XyxSTywWs1islvVCoTpqfrMwYAhRSAsu9kVIe2HAEKIQBgwhCmHAEKIQBgwhCmHAEKIQBgwhCmHAEKIQBgwhCmHAEKIQBgwhCmHAEKIQBgwhCmHAEKIQBgwhCmHAEKIQBgwhCmHAEKIQBgwhCmHAEKIQBgwhCmHAEKIQBgwhCmHAEKLQh7+/qVQqVToOEEJtGJvNNjU1bVj+4QOWn5+/YMEC+XBpCLV5MpmsqKho+/btDWdRcodub2/v5cuXU7FkhFohqVS6ZMkSpbPwHAwhCmHAEKKQmgZxaf3i86BcDADgawkMOoilEJ0NAMDVBXc+AEBOObwoAQCwM64d+7iqBvRYjS0PIQAMmNwP/4P4PACABzPAQAdKq2F6BACADRe+6w19bOHmS1h7EwBgWU+Y1AUAILMMHE0012KkDTBgtX4cCFUSAKjdKfHYcGIcAMC8SHiQBX1s4RMH8DAHgNrdFwBYczXSUqRNMGC1HHhvPWTSa48MmXVnqSZ6YKL3Vh02bjykCn5GVFjVB4QGqqshpBQGTIW+tppuAdJmjQZs8eLFT58+JacDAgJmz54NALm5ubt3737+/LmDg8PSpUsNDPBvO0JNaTRgubm5R48eZbPZAECn0wGAIIg1a9ZMmzbNy8srLCzs3LlzEydOVF9LNeSLM9DHFmZ6a7odSDspD5hIJAIAQ0NDxcLY2FhjY2MfHx8AmD59enl5uRrap3HZ5VBarelGIK2lPGDk5fBfffVVYWGhq6vrvHnzeDxednY2l8v96aefnj9/7uzsPGPGDPU2FSHtozxg1dXVbm5us2fPNjIy2rlz5/79+5ctW1ZeXh4VFbVq1aqQkJD9+/fv379/8eLF8qesW7fu2bNnAGBgYGBlZUXuA9uA8+MAANrKq0GUkEqlMplM6SzlAXN2dpZfDj98+PDVq1cDAIfDcXZ27tatG1m4atUqxafw+fzKykoA0NHRodFoDAbjA74AhFo5Go2mtFx5wMj+QycnJwBgMpksFgsAzM3N5RUYDEa9CM2ZM4ecyMnJ+e2338intAHZ5cBhgZGuptuBWjE6nd5YwJRfTZ+fn79p06a8vDyZTHb+/Hk/Pz8A6Nq1a2ZmZlJSEkEQ58+fJ3s72rwvzkBojKYbgbSW8j1Yz549c3Nzv/vuu5qamq5du5L9GSwWa/ny5Xv27CktLXV3d587d656m4qQ9mn0e7AxY8aMGTOmXqGHh8euXbsoblLr0tcWnE0BAAoKX8TGnlWc5eLib2XpCQDR0cdLSjPl5SwWu0/vOQBQUVGor6/kPg2o/cBLpVRY1ad2oqwsL/HJX4qzhEJXK0vPxMRLl69u0dc3Aag9CmfrcsmAVVeXY8DaOQxYc9nbdZ8/71LD8urqCrG4avHCCCazfk+IiQleyNje4S0DVPgjAe5nqq6GkFIYMBXC/oVb6ZpuBNJaGDCEKITnYCos8IMOTd4aQFdXn8ezbux7RtTOYcBUGN5JRQU3tyFubkPU0hakffAQESEKYcBUmBsJv8c1VaGkJDPxyV8EofxiatTOYcBUeFoIuRVNVXjxIurkqUVSaY26WoS0CQYMIQphJ4cKZz4DFv4VQu8KA6aCoY6mW4C0Gf5xVqFMDCKJphuBtBYGTIXR4bD7n6Yq2HTwHj7sewajjfyCG31YeIj4vsxM7c1M7TXdCtRK4R5MBW8L6GCk6UYgrYUBU+Enfxjv1lSFlJRbR47OxO/BkFIYsPdVVpb3/MU9vJIDKYUBU+H8M4jL1XQjkNbCTg4Vvr0MAJCId9BC7wQD1hS3vU3NXfeDh3x646aPyInVKxMobRLSLniI2CxNJw2hxmDAGoWhQu+vZSNcRkVFHT16tKioqGPHjvPnz+fz+WpqZivgtrf2TCynHHQY9QdEl9vxy0Brq65jP90qv00ias9aMMJlXl7ejh071q1b16FDhwMHDvz666/kqCttUv3dFwFAq83Y7n/g9BOwMgQPpitP8gQApKDDADFZ0dVlkKi6jExX6vO7l/7aaGXpaWnpYWnpIRS4NLx3ImrbWjDCZWJiYufOnckhV0aNGrV06VI1tK+1UNgbzfYGH0tIyIPKjBwAIIDJAPFf3OMCyf2uldsGD3qzWfQ5vA4dPsrKSkh4HCmTSel0ZtCEXx3sewBAcXGGsbEVjYaH6G1cC0a49PPzIwcHA4DU1NSOHTuqr5lqJ++X9/8dhjjC4h5vZtkYgY0RjHIG6H0LAB5En7p08ft+bh25em5Le04FgNNPIPwxdBbAp66uIwLWAkBNjSgn50lWdoLA3BkAZDLpr/sDaTS6hYWbpYWHlaWHtXVXIyMLtb9KRLkWjHBJHi4CwK1bt3777bdly5YpPmXr1q3Pnz8HAD09PR6P12ZGuAwbRuOwQCQiGq0hrQGA5X4iJpMgX7Qxiy7UZ1x/Qe8urLEzkAHAhjssAx1PD74HnSEViUQEIRsduC0nJzEnJzHhcWTU/UMeHiOGDfkeAF5lPhKJyiwt3DkcE/W8QPT+PswIlwBQVla2c+fOgoKCtWvX2tq+deN1fX19LpcLADo6OtD4gH9ax8KA/L/Rl0O+UhqNJn/JPW2Injby35DRCIDiatq1l/SLqeBvLwOAV2XMyyW9PGx6DvQmjHSJsrI8mUxCPv1R7KnExIsAwOUKLS08hEL3bh9NwN/CtHJNfNpbMMJlTU3N6tWrPT09v/vuu4ZLrDfCpa5uezmbZzKZAKCrq9tEB8buYQAAJSIgN0t6OfweDxU1MM8H5vmArq7N3QzQKQQ3Powd81Nh33mZWfFZWQlZWQnRMcf69J4BQCsqSr91ez/ZXyIQOGPkWhWpVEp2BDakPGD5+fkHDhzYtGmTmZmZfITLe/fu6enpTZs2jcKWtj4Nz8HqsbTyHDjgGzpd9TUxxrWH2DDAHu7PgBcloF8Xk18eQFwuMGhwYzLN1NTOiGfHEI7w/wQYNBm586yoKMzOToyL/5MgZAwGSyhwGTjgGzs73/d+fYhaLRjhMiUlJSEhYeTIkWQdLpd75MgR9bX0fTxKhg1hSsoJAmQyUDpeu64OHNnQnGULzJ0E5k4tbRGdBh15bx7+PhqSCyC5EEw5AABPC2HcCdBhwAQP+tKeAACmQq9Zs85IaiqzcxLJnZuubu3B639Cx7L1uJYWHpaWHlaWHkZGli1tDKJOC0a4nDZtmrbuvgw44K6szzMtCx4kwJgBwGywHVi1JRYG6hgBnUUHD3PwqBtl3oEHB0dBQh5Y1d0Wf8tdiHwGbnzOyj7devh1kz+RIGQuLgMzM+Nj487evfdfAHBxHjh+3E4AKC/Pp9OZHA4PkOa0j4t9HW1gzZdKys9ehwcJsHw66DdyXQbA76NVLPtF2v3o6ONjRm9uzlFiM7GZ4GsFvlZvSkY4gRkH4vNq73IlkcHQo+BkCj2s6cG9a89+S0uzMrMSWKzaI9E7d/97/8HvPJ513c7N09q6ywdsZDP97yVUSYBOg08cAADKquHuKwAAoQF0EQAA/PsiLeHpPwBgza39Wybs0NPSzBIAEhMviURl8kWx2YbkMAAi0Ws2u8khOVqN9hEwKpUUv0p88lfgqI2Ufna9LcBb4XsykQQGdYSEPIjJgeDOAACXn8NfqZYe5pYD62Lp6zNRKHTJykrIzIpPSr4qk0mXLrmno8Osri5PSIi0tPIQmDu9b5vziyElo+kq6x+7ZIp1dGnEv13jASBLYvhNvD0A2BrByj7Q0wZuxP5blrAWAF7UPaXPsF8szSyTkq/+eWFNdXW5fFFmpvZkwMrK8jBgbcTNlyA0qB0HvfUw0IElH79VIpZCeilcTgUbLthwAQDCU61N9Kw9u40aagZSaU1BwXMdHX0AyMtPibz0A0HImExdodDF0sKjc+eRlhbu79KOe3GwbGfTVU7rcgig0wgCxBUA4GhjERWxBwD6HYLkAuhpA3NHjK4eOhoA9Fi193iVEgAABQXPCYJQ+vMfPt/xXVqrCRgwFdb/D4Y4gnPjvYitREAnCOgEYmntQwLg8nNILgRjNtyeCgwGi9B3jkgGTwHYWXf9dvHd7OzErOyEzMz45KfXbKy7kgG7fGUrg8EijycNDc2bWh+pjzec2KKkPOIGhP8NRzcCgOHbcxg6LO7b57S6DNB9u5uJ0Ua+QwXAgLUxOnWfVBrAqfFQLobMulOYh9mw7CoAwNxuEOJrYGfnW23o6+AJQoM3Ty8tzX6Rdv/2nVAAMDQ0d3HxHzp4RVPrMzYEY0Ml5ffjgU5T3rFU5+gYMOc0+4VpLQyYCp+5t7rjw+Yz0HnT+OGdoIcVxOe9uQvdmhsQmwt8Dpz5DEz0QEbAJ8O3GelCcXFGVvTm2OMAABQCSURBVFZCZlaCnl7teU7U/cPR0cfJ3wRYWnpYCF3f/2cBrmbvuQDtgAFTYaa3igpeXp96eX2qlra8L1MO9LN783DrIIjLhaeFtb9tSy2GUX9AByP41NVmpreNu/tQeU2hwMXOzjczK/5x4iWZTEKnM0LmRhobWwEQublP+XxHOl3Zd4kIA9aeWRmClSEMresv4HNgwwCIy30z3sXmOxD1CjzMYdZHvgHDfAFAIqnOyUnKzn5MXvtfVJS+P/RTFostFLqSl3HZdujWrJM3gL4HYdZHMNGz0Qq9es7s1XPme73CVgB/j6TCjij4O7WpCmJxRXHxK4DGL7fXEsZsGO0C3/eFz+vu5eMlBBcz+DcH6DQAACkBMy/oHk7rUmwSRP6SjcsVBk8M7d1rtj7H5HHipdNnvo1PuEA+lyBkT5/dKC8vaGx1ZWKobgejauAeTIXzz0BCwKDGT9cfP77054XvVyyLbnu/Vh7U8a0XXiEGri5ceQ6pRbXlD3N0o/J6eFr2GPQRGLOhrCxPfhWyTCb5IzwEALhcoZWlh62tj6/PRMWFiySg2+SnTyQqE4leGxtbNVWp1cM9GGouri7sHALXJsHegNqStBI4/hjmX4SoVwAAhobmf2fw7mSASAIMhs68uedHB25ydfEvLy94+uwG+ZTnz++djVjxzz//ZyqJ23RL3MTqHkb/se8/Y5qooBVwD6bC3mHAbWt7pvcl/9rqcw/43AMySoGnBwBAAGy7B4WVMDcOQgBMTewYHDuJ2fC+A4Bd90ETVZfl5iTFxl34BKQyYIYecBoduLlueBqC/OmA4g0n5dNaesNJDJgKTlrbR682NnX9/jSAG5MhtQhYIoAHAAC30mHpFWDQYaEfTO0KAGBuO2iG86Cuv4oMZBmmkriMwvtf6JsCQE1N1fYd/YUCF0tLD3nS2gAMWHOlpt45dWaJYsmQQcs6dx5paGjO4fC27+gvL9fT486fdwkACgpftLehwxg0cDIFMK59OKgj2HAhIQ86C2pLFv4ND7MAaOxSRqdSRqfnup+Sd6KQyaQf95ialZUQn3C+zaQLMGAqjQ6HgfYQ4gsmJh16fjxdcZZA4AwAjo69Bw9a+vr1mxEi5L0dHD1jaJ+2HgYAcBujm3i6qxC6Ct/M+bo7fHHmrbrkzfB0dQ1695pNligeImo7DJgKZWIQSQEAeDybegGT8/QYrrS8Pf4Wy21M/YeJpxUL6qWrzcNeRBUMdYCNVyl8II3djbwN36Uc92AqnPlM0y1onV6XQ0YuvMqFjFzIK4L8YniVCy+zldRU2Ik1cxQoLe0wVAoDhhpXXQN5RfBKIUIZOfAqF7IKQFr3wxhdFpibgLUA3DtCv26wJ7z+Qt4+RJT75QF8bA3dGr+BSErq7ZSUW0MGL/8gL0VTMGAqxGSDKQds2/Y46OTu6E2KciGfnM4Dou4SMK4B2AiAz4MeXcBaADYCsBYAnwd8Hijew2/eZ/VPwxpx8BEYsJoKWE7Ok0exZzFgbdy3V1Tctk1rSKRQVPomQvL9UloWVFTV1mEygMet3SN5u9ZGyNwE7CybuG1JfYmn4b9nYevhxvZd7QoGrM2RH9dl5EB+MeQXqz6u4/PARgjWArDkA+MD9XuxdZqev9kfHNvB3cExYCoM7wRurXMUtIbHdeROqaBE9XGdueY/2uRNpto8DJgKC/w0uvrGjuteZEJl3fAaisd1PTq/iZC9FXDYTS4dUU5FwEQi0dWrVwMCai+fvnXr1uHDhysrK728vEJCQuTjraD31ehxXT5I64btUMNxnRqNOAaTusA4t0Yr+HWf1O2jz9XYIkqoCFhoaGhCQgIZsJKSkp07d65Zs8bW1nbz5s1nzpyZMGGCWhqpSaEx4GwKfWxV12yWxo7r8ovf1GnFx3UfUGYZlFUDAEil4pqatwa70tHh0OlMJlNXKq0RiV7Ly2k0OnnDcIKQacvYhU0FLCoqKjX1za95s7OzeTyeh4cHAHTv3j0xMZHy1rUC4Y9hiGMLA1YjgeLXKo7rWEwQmgKfV/+4zsEK9NrUccH6/0FRFbDo8NMnAABZZbDlLgCApG7H/MfVC6kPVik+ZdDIX/w6DwCAsP9+XliYJi83M7WfO+dPACgoeK4tt0ZsNGDFxcXHjh2bNWvWL7/8QpbY2tqKRKJ79+517Njx9u3bffv2VVcjW6uWHtcN/rg2RVp7XPcOysTwuhpYdZebSQl4XQ0AMM8HpnkBALD5vvm22wDA3wE6mQAA6BjXXuw7eNAysbhCvijyxqkAwOUqXD7cuikPGEEQO3funDp1quIwzRwOZ/To0T/++KOurq6ZmdnAgQMVn6J1I1yyvYNqp3wmimL+b/dDZvprGgCs61PDZkKZmLb+NhMAfIQwSlgm/jc7Kk12qsCEVlUdmP2wz9N7tPziXBFTWHfPCcJQn7A2J6zMoZcXweeR04S1OWGor3z1NWKoUcOr1AymRMKsG+l7Xa/aQvITwdeBPYPeKglwNQ1wrf/HmnyutVU3peUAzFb1AWvxCJeRkZFWVlZdu3ZNT0+XF8bGxl68eDE0NJTH4x09enTLli0rV66Uz9WuES51vd46e2R7B1XsCi8rk9DEEsb1f5mZOYzs1+V6/WhiiU1OSqcbBwBAZtetvOsI0GGKy0VgLZD5eYotbGs6cAkzY8LSrLHjula9FSjWyj8DH1CLR7h89uzZ/fv3r127JpPJRCLRhAkT9u3bFx8f7+3tLRAIAGDQoEHffPON4lO0fYTL7+crXNXLNTCxMPuvZR5Y8sHHHEYtBguzfhb8fnzy5yeuZK0OGmimlqgb9VPT7VCTFo9wuWDBAnIiPT19w4YN+/fvBwAnJ6d9+/YNHz6cz+dHRkY6OztT1FyN2bsCrAVgYdaCy4LaudincOaakvLkNJBIYc0+JbOMDWHBRCXlbVQLvmj29fXNyspas2ZNdXW1i4vL119/TV2zNAAvnHsHBcVwL1ZJuYwAPk/5LEH7usmJioB16NCB3H2RAgMDAwMDKW6SWiSebuZF36gpA7vDwO6abkSr1i56ipVLPA0b5wMA/HMUd1+IIu04YAhRDwOGEIUwYAhRCAOGEIUwYAhRCAOGEIUwYAhRCAOGEIUwYAhRCAOGEIUwYAhRCAOGEIUwYAhRCAOGEIUwYAhRCAOGEIUwYAhRCAOGEIUwYAhRCAOGEIUwYAhRCAOGEIUwYAhRCAOGEIVUBEwkEl24cKE5hQihhlQELDQ0NCIiojmFCKGGmgpYvSFkmyhECCnVgiFkGysk1Rvhsrq6mqIWvwNaZh7976iG5fQnL+gAkgNnQIdVfx6TIf0iQB2NQ9qvxSNcKh1CVmmhVqBl5jEP/qlkhkwGHD3m0YvQYIRCgs3CgKH314IhZJUWyi1evJicaI0jXPb+CKIOt+gZNIDW9AJQq9biES6VDiGrtNDIyIjKliOk3VowhKzSQoRQE/CLZoQoRCMI4sMusbCw8LvvvjM2Nv6wi9WU8vJyFovVuk4p24SysjJdXV0dHR1NN+QDIAhCIBAsXLiw4awPH7A2ZsSIEZ988slXX32l6Ya0NT179pw9e/akSZM03RBq4SEiQhTCgCFEoUav5ECkyZMn29nZaboVbdCcOXO8vLw03QrK4TkYQhTCQ0SEKIQBQ4hCGDCEKIQBQ2oVHx9PXs6q6YaoCXZyNOrmzZuGhobe3t6abkjbQRDEtGnTxGKxgYHBZ5991q9fv8YuQm8zGGvWrNF0G1qpsrKyH374wdHR0cLCQtNtaSNoNJpIJOJyuaNGjTp9+vTZs2f19fVtbW1pDX6P12a08b8f7+PVq1fGxsbbtm2LiYnRdFvajhEjRjx8+NDOzm779u0BAQE///zzvHnzbty40VYPGnEP1qhr16599dVXXbp02bJli729Pe7H3kdcXFxeXp5AINDR0RGJRLGxsVZWVv/5z38WLVrk6up65MiRixcv+vr66uvra7qlHxqBVImNjQ0KCoqOjtZ0Q7RYdHR0UFBQXFwcQRCvX78ODg6eOXOmfJNKJJJ///1Xow2kCu7BVBMIBJ06dcL92PuwsLCwt7ffsmWLk5OTjY1NWVkZh8P59NNPybl0Ol0oFGq2hRTBc7BGEQr9q507d166dGlaWprmmqP1vL29Fy1atGnTpvj4+MDAwH/++SczM1PTjaIc7sGUKy4u/v7773v27Mli1d7RTSAQuLq6arZV2iUuLm7//v0FBQV0Op3H49HpdPl+zNPTU09P7969e7169dJ0M6mFV9MrUVpaunbt2kmTJnE4HE23RYtJJJLY2NiSkpLbt29nZmY6OTm5u7t7eHiEhIRs2rRp9uzZXC5X022kHH7RrIRYLE5LS3NyctJ0Q7ReTEzMtm3bli1b1rFjx8TExISEhISEhJcvX9LpdJlMtmfPHnNzc023kVoYMEQtecY8PT3JEpFI9OTJk9evX/ft21ezbVMDDBiiXMOMtR/tMWA5OTnHjx9//vy5ra3tjBkzmrgT+NmzZ4cMGcJms9XZvDap3Was3XXTP3v2bOnSpdbW1jNnzuzatauhoWFOTo7SmuHh4cbGxpiuD0LeR5+Xl6fptqhV+9qDSaXSL7/8cubMmb6+vmTJsWPHTp06tWLFinpXzYeHhwsEgn79+mmglW1XdnZ2e/umvn3twZKTk9lstmK6oqOjv/322x9//FHxil5MF0XaW7qgvQWMTqfLLyeVSqXl5eXr1q3z9fV1d3ffvHkzmTFMF/qA2sUXzXFxcTQazdPT08rK6vnz5wUFBWZmZgwGY+bMmWQFAwODdevWsVgssVjs4ODg4+Oj2QajNqNd7MEkEgl5CZyhoeGYMWO2bNlSWVkpn1tSUvLs2TNHR0cHBwcdHR1MF/qA2sW1iIqXcvfr1+/ff/89evSovr4+m81OTEzctm3bZ5995uDgoOlmojaoHfUiKn4Vc+XKlatXr6anp1tYWAQFBeGNNxBF2mzA4uLizp496+7u7u7u3qlTJwaDAe34606kKW02YDExMRs2bLC1tSUIQvFS7vLy8t27d2PGkHq0wYAlJydHREQsXLgwNja2nV/KjTSurQUsLi6usrLy5MmTxsbGy5cvl2esfV7KjTSurXXTSySSXbt2jR07tqSk5Mcff+zSpYv8Z+pkBTab7eXlhelC6tHWuunJHvkdO3ZMnTo1Jibm4cOHY8eOdXBwIPvoBQKBphuI2pe2dohIInsL58+fX+9Y8eeff8bzLqRObSFgTfTIK2YsLy+vHV5sijSrLVyL2MTNVXbt2kVm7O7du71799Z0S1G7o917sNevX5N3Jmr65io7duywsrLSdGNRe6TFAYuLi9uxY8fu3bvJm6u185uroFZK7Tfr/jBiY2MnTZqUnJysWKh4A3SEWgOtDFjDdOXn55MTmDHUqmjfF80JCQk//vjjd999J78xaFhY2L59+8jpdntzFdQ6aV/ATE1N2Wx2VFQU+TAsLCwlJWXx4sXyCt7e3lu3bsXvu1BroE2dHPI+w+zs7BUrVvTv318sFqekpKxZs4a8uVplZeWff/45fvz4NjwkKdIuWrMHi4uLW7BgAflTfwsLi40bN16/fv3OnTuK6Vq9erVMJsN0odZDOwIWFxdHdsHLhzshMwYAx48fh7p0ffTRRxMmTNBkQxF6mxYcIpLpUuzVIG8LBXXHir17905MTMR0oVaote/Bmu4zJPdjt27dwnSh1qm1X4so7zMkA0b2GSr+xMbCwuKXX35pYgAHhDSo9QYsLS3t4MGD1dXVwcHBR44cAYDG+gwxXajVaqWHiHFxcatXr/bx8encufOBAwcWL16MfYZIG7XGgJG9GitXrgwICJgwYUKvXr3KysqwzxBpo1Z3iPj48eONGzeuW7dO3qtRVFR07tw5Ho+3cOHC7du3SyQS7DNE2qLV7cEEAgGXy7116xb58NixY0VFRcHBwebm5tu3b58xYwb2GSIt0hq/BysoKFixYkX37t05HE50dPS6devI75cvXLhw6NChWbNm+fv7a7qNCDVLawlYQUHB1atXa2pqevfubWtrS2asqqpq//798qs3AKCwsNDU1FSD7USoRVrFIeLTp08XLVpUXFwsFovDw8MJgjAzM9u4caOent6xY8cUa2K6kHbR/B5MLBbPnz9/7ty5Xbp0qTdLfqw4ffp0jbQNofek+T1YSkqKiYlJvXQ9evQoPDyc3I/dv39fcQBlhLSI5gNWU1NDp9dvBpfLPXHihEgkMjMz27FjB47fhbSU5gPm6ur67Nmz7OxsxUIHBwd9ff2srCwAUOzkQEi7aCZgUqn05cuXFRUVAKCjoxMUFLRp0ybyISkrK6u6uhpvZoi0nQY6OZKTk7dt28ZgMAoLCzdu3Ojo6EgQxM6dOxMTE6dNm+bu7p6RkbF3794RI0YMHjxYzW1D6MNSd8BycnJWr169ZMmSTp065ebmKg53cuPGjcjIyNTUVKFQOHHixI8//lidDUOICuoO2P79+62trQMCAsiHSUlJt27dsrW1HTBgAJPJBACCIPACedRmqPti39evX5MTWVlZhw8fjo2N7d69+7lz55KSkr766isAwHShtkTde7DHjx9///331tbW6enpw4YNCwoK4nA4JSUls2bNIn+KglBbou49mLu7++bNm1++fNm5c2fyxjUAUFFRYWJiouaWIKQGGrtUqqamRiaT6erqFhcXr127duzYsb169dJISxCijsZ+cHnhwoULFy44ODg8e/Zs/PjxmC7UJmnyYt/4+Pjy8nJHR0c+n6+pNiBEKc1fTY9QG6b5axERasMwYAhRCAOGEIUwYAhRCAOGEIUwYAhRCAOGEIUwYAhRCAOGEIX+H7yZx6/Fd3rbAAAAAElFTkSuQmCC" /><!-- --></p>
<pre><code>#&gt; 
#&gt; attr(,&quot;class&quot;)
#&gt; [1] &quot;gg_list&quot; &quot;list&quot;</code></pre>
<p>A new argument has been added to control the theme (e.g.Â setting the
angle of the axis); see an example below:</p>
<div class="sourceCode" id="cb116"><pre class="sourceCode r"><code class="sourceCode r"><span id="cb116-1"><a href="#cb116-1" tabindex="-1"></a>ggtheme <span class="ot">&lt;-</span> ggplot2<span class="sc">::</span><span class="fu">theme</span>(</span>
<span id="cb116-2"><a href="#cb116-2" tabindex="-1"></a>  <span class="at">panel.grid =</span> ggplot2<span class="sc">::</span><span class="fu">element_line</span>(<span class="at">colour =</span> <span class="st">&quot;black&quot;</span>, <span class="at">linetype =</span> <span class="dv">3</span>),</span>
<span id="cb116-3"><a href="#cb116-3" tabindex="-1"></a>  <span class="at">panel.background =</span> ggplot2<span class="sc">::</span><span class="fu">element_rect</span>(<span class="at">fill =</span> <span class="st">&quot;white&quot;</span>),</span>
<span id="cb116-4"><a href="#cb116-4" tabindex="-1"></a>  <span class="at">legend.position =</span> <span class="st">&quot;top&quot;</span>,</span>
<span id="cb116-5"><a href="#cb116-5" tabindex="-1"></a>  <span class="at">axis.text.x =</span> ggplot2<span class="sc">::</span><span class="fu">element_text</span>(<span class="at">angle =</span> <span class="dv">22</span>, <span class="at">hjust =</span> <span class="dv">1</span>, <span class="at">vjust =</span> <span class="dv">1</span>)</span>
<span id="cb116-6"><a href="#cb116-6" tabindex="-1"></a>)</span>
<span id="cb116-7"><a href="#cb116-7" tabindex="-1"></a><span class="fu">run</span>(mng01, syn_data, <span class="at">dataset =</span> <span class="st">&quot;adlb&quot;</span>, <span class="at">ggtheme =</span> ggtheme)</span>
<span id="cb116-8"><a href="#cb116-8" tabindex="-1"></a><span class="co">#&gt; $`Alanine Aminotransferase Measurement`</span></span></code></pre></div>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<pre><code>#&gt; 
#&gt; $`C-Reactive Protein Measurement`</code></pre>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<pre><code>#&gt; 
#&gt; $`Immunoglobulin A Measurement`</code></pre>
<p><img src="data:image/png;base64,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" /><!-- --></p>
<pre><code>#&gt; 
#&gt; attr(,&quot;class&quot;)
#&gt; [1] &quot;gg_list&quot; &quot;list&quot;</code></pre>
</div>
</div>
</div>



<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
